Download - Heart Failure Society of America

13th Annual 

Scientific Meeting 

2009 Program 

September 13 – 16, 2009 

Hynes Convention Center 

Boston, MA 

www.hfsa.org

Table of Contents 

President’s Message. ..................................... 2 

About the HFSA......................................... 3 

Society Officers and Council. .............................. 4 

Scientific Program Committee. ............................. 5 

Meeting Content ......................................... 5 

General Meeting Information ............................... 6 

Complimentary Food Events................................ 8 

2009 HFSA Satellite/Scientific Program Activity Supporters....... 9 

2009 HFSA Corporate Members............................. 9 

Liability Statement ....................................... 9 

CME Information ....................................... 10 

Disclosure Information ................................... 11 

Scientific Program Learning Objectives ...................... 11 

2009 Abstract Reviewers.................................. 12 

2009 HFSA Faculty...................................... 14 

Program-at-a-Glance..................................... 23 

September 13: (Sunday) 

Satellite Symposia..................................... 30 

Special Scientific Session............................... 34. 

Satellite Symposia..................................... 35 

September 14: (Monday) 

Morning Scientific Sessions ............................. 37 

Oral Abstract Session .................................. 44 

How-To Sessions...................................... 45 

Afternoon Scientific Sessions............................ 46 

Monday Posters....................................... 55 

September 15: (Tuesday) 

Morning Scientific Sessions ............................. 90 

Oral Abstract Session ................................. 102 

How-To Sessions..................................... 103 

Award Presentations .................................. 104 

Afternoon Scientific Sessions........................... 104 

Tuesday Posters ..................................... 111 

September 16: (Wednesday) 

Morning Scientific Sessions ............................ 144 

Exhibitors and Exhibit Floor Plan.......................... 154 

Clinical Trial Row...................................... 156 

Exhibitor Descriptions................................... 157 

Author Index.......................................... 169 

Hynes Convention Center Floor Plans. ..................... 210 

1

President’s Message 

On behalf of the Executive 

Council and the Program 

Committee of the Heart Failure 

Society of America it is my 

pleasure to welcome you to the 

13th Annual Scientific Meeting. 

The Program Committee has 

put together a very exciting 

lineup that should be of great 

interest to you in your clinical 

and research activities. 

The program has been carefully 

designed to provide state of the 

art information in the field of 

heart failure ranging from basic 

science to clinical practice. The 

program includes simultaneous symposia, how-to sessions, oral abstract 

sessions, debates, poster sessions, and late-breaking clinical trials, all 

to provide the latest insights and most informed reviews. Areas where 

there have been new advances and topics that are controversial are 

included in the program. Some of the sessions will focus on a benchto-bedside 

approach; it is our hope that you will choose to spend time 

in sessions out of your main areas of interest and benefit from this 

unique aspect of our meeting which offers a broad view of what is 

happening in heart failure. As what has now become a tradition, Hyde 

Park and Heart Failure Court of Appeals are making return visits. 

These two sessions give the audience an opportunity to sit back, relax, 

enjoy and laugh a little while the presenters provide novel insights into 

important issues in the care of heart failure patients. 

We evaluate our meeting’s success not only by the knowledge gained 

but also by the enjoyment that attendees have in gaining it. We hope 

you should find this year’s program rewarding in every sense of the 

word. As always we welcome and encourage your feedback on the 

program. 

I hope you will leave Boston energized, take home new ideas and 

insights, and plan to join us in San Diego for the next HFSA Annual 

Scientific Meeting. 

Douglas L. Mann, MD 

President 

Heart Failure Society of America 

2008-10 

About the HFSA 

The Heart Failure Society of America (HFSA) represents the first 

organized effort by heart failure experts from the Americas to provide 

a forum for all those interested in heart failure research and patient care. 

The HFSA is dedicated to: 

Promoting research related to all aspects of heart failure and to provide 

a forum for presentation of basic, clinical, and population-based research. 

Educating health care professionals through programs, publications 

and other media in the areas of basic science, clinical medicine, patient 

management, and social, ethical and economic issues to enable them to 

diagnose and treat heart failure and concomitant medical conditions more 

effectively. 

Encouraging primary and secondary preventive measures to reduce the 

incidence of heart failure; to serve as a resource for government, private 

industry, and health care providers to facilitate the establishment of 

programs and policies that will better serve the patient. 

Enhancing quality and duration of life in those with heart failure. 

Promoting and facilitating the formal training of physicians, scientists, 

and allied health care providers in the field of heart failure. 

Society Membership Information 

Membership in the Society is open to all health care professionals 

with an interest in cardiovascular medicine. For information about the 

HFSA or to become a member, call or write: 

Heart Failure Society of America, Inc. 

Court International 

Suite 240 South 

2550 University Avenue West 

St. Paul, MN 55114 

phone: 651-642-1633 

fax: 651-642-1502 

e-mail: info@hfsa.org 

Interested participants can also visit the HFSA exhibit booth (#2906) 

at this 13th Annual Scientific Meeting or visit the HFSA web site at 

www.hfsa.org. 

2 3

Officers: 

President: 

Vice-President: 

Secretary: 

Treasurer: 

Immediate Past President: 

Members: 

Ex Officio Members: 

Executive Council 


St. Louis, MO 

Barry M. Massie, MD 

San Francisco, CA 

Mariell L. Jessup, MD 

Philadelphia, PA 

Inder S. Anand, MD, PhD 

Minneapolis, MN 

Barry H. Greenberg, MD 

San Diego, CA 

J. Malcolm O. Arnold, MD 

London, ON, Canada 

John Chin, MD 

Sacramento, CA 

Thomas Force, MD 


JoAnn Lindenfeld, MD 

Denver, CO 

Mandeep R. Mehra, MD 

Baltimore, MD 

Mariann R. Piano, RN, PhD 

Chicago, IL 

Randall C. Starling, MD 

Cleveland, OH 

Clyde W. Yancy, MD 

Dallas, TX 

Michael R. Zile, MD 

Charlotte, SC 

Jay N. Cohn, MD 


Allen Farber, Esq 

Washington, DC 

Isabella Liang, PhD 

Bethesda, MD 

Alice M. Mascette, MD 

Bethesda, MD 

2009 Scientific Program Committee 

Walter J. Koch, PhD (co-chair) 

Christopher M. O’Connor, MD (co-chair) 


Burns C. Blaxall, PhD 

Blase A. Carabello, MD 

Horng H. Chen, MB, BCh 

Prakash C. Deedwania, MD 

Mark H. Drazner, MD 

Carla S. Dupree, MD, PhD 

James C. Fang, MD 

G. Michael Felker, MD 

Maureen P. Flattery, RN, NP 

Roger J. Hajjar, MD 

Joshua M. Hare, MD 

Tamara B. Horwich, MD 

David A. Kass, MD 



Sanjiv M. Narayan, PhD 

Myung H. Park, MD 

Soon J. Park, MD 

Howard A. Rockman, MD 

Joseph G. Rogers, MD 

Robert S. Ross, MD 

William C. Stanley, PhD 

David J. Whellan, MD, MHS 

Suzanne J. Wingate, RN, PhD 

Meeting Content: 

The 2009 HFSA Annual Scientific Meeting provides a forum for 

the open exchange and discussion of research results and scientific 

advancements in the field of heart failure; however HFSA makes no 

representation or warranty as to the truth, originality, or accuracy 

of the information presented. Nor are the views expressed by the 

individual speakers necessarily the views of HFSA. HFSA supports 

the ACCME’s policy on evidence-based content and encourages 

faculty to adhere to these standards when preparing a presentation. 

4 5

General Meeting Information 

Boston, MA 

All activities listed in this program book will take place at the Hynes 

Convention Center. See pages 210-211 for floor plans of meeting 

space. 

CME Accreditation/Registration 


Court International, Suite 240 South 



651-642-1633; fax: 651-642-1502 

Registration Hours 

Meeting Registration Desk, Hynes Convention Center (2nd floor). 

Saturday, September 12: 

9:00 AM-5:00 PM 

Sunday, September 13: 

8:00 AM-5:00 PM 

Monday, September 14: 

7:00 AM-5:00 PM 

Tuesday, September 15: 

7:00 AM-5:00 PM 

Wednesday, September 16: 

7:00 AM-10:00 AM 

What’s Included in Registration Fees 

The registration fee includes admittance to satellite programs, 

scientific sessions, poster sessions, commercial exhibits, and the 

Opening Reception. 

Scientific Meeting Evaluation 

There are two ways to complete the scientific meeting evaluation 

form: (1) complete the evaluation form found in your congress bag 

and return to the Registration Desk (Hynes Convention Center) ; OR 

(2) complete the form on-line after the meeting (attendees to be 

notified by e-mail with instructions). 

E-Mail From the Exhibit Floor (Booth #2522) 

During the meeting computers will be available in the Exhibit Hall for 

attendees to check their e-mail. Please note your e-mail account must be 

accessible through a web-based browser, e.g., Internet Explorer. 

No Smoking Policy 

HFSA prohibits smoking in all areas of the meeting and all hotel meeting 

rooms hosting HFSA functions. Thank you for your cooperation. 

Special Needs 

The HFSA strives to hold meetings that are accessible to all. 

Please tell us what you require to help make your participation 

more enjoyable and meaningful. Contact Gudrun Echterhoff, Global 

Meetings & Incentives at gudrun@global-mtgs.com (201-850-7607 / 

201-633-4708) 

Speaker Ready Room – Room 309 (Hynes Convention Center) 

Saturday, September 12 

1:00 PM-5:00 PM 

Sunday, September 13 

7:00 AM-6:00 PM 

Monday, September 14 

6:00 AM-6:00 PM 

Tuesday, September 15 

6:00 AM-6:00 PM 

Wednesday, September 16 

6:00 AM-NOON 

Press Room – Room 308 (Hynes Convention Center) 


8:00 AM-6:00 PM 


7:00 AM-6:00 PM 


7:00 AM-6:00 PM 


7:00 AM-NOON 

Exhibit Hall Dates and Hours 

Exhibits: The exhibits are located in Exhibit Hall D, Hynes 

Convention Center See page 155 for list of exhibitors and location. 





6:00 PM-8:00 PM 

9:00 AM-7:00 PM 

9:00 AM-7:00 PM 

CLOSED 

Clinical Trial Row: (Exhibit Hall) This provides an opportunity for 

attendees to learn more about ongoing clinical trials in heart failure. 

These boards have been rented by groups supporting clinical trials. 

The HFSA assumes no responsibility or liability for information posted 

about a clinical trial on these boards. 

Poster Sessions 

Poster Sessions will be held in the Exhibit Hall C (enter through 

Exhibit Hall D) as follows: 

Poster Display: 

Monday, September 14 and 

9:00 AM-7:00 PM 


Presenters at 

their Posters: 

5:45 PM-6:45 PM 

Annual Business Meeting: 

The Annual Business Meeting of the HFSA will be held on 

Wednesday, September 16, 8:15 AM, Room 306. 

Questions? 

Look for staff wearing golf shirts with the HFSA logo. 

6 7

General Meeting Information (continued) 

Complimentary Food Events 

The following complimentary food events will be offered. All food 

events, except as otherwise noted, will take place in Exhibit Hall D. 

SUNDAY, September 13 

Opening Reception (Buffet) 

MONDAY, September 14 

Continental Breakfast 

Meeting foyer area (3rd floor) 

Refreshment Break 


Poster Session and Reception 

(Wine & Hors d’oeuvres) 

6:00 PM-8:00 PM 

7:30 AM-8:30 AM 

10:00 AM-10:30 AM 

3:30 PM-4:00 PM 

5:30 PM-7:00 PM 

2009 HFSA Satellite/Scientific Program 

Activity Supporters 

Actelion Pharmaceuticals, Ltd. 

ARCA Biopharma, Inc. 

BG Medicine 

Biogen Idec 

Boston Scientific Corporation 

Forest Laboratories, Inc. 

Medtronic, Inc. 

Otsuka America Pharmaceuticals, Inc. 

XDx, Inc. 

Zoll Lifecor Corporation 

Trainee Travel Grants 

Funds to support trainee poster presenters have been provided by 

Otsuka America Pharmaceuticals, Inc. and Medtronic, Inc. 

TUESDAY, September 15 





Poster Session and Reception 

(Wine & Hors d’oeuvres) 

WEDNESDAY, September 16 





7:30 AM-8:30 AM 

10:00 AM-10:30 AM 

3:30 PM-4:00 PM 

5:30 PM-7:00 PM 

7:30 AM-8:30 AM 

10:00 AM-10:30 AM 

2009 HFSA Corporate Members 

AstraZeneca 


GlaxoSmithKline 


Merck & Co., Inc. 

Ortho-McNeil 

Otsuka America Pharmaceuticals, Inc. 

St. Jude Medical 

Liability Statement 

Disclaimer: The Heart Failure Society of America (HFSA) cannot 

accept, and hereby specifically disclaims, any liability for death, 

injury, any loss, cost or expense suffered or incurred by any person 

if such loss is caused by, arises from or results from the act, default 

or omission of any person other than an employee or agent of HFSA. 

In particular, neither HFSA nor its agents can accept, and hereby 

specifically disclaims, any liability for losses arising from, caused by, 

or resulting from, the provision or non-provision of services provided 

by the hotels, companies, or transport operators. Neither HFSA nor 

its agents can accept, and hereby specifically disclaims, liability for 

losses suffered by reason of war including threat of war, riots and 

civil strife, terrorist activity, natural disaster, weather, fire, flood, 

drought, technical, mechanical or electrical breakdown within any 

premises visited by delegates and/or participants in connection with 

the meeting, industrial disputes, government action, regulations or 

technical problems that affect or may affect the services provided in 

connection with the meeting. HFSA is not able to warrant and does 

not warrant that a particular person will appear as a speaker. As a 

condition to any participation in or attendance at the Annual Scientific 

Meeting or any function associated or affiliated herewith, each 

attendee and participant accepts the foregoing disclaimer. 

8 9

CREDIT STATEMENTS 

Scientific Program and 

Special Sunday Scientific Session 

Physicians: The Heart Failure Society of America is accredited by the 

Accreditation Council for Continuing Medical Education to provide 

continuing medical education for physicians. 

The Heart Failure Society of America designates the Scientific 

Program for a maximum of 19 AMA PRA Category 1 Credits 

and the Sunday Excellence in Basic Science Session for a maximum 

of 2.75 AMA PRA Category 1 Credits. Physicians should only claim 

credit commensurate with the extent of their participation 

in the activity. 

Nurses: This program has been approved by the American Association 

of Critical Care Nurses (AACN) for 19 contact hours, Category CERP, 

File number 00015340. 

Satellite Symposia 

September 13 (Sunday) 

Physicians: The Heart Failure Society of America (HFSA) is 

accredited by the Accreditation Council for Continuing Medical 

Education to provide continuing medical education for physicians. 

The HFSA designates each satellite program as an educational activity 

for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians 

should only claim credit commensurate with the extent of their 

participation in each program. 

Nurses: This program has been designed to meet Minnesota Board of 

Nursing continuing education requirements and is acceptable for 2.0 

contact hours of continuing education. 

CME Certificates Available On-Site 

CME certificates (scientific and satellite sessions) for physicians 

and nurses will be available on-site. Please visit CME kiosks in 

registration area to print your CME certificate(s). 

All main entrances to meeting rooms for the scientific sessions 

and the satellite programs will be “gated” to capture attendee 

information. This is the only information that will be used to 

verify attendance for credit certificates. Please make sure you 

enter each session through a gated entrance. 

Presenter Disclosure Information 

The Heart Failure Society of America has a disclosure policy that 

requires oral presenters to disclose whether or not they have relevant 

financial relationships with any commercial interest and whether or 

not off-label or investigational drug/device use will be discussed. 

It is not assumed that these financial relationships will have an 

adverse impact on oral and poster presentations. They are provided 

to fully inform meeting participants. 

Oral Presenters: 

To comply with this policy each oral presenter has been asked to 

include a disclosure slide as the first slide of his/her presentation. 

The slide is intended to disclose to the attendees any relevant financial 

relationship with pharmaceutical companies, biomedical device 

manufacturers, or other corporations whose products or services are 

related to the subject matter being presented. The slide should also 

indicate whether or not off-label or investigational drug/device use 

will be discussed. Each speaker is expected to address the slide. 

All presenter disclosure information received is listed in the HFSA 

Presenter/Author Disclosure Booklet. A booklet is in each meeting 

congress bag. 

Poster Presenters: 

To comply with this policy, poster presenters are also listed in the 

HFSA Presenter/Author Disclosure Booklet. Listings will include 

relevant financial relationships with pharmaceutical companies, 

biomedical device manufacturers, or other corporations whose 

products or services are related to the subject matter 

being presented. 

Scientific Program Learning Objectives 

Following this meeting, participants will be able to: 

1. Describe the epidemiology of heart failure including 

environmental factors and implement strategies for the 

prevention of heart failure. 

2. Describe current knowledge about the scientific basis of heart 

failure at the levels of cardiovascular physiology, neurohormones, 

tissue factors, and molecular biology and genetics. 

3. Implement optimal therapeutic options for heart failure, including 

pharmacologic agents, diet and exercise, surgery, and devices. 

4. Demonstrate awareness of psychosocial, economic and ethical 

issues in the treatment of patients with heart failure. 

5. Implement strategies for effective management of the patient with 

heart failure. 

6. Identify the findings of basic science and current clinical trials and 

their implications for current and future heart failure therapy. 

10 11

Nancy M. Albert, RN, PhD 

Cleveland, OH 





Linda S. Baas, RN, PhD 

Cincinnati, OH 


West Henrietta, NY 

Cheryl A. Westlake Canary, RN, PhD 

San Clemente, CA 


Rochester, MN 


Fresno, CA 

Teresa DeMarco, MD 


David DeNofrio, MD 

Boston, MA 


Dallas, TX 

Mark E. Dunlap, MD 

Cleveland, OH 


Cleveland, OH 

David S. Feldman, MD, PhD 



Durham, NC 

Maureen P. Flattery, RN, NP 

Richmond, VA 

Gregg C. Fonarow, MD 

Los Angeles, CA 

Marie Galvao, RN, MSN 

Bronx, NY 

Jalal K. Ghali, MD 

Detroit, MI 

A. Martin Gerdes, PhD 

Sioux Falls, SD 

Michael M. Givertz, MD 

Boston, MA 

Steven Goldman, MD 

Tucson, AZ 

2009 Abstract Reviewers 

Stephen S. Gottlieb, MD 

Baltimore, MD 


New York, NY 

Paul J. Hauptman, MD 

St. Louis, MO 

Edward P. Havranek, MD 

Denver, CO 

Paul A. Heidenreich, MD 

Palo Alto, CA 

Adrian F. Hernandez, MD 

Durham, NC 

Ray E. Hershberger, MD 

Miami, FL 



Steven R. Houser, PhD 


Sharon A. Hunt, MD 

Stanford, CA 



Walter J. Koch, PhD 


Marvin W. Kronenberg, MD 

Nashville, TN 

David E. Lanfear, MD 

Detroit, MI 

Carl V. Leier, MD 

Columbus, OH 

Wayne C. Levy, MD 

Seattle, WA 

Ronglih Liao, PhD 

Boston, MA 


Denver, CO 

Kenneth B. Margulies, MD 




Alan B. Miller, MD 

Jacksonville, FL 

Judith E. Mitchell, MD 

New York, NY 

John B. O’Connell, MD 

Atlanta, GA 

Christopher M. O’Connor, MD 

Durham, NC 


Baltimore, MD 


Rochester, MN 

J. Herbert Patterson, PharmD 

Chapel Hill, NC 

Ileana L. Piña, MD 

Cleveland, OH 

Thomas S. Rector, PhD 


Margaret M. Redfield, MD 

Rochester, MN 

Barbara J. Riegel, RN, DNSc 



Durham, NC 


San Diego, CA 

Hani N. Sabbah, PhD 

Detroit, MI 

Douglas B. Sawyer, MD, PhD 

Nashville, TN 

Leslie A. Saxon, MD 


Douglas D. Schocken, MD 

Durham, NC 

Marc A. Silver, MD 

Oak Lawn, IL 

John A. Spertus, MD, MPH 

Kansas City, MO 

Francis G. Spinale, MD 

Charleston, SC 


Baltimore, MD 

William G. Stevenson, MD 

Boston, MA 

W.H. Wilson Tang, MD 

Cleveland, OH 

Patricia A. Uber, PharmD 

Baltimore, MD 

Eric J. Velazquez, MD 

Durham, NC 

Hector O. Ventura, MD 

New Orleans, LA 

Mary N. Walsh, MD 

Indianapolis, IN 

Yibin Wang, PhD 


David J. Whellan, MD 



Silver Spring, MD 



12 13

2009 HFSA Faculty 

13th Annual Scientific Meeting 

Keith D. Aaronson, MD 

University of Michigan 

Ann Arbor, MI 

William T. Abraham, MD 

The Ohio State University 

Columbus, OH 

Kirkwood F. Adams, Jr., MD 

The University of North Carolina 


Patricia A. Adams, BSN 

Duke University 


Philip B. Adamson, MD 

Oklahoma Heart Hospital 

Oklahoma City, OK 

Nancy M. Albert, RN, PhD 

Cleveland Clinic Foundation 

Cleveland, OH 

Larry A. Allen, MD, MHS 

University of Colorado 

Denver, CO 


University of Minnesota 


Stefan D. Anker, MD, PhD 

Charité Hospital 

Berlin, Germany 

Piero Anversa, MD 

Brigham and Women’s Hospital 

Boston, MA 


London Health Sciences Center 


Euan A. Ashley, MD, PhD 

Stanford University 

Stanford, CA 

Alan J. Bank, MD 

St. Paul Heart Clinic 

St. Paul, MN 

Kenneth L. Baughman, MD 


Boston, MA 

Nanette H. Bishopric, MD 

University of Miami 

Miami, FL 


University of Rochester 

Rochester, NY 

John P. Boehmer, MD 

Penn State University 

Hershey, PA 

Roberto Bolli, MD 

University of Louisville 

Louisville, KY 

Robert C. Bourge, MD 

University of Alabama 

Birmingham, AL 

Charles R. Bridges, Jr., MD, ScD 

University of Pennsylvania 


Michael R. Bristow, MD, PhD 


Denver, CO 

Joan Heller Brown, PhD 

University of California, San Diego 

La Jolla, CA 

John C. Burnett, Jr., MD 

Mayo Clinic & Foundation 

Rochester, MN 

Javed Butler, MD, MPH 

Emory University 

Atlanta, GA 

Atul J. Butte, MD, PhD 


Stanford, CA 

Robert M. Califf, MD 


Durham, NC 

Cheryl A. Westlake Canary, RN, PhD 

Cal State University, Fullerton 

San Clemente, CA 

Thomas P. Cappola, MD, ScM 



Blase A. Carabello, MD 

Baylor College 

Houston, TX 

Peter E. Carson, MD 

Washington VAMC 


Alessandro Cataliotti, MD 


Rochester, MN 

Hunter C. Champion, MD, PhD 

University of Pittsburgh 

Pittsburgh, PA 

Margaret P. Chandler, PhD 

Case Western Reserve University 

Cleveland, OH 

Patricia P. Chang, MD, MHS 

University of North Carolina 


Sandra V. Chaparro, MD 


Miami, FL 

Kanu Chatterjee, MB 

University of Iowa 

Iowa City, IA 

Hina W. Chaudhry, MD 

Mount Sinai School of Medicine 

New York, NY 



Rochester, MN 

Ming Hui Chen, MD, MMSc 

Children’s Hospital of Boston 

Boston, MA 

John G.F. Cleland, MD 

University of Hull 

Kingston-upon-Hull, UK 

Robert J. Cody, MD, MBA 

Merck & Co., Inc. 

Whitehouse Station, NJ 

Jay N. Cohn, MD 



Wilson S. Colucci, MD 

Boston University 

Boston, MA 

Maria Rosa Costanzo, MD 

Midwest Heart Specialists 

Naperville, IL 

James P. Daubert, MD 


Durham, NC 


VA Central California 

Health Care System 

Fresno, CA 

14 15 

Frederica del Monte, MD, PhD 

Beth Israel Deaconess 

Medical Center 

Boston, MA 

Anita Deswal, MD, MPH 

Baylor University 

Houston, TX 

Kenneth Dickstein, MD, PhD 

University of Bergen 

Stavanger, Norway 

Erin K. Donaho, RN, BSN 

St. Luke’s Episcopal Hospital 

Houston, TX 

Gerald W. Dorn, II, MD 

Washington University 

St. Louis, MO 

Kathleen Dracup, RN, DNSc 

University of California, 

San Francisco 



University of Texas Southwestern 

Dallas, TX 

David E. Duncan 

University of Berkeley 

Berkeley, CA 

Mark E. Dunlap, MD 

MetroHealth Medical Center 

Cleveland, OH 

Carla S. Dupree, MD, PhD 



Andrea Eckhart, PhD 

Thomas Jefferson University 


Uri Elkayam, MD 

University of Southern California 


Justin A. Ezekowitz, MBBCh 

University of Alberta 

Edmonton, AB, Canada 



Cleveland, OH 

Arthur M. Feldman, MD, PhD 



David S. Feldman, MD, PhD 

Minneapolis Heart Institute 

Minneapolis, MN



Durham, NC 

Maureen P. Flattery, RN, MS, NP 

Virginia Commonwealth 

University 

Richmond, VA 

Gregg C. Fonarow, MD 

UCLA 


Thomas Force, MD 



Paul R. Forfia, MD 



Gary S. Francis, MD 



Robert P. Frantz, MD 


Rochester, MN 

William H. Gaasch, MD 

Lahey Clinic 

Burlington, MA 

Julius M. Gardin, MD 

Hackensack University 

Hackensack, NJ 

Jalal K. Ghali, MD 

Detroit University Hospital 

Detroit, MI 

Mihai Gheorghiade, MD 

Northwestern University 

Chicago, IL 

Michael M. Givertz, MD 


Boston, MA 

Steven Goldman, MD 

VA Medical Center 

Tucson, AZ 

Steven R. Goldsmith, MD 

Hennepin County Medical Center 


Sidney Goldstein, MD 

Henry Ford Hospital 

Detroit, MI 

Sarah J. Goodlin, MD 

Patient Centered Research 

& Education 

Salt Lake City, UT 

John Gorcsan, III, MD 



Stephen S. Gottlieb, MD 

University of Maryland 

Baltimore, MD 

Alan H. Gradman, MD 

The Western Pennsylvania Hospital 


Barry H. Greenberg, MD 


San Diego, CA 



New York, NY 

Jennifer L. Hall, PhD 



H. Kirk Hammond, MD 


La Jolla, CA 

Eileen Handberg, ARNP, PhD 

University of Florida 

Gainesville, FL 

Joshua M. Hare, MD 


Miami, FL 

Robert A. Harrington, MD 


Durham, NC 

Paul J. Hauptman, MD 

St. Louis University 

St. Louis, MO 

Paul A. Heidenreich, MD 

VA/Stanford University 

Palo Alto, CA 

John F. Heitner, MD 

New York Methodist Hospital 

Brooklyn, NY 

Adrian F. Hernandez, MD 


Durham, NC 

Ray E. Hershberger, MD 


Miami, FL 

J. Thomas Heywood, MD 

Scripps Clinic 

La Jolla, CA 

James A. Hill, MD 


Gainesville, FL 


UCLA 


Steven R. Houser, PhD 

Temple University 


Jonathan G. Howlett, MD 

University of Calgary 

Calgary, AB, Canada 

Sharon A. Hunt, MD 


Stanford, CA 

James L. Januzzi, Jr., MD 

Massachusetts General Hospital 

Boston, MA 

Michael Jerosch-Herold, PhD 

Brigham & Women’s Hospital 

Boston, MA 




Daniel P. Judge, MD 

Johns Hopkins University 

Baltimore, MD 

Jan Kajstura, PhD 


Boston, MA 

Abraham M. Karkowsky, MD 

Food and Drug Administration 


David A. Kass, MD 


Baltimore, MD 

Sekar Kathiresan, MD 


Boston, MA 

Arnold M. Katz, MD 

Dartmouth University 

Norwich, VT 

Daniel P. Kelly, MD 

Burnham Institute for 

Medical Research 

Orlando, FL 

Raymond J. Kim, MD 


Durham, NC 

James K. Kirklin, MD 

University of Alabama 


Dalane W. Kitzman, MD 

Wake Forest University 

Winston-Salem, NC 

Walter J. Koch, PhD 



Todd M. Koelling, MD 


Ann Arbor, MI 

Marvin A. Konstam, MD 

Tufts Medical Center 

Boston, MA 

Harlan M. Krumholz, MD 

Yale University 

New Haven, CT 

David E. Lanfear, MD 

Henry Ford Hospital 

Detroit, MI 

Ann S. Laramee, APRN, MS 

Fletcher Allen Health Care 

Burlington, VT 

Richard T. Lee, MD 


Boston, MA 

Carl V. Leier, MD 


Columbus, OH 

Leslie A. Leinwand, PhD 


Boulder, CO 

Daniel J. Lenihan, MD 

Vanderbilt University 

Nashville, TN 

Terry A. Lennie, RN, MS, PhD 

University of Kentucky 

Lexington, KY 

Annarosa Leri, MD 


Boston, MA 

Daniel Levy, MD 

Framingham Heart Study-NHLBI 

Framingham, MA 

16 17

Wayne C. Levy, MD 

University of Washington 

Seattle, WA 

Eldrin F. Lewis, MD 


Boston, MA 

Ronglih Liao, PhD 


Boston, MA 

Stephen B. Liggett, MD 


Baltimore, MD 

Grace Lin, MD 


Rochester, MN 



Denver, CO 

William C. Little, MD 

Wake Forest University 


Peter P. Liu, MD 

University of Toronto 

Toronto, ON, Canada 

Alan S. Maisel, MD 

VAMC San Diego 

La Jolla, CA 

Michael L. Maitland, MD, PhD 

University of Chicago 

Chicago, IL 

Donna M. Mancini, MD 

Columbia University 

New York, NY 



St. Louis, MO 

Kenneth B. Margulies, MD 





San Francisco 


Paul J. Mather, MD 



Michael A. Mathier, MD 



Mathew S. Maurer, MD 

Columbia University 

New York, NY 

Patrick M. McCarthy, MD 


Chicago, IL 

John J.V. McMurray, MD 

Western Infirmary 

Glasgow, Scotland, UK 

Elizabeth M. McNally, MD, PhD 

University of Chicago 

Chicago, IL 

Dennis M. McNamara, MD 





Baltimore, MD 

Carmelo A. Milano, MD 


Durham, NC 

Alan B. Miller, MD 



Leslie W. Miller, MD 

Georgetown and Washington 

Hospital Center 


Jeffery D. Molkentin, PhD 

Cincinnati Children’s Hospital 



Ana I. Morales Reyes, MS, CGC 


Miami, FL 

Debra K. Moser, RN, DNSc 

University of Kentucky 

Lexington, KY 

Patrick Most, MD 



Matthew A. Movsesian, MD 

VA Salt Lake City 

Health Care System 

Salt Lake City, UT 

Dariush Mozaffarian, MD, DrPH 


Boston, MA 

Elizabeth Murphy, PhD 

NHLBI-NIH 

Bethesda, MD 

Anthony J. Muslin, MD 


St. Louis, MO 

Sanjiv M. Narayan, MD, PhD 

VAMC San Diego 

San Diego, CA 

Anju Nohria, MD 


Boston, MA 

Christopher M. O’Connor, MD 


Durham, NC 

Eric N. Olson, PhD 


Dallas, TX 

Brian O’Rourke, PhD 


Baltimore, MD 

Milton Packer, MD 


Dallas, TX 

Peter S. Pang, MD 


Chicago, IL 



Baltimore, MD 



Rochester, MN 

J. Herbert Patterson, PharmD 



Sara C. Paul, RN, MSN, FNP 

Western Piedmont Heart Centers 

Hickory, NC 

Marc A. Pfeffer, MD, PhD 

Brigham & Women’s Hospital 

Boston, MA 

Mariann R. Piano, RN, PhD 

University of Illinois 

Chicago, IL 

Ileana L. Piña, MD 


Cleveland, OH 

Peipei Ping, PhD 

UCLA 


Bertram Pitt, MD 


Ann Arbor, MI 

J. David Port, PhD 


Denver, CO 

Susan J. Pressler, RN, DNS 


Ann Arbor, MI 

Joseph Rabinowitz, PhD 



Kismet D. Rasmusson, RN, FNP 

Intermountain Medical Center 

Murray, UT 

Vivek Y. Reddy, MD 


New York, NY 

Margaret M. Redfield, MD 


Rochester, MN 

Michael W. Rich, MD 


St. Louis, MO 

Jeffrey Robbins, PhD 

Cincinnati Children’s Hospital 



Howard A. Rockman, MD 


Durham, NC 

Jo Ellen Rodgers, PharmD 





Durham, NC 

Anthony Rosenzweig, MD 

Harvard University 

Boston, MA 


VA Healthcare San Diego 

San Diego, CA 

Sharon Rubin, MD 



18 19

Stuart D. Russell, MD 


Baltimore, MD 

Mary Ryder, RN 

St. Vincent’s University Hospital 

Dublin, Ireland 

Hani N. Sabbah, PhD 

Henry Ford Health System 

Detroit, MI 

Junichi Sadoshima, PhD, MD 

UMDNJ 

Newark, NJ 

Douglas B. Sawyer, MD, PhD 

Vanderbilt University 

Nashville, TN 

Leslie A. Saxon, MD 

University of Southern California 


Douglas D. Schocken, MD 


Durham, NC 

Robert W. Schrier, MD 


Denver, CO 

David A. Schwartz, MD 

National Jewish Health 

Denver, CO 

Marc J. Semigran, MD 


Boston, MA 

Shey-Shing Sheu, PhD 


Rochester, NY 

Marc A. Silver, MD 

Advocate Christ Medical Center 

Oak Lawn, IL 

Mark S. Slaughter, MD 

University of Louisville 


Oliver Smithies, DPhil 



Scott D. Solomon, MD 


Boston, MA 

John A. Spertus, MD, MPH 

Mid America Heart Institute 


Francis G. Spinale, MD 

Medical University of 

South Carolina 


Deepak Srivastava, MD 


San Francisco 


Jonathan Stamler, MD 


Durham, NC 



Baltimore, MD 

Randall C. Starling, MD, MPH 


Cleveland, OH 

Charles J. Steenbergen, MD, PhD 


Baltimore, MD 

Richard M. Steingart, MD 

Memorial Sloan-Kettering 

Cancer Center 

New York, NY 

Lynne Warner Stevenson, MD 


Boston, MA 

William G. Stevenson, MD 


Boston, MA 

Devika Subramanian, PhD 

Rice University 

Houston, TX 

Mark D. Sullivan, MD, PhD 


Seattle, WA 

Benjamin C. Sun, MD 


Columbus, OH 

Mark A. Sussman, PhD 

San Diego State University 

San Diego, CA 

Karl Swedberg, MD, PhD 

Sahlgrenska University 

Gothenburg, Sweden 

Nancy K. Sweitzer, MD, PhD 

University of Wisconsin 

Madison, WI 

W.H. Wilson Tang, MD 


Cleveland, OH 

John R. Teerlink, MD 

San Francisco VAMC 


Rong Tian, PhD, MD 


Seattle, WA 

Kathleen H. Toto, RN, NP 

Parkland Hospital 

Dallas, TX 

Patricia A. Uber, PharmD 


Baltimore, MD 

James E. Udelson, MD 

Tufts Medical Center 

Boston, MA 

Rutger J. van Bommel, MD 

Leiden University 

Leiden, The Netherlands 

Eva van Rooij, PhD 

miRagen Therapeutics 

Boulder, CO 

David R. Van Wagoner, PhD 


Cleveland, OH 

Eric J. Velazquez, MD 


Durham, NC 

Hector O. Ventura, MD 

Ochsner Medical Center 

New Orleans, LA 

Mary N. Walsh, MD 

St. Vincent Heart Center 

Indianapolis, IN 

Andrew Wang, MD 


Durham, NC 

Yibin Wang, PhD 

UCLA 


Laura F. Wexler, MD 

University of Cincinnati 


David J. Whellan, MD, MHS 



Bruce L. Wilkoff, MD 


Cleveland, OH 

Mark A. Winchester, MD 


Durham, NC 


Kaiser Permanente 

Mid-Atlantic States 


Matthew J. Wolf, MD, PhD 


Durham, NC 

Joseph Wu, MD 


Stanford, CA 

Sean M. Wu, MD, PhD 


Boston, MA 

Chen Yan, PhD 


Rochester, NY 

Clyde W. Yancy, MD 

Baylor University Medical Center 

Dallas, TX 

James B. Young, MD 


Cleveland, OH 


Medical University of 

South Carolina 


20 

21

Sunday-September 13, 2009 HFSA 13th Annual Scientific Meeting – September 13-16, 2009 – Boston, MA 

Ballroom A Ballroom B Ballroom C 302 304 312 

10:00 AM-NOON Satellite Symposium 

Understanding 

Pulmonary 

Hypertension: 

Tips for the Heart 

Failure Cardiologist 

NOON-1:00 PM 

1:00-3:00 PM Satellite Symposium 

Cardiac Resynchronization 

Therapy to 

Improve Outcomes 

in Heart Failure: 

Evidence, Guidelines, 

Challenges, and New 

Opportunities 

3:00-4:00 PM 

4:00-6:00 PM Satellite Symposium 

Mechanical 

Dyssynchrony in Heart 

Failure and Cardiac 

Resynchronization 

Therapy (CRT) 

6:00 PM Opening Reception 13 th Annual Scientific Meeting - Exhibit Hall D 

Satellite Symposium 

The Evolving Role of 

Remodeling, Fibrosis, 

and Biomarkers in the 

Continuum of Heart 

Failure 


Consensus or 

Contentious: 

Navigating 

Antihypertensive 

Therapy in Heart 

Failure with Preserved 

Ejection Fraction (EF) 


Acute Decompensated 

Heart Failure: It’s All 

About the Kidney 

Special Scientific Session 

Excellence in Basic 

Science (featured 

speaker: Oliver 

Smithies, DPhil) 

3:15 - 6:00 PM 

22 23

Monday-September 14, 2009 HFSA 13th Annual Scientific Meeting – September 13-16, 2009 – Boston, MA 


7:30 AM Continental Breakfast available in foyer areas 

8:00 AM Welcome/Opening Remarks, 

2009 HFSA Lifetime Achievement Award, 

JCF Editor-in-Chief presentation 

8:30 AM Opening Plenary Session 

Personalized Medicine: The Dawn of a New Era 

10:00 AM Coffee Break – Exhibit Hall Opens at 9:00 AM; see page 38 for Monday Posters; visit posters until 7:00 PM 

10:30 AM Late Breaking 

Clinical Trials I 

Symposium 

Heart Failure 

Guidelines: 2009 

Updates 

Nursing Investigator 

Award Session 

JNC New Investigator 

Clinical/Integrative 

Physiology Session 

JNC New Investigator 

Basic Science Session 

Monday-September 14, 2009 HFSA 13th Annual Scientific Meeting – September 13-16, 2009 – Boston, MA 


NOON Lunch Break – Exhibit Hall Opens at 9:00 AM; see page 38 for Monday Posters; visit posters until 7:00 PM 

12:30-1:30 PM Oral Abstract Session 

Leading Translational 

Research 

How To Sessions (6) See page 45 for locations 

2:00 PM Symposium 

Addressing 

Arrhythmias in 


Symposium 

Managing Congestion 

in Advanced 

Decompensated Heart 


Symposium 

State of the Art 

Cardiac Regeneration: 

From Cell to Patient 

3:30 PM Coffee Break – Exhibit Hall Opens at 9:00 AM; see page 38 for Monday Posters; visit posters until 7:00 PM 

4:00 PM HF Court of Appeals 

(1) Statins are Required 

for all Patients with HF 

and CAD; (2) Exercise 

Training is a Required 

Recommendation for 

All HF Patients 

Symposium 

Translation in Heart 

Failure Genomics 

5:30 PM Wine and Hors d’oeuvres in Poster Area Exhibit Hall C (presenters at their posters 5:45-6:45 PM) 

7:00 PM Exhibits Close (Exhibit Hall re-opens Tuesday 9:00 AM-7:00 PM) 

Symposium 

Novel Biomarkers in 


Symposium 

Myocardial 

Extracellular Matrix 

(ECM): Importance in 

Disease, Diagnosis & 

Management 

Symposium 

Emerging Concepts 

for microRNA in the 

Failing Heart 

Symposium 

Cardiac Mitochondria 

in Heart Failure 

24 

25

Tuesday-September 15, 2009 HFSA 13th Annual Scientific Meeting – September 13-16, 2009 – Boston, MA 



8:30 AM Symposium 

Evolving Therapies for 

Acute Decompensated 

Heart Failure (ADHF): 

How to Develop a 

New Drug 

Symposium 

What Every HF 

Specialist Should 

Know about the 

Explosion of Cancer 

Therapies 

Symposium 

Clinical Research at a 

Cross Roads 

10:00 AM Coffee Break – Exhibit Hall Opens at 9:00 AM; see page 95 for Tuesday Posters; visit posters until 7:00 PM 

10:30 AM Case Discussion Symposium 

Teaching Patients with 

Heart Failure: What 

We Know and What 

We Need to Learn 

Symposium 

Mechanical Cardiac 

Support in 2009 

Symposium 

Serial Monitoring of 

Patients with Heart 


Symposium 

Gender Issues in 

Cardiac Biology and 

Heart Failure Therapy 

Symposium 

Molecular Therapies 

for Heart Failure 

Symposium 

Intracellular 

Chaos in Failing 

Cardiomyocytes 

Tuesday-September 15, 2009 HFSA 13th Annual Scientific Meeting – September 13-16, 2009 – Boston, MA 


NOON Lunch Break – Exhibit Hall Opens at 9:00 AM; see page 95 for Tuesday Posters; visit posters until 7:00 PM 

12:30-1:30 PM Oral Abstract Session 

Leading Clinical 

Research 

How To Sessions (6) See page 103 for locations 

1:45 PM Announcement of 

Awards 

2:00 PM Hyde Park Session Symposium 

Latest Developments 

on Cardiac Repair 

With Stem Cells 

3:30 PM Coffee Break – Exhibit Hall Opens at 9:00 AM; see page 95 for Tuesday Posters; visit posters until 7:00 PM 

4:00 PM Debate session 

(1) Pivatol Clinical 

Trials Should only 

be done in North 

America; (2) Clinical 

Trials Should be 

Conducted in Targeted 

Populations 

Symposium 

Assessing Prognosis in 

Heart Failure Patients: 

Should We Care? 

5:30 PM Wine and Hors d’oeuvres in Poster Area Exhibit Hall C (presenters at their posters 5:45-6:45 PM) 

7:00 PM Exhibits Close 

Symposium 

What to Do when 

Patients Get Better? 

Symposium 

cGMP in HF: 

Pathophysiology and 

Novel Therapeutics 

Symposium 

Can Signaling 

Pathways be Used to 

Guide Therapeutic 

Advancement in 

Heart Failure? 

26 

27

Wednesday-September 16, 2009 HFSA 13th Annual Scientific Meeting – September 13-16, 2009 – Boston, MA 

Ballroom A 302 304 306 311 


8:15 AM HFSA Business 

Meeting 


The Continuum of 

Care: From ED to 

Hospital to Home 

10:00 AM Coffee Break in meeting foyer areas 

Late Breaking Clinical 

Trials II 


Insights from Recent 

Trials and Registries 

Symposium 

Putting Heart Failure 

on the Map through 

Education 

Symposium 

ADHF as a Non- 

Cardiac Disorder 

Symposium 

The Forgotten Right 

Ventricle (RV) 

and Pulmonary 

Hypertension (PH) 

Symposium 

Valvular Heart Disease 

and Heart Failure 

12:00 PM Scientific Meeting adjourned. 14 th Annual Scientific Meeting: September 12-15, 2010, San Diego, CA 

Symposium 

Assessment and 

Management 

Symposium 

Polyunsaturated 

Fatty Acids and 


28

Welcome to the 

13th Annual 


September 13 – 16, 2009 

Hynes Convention Center 

Boston, MA 

www.hfsa.org 

29

Sept. 13 

Sunday 

AM 

SATELLITE SYMPOSIUM 


10:00 AM-NOON 

Room 302 



10:00 AM-NOON 

Room 304 

Sept. 13 

Sunday 

AM 

sunday 

Understanding Pulmonary Hypertension: 

Tips for the Heart Failure Cardiologist 

The Evolving Role of Remodeling, Fibrosis, and 

Biomarkers in the Continuum of Heart Failure 

Sunday 

Chair: 

Michael A. Mathier, Pittsburgh, PA 

Chair: 

Barry M. Massie, San Francisco, CA 

10:00 Welcome and Introduction 


10:10 Pulmonary Hypertension vs. Heart Failure: 

Is this Heart Failure Left- or Right-Sided? 

Milton Packer, Dallas, TX 

Learning Objective: Distinguish current and emerging 

treatment strategies for patients with pulmonary arterial 

hypertension (PAH) and left heart failure. 

10:30 Questions and Answers 

10:35 Echo versus Cath: Separating the Right from the Left 

Paul R. Forfia, Philadelphia, PA 

Learning Objective: Describe the history of PAH and the 

use of tools such as Echo and catheterization to effectively 

screen and diagnose patients with PAH. 


11:00 Management of PAH: Similarities and Differences with 

Heart Failure Care 


Learning Objective: Describe the similarities and differences 

between managing heart failure and managing PAH. 


11:25 New Patient Population Research and Treatment 

Strategies for Pulmonary Hypertension 

Myung H. Park, Baltimore, MD 

Learning Objective: Identify new populations at risk for 

PAH and describe potential management issues. 

10:00 Welcome and Overview 


10:10 Myocardial Remodeling and Heart Failure: 

What We Now Know 

Scott D. Solomon, Boston, MA 

Learning Objective: Outline the processes involved in the 

progression of myocardial remodeling in heart failure. 

10:30 The Evolution of Biomarkers in Heart Failure: 

Focus on Remodeling and Fibrosis 

Jay N. Cohn, Minneapolis, MN 

Learning Objective: Descibe how the use of biomarkers has 

evolved in diagnosis and management of heart failure. 

10:50 Using Biomarkers for Risk Assesment, Patient 

Management, and Facilitation of Therapeutic 

Intervention Remodeling in Heart Failure: 

Current Practices, Future Potential 

James L. Januzzi, Jr., Boston, MA 

Learning Objective: Identify biomarkers commonly 

used, and new biomarkers with potential for use in risk 

assessment, patient management, and facilitation of 

therapeutic intervention in heart failure patients with 

remodeling. 

11:20 Panel Discussion/Audience Questions & Answers 

Faculty 

11:50 Closing Remarks 


Supported by an educational grant from BG Medicine 


11:50 Panel Discussion 

Supported by an educational grant from Actelion 

This program is not part of the scientific program 

as planned by the HFSA Scientific Program 

Committee. 

30 



Committee. 

31

Sept. 13 

Sunday 

PM 



1:00-3:00 PM 

Room 302 



1:00-3:00 PM 

Room 304 

Sept. 13 

Sunday 

PM 

sunday 

Cardiac Resynchronization Therapy to 

Improve Outcomes In Heart Failure: Evidence, 

Guidelines, Challenges, and New Opportunities 

Consensus or Contentious: Navigating 

Antihypertensive Therapy in Heart Failure 

with Preserved Ejection Fraction (EF) 

Sunday 

Chair: 

Gregg C. Fonarow, Los Angeles, CA 



1:05 Heart Failure Guidelines 2009: Integrating CRT, Optimal 

Medical Therapy, and What it Means for your Patients 

Clyde W. Yancy, Dallas, TX 

Learning Objective: Describe the latest heart failure 

guidelines and indications for CRT. 

1:25 Questions & Answers 

1:30 Treatment Gaps and Variation in CRT Uses in Clinical 

Practice: Implementation Opportunities 


Learning Objective: Identify current treatment gaps in CRT 

implementation, explain how to overcome barriers to treatment, 

and define how implementation and optimization of evidenc-based 

guidelines can improve outcomes in patients indicated for CRT. 


1:55 Issues for Physicians Managing CRT Patients: 

Maximizing Device Features for Optimal Outcomes 

Philip B. Adamson, Oklahoma City, OK 

Learning Objective: Describe issues facing physicians who 

manage patients with CRT and identify strategies to improve 

patient care, including the role of devices in proactive heart failure 

management and potential value of remote monitoring. 


2:20 The Future of CRT: Why You Should be Excited! 

William T. Abraham, Columbus, OH 

Learning Objective: Discuss recent clinical trial results with 

CRT and the potential implications of forthcoming clinical 

trials which may extend the role of CRT. 



Faculty 

Supported by an educational grant from Medtronic, Inc. 

Chair: 

Alan H. Gradman, Pittsburgh, PA 

1:00 Introduction: Hypertension and Heart Failure – 

The Evil Twins 


1:10 Epidemiology of Hypertension and Heart Failure with 

Preserved EF 

Daniel E. Levy, Framingham, MA 

Learning Objective: Explain the relationship between 

hypertension and heart failure with preserved EF. 

1:35 Pathophysiology of Elevated Blood Pressure and 

Preserved EF 

David A. Kass, Baltimore, MD 

Learning Objective: Describe the primary mechanisms by 

which hypertension causes heart failure with preserved EF. 

2:00 Antihypertensive Agents in the Treatment of Heart 

Failure with Preserved EF: Renin-Angiotensin- 

Aldosterone System (RAAS) Inhibitors 

William C. Little, Winston-Salem, NC 

Learning Objective: Discuss the evidence and rationale in 

the selection of antihypertensive agents in patients having 

heart failure with preserved EF. 

2:25 Antihypertensive Agents in the Treatment of Heart 

Failure with Preserved EF: Beta-Blockers 


Learning Objective: Recognize the importance of 

mechanisms of action of commonly used and newer 

beta-blockers in determining their utility for patients 

having hypertension and heart failure with preserved EF. 


Faculty 

Supported by an educational grant from Forest 

Laboratories, Inc. 



Committee. 

32 



Committee. 

33

Sept. 13 

Sunday 

PM 

SPECIAL SCIENTIFIC SESSIoN 


3:15-6:00 PM 

Room 312 



4:00-6:00 PM 

Room 302 

Sept. 13 

Sunday 

PM 

sunday 

Excellence in Basic Science 

Moderators: Walter J. Koch, Philadelphia, PA 

Thomas Force, Philadelphia, PA 

Chair: 

Mechanical Dyssynchrony in Heart Failure and 

Cardiac Resynchronization Therapy (CRT) 

Alan J. Bank, St. Paul, MN 

Sunday 

3:15 Mouse Models of Cardiovascular Disease 

Oliver Smithies, Chapel Hill, NC 

The 3rd Distinguished Lecture in Basic Science 

(Award to be presented immediately following lecture) 

4:00* Cardiac Transgenesis 

Jeffrey Robbins, Cincinnati, OH 

4:30* Mouse Models for Identifying Skeletal Muscle Pathology 

Jeffery D. Molkentin, Cincinnati, OH 

4:00 Introduction and Overview 


4:10 Mechanisms of Cardiac Dyssynchrony and 

Resynchronization in Heart Failure 


Learning Objective: Describe cellular and molecular 

mechanisms of cardiac dyssynchrony and resynchronization 

in heart failure. 

5:00* Mouse Models of microRNA Regulation 

Eric N. Olson, Dallas TX 

5:30* Biased Signaling by GPCRs 

Howard A. Rockman, Durham, NC 

*25 minute presentation, 5 minute audience discussion 

4:30 Mechanical Dyssynchrony and Prognosis in 

Heart Failure/CRT 

Rutger J. van Bommel, Leiden, The Netherlands 

Learning Objective: Define mechanical dyssynchrony and 

the impact of mechanical dyssynchrony on the prognosis of 

heart failure patients. 

Learning Objectives: 

Discuss the development of mouse models of cardiovascular 

disease and their role in current cardiovascular research. 

4:50 Role of Mechanical Dyssynchrony in the Selection of 

Patients for CRT: PROMISE-CRT Study 


Describe current research in cardiac transgenesis. 

Describe biased signaling by G protein-coupled receptors and its 

implication for the treatment of patients with heart failure 

Learning Objective: Summarize the results of the PROMISE- 

CRT study and its implications for the use of mechanical 

dyssynchrony in the selection of patients for CRT. 

5:10 New Imaging Modalities for Measuring Mechanical 

Dyssynchrony 

John Gorcsan, III, Pittsburgh, PA 

Learning Objective: Differentiate imaging options for 

measuring mechanical dyssynchrony. 

5:30 Case Studies: Mechanical Dyssynchrony Impacting 

Clinical Decisions in Patients with HF/CRT 

Alan J. Bank, John P. Boehmer (Hershey, PA), John Gorcsan, 

III, David A. Kass, Rutger J. van Bommel 

This program is part of the scientific program 


Committee. 


Faculty 

Supported by an educational grant from 


6:00 Opening Reception 

2009 HFSA Annual Scientific Meeting 

Exhibit Hall D 



Committee. 

34 

35

Sept. 13 

Sunday 

PM 



4:00-6:00 PM 

Room 304 

OPENING PLENARY SESSION 


8:00-10:00 AM 

Ballrooms A and B 

Sept. 14 

Monday 

AM 

sunday 

Acute Decompensated Heart Failure: 

It’s All About the Kidney 

8:00 Welcome and Opening Remarks 

Walter J. Koch, Philadelphia, PA 

Christopher M. O’Connor, Durham, NC 

Chair: 




4:10 The Pathophysiology of the Cardiorenal Syndrome 


Learning Objective: Discuss the pathophysiology and 

clinical consequences of the cardiorenal syndrome. 


4:35 Renal Consequences of Neurohormonal Activation in 


James E. Udelson, Boston, MA 

Learning Objective: Discuss the renal consequences of 

neurohormonal activation in patients with heart failure. 


5:00 Hyponatremia in Heart Failure 

Robert W. Schrier, Denver, CO 

Learning Objective: Explain the role of free water clearance 

and clinical implications of hyponatremia in patients with 



5:25 Novel/Emerging Biomarkers in Renal Disease: 

Beyond BUN and Creatinine 

John C. Burnett, Jr., Rochester, MN 

Learning Objective: Discuss the prognostic value 

of emerging biomarkers in renal disease and acute 

decompensated heart failure. 



Supported by an educational grant from Otsuka America 

Pharmaceuticals, Inc. 

8:10 Special Presentation to Barry M. Massie 

Editor-in-Chief, JCF 2002-09 

8:20 Presentation of 2009 HFSA Lifetime Achievement Award 

Personalized Medicine: The Dawn of a New Era 

Moderators: Gary S. Francis, Minneapolis, MN 


8:30 Genes, Environment, and Complex Human Disease: 

A Physician Scientist’s Perspective 

David A. Schwartz, Denver, CO 

8:55 Emerging Utilization of Bioinformatics for 

Personalized Medicine 

Atul J. Butte, Stanford, CA 

9:20 One Man’s Quest for Personalized Medicine 

David E. Duncan, Berkeley, CA 


Learning Objective: Recognize the impact of genetic 

information and testing on individual health and well-being. 

Monday 



Committee. 

36 

10:00 Coffee Break 

Refreshments served in Exhibit Halls C and D 

37

Sept. 14 

Monday 

AM 

POSTERS DISPLAYED 


9:00 AM-7:00 PM 

Exhibit Hall 

LATE BREAKING CLINICAL TRIALS 


10:30 AM-NOON 

Ballroom A 

Sept. 14 

Monday 

AM 

PRESENTER AT POSTER 5:45 PM-6:45 PM 

Late Breaking Clinical Trials I 

Categories Poster # 

Moderators: Marc A. Pfeffer, Boston, MA 


Monday 

Cardiovascular Physiology 024-053 

Cardiovascular Structure 083-087 

Neurohormones/Cytokines 093-104 

10:30 Superior Performance of Intrathoracic Impedance- 

Derived Fluid Index versus Daily Weight Monitoring 

in Heart Failure Patients: Results of the Fluid 

Accumulation Status Trial (FAST) 

William T. Abraham, Steven Compton, Garrie Haas, Blair 

Foreman, Robert C. Canby, Robert Fishel, Scott McRae, 

Gloria B. Toledo, Shantanu Sarkar on Behalf of the FAST 

Investigators. The Ohio State University, Columbus, OH 

Monday 

Molecular Biology and Genetics 117-125 

10:45 Commentary: Lynne Warner Stevenson, Boston, MA 

Surgery, Transplantation, Devices 136-157 

Electrophysiology/Arrhythmias 180-189 

Clinical Trials 200-217 

10:52 Improving Evidence-Based Care for Heart Failure in 

Outpatient Cardiology Practices: Primary Results of 

IMPROVE HF 

Gregg C. Fonarow, Clyde W. Yancy, Nancy M. Albert, Anne B. 

Curtis, Wendy Gattis Stough, Mihai Gheorghiade, J. Thomas 

Heywood, Mark L. McBride, Mandeep R. Mehra, Christopher 

O’Connor, D. Reynolds, Mary N. Walsh. UCLA, Los Angeles, CA 

11:07 Commentary: Hector O. Ventura, New Orleans, LA 

Cardiovascular Pharmacology 235-246 

Epidemiology, Prevention 260-271 

Outcomes 283-316 

11:15 Reduction in the Risk of Heart Failure with Preventive 

Cardiac Resynchronization Therapy: MADIT-CRT 

Arthur J. Moss, David S. Cannom, Helmut Klein, W. Jackson 

Hall, Mary W. Brown, James P. Daubert, N.A. Mark Estes, 

Elyse Foster, Henry Greenberg, Steve I. Higgins, Marc 

Pfeffer, David Wilber, Wojciech Zareba for the MADIT-CRT 

Investigators. University of Rochester, Rochester, NY 

Clinical Care/Management Strategies 351-381 

Listing for Monday posters begins on page 55 

Listing for Tuesday posters begins on page 111 

11:30 Commentary: John G.F. Cleland, Kingston-upon-Hull, UK 

11:38 Effects of Rolofylline, A Selective Adenosine A 1 

Antagonist in Patients Hospitalized for ADHF and Renal 

Impairment: Findings from the PROTECT Study 

Christopher M. O’Connor for the PROTECT Study and 

Investigators, Duke University, Durham, NC 

11:53 Commentary: Mihai Georghiade, Chicago, IL 

Learning Objective: Describe the results of recent trials and 

their implications for the care of patients with heart failure. 



38 

39

Sept. 14 

Monday 

AM 

GUIDELINE SESSION 


10:30 AM-NOON 

Ballroom C 

NURSING INVESTIGATOR SESSION 


10:30 AM-NOON 

Room 302 

Sept. 14 

Monday 

AM 

Heart Failure Guidelines: 2009 Updates 

Nursing Research Award 

Monday 

Moderators: JoAnn Lindenfeld, Denver, CO 

Carla S. Dupree, Chapel Hill, NC 

10:30 Overview of Updates 

JoAnn Lindenfeld, Denver, CO 

10:35 Implantable Devices and Surgical Options: Prophylactic 

ICD Placement, CRT, “Bridge to Decision” 

Randall C. Starling, Cleveland, OH 

10:55 Discussant: John P. Boehmer, Hershey, PA 

11:05 Disease Management and Nonpharmacologic 

Management: The Obesity Paradox, Sudden Cardiac 

Death, Defibrillator Inactivation, Exercise 

Nancy M. Albert, Cleveland, OH 

11:20 Discussant: Mary N. Walsh, Indianapolis, IN 

11:30 Acute Decompensated Heart Failure: New Guidelines, 

More Consensus than Evidence 

Michael M. Givertz, Boston, MA 

11:50 Discussant: Paul J. Mather, Philadelphia, PA 

Learning Objective: Identify changes in practice 

recommendations and implement them for the care of 

patients with heart failure. 

Moderators: Mariann R. Piano, Chicago, IL 

Susan J. Pressler, Ann Arbor, MI 

10:30* Comparison of the Impact of PHQ-9 Scores with 011 

and without Physical Symptom Items on Event- 

Free Survival in Patients with Heart Failure 

Kyoung Suk Lee, Terry A. Lennie, Seongkum Heo, 

Jia-Rong Wu, Misook L. Chung, Debra K. Moser, 

University of Kentucky, Lexington, KY 

10:48* Acute Hemodynamic Effects of Nebulised 012 

Furosemide in Stable Heart Failure 

Phillip J. Newton, Patricia M. Davidson, Henry 

Krum, Richard Ollerton, Peter Macdonald, Curtin 

University of Technology, Chippendale, NSW, Australia 

11:06* Against Medical Advice and Improved Heart 013 

Failure Care 

Merian F. Caboral, Judith E. Mitchell, SUNY, 

Brooklyn, NY 

11:24* Depressive Symptoms, Poor Nutritional Intake 014 

and Event-Free Survival in Patients with Heart 

Failure: A Deadly Chain of Events 

Eun Kyeung Song, Debra K. Moser, Heather Payne- 

Emerson, Seongkum Heo, Sandra B. Dunbar, Susan J. 

Pressler, Terry A. Lennie, University of Kentucky, 


11:42* Uncertainty and Emotional Distress in Patients 015 

with Heart Failure and their Primary Caregivers: 

A Novel Study 

Karen I. Harkness, McMaster University, Hamilton, 

ON, Canada 


Learning Objective: Discuss results of recent research and 


Monday 

40 

41

Sept. 14 

Monday 

AM 

JNC NEW INVESTIGATOR SESSION 


10:30 AM-NOON 

Room 304 

JNC NEW INVESTIVATOR SESSION 


10:30 AM-NOON 

Room 306 

Sept. 14 

Monday 

AM 

Jay N. Cohn New Investigator Award: 

Clinical/Integrative Physiology 

Jay N. Cohn New Investigator Award: 

Basic Science 

Monday 

Moderators: Inder S. Anand, Minneapolis, MN 

Michael R. Bristow, Denver, CO 

10:30* Prevention of Cardiorenal Fibrosis and Suppression 006 

of Proteinuria and Aldosterone Activation Following 

Experimental Myocardial Infarction with the Novel 

Natriuretic Peptide CD-NP 

Fernando L. Martin, S. Jeson Sangaralingham, Paul M. 

McKie, Brenda K. Huntley, Gerald E. Harders, Horng 

H. Chen, John C. Burnett, Mayo Clinic, Rochester, MN 

10:48* Familial Dilated Cardiomyopathy Caused by an 007 

Alpha-Tropomyosin Mutation: The Distinctive 

Natural History of Sarcomeric DCM 

Neal K. Lakdawala, Lisa Dellefave, Elizabeth Sparks, 

Allison Cirino, Steve Depalma, Birgit Funke, Steven D. 

Colan, Hugh Watkins, Paul Robinson, Charles S. Redwood, 

Christine E. Seidman, J.G. Seidman, Elizabeth M. McNally, 

Carolyn Y. Ho, Brigham and Women’s Hospital, 

Boston, MA 

11:06* Anti-Remodeling Effects of Chronic Phosphodiesterase- 008 

Type 5 Inhibition are Dependent on Impaired cGMP- 

Dependent Protein Kinase Signaling 

Selma F. Mohammed, Josef Korinek, Ahmed D. Abdairhim, 

Carolyn S.P. Lam, Robert D. Simari, , John 

C. Burnett, Jr., Margaret M. Redfield, Mayo Clinic, 

Rochester, MN 

11:24* Suppression of Erythroid Cell Development in 009 

Patients with Chronic Heart Failure and Anemia 

of Unknown Origin: Evidence of an Immune Basis 

Darlington O. Okonko, Stephen B. Marley, Stefan D. 

Anker, Myrtle Y. Gordon, Philip A. Poole-Wilson, 

Imperial College, London, UK 

11:42* Malnutrition as Assessed by Nutritional Risk 010 

Index is Associated with Worse Outcome in Patients 

Admitted with Acute Decompensated Heart Failure 

Emad Aziz, Eyal Herzog, Amjad Nader, Hari Om 

Sharma, Sandeep Pulimi, Manpreet Singh, Suchita 

Mishra, Deborah Tormey, Mina Botross, Marrick Kukin, 

St. Luke’s-Roosevelt Hospital Center, New York, NY 


Learning Objective: Discuss results of recent research and 


42 

Moderators: David E. Lanfear, Detroit, MI 

Hani N. Sabbah, Detroit, MI 

10:30* TLR4-Mediated Signals Converge on the PGC-1 001 

Family of Nuclear Receptor Coactivators to 

Control Myocardial Metabolism and Function 

Joel D. Schilling, Teresa Leone, Ling Lai, Nanda 

Sambandam, Daniel P. Kelly, Washington University, 

St. Louis, MO 

10:48* Tetrahydrobiopterin Rescues β3-/- Mice from 002 

Cardiac Hypertrophy and Impaired Function 

Induced by Pressure Overload 

Jordan S. Leyton-Mange, Xiaulin Niu, Ronghua Yang, 

Karen L. Miller, An L. Moens, Ashley B. Hale, Djahida 

Bedja, Kathleen L. Gabrielson, Keith M. Channon, David 

A. Kass, Lili A. Barouch, Johns Hopkins University, 

Baltimore, MD 

11:06* Modulating Neuregulin/ErbB4 Signaling to 003 

Promote Cardiomyocyte Replacement 

Kevin Bersell, Shima Arab, Bernhard Haring, Bernhard 

Kuhn, Harvard University, Boston, MA 

11:24* Survival and Cardiac Remodeling After 004 

Myocardial Infarction Are Critically Dependent 

on the Host Innate Immune Interleukin-1 Receptor 

Associated Kinase-4 (IRAK-4) Signaling: A Regulator 

of Bone Marrow-Derived Dendritic Cells 

Yuichiro Maekawa, Nobuo Mizue, Annie Chan, Yu Shi, 

Youan Liu, Chen Manyin, Fayez Dawood, Geoffrey de 

Coute, Guo Hua Li, Jeffrey A. Medin, Peter P. Liu, Keio 

University, Tokyo, Japan 

11:42* APJ Receptor Activity Can Be Independent By 005 

Its Ligand Apelin 

Maria Cecilia Scimia, Zhenghong Ling, Rolf Bodmer, 

Mark Mercola, Pilar Ruiz-Lozano, The Burnham Institute 

for Medical Research, La Jolla, CA. 


Learning Objective: Discuss results and implications of 

basic science research in heart failure. 

43 

Monday

Sept. 14 

Monday 

PM 

Monday 

ORAL ABSTRACT SESSION 


12:30-1:30 PM 

Ballroom A 

Leading Translational Research 

Moderators: Arnold M. Katz, Norwich, VT 

Jonathan G. Howlett, Calgary, AB, Canada 

12:30* Genetic Deletion of β-Arrestin-1 Improves 016 

Function of the Infarcted Heart by Reducing 

Cardiac β-Adrenergic Receptor Desensitization 

and Cardiotoxic Neurohormonal Overstimulation 

Anastasios Lymperopoulos, Guiseppe Rengo, Erhe 

Gao, Walter J. Koch, Thomas Jefferson University, 


12:45* Cardio-Humoral Actions of the Phosphodiesterase-V 017 

Inhibitor Vardenafil in Experimental Diabetic 

Cardiomyopathy 

Syed Ameeduddin, Josef Korinek, Elise A. Oehler, S. 

Jeson Sangaralingham, Fernando L. Martin, Alessandro 

Cataliotti, John A. Schirger, Horng H. Chen, Mayo Clinic, 

Rochester, MN 

1:00* Gene Expression Signature of Non-Ischemic 018 

Cardiomyopathy Using an Inflammatory 

Pathway RNA Array 

David C. Ishizawar (2008-09 HFSA Research Fellow), 

Karen Hanley-Yanez, Leslie T. Cooper, Jeffrey D. Alexis, 

Peter P. Liu, Daniel F. Pauly, Richard Sheppard, Dennis M. 

McNamara, University of Pittsburgh, Pittsburgh, PA 

1:15* Myocyte-Endothelial Cell Cross Talk Involves P38 019 

MAP Kinase Mediated Paracrine Signaling from 

Cardiomyocytes 

Beth A. Rose, Shuxun Ren, Luisa Iruela-Arispe, Yibin 

Wang, UCLA, Los Angeles, CA 


Learning Objective: Discuss the results of recent research 

bridging the gap between the laboratory and the clinical care 

of patients with heart failure. 

HOW TO SESSIONS 


12:30-1:30 PM 

Location 

1. Heart Failure Certification: What Does It Mean? Room 302 

Mariell L. Jessup, Philadelphia, PA 

Marvin A. Konstam, Boston, MA 

Laura F. Wexler, Cincinnati, OH 

Learning Objective: Discuss the purpose of certification in 

advanced heart failure and transplant cardiology and identify 

the steps necessary to achieve it. 

2. How to do a Comprehensive Echocardiographic Room 311 

Assessment of a Patient with Heart Failure 

Grace Lin, Rochester, MN 

Scott D. Solomon, Boston, MA 

Eric J. Velazquez, Durham, NC 

Learning Objective: Perform a comprehensive 

echocardiographic assessment of a patient with heart failure. 

3. How to Incorporate Cardiac MRI into Your Practice Room 310 

Raymond J. Kim, Durham, NC 

John F. Heitner, Brooklyn, NY 

Michael Jerosch-Herold, Boston, MA 

Learning Objective: Outline the steps necessary to 

incorporate cardiac MRI into a practice seeing heart 

failure patients and the reasons for doing so. 

4. How to Optimize Bi-Ventricular Pacers Room 304 

William T. Abraham, Columbus, OH 

Leslie A. Saxon, Los Angeles, CA 

Nancy K. Sweitzer, Madison, WI 

Learning Objective: Discuss methods for optimizing 

CRT in patients with heart failure. 

5. When to Do an Endomyocardial Biopsy on a Room 306 

Patient with New Heart Failure 

Sandra V. Chapparo, Miami, FL 

Sharon A. Hunt, Stanford, CA 

Dennis M. McNamara, Pittsburgh, PA 

Learning Objective: List the criteria for performing an 

endomyocardial biopsy on a patient with new heart failure. 

Sept. 14 

Monday 

PM 

Monday 

6. How to Conduct Disease Management in an Room 312 

Outpatient Setting 

Paul J. Hauptman, St. Louis, MO 

Debra K. Moser, Lexington, KY 

Kathleen H. Toto, Dallas, TX 

Learning Objective: List the components of effective 

disease management in an outpatient setting and outline 

a plan for implementing them in your clinic. 

44 

45

Sept. 14 

Monday 

PM 

SYMPOSIUM 


2:00-3:30 PM 

Ballroom A 

SYMPOSIUM 


2:00-3:30 PM 

Ballroom C 

Sept. 14 

Monday 

PM 

Monday 

Addressing Arrhythmias in Heart Failure 

Moderators: Prakash C. Deedwania, Fresno, CA 

James P. Daubert, Durham, NC 

2:00 The Changing Epidemiology of Heart Rhythm Disorders 

Sanjiv M. Narayan, San Diego, CA 

2:20 Efficacy of Medications for Atrial Arrhythmias in 

Heart Failure Patients 

William G. Stevenson, Boston, MA 

2:40 Device Mishaps in Heart Failure Patients and 

How to Avoid Them 

Bruce L. Wilkoff, Cleveland, OH 

3:00 Should I Be Referring all of my Heart Failure Patients 

with ICD Therapy for VT Ablation? 

Vivek Y. Reddy, New York, NY 


Learning Objective: Describe methods to more effectively 

treat or refer patients with heart failure. 

Managing Congestion in Advanced 

Decompensated Heart Failure 

Moderators: Mihai Gheorghiade, Chicago, IL 

Kanu Chatterjee, Iowa City, IA 

2:00 Loop Diuretics: Help or Harm? 

G. Michael Felker, Durham, NC 

2:20 Adenosine Antagonists: Will Targeting the 

Kidney Benefit the Patient? 

Michael M. Givertz, Boston, MA 

2:40 Vasopressin Antagonists: Beyond EVEREST? 

Steven R. Goldsmith, Minneapolis, MN 

3:00 Ultrafiltration: Unloading Lessons from Recent Studies 

Maria Rosa Costanzo, Naperville, IL 


Learning Objective: Evaluate treatment options to manage 

congestion in patients with advanced decompensated heart 

failure. 

Monday 





46 

47

Sept. 14 

Monday 

PM 

SYMPOSIUM 


2:00-3:30 PM 

Room 302 

SYMPOSIUM 


2:00-3:30 PM 

Room 304 

Sept. 14 

Monday 

PM 

Monday 

State of the Art Cardiac Regeneration: 

From Cell to Patient 

Moderators: Jan Kajstura, Boston, MA 

Matthew J. Wolf, Durham, NC 

2:00 Clinical Use of Stem Cells in the Heart: 

What Have We Learned? 

Richard T. Lee, Boston, MA 

2:20 How Well do Preclinical Studies Predict Outcomes 

in the Clinic? 

Joshua M. Hare, Miami, FL 

2:40 Should Bone Marrow Cell Trials be Conducted or 

Should a More Specific Cell Population be Used? 

Roberto Bolli, Louisville, KY 

3:00 Stem Cell Identification in Failing Human Hearts 

Kenneth B. Margulies, Philadelphia, PA 


Learning Objective: Describe current knowledge, research 

issues, and clinical practice in cardiac regeneration. 

Novel Biomarkers in Heart Failure 

Moderators: Alessandro Cataliotti, Rochester, MN 

Anita Deswal, Houston, TX 

2:00* Beyond BNP: What Can ST2 and Gal3 Tell Us? 


2:18* Novel Mid-Regional Peptide Markers: 

Why Do We Need New Markers? 

Alan S. Maisel, La Jolla, CA 

2:36* BNP Assays: What are We Actually Measuring? 


2:54* Myeloperoxidase (MPO): Why Measure? 

W.H. Wilson Tang, Cleveland, OH 

3:12* Renal Markers: Can We Do Better than Creatinine? 

Horng H. Chen, Rochester, MN 

*15 minute presentations, 3 minute discussion 

Learning Objective: Identify the limitations of current 

biomarkers and the clinical potential of selected novel 

biomarkers in heart failure. 

Monday 





48 

49

Sept. 14 

Monday 

PM 

SYMPOSIUM 


2:00-3:30 PM 

Room 311 

HEART FAILURE COURT OF APPEALS 


4:00-5:30 PM 

Ballroom B 

Sept. 14 

Monday 

PM 

Monday 

Emerging Concepts for microRNA in 

The Failing Heart 

Moderators: David S. Feldman, Minneapolis, MN 

J. David Port, Denver, CO 

2:00* Epigenetic Studies of Cardiac miRNAs 

Gerald W. Dorn, II, St. Louis, MO 

2:22* Development of miRNA Function in the Heart 

Deepak Srivastava, San Francisco, CA 

2:44* Therapeutic Potential of Cardiac miRNAs 

Eva van Rooij, Boulder, CO 

3:07* Novel Regulation of miRNAs in Angiogenesis and 


Nanette H. Bishopric, Miami, FL 

*20 minute presentation, 2-3 minute audience discussion 

Learning Objective: Describe new concepts for microRNA 

in the failing heart. 

Judges: 

Heart Failure Court of Appeals 

Barry H. Greenberg, San Diego, CA 

Marvin A. Konstam, Boston, MA 

Douglas L. Mann, St. Louis, MO 

4:00 Opening Remarks 

Judge Marvin A. Konstam Presiding 

4:05 Case I: Statins are required for all Patients with 

Heart Failure and Coronary Artery Disease 

Brought by: Gregg C. Fonarow, Los Angeles, CA 

Countered by: John G.F. Cleland, Kingston-upon-Hull, UK 

(15 minutes for each to present) 

4:35 Questions from the Judges and Audience 

4:45 Judgment Rendered 

4:45 Case II: Exercise Training is a Required 

Recommendation for All Heart Failure Patients 

Brought by: Ileana L. Piña, Cleveland, OH 

Countered by: Gary S. Francis, Minneapolis, MN 

(15 minutes for each to present) 

5:15 Questions from the Judges and Audience 

5:25 Judgment Rendered 

Learning Objective: Outline arguments for and against the 

use of statins for all patients with heart failure and coronary 

artery disease and the use of required exercise training for 

all patients with heart failure. 

Monday 



5:30 Poster Session and Reception Exhibit Halls C and D 

Presenters at their Posters 5:45-6:45 PM 

Refreshments and Hors d’oeuvres served 

50 

51

Sept. 14 

Monday 

PM 

SYMPOSIUM 


4:00-5:30 PM 

Room 302 

SYMPOSIUM 


4:00-5:30 PM 

Room 304 

Sept. 14 

Monday 

PM 

Monday 

Translation in Heart Failure Genomics 

Moderators: Burns C. Blaxall, Rochester, NY 

Elizabeth M. McNally, Chicago, IL 

4:00 Genes for Prognosis: New Targets and Patient Scores 

Sekar Kathiresan, Boston, MA 

4:20 A Systems Biology Approach to Personalized Medicine 

Euan A. Ashley, Stanford, CA 

4:40 Adrenergic Polymorphisms and Beta-Blockade in 


Stephen B. Liggett, Baltimore, MD 

5:00 Transcriptomics in Heart Failure 

Thomas P. Cappola, Philadelphia, PA 


Learning Objective: Describe new concepts for translating 

novel genomic data into clinical practice. 

Myocardial Extracellular Matrix (ECM): 

Importance in Disease, Diagnosis and 

Management 

Moderators: William H. Gaasch, Burlington, MA 

Michael R. Zile, Charleston, SC 

4:00* Mechanisms Controlling the Myocardial ECM and 

Fibroblast Form and Function in CV Disease: Future 

Directions for Clinical Therapeutics 

Francis G. Spinale, Charleston, SC 

4:22* Methods to Monitor Changes in the Myocardial ECM: 

Diagnostic Utility 

Peter P. Liu, Toronto, ON, Canada 

4:45* Management to Prevent or Reverse Changes in the 

Myocardial ECM: Current and Future 

William C. Little, Winstom-Salem, NC 

5:07* Why Should a Heart Failure Provider Care about the 

Myocardial ECM? 

William S. Colucci, Boston, MA 


Learning Objective: Discuss the role of the myocardial 

extracellular matrix in the diagnosis and management of 


Monday 







52 

53

Sept. 14 

Monday 

PM 

Monday 

SYMPOSIUM 


4:00-5:30 PM 

Room 311 

Cardiac Mitochondria in Heart Failure 

Moderators: Shey-Shing Sheu, Rochester, NY 

Rong Tian, Seattle, WA 

4:00* Mitochondria and Cardiomyocyte Survival 

Jeffery Molkentin, Cincinnati, OH 

4:23* Nuclear Receptor Regulation of Cardiac Mitochondria 

Daniel P. Kelly, Orlando, FL 

4:45* Mitochondrial Oscillations in Physiology and 

Pathophysiology 

Brian O’Rourke, Baltimore, MD 

5:07* Mitochondrial Dysfunction in Heart Failure 

Margaret P. Chandler, Cleveland, OH 


Learning Objective: Describe latest developments in the 

study of mitochondria and their role in heart function and 

failure. 

P024 

P025 

P026 

P027 

P028 

P029 

Posters 

Cardiovascular Physiology 

Results of a Pre-Clinical Trial of Periostin Peptide in 

Myocardial Infarction 

Dennis Ladage 1 , Yoshiaki Kawase 1 , Scott Shapiro 1 , Mario 

Garcia 1 , Roger Hajjar 1 , Bernhard Kuhn 2 ; 1 Cardiovascular 

Research Center, Mount Sinai School of Medicine, New York, 

NY; 2 Dept. of Pediatrics, Havard Medical School, Boston, MA 

Effect of Right Ventricular Function on Cardio-Renal 

Interactions during the Treatment of Decompensated 


J. Testani 1 , B. McCauley 1 , A. Khera, A. Yu 1 , S. Wiegers 1 , 

A. Owens 1 , M. St. John Sutton 1 , J. Kirkpatrick 1 ; 1 Medicine- 

Cardiovascular Division, University of Pennsylvania, 


Pressure Overload Leads to Severe Concentric 

Hypertrophy in Adiponectin-Deficient Mice 

Karen M. O’Shea 1,2 , David J. Chess 2 , Kenneth Walsh 3 , William 

C. Stanley 1,2 ; 1 Nutrition, Case Western Reserve University, 

Cleveland, OH; 2 Medicine, University of Maryland, Baltimore, 

Baltimore, MD; 3 Molecular Cardiology, Boston University, 

Boston, MA 

Cardiac-Specific Deletion of Integrin-Linked Kinase 

Induces Fibrosis, Apoptosis and Cardiomyopathy 

Jing Dai 1 , Takashi Matsui 1 , E. Dale Abel 2 , Christine E. Seidman 3 , 

J.G. Seidman 4 , Anthony Rosenzweig 1 ; 1 Beth Israel Deaconess 

Medical Center, Boston, MA; 2 University of Utah, Salt Lake 

City, UT; 3 Brigham and Women’s Hospital, Boston, MA; 

4 

Harvard Medical School, Boston, MA 

Mild Hypothermia Delays the Evolution of Early 

LV Dilatation and Late Stone Heart from Untreated 

Sustained Ventricular Fibrillation 

Vincent L. Sorrell 1 , Nishant Kalra 1 , Ronald Hilwig 1 , Robert 

Berg 1 , Karl B. Kern 1 , Gordon A. Ewy 1 ; 1 Cardiology, University 

of Arizona, Tucson, AZ 

Sept. 14 

Monday 

Posters 

Influence of Cardiac Resynchronization Therapy on 

Cardiac Structural and Electrical Remodeling 

Steven Eddy 1 , Vince Huebert 1 , Milan Seth 1 , Stephen Ackerman 2 , 

Michael Chisner 3 ; 1 CRM-Clinical Affairs, Boston Scientific, St. 

Paul, MN; 2 Nebraska Heart Institute, Lincoln, NE; 3 Cardiology 

Associates, Savannah, GA 

Monday 

5:30 Poster Session and Reception Exhibit Hall C and D 



54 

55

Sept. 14 

Monday 

Posters 

Posters 


Posters 


Sept. 14 

Monday 

Posters 

P030 

Hypoxia, Not the Frequency of Sleep Apnea, Causes 

Acute Hemodynamic Stress in Patients with Congestive 


Joshua D. Gottlieb 1 , Alan Schwartz 2 , Samer S. Najjar 3 , Stephen 

S. Gottlieb 4 ; 1 Economics, Harvard University, Cambridge, MA; 

2 

Johns Hopkins University, Bayview Medical Center, Baltimore, 

MD; 3 National Institute on Aging, Baltimore, MD; 4 University 

of Maryland, Baltimore, MD 

P036 

Regional Right Ventricular Wall Stress and Thickness in 

Pulmonary Hypertension 

Chirag A. Chauhan 1 , Derek R. Wisnieski 4 , Christopher R. 

Deible 2 , Michael A. Mathier 3 , Joan Lacomis 2 , Sanjeev G. Shroff 4 , 

Michael R. Pinsky 5 , Marc A. Simon 3 ; 1 Department of Internal 

Medicine, University of Pittsburgh, Pittsburgh, PA; 2 Department 

of Radiology; 3 Cardiovascular Institute; 4 Department of 

Bioengineering; 5 Department of Critical Care Medicine 

Monday 

P031 

P032 

P033 

P034 

P035 

Oral Administration of the Glutathione Peroxidase 

Mimic SYI-2074 Ameliorates Post-MI Heart Failure in 

Type 1 Diabetes Mellitus 

Lyman J. Roberts II, Brooke Gliga, ZhiZhang Wang, Michael F. 

Hill; Medicine, Vanderbilt University Medical Center, Nashville, 

TN 

Peak VO2 as a Predictor of Ambulatory Activity of Daily 

Living in Patients with Chronic Heart Failure 

Prabhu T. Alahakoon 1 , Alex J. Auseon 1 , Carl V. Leier 1 , Philip F. 

Binkley 1 ; 1 Cardiovascular Medicine, The Ohio State University 

Medical Center, Columbus, OH 

Incidence of Severe Isolated Tricuspid Regurgitation 

(TR) Mimicking the Signs of Constrictive Pericarditis 

Anitha Rajamanickam 1 , Ali Usmani 1 , Mazen Hanna 2 ; 

1 

Department of Hospital Medicine, Cleveland Clinic, Cleveland, 

OH; 2 Department of Cardiovascular Medicine, Cleveland Clinic, 

Cleveland, OH 

Identification of Lin-CD34+/CD38-/CD90+/CD45RA- 

Progenitors in the Failing Human Heart 

Asangi R. Kumarapeli 1 , Gwenn Danet-Desnoyers 1 , Andrew D. 

Bantly 2 , Jonni S. Moore 2 , Kenneth B. Margulies 1 ; 1 Department 

of Medicine, University of Pennsylvania School of Medicine, 

Philadelphia, PA; 2 Department of Pathology and Laboratory 

Medicine, University of Pennsylvania School of Medicine, 


Histologic Correlates of Delayed Enhancement CMR in 

Ischemic and Nonischemic Heart Failure 

Omar M. Cheema 1 , Keith Youker 1 , Ankit A. Patel 1 , Ahmad 

Khalil 1 , Jerry D. Estep 1 , Carlos M. Orrego 1 , Guillermo A. Torre 1 , 

Dipan J. Shah 1 ; 1 Cardiology, Methodist DeBakey Heart Vascular 

Center, Houston, TX 

P037 

P038 

P039 

P040 

P041 

The Effects of Pulmonary Arterial Hypertension on Left 

Ventricular Systolic and Diastolic Synchrony 

Sameer J. Khandhar, Kathy Edelman, Beth Gulyasy, Angel 

Lopez-Candales; Cardiovascular Institute, University of 

Pittsburgh Medical Center, Pittsburgh, PA 

The Prevalence and Characteristics of Chronotropic 

Incompetence in a General Heart Failure Population: 

Results from the PEGASUS CRTTrial 

Stuart D. Russell 1 , John D. Day 2 , Kira Q. Stolen 3 , Stacia Merkel 

Kraus 4 , Shelly Christman 3 , David O. Martin 5 ; 1 Johns Hopkins 

Hospital, Baltimore, MD; 2 Intermountain Medical Center, 

Salt Lake City, UT; 3 Boston Scientific CRM, St. Paul, MN; 

4 

The Integra Group, Brooklyn Park, MN; 5 Cleveland Clinic, 

Cleveland, OH 

Effects of Antihypertensive Medications on Proteolytic 

Determinants of Myocardial Extracellular Matrix 

Composition in Patients with Hypertensive Heart Disease 

S. Mehurg 1 , S. DeSantis 1 , C. Baicu 1 , R. Stroud 1 , S. Thompson 1 , 

C. McClure 1 , C. Koval 1 , J. Mulcahy 1 , F. Spinale 1 , M. Zile 1 ; 

1 

Medical University of South Carolina, Charleston, SC 

LV Lead Repositioning to Apico-Lateral Position in Non 

Responders to Resynchronization Therapy Improves 

Patients Acutely and in Long Term Follow Up 

Dusan Z. Kocovic, Nancy Britton, Mark Heimann, Scott Cox, 

Steven Rothman; Cardiology, Lankenau Hospital, Wynnewood, 

PA 

Hemodilation Is a Main Cause of Anemia in Patients 

with Advanced Congestive Heart Failure 

Dmitry V. Preobrazhensky 1 , Nataliya I. Nekrasova 1 , Irina D. 

Vyshinskaya 1 , Irina V. Talysina 1 , Talantbek A. Batyraliev 2 ; 

1 

Department of Cardiology, Moscow Medical Academy, 

Moscow, Russian Federation; 2 Department of Cardiology, Sani 

Konukoglu Medical Center, Gaziantep, Turkey 

Monday 

56 

57

Sept. 14 

Monday 

Posters 

Posters 


Posters 


Sept. 14 

Monday 

Posters 

Monday 

P042 

P043 

P044 

P045 

P046 

Simultaneous Electrical and Mechanical Mapping Using 

3D Cardiac Mapping System: Novel Approach for 

Optimal Cardiac Resynchronization Therapy 

Kyungmoo Ryu 1 , Andre d’Avila 2 , E. Kevin Heist 2 , Stuart P. 

Rosenberg 1 , Jessie Chou 1 , Michael Yang 1 , Jagmeet P. Singh 2 ; 

1 

St. Jude Medical, Inc., Sylmar, CA; 2 Medicine, Massachusetts 

General Hospital, Boston, MA 

Endothelium-Independent Microvascular Dysfunction 

Induced by AL Amyloidosis Light Chains in Human 

Adipose Arterioles: Novel Mechanism of Amyloid Injury 

Megan Bright 1 , Seth Truran 1 , Brittany Schlundt 1 , David D. 

Gutterman 1 , Parameswaran Hari 2 , Raymond Q. Migrino 1 ; 

1 

Medicine (Cardiovascular Medicine), Medical College of 

Wisconsin, Milwaukee, WI; 2 Medicine (Hematology-Oncology), 

Medical College of Wisconsin, Milwaukee, WI 

Simvastatin Attenuates Endothelial Dysfunction in 

Human Adipose Arterioles Exposed to AL Amyloid Light 

Chain Proteins 

Raymond Q. Migrino 1 , Seth Truran 1 , Brittany Schlundt 1 , 

Mitchell Timmons 1 , Megan Bright 1 , Parameswaran Hari 2 , David 

D. Gutterman 1 ; 1 Medicine (Cardiovascular Medicine), Medical 

College of Wisconsin, Milwaukee, WI; 2 Medicine (Hematology- 

Oncology) 

Hypertension in Heart Failure with Normal LVEF 

Is Characterized by LVH, Decreased Atrial Ejection 

Function and Two Distinct Patterns of Abnormal LV 

Filling 

M. Rizwan Khalid 1 , Zaruhi V. Babayan 2 , Edward S. Bennett 3 , 

Fatima R. Khalid 1 , Frank C. Messineo 4 , Icilma V. Fergus 5 ; 

1 

Cardiology, Emory University, Atlanta, GA; 2 Cardiology, Albert 

Einstein Montefiore Medical Ctr, Bronx, NY; 3 Emergency 

Medicine, New York Hospital Queens, Flushing, NY; 

4 

Cardiology, Lenox Hill Hospital, New York, NY; 5 Cardiology, 

Harlem Hosp Ctr, New York, NY 

Reduced Stroke Work Indexed to Left Ventricular Mass 

Is Associated with Reduced Survival in Patients with 

Transthyretin (ATTR) Cardiac Amyloidosis 

Taslima Bhuiyan 1 , Ayan R. Patel 2 , Frederick L. Ruberg 3 , Jeff 

Packman 2 , Donna Grogan 4 , Mathew Maurer 1 ; 1 Center for 

Advanced Cardiac Care, Columbia University Medical Center, 

New York, NY; 2 Cardiovascular Imaging and Hemodynamic 

Lab, Div of Cardiology, Tufts Medical Center, Boston, MA; 

3 

Amyloid Treatment and Research Program and Section of 

Cardiology, Dept of Medicine, Boston University School 

of Medicine, Boston, MA; 4 FoldRx Pharmaceuticals, Inc., 

Cambridge, MA 

P047 

P048 

P049 

P050 

P051 

P052 

Novel Method of Assessing Left Atrial Systolic Force and 

Its Quantification in Normal Versus Refractory Heart 

Failure Patients 

Sanjay Kumar 1 , Saurabh Kaushik 2 , Richard A. Grimm 1 ; 

1 

Cardiovascular Medicine, Cleveland Clinic Foundation, 

Cleveland, OH; 2 NYU Langone Medical Center, New York, NY 

Developmental Inotropic Sensitivity to Isoproterenol in 

Developing Zebrafish Hearts In Vivo 

Hannah L. Semigran 1 , Calum A. MacRae 1 , Jordan T. Shin 1 ; 

1 

CVRC, Massachusetts General Hospital, Charlestown, MA 

Impact of Longitudinal Cardiac Rotation on Left 

Ventricular Diastolic Asynergy 

Chirapa Puntawangkoon 1 , David Verhaert 1 , Bruce Wilkoff 1 , 

Richard A. Grimm 1 , James D. Thomas 1 , Zoran B. Popovic 1 ; 

1 

Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH 

Black Bean Extract Inhibits Cardiac Fibrosis and 

Restores Cardiac Function in an Acute Non-Ischemic 

Cardiomyopathy Mouse Model 

Keith A. Youker 1 , Ahmad Khalil 1 , Carlos Orrego 1 , Jose Flores- 

Arredondo 2 , Sergio Serrano 2 , Jorge Moreno 2 , Guillermo Torre- 

Amione 1 ; 1 Cardiology, The Methodist DeBakey Heart Vascular, 

The Methodist Hospital, Houston, TX; 2 Cardiology, Instituto 

Tecnológico y de Estudios Superiores de Monterre, Monterrey, 

Nuevo Leon, Mexico 

Differential Changes in Rv and Lv Filling Pressures 

during Acute Decompensation in Chronic Heart Failure 

Patients 

Philip B. Adamson 1 , Robert C. Bourge 2 , William T. Abraham 3 , 

Yong K. Cho 4 , Tom D. Bennett 4 ; 1 Oklahoma Cardiovascular 

Associates, Oklahoma City, OK; 2 University of Alabama 

Birmingham, Birmingham, AL; 3 Ohio State University, 

Columbus, OH; 4 Medtronic, Inc., Mounds View, MN 

Preferential Recruitment of Progenitors Following 

Myocardial Injury 

Jeremy A. Elser 1 , Andrew Bantly 2 , Kenneth B. Margulies 3 ; 

1 

Department of Bioengineering, University of Pennsylvania, 

Philadelphia, PA; 2 Pathology and Laboratory Medicine, 

University of Pennsylvania School of Medicine, Philadelphia, 

PA; 3 Department of Medicine, University of Pennsylvania 

School of Medicine, Philadelphia, PA 

Monday 

58 

59

Sept. 14 

Monday 

Posters 

Posters 


Posters 

Neurohormones/Cytokines 

Sept. 14 

Monday 

Posters 

Monday 

P053 

P083 

P084 

Pulmonary Artery Systolic Pressure Is an Independent 

Predictor of Exercise Capacity in Hypertrophic 


Carolyn S.P. Lam 1 , Paul Sorajja 1 , Steve R. Ommen 1 ; 1 Mayo 

Clinic, Rochester, MN 

Cardiovascular Structure 

Dyssynchrony of the Left Ventricular Apical Segments, 

Should It Be Used to Select Patients for Cardiac 

Resynchronization Therapy and to Predict Outcomes? 

Ali Ahmad 1 , Zoran Popovic 1 , Dawood Elgergawy 2 , Deborrah 

Agler 1 , Richard Grimm 1 ; 1 Cardiovascular Medicine, Cleveland 

Clinic, Cleveland, OH; 2 Medicine, New York Methodist 

Hospital, New York, NY 

Prognostic Impact of Mitral Regurgitation in Heart 

Failure Depends on Left Ventricular Systolic Function 

Jens Jakob Thune 1 , Redi Pecini 1 , Jesper Kjaergaard 1 , Christian 

Hassager 1 , Christian Torp-Pedersen 2 , Lars Kober 1 ; 1 Dept. of 

Cardiology, Copenhagen University Hospital, Rigshospitalet, 

Copenhagen, Denmark; 2 Dept. of Cardiology, Copenhagen 

University Hospital, Gentofte, Gentofe, Denmark 

P093 

P094 

B-Type Natriuretic Peptide Single Nucleotide 

Polymorphism rs198389 Impacts Test Characteristics of 

Common Assays 

Lisa C. Costello-Boerrigter 1 , Guido Boerrigter 1 , Syed 

Ameenuddin 1 , Douglas W. Mahoney 2 , Joshua P. Slusser 3 , 

Denise M. Heublein 1 , Margaret M. Redfield 1 , Richard J. 

Rodeheffer 1 , Timothy M. Olson 4 , John C. Burnett, Jr. 1 ; 1 Division 

of Cardiovascular Diseases, Mayo Clinic, Rochester, MN; 

2 

Department of Epidemiology, Mayo Clinic, Rochester; 

3 

Department of Biostatistics, Mayo Clinic, Rochester, MN; 

4 

Department of Pediatric Cardiology, Mayo Clinic, Rochester, 

MN 

B-Type Natriuretic Peptide Single Nucleotide 

Polymorphism rs198389 and Survival in the General 

Community 

Guido Boerrigter 1 , Lisa C. Costello-Boerrigter 1 , Syed 

Ameenuddin 1 , Douglas W. Mahoney 2 , Joshua P. Slusser 3 , 

Denise M. Heublein 1 , Margaret M. Redfield 1 , Richard J. 

Rodeheffer 1 , Timothy M. Olson 4 , John C. Burnett, Jr. 1 ; 1 Division 

of Cardiovascular Diseases, Mayo Clinic, Rochester, MN; 

2 

Division of Epidemiology, Mayo Clinic, Rochester, MN; 

3 

Division of Biostatistics, Mayo Clinic, Rochester, MN; 

4 

Division of Pediatric Cardiology, Mayo Clinic, Rochester, MN 

Monday 

P085 

P086 

P087 

LV-First Pacing Reduces Regional Intra-Ventricular 

Mechanical Delay in Heart Failure with a Preserved 

Ejection Fraction 

Yih-Chih Wang 1 , Rodolphe P. Katra 2 , Chih-Chieh Yu 1 , Kathryn 

Hilpisch 2 , Vincent Splett 2 , Lian-Yu Lin 1 , Fu-Chun Chiu 1 , Jiunn- 

Lee Lin 1 ; 1 Natl Taiwan Univ Hosp, Taipei, Taiwan; 2 Medtronic, 

Mounds View, MN 

Impact of Sildenafil on Cardiac Structure and Function 

in Patients with Pulmonary Arterial Hypertension 

Praneet Kumar 1 , Sabe De 2 , Raed Dweik 3 , W.H. Wilson 

Tang 2 ; 1 Internal Medicine, Cleveland Clinic Foundation; 

2 

Cardiovascular Institute; 3 Pulmonary Institute, Cleveland Clinic 

Foundation, Cleveland, OH 

Acute Effects of Biventricular Versus Right Ventricular 

Pacing on Left Ventricular Function and Twist Assessed 

by Magnetic Resonance Imaging in a Canine Post 

Myocardial Infarction Model of Cardiomyopathy 

Yasmin Masood 1 , Peter VanBuren 1 , Daniel Lustgarten 1 , Timothy 

Christian 1 , James Calame 1 , Zengyi Chen 1 , Stephen Bell 1 , Martin 

M. LeWinter 1 ; 1 Cardiology, University of Vermont, Burlington, 

VT 

P095 

P096 

P097 

P098 

Clinical Results for the New PresageTM Soluble ST2 

Assay in Acutely Destabilized Heart Failure: Results 

from the PRIDE Study 

Anju Bhardwaj 1 , Ravi Shah 1 , James L. Januzzi 1 ; 1 Cardiology, 

Massachusetts General Hospital, Boston, MA 

Natriuretic Peptides for the Detection of Central Sleep 

Apnea among Heart Failure Patients 

Andrew D. Calvin 1 , Virend K. Somers 2 , Jennifer M. Fitz- 

Gibbon 2 , Christelle van der Walt 2 , Lyle J. Olson 2 ; 1 Mayo School 

of Graduate Medical Education, Mayo Clinic, Rochester, MN; 

2 

Division of Cardiovascular Diseases, Mayo Clinic, Rochester, 

MN 

N-Terminal Pro-Brain Natriuretic Peptide as Predictor 

of 5 Years All Cause-Mortality in General Population 

Ovidiu Chioncel 1 , Emil Cochino 2 , Gilda Teisanu 1 , Cezar 

Macarie 1 ; 1 Cardiologie, Institutul de Urgenta pentru Boli 

Cardiovasculare C.C.Iliescu, Bucuresti, Bucharest, Romania; 

2 

Help Data Management, Bucharest, Romania 

ST2 Predicts Mortality in Outpatients Referred for 

Echocardiograms 

Lori B. Daniels 1 , Kim Tran 2 , Kabir Singh 1 , Alan S. Maisel 1,2 ; 

1 

Division of Cardiology, University of California, San Diego, La 

Jolla, CA; 2 Division of Cardiology, Veterans Affairs San Diego 

Medical Center, La Jolla, CA 

60 

61

Sept. 14 

Monday 

Posters 

Posters 


Posters 

Molecular Biology and Genetics 

Sept. 14 

Monday 

Posters 

Monday 

P099 

P100 

P101 

P102 

P103 

Antibody Titers to Influenza Vaccine Wane in Patients 

with Heart Failure 

Orly Vardeny 1 , John J. Moran 1 , Maryl R. Johnson 2 , Nancy 

K. Sweitzer 2 ; 1 School of Pharmacy, University of Wisconsin, 

Madison, WI; 2 Cardiovascular Division, Department of 

Medicine, University of Wisconsin, Madison, WI 

GH Repletion Increases Intracardiac Ang-1-7/ACE2 and 

Restores Diastolic Function in Aged Male BNF344 Rats 

Leanne Groban 1,2 , Marina R. Lin 1 , Jewell A. Jessup 2 , Mark C. 

Chappell 2,4 , Judy K. Brunso-Bechtold 3 ; 1 Anesthesiology, Wake 

Forest University School of Medicine, Winston Salem, NC; 

2 

Physiology and Pharmacology; 3 Neurobiology and Anatomy; 

4 

Hypertension and Vascular Research Center 

Simulataneous Assessment of Processed BNP1-32 and 

Unprocessed proBNP1-108 Improves Risk Stratification 

in Ambulatory Patients with Moderate to Severe Systolic 

Heart Failure: Results from the Penn Heart Failure 

Cohort 

Daniel L. Dries 1 , Bonnie Ky 1 , Alan Wu 2 , Thomas A. Cappola 1 ; 

1 

Cardiovascular Institute, Heart Failure Transplant Group, 

Hospital of the University of Pennsylvania, Philadelphia, PA; 

2 

Department of Laboratory Medicine, University of California 

San Francisco 

A Novel Designer Natriuretic Peptide CD-NP Suppresses 

TGF-beta 1 Induced Collagen Type I Production in 

Human Cardiac Fibroblasts 

Tomoko Ichiki 1 , Brenda K. Huntley 1 , S. Jeson Sangaralingham 1 , 

Horng H. Chen 1 , John C. Burnett, Jr. 1 ; 1 Division of 

Cardiovascular Diseases, Mayo Clinic, Rochester, MN 

Pentraxin 3 (PTX3) Levels Are Associated to In-Hospital 

Mortality in Patients with Acute Decompensated Heart 


Andreia Biolo 1,2 , Daiane Silvello 1,2 , Livia A. Goldraich 1,2 , Katia 

G. Santos 1,2 , Nadine Clausell 1,2 , Emilio Moriguchi 1,2 , Luis E. 

Rohde 1,2 ; 1 Cardiology, Hospital de Clínicas de Porto Alegre, 

Porto Alegre, RS, Brazil; 2 PPG Cardiologia, Universidade 

Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil 

P117 

P118 

P119 

P120 

P121 

Aggregated Genetic Polymorphisms of Beta-Receptors 

and Heart Failure Mortality in a Cohort of Heart 

Failure Outpatients 

Roberto Salvaro 1,2 , Andreia Biolo 1,2 , Daiane Silvello 1,2 , Fabio M. 

Velho 1,2 , Nadine Clausell 1,2 , Katia G. Santos 1,2 , Luis E. Rohde 1,2 ; 

1 

Cardiology, Hospital de Clínicas de Porto Alegre, Porto Alegre, 

RS, Brazil; 2 PPG - Cardiologia, Universidade Federal do Rio 

Grande do Sul, Porto Alegre, RS, Brazil 

Human C-Reactive Protein Paradoxically Protects 

Against Myocardial Infarction (MI) in Mice: Role of 

hCRP in Bone Marrow Cell Mobilization 

Yu Shi 1 , Guohua Li 1 , Derek Wang 1 , Manyin Chen 1 , Masahiro 

Fukuoka 1 , Shezad Tejani 1 , Meredith Li 1 , Fayez Dawood 1 , 

Alexander J. Szalai 2 , Subodh Verma 3 , Peter P. Liu 1 ; 1 Cardiology, 

Toronto General Hospital, Toronto, ON, Canada; 2 Medicine, The 

University of Alabama, Birmingham, AL; 3 Cardiac Surgery, St. 

Michael’s Hospital, Toronto, ON, Canada 

Mindin, a Regulator of Innate Immunity and Inhibitor 

of Angiogenesis, Contributes to Mortality and Adverse 

Remodeling Post Myocardial Infarction 

Mark S. Moon 1,2 , Chen Liu 2 , Masahiro Fukuoka 2 , Fayez 

Dawood 2 , Manyin Chen 2 , Sara Arab 2 , Hong-Liang Li 2 , Geoffrey 

de Couto 1,2 , Mei Sun 2 , Yu Shi 2 , Youan Liu 2 , Liyong Zhang 2 , 

Peter P. Liu 1,2,3 ; 1 University of Toronto, Toronto, ON, Canada; 

2 

Division of Cardiology, University Health Network, Toronto, 

ON, Canada; 3 Canadian Institutes of Health Research, Ottawa, 

ON, Canada 

Impaired Thiol Reductive Capacity as a Result of High 

Glucose Induced TxnIP Expression Contributes to 

Oxidative Stress in Diabetic Cardiomyopathy 

Kim A. Connelly 1 , Andrew Advani 1 , Kerri Thai 1 , Darren 

J. Kelly 2 , Richard E. Gilbert 1 ; 1 Medicine/Cardiology and 

Endocrinology, Keenan Research Institute, Li ka Shing 

Knowledge Centre, St Michael’s Hospital, University of 

Toronto, Toronto, ON, Canada; 2 Medicine, St Vincent’s 

Hospital, University of Melbourne, Melbourne, Vic, Australia 

Withdrawn 

Monday 

P104 

Hyponatremia Is One of the Important Pognostic 

Factors in Acute Myocardial Infarction 

Yuko Tada 1 , Tomohiro Nakamura 1 , Norifumi Kubo 1 , San-e 

Ishikawa 1 , Shin-ichi Momomura 1 ; 1 Cardiology, Jichi Medical 

School Saitama Medical Center, Saitama, Japan 

P122 

Mice Deficient for the Stress-Induced Transcriptional 

Regulator p8 Have a Decreased Metalloprotease 9 

Induction and Cardiac Fibrosis after Transverse Aortic 

Constriction 

Sandro Goruppi 1 , Serban Georgescu 1 , Juan Iovanna 2 , Mark 

Aronowitz 1 , Richard Patten 1 , John Kyriakis 1 ; 1 Molecular 

Cardiology Research Institute, Tufts Medical Center, Boston, 

MA; 2 INSERM, Marseille, France 

62 

63

Sept. 14 

Monday 

Posters 

Posters 


Posters 

Surgery, Transplantation, Devices 

Sept. 14 

Monday 

Posters 

Monday 

P123 

P124 

P125 

P136 

Asymptomatic Carriers of MYBPC3 Gene Mutation for 

Hypertrophic Cardiomyopathy Are Characterized by 

Normal Early Diastolic Tissue Doppler Velocities and 

Longitudinal Strain 

Sabe De 1 , Allen Borowski 1 , Heng Wang 2 , Leah Nye 2 , Baozhong 

Xin 2 , James Thomas 1 , W.H. Wilson Tang 1 ; 1 Cardiovascular 

Medicine, Cleveland Clinic Foundation, Cleveland, OH; 2 Das 

Deutsch Center (DDC) Clinic for Special Needs Children, 

Middlefield, OH 

Cardiac Myocyte-Derived Reactive Oxygen Species Are 

Required for Physiologic Myocardial Hypertrophy and 

Angiogenesis 

Andreia Biolo 1,2 , Jessica DeNapoli 2 , Brian Betensky 2 , Robert 

Doody 2 , Deborah Siwik 2 , Wilson S. Colucci 2 ; 1 Cardiology, 

Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil; 

2 

Myocardial Biology Unit, Boston University Medical Center, 

Boston, MA 

Genetic Diversity and Novel SNP Discovery in 

Signaling Genes Revealed by Pooled Sequencing of 

Cardiomyopathy DNAs 

Scot J. Matkovich 1 , Todd E. Druley 2,3 , Derek J. Van Booven 1 , 

Sung Chun 3 , Francesco M.L. Vallania 3 , Anna Hindes 1 , Justin 

C. Fay 3 , Robi D. Mitra 3 , Gerald W. Dorn II 1 ; 1 Center for 

Pharmacogenomics, Washington University School of Medicine, 

St Louis, MO; 2 Department of Pediatrics, Washington University 

School of Medicine, St Louis, MO; 3 Center for Genome 

Sciences, Washington University School of Medicine, St Louis, 

MO 


Chronic Vagus Nerve Stimulation – Effects on Heart 

Rate and Heart Rate Variability Corroborate Clinical 

Improvement 

R. Dennert 1 , H.J. Crijns 1 , G.M. De Ferrari 2 , A. Sanzo 2 , G. 

Milasinovic 3 , S. Raspopovic 3 , M. Borggrefe 4 , J. Kuschyk 4 , 

A. Schone 4 , H. Klein 5 , J. Smid 5 , A. Gavazzi 6 , A. Iacovoni 6 , 

M. Zabel 7 , P.J. Schwartz 2 ; 1 University Hospital Maastricht, 

Maastricht, Netherlands; 2 University of Pavia IRCCS Policlinico 

S. Matteo, Pavia, Italy; 3 Clinical Center of Serbia, Belgrade, 

Serbia; 4 Ruprechts-Karl University Hospital, Mannheim, 

Germany; 5 Otto von Guericke University Hospital, Magdeburg, 

Germany; 6 Ospedali Riuniti, Bergamo, Italy; 7 Georg-August 

University Hospital, Göttingen, Germany 

P137 

P138 

P139 

P140 

P141 

P142 

Which Type of Stem Cells to Choose for Endocardial 

Injections in Ischemic Heart Failure Patients: Bone 

Marrow or Peripheral Blood? 

Evgeniy Pokushalov 1 , Alexander Romanov 1 , Sergey Artemenko 1 , 

Olga Poveschenko 1 , Alexander Cherniavskiy 1 ; 1 Arrhythmia 

Department, Saye Research Institute of Circulation Pathology, 

Novosibirsk, Russian Federation 

Efficiency of Intramyocardial Injections of Autologous 

Bone Marrow Mononuclear Stem Cells in Patients with 

Ischemic Heart Failure: Long-Term Results 

Evgeniy Pokushalov 1 , Alexander Romanov 1 , Sregey Artemenko 1 , 

Petr Larionov 1 , Alexander Cherniavskiy 1 ; 1 Arrhythmia 

Department, State Research Institute of Circulation Pathology, 

Novosibirsk, Russian Federation 

Coronary Artery Bypass Grafting with and without 

Concomitant Epicardial Cardiac Resynchronization 

Therapy in Patients with Ischemic Heart Failure: Long- 

Term Results 

Evgeniy Pokushalov 1 , Alexander Romanov 1 , Darya Prohorova 1 , 

Alexander Cherniavskiy 1 ; 1 Arrhythmia Department, State 

Research Institute of Circulation Pathology, Novosibirsk, 

Russian Federation 

Construction of a Spontaneously Contracting 

Biologically Active Cardiomyocyte Scaffold 

Jordan J. Lancaster 1 , Nicholle M. Johnson 1 , Elizabeth Juneman 1 , 

Hoang M. Thai 1 , Joeseph Bahl 1 , Steven Goldman 1 ; 1 Cardiology, 

Southern Arizona VA Health Care System, Tucson, AZ 


Continuous Flow LVADs Exert Lower Levels of 

Sustained Mechanical Unloading Compared to Pulsatile 

Devices: A Need for Prospective Evaluation to Optimize 

Continuous Flow Support 

Jerry D. Estep 1 , Aliya Mushtag 2 , Rishi Bhardway 2 , Matthias 

Loebe 3 , Carlos Orrego 1 , Guillermo Torre-Amione 1 ; 1 Cardiology, 

The Methodist Hospital, Houston, TX; 2 Internal Medicine, The 

Methodist Hospital, Houston, TX; 3 Cardiothoracic Surgery, The 

Methodist Hospital, Houston, TX 

Right Ventricular Strain Changes in Patients with Left 

Ventricular Assist Devices Sent for Echocardiographic 

Optimization 

Sabe De 1 , David Verhaert 1 , Deborah Agler 1 , Zoran Popovic 1 , 

Maria Mountis 1 , Randall Starling 1 , W.H. Wilson Tang 1 , James 

Thomas 1 , Richard Grimm 1 ; 1 Cardiovascular Medicine, Cleveland 

Clinic Foundation, Cleveland, OH 

Monday 

64 

65

Sept. 14 

Monday 

Posters 

Posters 


Posters 


Sept. 14 

Monday 

Posters 

P143 

Relation between Temporal Changes in Mitral 

Regurgitation Severity and Reverse Remodeling in 

Patients Undergoing Cardiac Resynchronization 

Therapy 

David Verhaert 1 , Sabe De 1 , Chirapa Puntawangkoon 1 , Bruce L. 

Wilkoff 1 , Randall C. Starling 1 , James D. Thomas 1 , W.H. Wilson 

Tang 1 , Richard A. Grimm 1 , Zoran B. Popovic 1 ; 1 Department of 

Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH 

P148 

The Effect of Adiponectin on the Acute and Chronic 

Rejection of Mice Cardiac Transplantation Model 

Takashi Ishihara 1 , Go Haraguchi 1 , Jun-ichi Suzuki 2 , Masanori 

Konishi 1 , Hirokazu Ohigashi 1 , Mitsuaki Isobe 1 ; 1 Department of 

Cardiovascular Medicine, Tokyo Medical and Dental University, 

Bunkyo-ku, Tokyo, Japan; 2 Department of Advanced Clinical 

Science and Therapeutics, University of Tokyo, Bunkyo-ku, 

Tokyo, Japan 

Monday 

P144 

P145 

P146 

P147 

Initial FDA Post-Approval Study INTERMACS Registry 

Results with a Continuous Flow Left Ventricular Assist 

Device as a Bridge to Heart Transplantation 

Randall C. Starling 1 , Yoshifumi Naka 6 , Andrew J. Boyle 8 , 

Gonzolo Gonzalez-Stawinski 1 , Ranjit John 8 , Ulrich Jorde 6 , Stuart 

D. Russell 3 , John V. Conte 3 , Keith D. Aaronson 4 , Edward C. 

McGee 2 , William G. Cotts 2 , David DeNofrio 7 , Duc Thinh Pham 7 , 

David Farrar 5 , Francis D. Pagani 4 ; 1 Cleveland Clinic, Cleveland, 

OH; 2 Northwestern Univ, Chicago, IL; 3 Johns Hopkins Univ, 

Baltimore, MD; 4 Univ of Michigan, Ann Arbor, MI; 5 Thoratec 

Corp, Pleaston, CA; 6 Columbia Univ, New York, NY; 7 Tufts 

Univ, Boston, MA; 8 Univ of Minnesota, Minneapolis, MN 

Renal Recovery after Implantation of a Left Ventricular 

Assist Device: “The Hibernating Kidney” 

Nitasha Sarswat 1 , Ronald Zolty 1 , Simon Maybaum 1 , Timothy 

J. Vittorio 2 ; 1 Cardiology, Albert Einstein College of Medicine, 

Bronx, NY; 2 Cardiology, Mount Sinai, New York, NY 

Health-Related QOL and Neurocognitive Status 

before and after Implantation of the HeartWare® Left 

Ventricular Assist System 

Emma J. Birks 1 , Mario Dulay 3 , Gerry O’Driscoll 2 , Peter Jansz 4 , 

George Wieselthaler 5 , Martin Strueber 6 ; 1 Mechanical Circulatory 

Support, Harefield Hospital, Harefield, Middlesex, United 

Kingdom; 2 Transplantation, Royal Perth Hospital, Perth, 

Australia; 3 Baylor College of Medicine, Houston, TX; 4 St 

Vincents Hospital, Sydney, Australia; 5 Cardiac Surgery, Vienna, 

Austria; 6 Cardiac Surgery, Hannover, Germany 

Novel Ovine Model of Heart Failure Induced by 

Autologous Platelet Aggregates 

Pawel Kwiatkowski, Chittoor Sai-Sudhakar, Angela Phillips, 

Sampath Parthasarathy, Benjamin Sun; Department of Surgery, 

Division of Cardiothoracic Surgery, Ohio State University 


P149 

P150 

P151 

P152 

P153 

Persistent Right Ventricular Failure after LVAD 

Implantation for Bridge-To-Transplant Does Not Reduce 

Survival to Transplantation 

Robert J. Brewer 1 , Jeffrey A. Morgan 1 , Hassan Nemeh 1 , Celeste 

Williams 2 , Barbara Czerska 2 , Cristina Tita 2 , Conrad Drost 1 , 

Cheryl Smith 1 , Josh Chernich 1 , David Lanfear 2 ; 1 Cardiac 

Thoracic Surgery, Henry Ford Hospital, Detroit, MI; 2 Advanced 

Heart Failure Cardiac Transplantation, Henry Ford Hospital, 

Detroit, MI 

Diastolic Heart Failure – A Mechanical Solution to a 

Mechanical Problem 

Yair Feld 1 , Dubi Shay 2 , Amit Tubishevitz 3 , Remo Almog 3 , Yael 

Ben Shabat 3 , Michal Lipperman 3 , Lior Rosen 3 ; 1 Genegrafts, 

Haifa, Israel; 2 Tel Aviv University, Tel Aviv, Israel; 3 CorAssist 

Cardiovascular Ltd, Herzeliya Pituach, Israel 

Diastolic Heart Failure – Minimally Invasive Approach 

for Device-Based Treatment 

Shay Dubi, Lea Lak, Rona Shofti, Sherman Amir, Micahl 

Shmilovitch, Yair Feld, Ehud Schwammenthal, Shemy Carasso, 

Amir Elami; Tel Aviv University, Tel Aviv, Israel; CorAssist 

Cardiovascular Ltd, Herzeliya Pituach, Israel; Technion Medical 

School, Haifa, Israel; CorAssist Cardiovascular Ltd, Herzeliya 

Pituach, Israel; CorAssist Cardiovascular Ltd., Herzeliya 

Pituach, Israel; Genegrafts, Haifa, Israel; Sheba Hospital, Tel 

Hashomer, Israel; Rambam Hospital, Haifa, Israel; Haddasa 

Hospital, Jerusalem, Israel 

Implantable Cardioverter-Defibrillator Events in 

Patients with Left Ventricular Assist Devices 

Amrut V. Ambardekar 1 , William H. Sauer 1 , Andreas Brieke 1 , 

Christopher M. Lowery 1 , Larry A. Allen 1 ; 1 Division of 

Cardiology, Univ. of Colorado, Aurora, CO 

Risk Factors for Peri-Operative Stroke after Heart 

Transplantation: An Analysis of the United Network for 

Organ Sharing (UNOS) Thoracic Registry 

Vishnu Patlolla 1 , Vanajakshi Mogulla 2 , David DeNofrio 2 , Rajan 

Krishnamani 2 ; 1 Division of Cardiology, UMass Medical Center, 

Worcester, MA; 2 Division of Cardiology, Tufts Medical Center, 

Boston, MA 

Monday 

66 

67

Sept. 14 

Monday 

Posters 

Posters 


Posters 

Electrophysiology/Arrhythmias 

Sept. 14 

Monday 

Posters 

Monday 

P154 

P155 

P156 

P157 

P180 

Prevalence of Reduced Cardiac Index in a Post-Cardiac 

Transplant Population 

J. Testani 1 , A. Yu 1 , B. McCauley 1 , A. Khera 1 , A. Owens 1 , J. 

Kirkpatrick 1 , M. St. John Sutton 1 , S. Wiegers 1 ; 1 Medicine- 

Cardiovascular Division, University of Pennsylvania, 


Hemodynamically Compromising Rejection Predicts 

Future Events 

Nadew S. Sebro 1 , James F. Paulson 1 , John M. Herre 1 ; 1 Eastern 

Virginia Medical School, Norfolk, VA 

Combination of Axial Flow Circulatory Support and 

Aggressive Neurohormonal Blockade for Recovery of 

Cardiac Function in Advanced Heart Failure 

S. Murthy 1 , G. Kamalakkannan 1 , D. Bartov 1 , P. Edwards 1 , 

D. Spevack 1 , R. Zolty 1 , D. D’Alessandro 1 , D. Goldstein 1 , S. 

Maybaum 1 ; 1 Albert Einstein College of Medicine, NY 

Myocardial Sarcoplasmic Reticulum Ca2+-ATPase 

and Ryanodine Receptor-2 mRNA Expression Are Not 

Associated with Rejected Heart with Reduced Diastolic 

Function in Heart Transplant Recipients 

Yusuke Sata 1 , Tomoko S. Kato 1 , Kazuo Komamura 1 , Hatsue 

Ueda 2 , Junjiro Kobayashi 3 , Takeshi Nakatani 1 ; 1 National 

Cardiovascular Center, Division of Cardiology, Suita, Osaka, 

Japan; 2 National Cardiovascular Center, Division of Pathology, 

Suita, Osaka, Japan; 3 National Cardiovascular Center, Division 

of Surgery, Suita, Osaka, Japan 


AFFIRM: Heart Failure Is More Severe in Atrial 

Fibrillation Than in Sinus Rhythm 

Maya Guglin, Ren Chen, Anne B. Curtis; Cardiology, University 

of South Florida, Tampa, FL 

P181 

P182 

P183 

P184 

ICDs and Sudden Death in Recent Onset 

Cardiomyopathy: Results from IMAC 

Richard Sheppard 1 , Paul Mather 2 , Randall C. Starling 4 , John 

Boehmer 5 , Jeffrey Alexis 6 , Vinay Thohan 7 , Daniel Pauly 8 , David 

Markham 9 , Mark Zuker 10 , Dennis M. McNamara 3 , for the IMAC 

Investigators; 1 Division of Cardiology, SMBD Jewish General 

Hospital, Montreal, QC, Canada; 2 Heart Failure and Cardiac 

Transplant Center, Jefferson Medical College, Philadelphia, 

PA; 3 Cardiovascular Institute, UPMC, Pittsburgh, PA; 4 Heart 

Failure and Cardiac Transplant Medicine, Cleveland Clinic, 

Cleveland, OH; 5 Division of Cardiology, Pennsylvania State 

College of Medicine, Hershey, PA; 6 Cardiovascular Research 

Institute, University of Rochester Medical Center, Rochester, 

NY; 7 Heart Failure and Heart Transplant Program, Wake Forest 

University Baptist Medical Center, Winston-Salem, NC; 

8 

Division of Cardiovascular Medicine, University of Florida, 

Gainesville, FL; 9 Heart Transplant Program, UT Southwestern 

Medical Center, Dallas, TX; 10 Heart Failure and Cardiothoracic 

Transplantation, Newark Beth Israel Medical Center, Newark, 

NJ 

Is Appropriate Shock Therapy Associated with an 

Adverse Prognosis among Patients with an Implantable 

Cardioverter Defibrillator and an Ejection Fraction > 

35%? 

Sanjeev P. Bhavnani 1 , Faisal Zaeem 1 , Craig Coleman 1 , Danette 

Guertin 1 , Jeffrey Kluger 1 ; 1 Cardiology and Heart Rhythm 

Management, Hartford Hospital, Hartford, CT 

Prevention of Paced Myocardial Dysfunction: A 

Comparative Analysis of Chronic Pacing Sites in the 

Young 

Peter P. Karpawich, Wei Du, Mark V. Zilberman; Pediatric 

Cardiology, Childrens Hospital Michigan/Wayne State, Detroit, 

MI 

Value of Mitral Doppler Inflow Pattern to Optimize 

Atrioventricular Delay in Dual (DDD) and Triple 

Chamber (CRT) Pacemakers 

Raul Chirife 1 , Hugo Mosto 2 , Julio Pastori 2 , Juan P. Guerchi 3 , 

Hugo Grancelli 3 , Enrique Gayet 1 , Cristina Tentori 1 ; 1 Cardiology, 

Hospital Fernández, Buenos Aires, BA, Argentina 

Monday 

P185 

Predictive Value of New York Heart Association 

Class in Determining Functional Status by Means of 

Cardiopulmonary Exercise Testing in a Multi-Ethnic 

Community 

Christopher J. Varughese 1 , Iosif Kelesidis 1 , Patrick Hourani 1 , 

Ronald Zolty 1 ; 1 Cardiology/Division of Congestive Heart 

Failure, Einstein - Montefiore Medical Center, Bronx, NY 

68 

69

Sept. 14 

Monday 

Posters 

Posters 


Posters 

Clinical Trials 

Sept. 14 

Monday 

Posters 

Monday 

P186 

P187 

P188 

P189 

P200 

Stroke Risk in Patients with Cardiac Resynchronization 

Therapy from the ADVANCENT Heart Failure Registry: 

Not Related to Atrial Fibrillation in Those Older Than 

75 Years 

Kathleen L. Tong 1 , Bobbi Hoppe 2 , Ezra Amsterdam 1 , Yingbo 

Yang 1 , Uma Srivatsa 1 ; 1 Cardiology, University of California at 

Davis, Sacramento, CA; 2 Cardiology, North Memorial Hospital, 


The Degree of Clinical and Anatomic Response to 

Cardiac Resynchronization Therapy Correlates 

Significantly with Clinical Outcomes 

Olujimi A. Ajijola 1 , Iryna Makovey 1 , Melanie Barantke 1 , E. 

Kevin Heist 1 , Tanya Harrell 1 , Gaurav Upadhyay 1 , Dan Blandea 1 , 

David McCarty 2 , Eric A. Macklin 3 , Mary Orencole 1 , Marc 

Semigran 4 , Jeremy N. Ruskin 1 , Michael Picard 2 , Jagmeet P. 

Singh 1 ; 1 Cardiac Arrhythmia Service, Massachusetts General 

Hospital, Boston, MA; 2 Division of Echocardiography, 

Massachusetts General Hospital, Boston, MA; 3 Biostatistics 

Center, Massachusetts General Hospital, Boston, MA; 4 Heart 

Failure Service, Massachusetts General Hospital, Boston, MA 

Similar Patterns of Autonomic Dysfunction and Exercise 

Capacity in Patients with Chronic Heart Failure and 

Lung Cancer 

Thomas Kung 1 , Carola Misgeld 1 , Matthias Paland 1 , Wolfram 

Doehner 1 , Stefan D. Anker 1 , Matthias Rauchhaus 2 , Stephan von 

Haehling 1 ; 1 Cardiology, Applied Cachexia Research, Charite- 

Berlin, Berlin, Germany; 2 Cardiology, Charite-Berlin, Berlin, 

Germany 

Successful Treatment of Sarcoid Related Ventricular 

Tachycardia Storm with Immunosuppression and 

Catheter Ablation 

Christopher S. Stees 1 , William H. Sauer 1 , Royce Bargas 1 , 

Andreas Brieke 1 , Howard Weinberger 2 , Michelle S.C. Khoo 1 ; 

1 

Division of Cardiology Section of Electrophysiology, 

University of Colorado at Denver, Aurora, CO; 2 Division of 

Cardiology, National Jewish Medical Center, Denver, CO 


Cardiac Resynchronization Therapy in Patients with 

Left Ventricular Ejection Fraction Above 35% 

Eugene S. Chung 1 , Rodolphe Katra 2 , Stefano Ghio 3 , Jeroen Bax 4 , 

Bart Gerritse 2 , Brett J. Peterson 2 , David Feldman 5 , William T. 

Abraham 5 ; 1 The Christ Hospital, Cincinnati, OH; 2 Medtronic, 

Inc, Minneapolis, MN; 3 Ospedale Policlinico S. Matteo, Pavia, 

Italy; 4 Leiden University, Leiden, Netherlands; 5 The Ohio State 

University, Columbus, OH 

P201 

P202 

P203 

A High Incidence of Ventricular Recovery in Acute 

Cardiomyopathy Patients Supported with a Left 

Ventricular Assist Device: Results of the IMAC 2 Trial 

John P. Boehmer 1 , Randall C. Starling 2 , Leslie T. Cooper 3 , 

Guillermo Torre-Amione 4 , Ilan Wittstein 5 , G. William Dec 6 , 

David W. Markham 7 , Mark J. Zucker 8 , Dennis M. McNamara 9 ; 

1 

The Heart Vascular Institute, The Penn State University College 

of Medicine, Hershey, PA; 2 Kaufman Center for Heart Failure, 

Cleveland Clinic, Cleveland, OH; 3 Cardiovascular Diseases, 

Mayo Clinic, Rochester, MN; 4 Cardiology, The Methodist 

Hospital, Houston, TX; 5 Cardiology, The Johns Hopkins 

Hospital, Baltimore, MD; 6 Cardiology, The Massachusetts 

General Hospital, Boston, MA; 7 Cardiology, UT Southwestern 

Medical Center, Dallas, TX; 8 Cardiology, Newark Beth Israel 

Medical Center, Newark, NJ; 9 UPMC Cardiovascular Institute, 

University of Pittsburgh, Pittsburgh, PA 

Improvement in Renal Function during Hospitalization 

for Acute Decompensated Heart Failure Is Not 

Associated with Favorable Outcomes 

Mahoto Kato 1 , Michael M. Givertz 1 , Todd M. Koelling 2 , Anju 

Nohria 1 ; 1 Heart Falire, Cardiovascular Medicine, Brigham and 

Women’s Hospital, Boston, MA; 2 Division of Cardiovascular 

Medicine, University of Michigan Medical Center, Ann Arbor, 

MI 

Changes in Dyspnea during Treatment of Acute 

Heart Failure Are Correlated with Clinical Signs, 

Rehospitalizations and Mortality. Results from the Pre- 

RELAX-AHF Trial 

Marco Metra 1 , John R. Teerlink 2 , Beth D. Weatherley 4 , Barry 

H. Greenberg 5 , G. Michael Felker 3 , Piotr Ponikowski 6 , Adrian 

A. Voors 7 , Gerasimos Filippatos 9 , John Feaganes 4 , Elaine 

Unemori 8 , Sam L. Teichman 8 , Gad Cotter 4 ; 1 Cardiology, 

University, Brescia, BS, Italy; 2 San Francisco VAMC, UCSF, 

San Francisco, CA; 3 Duke Clinical Research Institute, Duke 

University, Durham, NC; 4 Momentum Research, Inc, Durham, 

NC; 5 Advanced Heart Failure Program, University of California, 

UCSD Medical Center, San Diego, CA; 6 Cardiology, Military 

Hospital, Department of Health Sciences, Medical University, 

Wroclaw, Poland; 7 Cardiology, University Medical Center 

Groningen, Groningen, Netherlands; 8 Corthera, Inc, San Mateo, 

CA; 9 Cardiology, Athens University Hospital Attikon, Athens, 

Greece 

Monday 

70 

71

Sept. 14 

Monday 

Posters 

Posters 


Posters 


Sept. 14 

Monday 

Posters 

Monday 

P204 

P205 

P206 

P207 

Improved Functional Capacity and Cardiovascular 

Structure after Baroreflex Activation Therapy in 

Resistant Hypertension Patients with Symptomatic 

Heart Failure: Results from European and United States 

Trials of the Rheos® System 

John D. Bisognano 1 , Peter de Leeuw 2 , David S. Bach 3 , Eric G. 

Lovett 4 , Christopher L. Kaufman 4 ; 1 University of Rochester 

Medical Center, Rochester, NY; 2 University Hospital Maastricht, 

Maastricht, Netherlands; 3 University of Michigan, Ann Arbor, 

MI; 4 CVRx, Inc., Minneapolis, MN 

Withdrawn 

A Phase 2 Randomized, Double-Blind, Placebo- 

Controlled Exploratory Efficacy Study of Sitaxsentan 

Sodium to Improve Impaired Exercise Tolerance in 

Subjects with Diastolic Heart Failure 

M.R. Zile 1 , R.J. Barst 2 , R. Bourge 3 , M.M. Redfield 4 , W.C. 

Little 5 ; 1 Medical University of South Carolina, Charleston, SC; 

2 

Columbia University College of Physicians Surgeons, New 

York, NY; 3 University of Alabama at Birmingham, Birmingham, 

AL; 4 Mayo Clinic, Rochester, MN; 5 Wake Forest University, 


Worsening Renal Function in Acute Heart Failure: 

Change in Blood Pressure and Effects of Relaxin 

G. Michael Felker 1 , Adriaan A. Voors 2 , Marco Metra 3 , John 

R. Teerlink 4 , Piotr Ponikowski 5 , Barry H. Greenberg 6 , Elaine 

Unemori 7 , Gad Cotter 8 , Sam L. Teichman 7 ; 1 Division of 

Cardiology, Duke Clinical Research Institute, Durham, NC; 

2 

Department of Cardiology, University Medical Center, 

Gronigen, Netherlands; 3 Section of Cardiovascular Disease, 

University of Brescia, Brescia, Italy; 4 Section of Cardiology, 

University of California-San Francisco, San Francisco, CA; 

5 

Cardiology Department, Military Hospital, Wroclaw, Poland; 

6 

Division of Cardiology, University of California-San Diego, 

San Diego, CA; 7 Corthera, Inc, San Mateo, CA; 8 Momentum 

Research, Inc, Durham, NC 

P208 

P209 

P210 

P211 

P212 

Impact of Myocardial Fibrosis on Systolic Strain and 

Diastolic Performance Quantified by Myocardial 

Tagging and Velocity Encoded MRI in Patients with 

Hypertrophic Cardiomyopathy 

Thananya Boonyasirinant 1 , Randolph M. Setser 1 , Milind Y. 

Desai 1 , Scott D. Flamm 1 ; 1 Cardiology and Radiology, Cleveland 

Clinic, Cleveland, OH 

Influence of Atrial Fibrillation on the Use of CRT 

and ICD Therapy in Heart Failure: Findings from 

IMPROVE HF 

A.B. Curtis 1 , G.C. Fonarow 2 , C.W. Yancy 3 , N.M. Albert 4 , 

W. Gattis Stough 5 , M. Gheorghiade 6 , J.T. Heywood 7 , M.L. 

McBride 8 , M. Mehra 9 , C. O’Connor 10 , D. Reynolds 11 , M.N. 

Walsh 12 ; 1 USF; 2 UCLA; 3 Baylor; 4 CCF; 5 Campbell U; 

6 

Northwestern; 7 Scripps; 8 Outcome; 9 U MD; 10 DCRI; 11 OK U; 

12 

The Care Group 

Bnp Levels in Outpatients with Heart Failure: 

Frequency of Assessment, Relationship to Symptoms, 

Disease Severity, and HF Quality of Care Measures 

M. Gheorghiade 1 , G.C. Fonarow 2 , C.W. Yancy 3 , N.M. Albert 4 , 

A.B. Curtis 5 , W. Gattis Stough 6 , J.T. Heywood 7 , M.L. McBride 8 , 

M. Mehra 9 , C. O’Connor 10 , D. Reynolds 11 , M.N. Walsh 12 ; 

1 

Northwestern; 2 UCLA; 3 Baylor; 4 CCF; 5 USF; 6 Campbell U; 

7 

Scripps; 8 Outcome; 9 U. MD; 10 DCRI; 11 OK U.; 12 The Care Group 

Prevalence and Characteristics of Prolonged Qrs 

Duration in Outpatients with Left Ventricular Systolic 

Dysfunction: An IMPROVE HF Analysis 

J.T. Heywood 1 , G.C. Fonarow 2 , C.W. Yancy 3 , N.M. Albert 4 , A.B. 

Curtis 5 , W. Gattis Stough 6 , M. Gheorghiade 7 , M.L. McBride 8 , M. 

Mehra 9 , C. O’Connor 10 , D. Reynolds 11 , M.N. Walsh 12 ; 1 Scripps; 

2 

UCLA; 3 Baylor; 4 CCF; 5 USF; 6 Campbell U; 7 Northwestern; 

8 

Outcome; 9 U. MD; 10 DCRI; 11 OK U.; 12 The Care Group 

Hypertension, Potentially Leading to Heart Failure, 

Associated with Anti-Vascular Endothelial Growth 

Factor Therapy Can Be Predicted by Baseline Risk 

Factors and Serial B-Type Natriuretic Peptide Levels 

during Treatment 

Aarif Khakoo 1 , Mona Massey 1 , Cindy Chua 1 , Amy Chiu 1 , 

Elie Mouhayer 1 , Jean-Bernard Durand 1 , Daniel J. Lenihan 1 ; 

1 

Cardiology, UT MD Anderson Cancer Center, Houston, TX 

Monday 

72 

73

Sept. 14 

Monday 

Posters 

Posters 


Posters 

Cardiovascular Pharmacology 

Sept. 14 

Monday 

Posters 

Monday 

P213 

P214 

P215 

P216 

P217 

An Analysis of the Response to CK-1827452, a Selective 

Cardiac Myosin Activator, in Stable Heart Failure 

Patients Stratified by Baseline Cardiac Function 

Fady I. Malik 1 , Khalil G. Saikali 1 , Michael M. Chen 1 , Jacqueline 

H. Lee 1 , Jonathan H. Goldman 2 , Andrew A. Wolff 1 , John R. 

Teerlink 3 , CY 1121 Investigators; 1 Cytokinetics, Inc., South San 

Francisco, CA; 2 ICON Medical Imaging, Inc., Warrington, PA; 

3 

UCSF, San Francisco, CA 

Pharmacokinetics (PK) of Adenosine A1 Receptor 

Antagonist BG9928 in Healthy Subjects, Elderly 

Subjects, and Subjects with Severe Renal Insufficiency 

(SRI) 

Thomas C. Marbury 1 , Barry Ticho 2 , Scott Stecher 2 , Ying Zhu 2 , 

Suzanne K. Swan 3 ; 1 Orlando Clinical Research Center, Orlando, 

FL; 2 Biogen Idec, Cambridge, MA; 3 Division of Nephrology, 

University of Minnesota, Minneapolis, MN 

In Hospital Early (Within 5 Days) Worsening HF 

Predicts Adverse Outcome in Patients Admitted for AHF 

– Results from the Pre-RELAX-AHF Study 

B. Davison Weatherley, G. Cotter, GM Felker, J.R. Teerlink, G. 

Filippatos, B. Greenberg, A. Voors, M. Metra, S.L. Teichman, E. 

Unemori; Momentum Research,Inc., Durham, NC; Cardiology, 

Duke Clinical Research Institute, Durham, NC; Section of 

Cardiology, Veterans Affairs Medical Center, University of 

California, San Francisco, CA; Athens University Hospital, 

Athens, Greece; Advanced Heart Failure Program, University 

of California, San Diego, CA; Department of Cardiology, 

University Medical Center, Groningen, Netherlands; Cardiology, 

University of Brescia, Brescia, Italy; Corthera,Inc, SanFrancisco 

Baseline Dyssynchrony Affects the Degree of RV-Pacing 

Induced Dyssynchrony 

John P. McKenzie 1 , Kalyan Obalampalli 1 , Nooshin Shahabi 1 , 

Rachel Bigger 1 , Jimmy Grape 1 , Jennifer Graham 1 , Keith 

Williams 1 ; 1 Glendale Memorial Hospital and Health Center, 

Glendale, CA 

Chronic Monitoring of Heart Failure Patients: Results 

from the Multi-Sensor Monitoring in Congestive Heart 

Failure (MUSIC-Asia) Study 

Inder S. Anand 1 , Vijay K. Chopra 2 , Naveen C. Reddy 3 , Imad 

Libbus 4 ; 1 Cardiology, VA Medical Center, Minneapolis, MN; 

2 

Cardiology, Escorts Heart Institute Research Center, New 

Delhi, India; 3 Cardiology, Mediciti Hospital, Hyderabad, India; 

4 

Research Technology, Corventis, Inc., St. Paul, MN 

P235 

P236 

P237 

P238 

P239 

P240 

P241 

Glucagon-Like Peptide-1 Enhances Voltage-Gated Ca2+ 

Currents of Canine Ventricular Myocytes 

Yong-Fu Xiao 1 , Alena Nikolskaya 1 , Deborah A. Jaye 1 , Daniel C. 

Sigg 1 ; 1 Cardiac Rhythm Disease Management, Medtronic, Inc., 

Mounds View, MN 

A Polymorphism in the Aldosterone-Receptor-Gene and 

Mortality in Chronic Heart Failure Patients 

Morten Petersen 1 , Jon T. Andersen 1 , Mette Nyegaard 2 , Christian 

Torp-Pedersen 3 , Lars Kober 4 , Henrik E. Poulsen 1 ; 1 Laboratory of 

Clinical Pharmacology, Rigshospitalet, Copenhagen, Denmark; 

2 

Institute of Human Genetics, Aarhus University, Aarhus, 

Denmark; 3 Department of Cardiology, Gentofte University 

Hospital, Hellerup, Denmark 

The Effect of Renin-Angiotensin System Inhibitors on 

Mortality and Heart Failure Hospitalization in Diastolic 

Heart Failure: A Pooled Analysis of Randomized 

Controlled Trials 

Ravi V. Shah 2 , Akshay S. Desai 1 , Michael M. Givertz 1 ; 

1 

Medicine, Brigham and Women’s Hospital, Boston, MA; 

2 

Medicine, Massachusetts General Hospital, Boston, MA 

Effect of GLP-1 Receptor Agonist on Acute Myocardial 

Infarction and Post-MI Chronic Heart Failure in Rats 

Ismayil Ahmet 1 , Kapil Kapoor 1 , Edward G. Lakatta 1 , Mark I. 

Talan 1 ; 1 Laboratory of Cardiovascular Sciences, NIA/NIH, 

Baltimore, MD 

Sustained Acting Atrial Natriuretic Peptide: A Novel 

Renal Selective Natriuretic Peptide Synthesized from a 

Human Frameshift Mutation of the Atrial Natriuretic 

Peptide Gene 

Paul McKie 1 , Cataliotti Alessandro 1 , Brenda Huntley 1 , Fernando 

Martin 1 , Timothy Olson 2 , John Burnett, Jr. 1 ; 1 Cardiorenal 

Research Laboratory, Mayo Clinic, Rochester, MN; 

2 

Cardiovascular Genetics, Mayo Clinic, Rochester, MN 

Thyroid Hormone Improves Left Ventricular Myocyte 

Remodeling after Myocardial Infarction in Rats 

Yue-Feng Chen 1 , Sapna Bhatia 1 , Rebecca A. Redetzke 1 , Tamora 

Coburn 1 , Anthony M. Gerdes 1 ; 1 Cardiovascular Health Research 

Center, Sanford Research/University of South Dakota, Sioux 

Falls, SD 

Intravenous Infusion of CXL-1020, a Novel Nitroxyl 

(HNO) Donor, Improves Left Ventricular Systolic and 

Diastolic Function in Dogs with Advanced Heart Failure 

Mengjun Wang 1 , Reza Mazhari 2 , Itamar Ilsar 1 , Alice Wang 1 , 

Michael S. Sabbah 1 , Hani N. Sabbah 1 ; 1 Medicine, Henry Ford 

Health System, Detroit, MI; 2 Cardioxyl Pharmaceuticals, Inc., 

Hunt Valley, MD 

Monday 

74 

75

Sept. 14 

Monday 

Posters 

Posters 


Posters 

Epidemiology, Prevention 

Sept. 14 

Monday 

Posters 

Monday 

P242 

P243 

P244 

P245 

P246 

P260 

Potential Benefit of Erythropoiesis Stimulating Agents in 

Heart Failure Patients with Anemia: A Meta-Analysis 

Faramarz Tehrani 1 , Pavittarpaul Dhesi 1 , Daniel Daneshvar 1 , 

Anita Phan 1 , Asim Rafique 1 , Bojan Cercek 1 ; 1 Cardiology, Cedars 

Sinai Medical Center, Los Angeles, CA 

Vasodilators in Acute Heart Failure (AHF): Does Blood 

Pressure Matter? Results from Pre-Relax-AHF 

John R. Teerlink 1 , Marco Metra 2 , G. Michael Felker 3 , Adriaan 

A. Voors 4 , Barry H. Greenberg 5 , Piotr Ponikowski 6 , Sam L. 

Teichman 7 , Gad Cotter 8 ; 1 Cardiology, San Francisco Veterans 

Affairs Medical Center/ University of California, San Francisco, 

San Francisco, CA; 2 Experimental and Applied Medicine; 

Cardiology, University of Brescia, Brescia, BS, Italy; 3 Duke 

Clinical Research Institute, Durham, NC; 4 Cardiology, 

University Medical Center Groningen, Groningen, Netherlands; 

5 

Cardiology, University of California, San Diego, San Diego, 

CA; 6 Cardiology, Military Hospital, Department of Health 

Sciences, Medical University, Wroclaw, Poland; 7 Corthera, Inc, 

San Mateo, CA; 8 Momentum Research, Inc, Durham, NC 

Bucindolol Decreases Time to First HF Hospitalization in 

Patients with Chronic Kidney Disease 

JoAnn Lindenfeld 1 , Mona Fiuzat 2 , Gordon Davis 3 , Michael 

Bristow 1,3 ; 1 University of Colorado Health Sciences Center, 

Denver, CO; 2 Duke University Medical Center, Durham, NC; 

3 

ARCA Biopharma, Inc, Broomfield, CO 

Circulating Caspase-3 P17 Peptide Fragment in Patients 

with Heart Failure 

Mariela Agosto 1 , Whitney Besse 1 , Priscilla Owusu 1 , Janet Tate 1 , 

Jayne Schumacher 1 , Mary B. Barry 1 , Detlef Wencker 1 , David 

Hager 1 , Bruce T. Liang 1 ; 1 Cardiology, University of Connecticut 

Health Center, Farmington, CT 

Intravenous Infusion of Novel HNO Donor, CXL-1020, 

Improves Left Ventricular Contractile Function in 

Normal and Failing Dogs 

Samantapudi Daya 1 , Reza Mazhari 2 , Richard S. Tunin 1 , David 

A. Kass 1 ; 1 Medicine, Johns Hopkins University, Baltimore, MD; 

2 

Cardioxyl Pharmaceuticals, Inc., Hunt Valley, MD 


Quality of Life and Depressive Symptoms among 

Minorities with Acute Decompensated Heart Failure in 

Hospitals Serving a Majority Black Population 

V. Sharma 1 , S. Zehtabchi 2 , N. Rojas 1 , R. Amipara 1 , P. Khullar 1 , 

R. Birkhahn 3 ; 1 SUNY Downstate, Brooklyn, NY; 2 Kings County 

Hospital, Brooklyn, NY; 3 Methodist Hospital, Brooklyn, NY 

P261 

P262 

P263 

P264 

P265 

P266 

P267 

Sleep Apnea Testing and Outcomes in a Large Cohort 

of Medicare Beneficiaries with Newly Diagnosed Heart 


William T. Abraham 1 , Shahrokh Javaheri 2 ; 1 Division of 

Cardiovascular Medicine, The Ohio State University, Columbus, 

OH; 2 Sleepcare Diagnostics, Cincinnati, OH 

Functional Limitation in Heart Failure: Assessing the 

Impact of Peripheral Arterial Disease 

Bamidele Adesunloye 1 , Anekwe Onwuanyi 2 ; 1 Department 

of Medicine, Morehouse School of Medicine, Atlanta, GA; 

2 

Division of Cardiology, Morehouse School of Medicine, 

Atlanta, GA 

Gender Differences in Use of Implantable Cardiac 

Defibrillators and Resynchronization Therapy for Heart 

Failure in California, 2000-2006 

David P. Kao 1 , Heather Raff 1 , Pamela Peterson 1 ; 1 Cardiology, 

Department of Medcine, University of Colorado Denver, Aurora 

Prevalence of CHF among United States Population: An 

Analysis of NHANES 2005-2006 Data 

pramil Cheriyath 1 , Ian Peters 2 , Daniel Fischman 3 ; 1 Department 

of Medicine, PinnacleHealth Systems, Harrisburg Hospital, 

Harrisburg, PA; 2 Department of Public Health Sciences, 

Pennsylvania State University, Hershey, PA 

Can Heart Failure Medications Prevent Trastuzumab- 

Induced Cardiotoxicity? 

Christopher C. Reynolds 1 , Gregory Hartlage 2 , Ren Chen 3 , Vinod 

Patel 1 , Maya Guglin 1 ; 1 University of South Florida, Tampa, FL; 

2 

Emory University, Atlanta, GA; 3 H. Lee Moffitt Cancer Center, 

Tampa, FL 

Got “D” Blues in Kansas City: Surprising Findings of 

Vitamin D Deficiency in Chronic Heart Failure Patients 

Evelyn Dean 1 , Ann Homburger 1 , Sherry Moore 1 , Julie Rolstad 1 , 

Anthony Magalski 1 , Stephanie Lawhorn 1 ; 1 Heart Failure 

Department, Mid-America Heart Institute of Saint Luke’s 

Hospital of Kansas City, Kansas City, MO 

Relationships between Co-Morbidities, Reimbursement 

and Cost in the Treatment of Heart Failure 

Patrick J. Dunn; Quality Department, Medical Center of 

Lewisville, Lewisville, TX; Clinical Development, HealthCall, 

Crown Point, IN 

Monday 

76 

77

Sept. 14 

Monday 

Posters 

Posters 


Posters 

Outcomes 

Sept. 14 

Monday 

Posters 

Monday 

P268 

P269 

Incidence of Hospitalized Acute Decompensated Heart 

Failure in Four U.S. Communities: The Atherosclerosis 

Risk in Communities (ARIC) Study 

Patricia P. Chang 1 , Wayne D. Rosamond 1 , Eyal Shahar 2 , Alain 

G. Bertoni 3 , Stuart D. Russell 4 , Tandaw Samdarshi 5 , Thomas 

H. Mosley 5 , Hanyu Ni 6 , Lynne E. Wagenknecht 3 , Lloyd E. 

Chambless 1 ; 1 Collaborative Studies Coordinating Ctr, Univ of 

North Carolina, Chapel Hill, NC; 2 Epidemiology Biostatistics, 

Univ of Arizona, Tucson, AZ; 3 Public Health Sciences, Wake 

Forest Univ, Winston-Salem, NC; 4 Medicine, Johns Hopkins 

Univ, Baltimore, MD; 5 Medicine, Univ of Mississippi, Jackson, 

MS; 6 NHLBI, NIH, Bethesda, MD 

Impacts of “Warm &Wet” and “Cold &Wet” on Clinical 

Evaluations in the Real-World Acute Heart Failure 

Syndromes Patients: Data from Attend Registry 

Koji Murai 1 , Naoki Sato 1 , Katsuya Kajimoto 2 , Ryo Munakata 1 , 

Kuniya Asai 1 , Michitaka Nagashima 2 , Masayuki Mizuno 3 , 

Yuichiro Minami 3 , Keiji Tanaka 1 , Kyoichi Mizuno 1 , Teruo 

Takano 1 ; 1 Division of Cardiology, Nippon Medical School, 

Tokyo, Japan; 2 Department of Cardiology, Shonan Dai-ichi 

Hospital, Kanagawa, Japan; 3 Department of Cardiology, Tokyo 

Women’s Medical University, Tokyo, Japan 

P284 

P285 

P286 

Effects of Successful Depression Intervention on Health 

Status in Patients with Chronic Heart Failure and Major 

Depressive Disorder: Findings from the SADHART-CHF 

Randomized Controlled Trial 

Mona Fiuzat 1 , Wei Jiang 1 , John Spertus 2 , Maragatha 

Kuchibhatla 1 , Michael Cuffe 1 , Ranga Krishnan 1 , Christopher 

O’Connor 1 ; 1 Duke University Medical Center and Duke Clinical 

Research Institute, Durham, NC; 2 University of Missouri, 


Mode of Death in Advanced Heart Failure: Impact of 

Race, Etiology and Hemodynamics in the ESCAPE Trial 

Joseph Rogers, Mona Fiuzat, Gudaye Tassisa, Christopher 

O’Connor; Department of Medicine and Clinical Pharmacology, 

Duke University Medical Center and Duke Clinical Research 

Institute, Durham, NC 

Impact of Case Volume on Medicare’s Quality Care 

Performance Measures and Mortality Rates for Heart 


Jun R. Chiong 1 , Loretta J. Wilber 2 ; 1 Division of Cardiology, 

Loma Linda University; 2 School of Public Health, Loma Linda 

University, Loma Linda, CA 

Monday 

P270 

P271 

P283 

Prevalence and Clinical Characteristics Associated with 

Anemia in Chronic Heart Failure in Argentina. A Report 

from Hospical II Registry 

Maria L. Coronel 1 , Fabian Diez 2 , Perla Barrios 1 , Lilia L. Lobo 

Marquez 2 , Carlos Poy 2 , Roberto M. Colque 2 , Sergio V. Perrone 2 , 

Juan P. Cimbaro Canella 1 , Cristian Botta 2 , Eduardo R. Perna 1 ; 

1 

Heart Failure Clinic, Instituto de Cardiologia J. f. Cabral, 

Corrientes, Argentina; 2 Heart Failure Committee, Federacion 

Argentina de Cardiologia, Argentina 

Am I Going to Drop Dead? Patient Awareness of Cardiac 

Risk Factors 

Raffaele Corbisiero 1 , Rebecca Armbruster 1 , David Muller 2 ; 

1 

Electrophysiology, Deborah Heart Lung Center, Browns Mills, 

NJ; 2 Engineer, St Jude Medical, Sylmar, CA 

Outcomes 

Lack of Correlation between HF Performance Measures 

and 30-Day Rehospitalization Rates 

Mark E. Dunlap 1 , Peter J. Greco 1 , Barbara L. Halliday 1 , Douglas 

Einstadter 1 ; 1 Medicine, MetroHealth Campus of Case Western 

Reserve University, Cleveland, OH 

P287 

P288 

P289 

Impact of Kidney Function on Long-Term Survival 

in Pediatric Patients with End-Stage Heart Failure 

Undergoing Heart Transplantation: An Analysis of the 

United Network of Organ Sharing Database 

J.W. Rossano 1 , D.L. Morales 1 , F. Zafar 1 , S.L. Goldstein 1 , E.O. 

Smith 1 , S.W. Denfield 1 , J.J. Kim 1 , J.F. Price 1 , J.S. Heinle 1 , W.J. 

Dreyer 1 , J.L. Jefferies 1 ; 1 Pediatrics and Surgery, Baylor College 

of Medicine/Texas Children’s Hospital, Houston, TX 

Correlations between Heart Failure Symptoms, 

Uncertainty and Cognitive and Emotional Reasons for 

Delay 

Kristen A. Sethares 1 ; 1 Adult and Child Nursing, University of 

Massachusetts Dartmouth, North Dartmouth, MA 

Left Ventricular End-Diastolic Pressure Guided 

Treatment of Patients Hospitalized for Heart Failure 

Reduces Rehospitalization Rate 

G.V.R.K. Sharma 1,2 , Patricia Woods 1 , Carol O’Connell 4 , Louise 

Connolly 1 , Jacob Joseph 1,3 , Kevin McIntyre 4 ; 1 Department of 

Cardiology, VA Boston Healthcare System, West Roxbury, MA; 

2 

Harvard Medical School, Boston, MA; 3 School of Medicine, 

Boston University, Boston, MA; 4 CVP Diagnostics, Boston, MA 

78 

79

Sept. 14 

Monday 

Posters 

Posters 

Outcomes 

Posters 

Outcomes 

Sept. 14 

Monday 

Posters 

Monday 

P290 

P291 

P292 

P293 

P294 

Anxiety and Depression in Ethnic Minorities with 

Chronic Heart Failure 

Lorraine S. Evangelista 1 , Alvina Ter-Galstanyan 2 , Samira 

Moughrabi 1 ; 1 School of Nursing, University of California, Los 

Angeles, Los Angeles, CA; 2 School of Public Health, University 

of California, Los Angeles, Los Angeles, CA 

Persistence of Worsening Renal Function during Acute 

Heart Failure Hospitalization 

David E. Lanfear 1 , Oluchi Uju-Eke 1 , Oday L. Rabadi 1 , David 

Wu 2 , David Favro 1 , Janis Campbell 1 , Edward L. Peterson 1 , L. 

Keoki Williams 1 ; 1 Center for Health Service Research, Henry 

Ford Hospital, Detroit, MI; 2 Global Outcomes Research, Merck 

Co., Inc., Whitehouse Station, NJ 

Effect of Reduced Right Ventricular Ejection Fraction on 

Mortality in Advanced Systolic Heart Failure 

Philippe Meyer 1 , Michel White 1 , Ahmed Ali 2 ; 1 Montreal Heart 

Institute, Montreal, QC, Canada; 2 University of Alabama at 

Birmingham, Birmingham, AL 

Prolonged QRS Duration Does Not Worsen Five Year 

Survival for Patients with Diastolic Heart Failure 

Mohammad Hoque 1 , Hong Ra 1 , Prabhjot Nijjar 1 , Nazmul 

Huda 1 , Kinnari Murthy 1 , Darshak H. Karia 1 ; 1 Cardiology, Albert 

Einstein Medical Center, Philadelphia, PA 

Most Patients Cite Difficulty Breathing or Fatigue as 

Worst Symptom during Hospitalization: Hemodynamic 

Profiles Not Different 

Mahoto Kato 1 , Lynne W. Stevenson 1 , Patricia L. Campbell 1 , 

Christopher May 1 , Waleed Al-Habeeb 1 , Maryse Palardy 1 , Neal K. 

Lakdawala 1 , Eldrin F. Lewis 1 , Soko Setoguchi 1 ; 1 Heart Failure, 

Cardiovascular Medicine, Brigham and Women’s Hospital, 

Boston, MA 

P297 

P298 

P299 

P300 

Insurance Type Is Associated with Rate of Implantable 

Cardioverter Defibrillator Implantation and One-Year 

Mortality of Patients with Heart Failure (A New Jersey 

Statewide Study) 

William J. Kostis 1 , Yingzi Deng 2 , Abel E. Moreyra 2 , John B. 

Kostis 2 ; 1 Department of Medicine, Johns Hopkins University 

School of Medicine, Baltimore, MD; 2 Department of Medicine, 

UMNDJ-Robert Wood Johnson Medical School, New 

Brunswick, NJ 

The Conundrum of Appropriate ICD Utilization in 

Heart Failure Patients: Impact of Age, Comorbidities 

and Potential for Improved Ejection Fraction with 

Therapy 

Omar F. AbouEzzeddine 1 , Sultan A. Mirzoyev 2 , Margaret M. 

Redfield 3 ; 1 Department of Internal Medicine, Mayo Clinic, 

Rochester, MN; 2 Department of Nursing, Mayo Clinic, 

Rochester, MN; 3 Department of Cardiovascular Diseases, Mayo 


Baseline Characteristics and Outcomes of Patients 

Who Do Not Desire Resuscitation: An Analysis of the 

ESCAPE Trial 

Sandesh Dev, Mona Fiuzat, Christopher O’Connor, Gudaye 

Tassisa, Joseph Rogers; Duke University Medical Center and 

Duke Clinical Research Institute, Durham, NC 

Marital Status and Prognosis of Patients with Heart 


Erin O’Connor, Wei Jiang 1 , Maragatha Kuchibhatla 1 , Greg 

Clary 2 , Michael Cuffe 1 , Eric Christopher 1 , Jude Alexander 3 , 

Mona Fiuzat 1 , Christopher O’Connor 1 , Ranga Krishnan 1 ; 1 Duke 

University Medical Center and Duke Clinical Research Institute, 

Durham, NC; 2 Grace Hospital, Morganton, NC; 3 Shady Grove 

Adventist Hospital, Rockville, MD 

Monday 

P295 

P296 

Cardiac Resynchronization Therapy and 

Hyperresponders 

Ramesh Chandra 1 , Eugen Palma 1 , Ronald Zolty 1 ; 1 Medicine/ 

Cardiology, Albert Einstein College of Medicine/ Montefiore 

Medical Center, Bronx, NY 

REVEAL Registry: Correlation of Right Heart 

Catheterization and Echocardiogram in Patients with 

Pulmonary Arterial Hypertension 

Harrison W. Farber 1 , Aimee J. Foreman 2 , Michael D. McGoon 3 ; 

1 

Boston University School of Medicine, Boston, MA; 2 ICON 

Clinical Research, San Francisco, CA; 3 Mayo Clinic, Rochester, 

MN 

P301 

P302 

In-Hospital Mortality Associated with Device 

Implantation: Influence of Age and Procedural 

Complications 

Jason Swindle 1 , Michael W. Rich 2 , Paul J. Hauptman 1 ; 

1 

Department of Medicine and Center for Outcomes Research, 

Saint Louis University School of Medicine, Saint Louis, MO; 

2 

Department of Medicine, Washington University School of 

Medicine, Saint Louis, MO 

Reduced Metabolic Exercise Capacity Predicts Death 

and Heart Failure in Minimally Symptomatic Patients 

with Obstructive Hypertrophic Cardiomyopathy 

Paul Sorajja, Carolyn S.P. Lam, Rick A. Nishimura, Steve R. 

Ommen; Division of Cardiovascular Diseases, Mayo Clinic, 

Rochester, MN 

80 

81

Sept. 14 

Monday 

Posters 

Posters 

Outcomes 

Posters 

Outcomes 

Sept. 14 

Monday 

Posters 

Monday 

P303 

P304 

P305 

Adherence to the Low Sodium Diet in Patients with 

Heart Failure Is Best When Family Members Also 

Follow the Diet 

Misook L. Chung 1 , Debra K. Moser 1 , Terry A. Lennie 1 ; 1 College 

of Nursing, University of Kentucky, Lexington, KY 

Serum Sodium and Its Impact on Outcome in Patients 

Hospitalized for Heart Failure (SODIUM-HF) Study 

Aaron K.F. Wong 1 , Tiong K. Lim 1 , Mahesh Pauriah 1 , Simon A. 

Ogston 2 , AnnaMaria Choy 1 , Allan D. Struthers 1 , Chim C. Lang 1 ; 

1 

Medicine and Therapeutics, University of Dundee, Dundee, 

Scotland, United Kingdom; 2 Public Health, University of 

Dundee, Dundee, Scotland, United Kingdom 

Simultaneous N-ANP and ET-1 Profiling Better Predicts 

Modes of Death in Chronic Heart Failure 

Philip Jong 2 , Sylvie A. Ahn 1 , Jean-Marie Ketelslegers 1 , 

Walter Van Mieghem 3 , Michel F. Rousseau 1 ; 1 Division of 

Cardiology, University of Louvain, Brussels, Belgium; 2 Division 

of Cardiology, University of Toronto, Toronto, Canada; 

3 

Hartcentrum Limburg, Genk, Belgium 

P310 

P311 

Recovery and Outcomes of Peripartum 

Cardiomyopathy: Results of IMAC 2 Registry 

Leslie T. Cooper 1 , G. William Dec 2 , Paul Mather 3 , Jeffrey 

Alexis 4 , Guillermo Torre-Amione 5 , Ilan Wittstein 6 , Mark Zucker 7 , 

Jagat Narula 8 , Dennis M. McNamara 9 , IMAC Investigators; 

1 

Cardiovascular Division, Mayo Clinic, Rochester, MN; 

2 

Cardiology, Massachusetts General Hospital, Boston, MA; 

3 

Cardiovascular Division, Jefferson Hospital, Philadelphia, 

PA; 4 Cardiology Division, University of Rochester, Rochester, 

NY; 5 Cardiology Division, Methodist Hospital, Houston, 

TX; 6 Cardiology Division, Johns Hopkins, Baltimore, MD; 

7 

Cardiovascular Institute, Beth Israel Hospital, Newark, NJ; 

8 

Cardiology, University of California at Irvine, Irvine, CA; 

9 

Cardiovascular Institute, University of Pittsburgh Medical 

Center, Pittsburgh, PA 

Symptomatic Limitation of Exercise beyond the 

Anaerobic Threshold 

Mahoto Kato 1 , Daniel E. Forman 1 , Eldrin F. Lewis 1 , Lynne W. 

Stevenson 1 , Howard L. Hartley 1 ; 1 Cardiovascular Medicine, 

Brigham and Women’s Hospital, Boston, MA 

Monday 

P306 

P307 

New Heart Failure Score Predicts Outcomes in Heart 


Konstadina Darsaklis 1 , Sophia Farooki 1 , Viviane Nguyen 1 , Nadia 

Giannetti 1 ; 1 Cardiology, McGill University Health Center - 

Royal Victoria Hospital, Montreal, QC, Canada 

Cost of Exercise Training and Its Impact on Medical 

Resource Use and Costs: Results of HF-ACTION 

Shelby D. Reed 1 , David J. Whellan 2 , Yanhong Li 1 , Joelle Y. 

Friedman 1 , Ileana L. Pina 3 , Sharon J. Settles 1 , Linda Davidson- 

Ray 1 , Johanna Johnson 1 , Lawton S. Cooper 4 , Christopher M. 

O’Connor 1 , Kevin A. Schulman 1 ; 1 Duke Clinical Research 

Institute, Durham, NC; 2 Thomas Jefferson University, 

Philadelphia, PA; 3 Case Western Reserve University School 

of Medicine, Cleveland, OH; 4 National Heart Lung and Blood 

Institute, Bethesda, MD 

P312 

P313 

Heart Failure Patient Attitudes about Quality of Life 

Assessment in Clinical Practice in Urban Versus Rural 

Setting 

Sabrina Badloe 1 , Prashant Vaishnava 1 , Lee Arcement 2 , Eldrin 

F. Lewis 1 ; 1 Department of Medicine, Brigham and Women’s 

Hospital, Boston, MA; 2 Cardiovascular Group, Leonard Chabert 

Medical Center, Houma, LA 

Hemodynamic Parameters and Renal Function in 

Patients Hospitalized for Heart Failure 

Mahdi Chowdhury 1 , Perry Anarado 1 , Imad Hussain 1 , 

Amanda Methvin 1 , Andreas P. Kalogeropoulos 1 , Vasiliki V. 

Georgiopoulou 1 , Vikas Bhalla 1 , Deepa Mangalat 1 , Jeffrey Shih 1 , 

Syed A. Agha 1 , Wendy Book 1 , Sonjoy R. Laskar 1 , Andrew L. 

Smith 1 , Javed Butler 1 ; 1 Medicine/Cardiology, Emory University, 

Atlanta, GA 

P308 

P309 

Predictors of Mortality in African Americans 

Hospitalized with Systolic Heart Failure 

Jareer Farah 1 , Hammam D. Zmily 1 , Sandip Zalawadiya 1 , 

Omaima Ali 1 , Suleiman Daifallah 1 , Jalal K. Ghali 2 ; 1 Internal 

Medicine, Wayne State University/Detroit Medical Center, 

Detroit, MI; 2 Cardiology, Detroit Medical Center, Detroit, MI 

Prediction of Congestive Heart Failure as Adverse 

Outcome of Non-ST-Elevation Myocardial Infarction 

Lukasz R. Kiljanek 1 , Pramil Cheriyath 1 ; 1 Department of 

Medicine, PinnacleHealth Systems, Harrisburg Hospital, 

Harrisburg, PA 

P314 

Cardiac Index, Maximal Oxygen Consumption, and 

Outcomes in Patients with Advanced Heart Failure 

Amanda Methvin 1 , Perry Anarado 1 , Mahdi Chowdhury 1 , 

Imad Hussain 1 , Andreas P. Kalogeropoulos 1 , Vasiliki V. 

Georgiopoulou 1 , Vikas Bhalla 1 , Deepa Mangalat 1 , Jeffrey Shih 1 , 

Syed A. Agha 1 , Wendy Book 1 , Sonjoy R. Laskar 1 , Andrew L. 

Smith 1 , Javed Butler 1 ; 1 Medicine/Cardiology, Emory University, 

Atlanta, GA 

82 

83

Sept. 14 

Monday 

Posters 

Posters 

Outcomes 

Posters 

Clinical Care/Management Strategies 

Sept. 14 

Monday 

Posters 

Monday 

P315 

P316 

P351 

Characteristics of Peripartum Cardiomyopathy Patients 

Using a Wearable Cardiac Defibrillator 

Mitchell T. Saltzberg 1 , Nicole Bianco 2 ; 1 Division of Cardiology, 

ChristianaCare Health System, Newark, DE; 2 Zoll Lifecor 

Corporation, Pittsburgh, PA 

Myocardial Damage Is a Prevalent Condition with 

Long-Term Prognostic Implications in Patients with 

Acute Heart Failure Syndromes and Preserved Systolic 

Function. A Report from the CIAST-HF (Collaborative 

Italo-Argentinean Study on Cardiac Troponin-T in Heart 

Failure) Study 

Eduardo R. Perna 1 , Roberto Valle 2 , Juan P. Cimbaro Canella 1 , 

Giuseppe Di Tano 3 , Stella M. Macin 1 , Loredano Milani 4 , Maria 

L. Coronel 1 , Massimo Milli 5 , Jaime Parra Moreno 1 , Nadia 

Aspromonte 6 ; 1 Heart Failure Clinic, Instituto de Cardiologia J. 

F. Cabral, Corrientes, Argentina; 2 Heart Failure Unit, Ospedale 

Civile, Chioggia, Venezia, Italy; 3 Department of Cardiology, 

Ospedale Civile, Cremona, Italy; 4 Heart Failure Unit, Ospedale 

Civile S. Dona, Venezia, Italy; 5 Department of Cardiology, 

Ospedale Santa Maria Nuova, Firenze, Italy; 6 Heart Failure Unit, 

Ospedale Santo Spirito, Rome, Italy 


Noninvasive Resting Cardiac Output, but Not Resting 

Ejection Fraction Correlates Well with Maximal 

Aerobic Capacity in Children with Cardiomyopathy and 

Repaired Congenital Heart Disease 

Paul F. Kantor 1 , Jae Y. Lee 1 , Dragos Predescu 1 , Gareth Smith 1 , 

Cameron Slorach 1 , Andrew N. Redington 1 ; 1 Labatt Family Heart 

Centre, Hospital for Sick Children, Toronto, ON, Canada 

P353 

P354 

P355 

P356 

Initial BNP Level at Time of Referral Predicts Long- 

Term Mortality: A Retrospective Review of the UT 

Southwestern Heart Failure Database 

David W. Markham 1 , Lynn T. Fernandez 1 , Colleen H. Debes 1 , 

Brenda S. Thompson 1 , Colby R. Ayers 1 , Pradeep P.A. Mammen 1 , 

Parag C. Patel 1 , Clyde W. Yancy 2 , Mark H. Drazner 1 ; 1 Internal 

Medicine/Cardiology, University of Texas Southwestern 

Medical Center, Dallas, TX; 2 Cardiovascular Medicine, Baylor 

Heart and Vascular Institute at Baylor University Medical 

Center, Dallas, TX 

Comparison of Biomarkers Predicting Severity and 

Long-Term Respiratory Complications after Acute 

Pulmonary Embolism 

Hirokazu Ohigashi 1 , Go Haraguchi 1 , Hitoshi Hachiya 1 , Kenzo 

Hirao 1 , Mitsuaki Isobe 1 ; 1 Department of Cardiovascular 

Medicine, Tokyo Medical and Dental University, Bunkyoku, 

Tokyo, Japan 

Sociodemographic Barriers to Implementation of 

Heart Failure Disease Management within a Veterans 

Administration Medical Center 

Richard Schofield 1,2 , Lynnette Boyer 1 , Edlira Maska 1 , Tamarah 

Jungklaus 1 , Amy Mullikin 1 , Shawn Anderson 1 , Carsten 

Schmalfuss 1,2 , John Petersen 1,2 , Juan Aranda 1,2 ; 1 Cardiology 

Section, Department of Veterans Affairs Medical Center, 

Gainesville, FL; 2 Division of Cardiovascular Medicine, 

University of Florida College of Medicine, Gainesville, FL 

Cognitive Impairment in Chronic Heart Failure: 

Comparison of Two Potential Screening Instruments 

Lisa Bauer 1 , Bunny Pozehl 1 ; 1 College of Nursing, University of 

Nebraska Medical Center, Omaha, NE 

Monday 

P352 

Electrocardiographic Predictors of Abnormal Left 

Ventricular Diastolic Function: Importance of the QTc 

Interval 

Jane E. Wilcox 1 , Ankit Shah 1 , Sanjiv J. Shah 1 ; 1 Division of 

Cardiology, Northwestern University, Chicago, IL 

P357 

Sex and Age Differences in Heart Failure Management 

in Ontario – Results from the POWER Study (Project 

for an Ontario Women’s Health Evidence-Based Report). 

www.powerstudy.ca 

Nahid Azad 1 , B.L. Abramson 2 , R.L. Jaakkimainen 2 , M. Kapral 2 , 

R. Hall 2 , N. Degani 2 , G. Honein 2 , A.S. Bierman 2 ; 1 Medicine, 

Unversity of Ottawa, Ottawa, ON, Canada; 2 Li Ka Shing 

Knowledge Institute, St. Michael’s Hospital, U. of Toronto, 

Toronto, ON, Canada 

84 

85

Sept. 14 

Monday 

Posters 

Posters 


Posters 


Sept. 14 

Monday 

Posters 

Monday 

P358 

P359 

P360 

NT-proBNP Measurements at Discharge and Post- 

Hospitalization May Aid Allocation of Follow-Up 

Strategies 

Alexandra A. Bennett 1,2 , Graham R.D. Jones 2,3 , Peter S. 

Macdonald 2,3 , Jo-anne Brien 1,2 , 3 ; 1 Faculty of Pharmacy, University 

of Sydney, Sydney, Australia; 2 St Vincent’s Hospital, Sydney, 

Australia; 3 Faculty of Medicine, University of NSW, Sydney, 

Australia 

Noninvasive Evaluation of Systemic Vascular Resistance 

and Cardiac Output Would Provide the Most Optimal 

Drug Selection in Patients with Acute Decompensated 


Masataka Watanabe 1 , Kazuhiko Hashimura 1 , Takahiro Ohara 1 , 

Makoto Amaki 1 , Takuya Hasegawa 1 , Hiroyuki Yokoyama 1 , 

Hideaki Kanzaki 1 , Masafumi Kitakaze 1 ; 1 Cardiovascular 

Division of Medicine, National Cardiovascular Center, Suita, 

Osaka, Japan 

A Multidisciplinary Team Management Program to 

Decrease Re-Hospitalization in CHF Patients 

Casey Lawler 1 , Justin Kirven 1 , Pam Rush 1 , Steve Bergeson 1 ; 

1 

Minneapolis Heart Institute at Abbott-Northwestern Hospital, 


P364 

P365 

P366 

Hf Family Caregiver Outcomes and Associated Factors 

Sandra B. Dunbar 1 , Patricia C. Clark 2 , Rebecca A. Gary 1 , 

Christina Quinn 1 , Carolyn M. Reilly 1 , Andrew Smith 3 , Melinda 

Higgins 1 ; 1 Nell Hodgson Woodruff School of Nursing, Emory 

University, Atlanta, GA; 2 Brydine Lewis School of Nursing, 

Georgia State University, Atlanta, GA; 3 School of Medicine, 

Emory University, Atlanta, GA 

Hemodynamic Differences in Ambulatory Heart Failure 

Patients with Low vs High Heart Rates 

William T. Abraham 1 , Yong K. Cho 2 , Robert T. Taepke 2 , Tom D. 

Bennett 2 , Philip B. Adamson 3 , Robert C. Bourge 4 ; 1 Department 

of Internal Medicine, Ohio State University, Columbus, 

OH; 2 CRDM Research, Medtronic, Inc., Mounds View, MN; 

3 

Oklahoma Cardiovascular Associates, Oklahoma City, OK; 

4 

Cardiovascular Disease, University of Alabama Birmingham, 


Does Improvement in Ejection Fraction Imply Recovery 

of Normal Myocardial Function 

Marwan M. Mohammad, Amanda K. Lesinski, Binkley 

F. Philip; The Dorothy M.Davis Heart Lung Institute, 

Cardiovascular Medicine, The Ohio State University, Columbus, 

OH 

Monday 

P361 

P362 

Cardiovascular Comorbidities in Patients at the Time of 

Their Network Entry Visit to Specialized Heart Failure 

Outpatient Clinics in the Canadian Heart Failure 

Network (CHFN) 1999 to 2007 

Malcolm Arnold, Andrew Ignaszewski, Haissam Haddad, 

Jonathan Howlett, Marie-Helene LeBlanc, Canadian Heart 

Failure Network; Cardiology, University of Western Ontario, 

London, ON; Cardiology, St Paul’s Hospital, Vancouver, BC; 

Cardiology, Ottawa Heart Institute, Ottawa, ON; Cardiology, 

Foothills Hospital, Calgary, AB; Cardiology, Quebec Heart 

Institute, Quebec City, QC 

ß-Blocker Therapy Is Associated with Increased 

Re-Hospitalization for Heart Failure in Women with 

Heart Failure and Preserved Ejection Fraction 

S. Morteza Farasat 1 , Dennis T. Bolger 2 , Veena Shetty 1 , Elizabeth 

P. Menachery 2 , Gary Gerstenblith 2 , Edward K. Kasper 2 , 

Samer S. Najjar 3 ; 1 NIA-ASTRA at Harbor Hospital, MedStar 

Research Institute, Baltimore, MD; 2 Department of Medicine, 

Johns Hopkins University, Baltimore, MD; 3 Laboratory of 

Cardiovascular Science, National Institute on Aging, NIH, 

Baltimore, MD 

P367 

P368 

P369 

Pulmonary Artery Catheter Use in the Management of 

Critically Ill Patients at an Academic Medical Center 

Thomas S. Metkus 1 , Kenneth B. Christopher 1 ; 1 Department of 

Medicine, Brigham and Women’s Hospital, Boston, MA 

The Role of Questionnaire Scores and Laboratory Test 

Results in Identifying Hospitalizations and Deaths of 

Patients with Heart Failure 

Leonidas V. Athanasopoulos 1 , Athanasios Dritsas 1 , Dennis 

V. Cokkinos 1 ; 1 1st Cardiology Department, Onassis Cardiac 

Surgery Center, Athens, Greece 

Comorbid Renal Disease and Treatment Adherence Are 

Determinants of Symptom Recognition and Treatment in 

Patients with Symptomatic Heart Failure 

Christopher S. Lee 1 , Barbara Riegel 1 ; 1 Univ. of Pennsylvania 

School of Nursing, Philadelphia, PA 

P363 

Withdrawn 

86 

87

Sept. 14 

Monday 

Posters 

Posters 


Posters 


Sept. 14 

Monday 

Posters 

Monday 

P370 

P371 

P372 

P373 

P374 

The Mediating Role of Depression in Predictors 

of Instrumental Activities of Daily Living (IADL) 

Modification (Disability) in Persons with Heart Failure 

Yaewon Seo 1 , Louise LaFramboise 1 , Ioana Dumitru 1 ; 1 College of 

Nursing, Univerisity of Nebraska Medical Center, Omaha, NE; 

2 

College of Nursing, Univerisity of Nebraska Medical Center, 

Omaha, NE; 3 Cardiology, Univerisity of Nebraska Medical 

Center, Omaha, NE 

Knowledge, Attitudes, and Beliefs about Hypertension 

Vary by Ethnicity 

Randy Wexler 1 , Christopher Taylor 2 , Jonathon Scott 2 , Pleister 

Adam 3 , Craig Michael 3 , Feldman David 3 ; 1 Family Medicine, 

The Ohio State University, Columbus, OH; 2 Medical Dietetics, 

The Ohio State University, Columbus, OH; 3 Internal Medicine, 

Division of Cardiology, The Ohio State University, Columbus, 

OH 

Device Diagnostics Data by Remote Monitoring Provides 

Time Efficient Method of Managing Heart Failure 

Patients 

Lynn Broesch 1 , J. Thomas Heywood 1 ; 1 Heart Failure Recovery 

and Research Program, Scripps Clinic, La Jolla, CA 

Does a Normal BNP Exclude Heart Failure with 

Preserved Ejection Fraction? 

Barry A. Borlaug 1 , Rick A. Nishimura 1 , Paul Sorajja 1 , Carolyn 

S.P. Lam 1 , Margaret M. Redfield 1 ; 1 Cardiovascular Diseases, 

Mayo Clinic, Rochester, MN 

The 6 Minute Hall Walk (6-MHW) and the Modified 

Boston Heart Failure Score (BHF) in Heart Failure 

Patients: Cost Effective Interventions with Predictive 

Significance 

David J. Coyle 1 , John Mckenzie 2 , George Crossley 3 , John 

Andriulli 5 , Sanjeev K. Gulati 6 ; 1 University of Colorado 

Hospitals, Denver, CO; 2 Glendale Memorial Hospital Medical 

Center, Glendale, CA; 3 Mid-State Cardiology of St.Thomas 

Heart, Nashville, TN; 4 Medical College of Wisconsin, 

Milwaukee, WI; 5 Southern New Jersey Cardiac Specialists, 

Vorhees, NJ; 6 The Sanger Clinic, Charlotte, NC 

P377 

P378 

P379 

P380 

P381 

The Relationship of the LATITUDE Patient Symptom 

Report to Heart Failure Hospitalization 

John P. Boehmer 1 , Milan Seth 2 , Paul W. Jones 3 , Timothy E. 

Meyer 3 , Leslie A. Saxon 4 ; 1 Hershey Medical Center, Hershey, 

PA; 2 Integra Group, Brooklyn Park, MN; 3 Boston Scientific, St. 

Paul, MN; 4 University of Southern California, Los Angeles, CA 

Is the Measurement of B-Type Natriuretic Peptide in 

the Emergency Room Useful in Established Congestive 

Heart Failure Exacerbation? 

David J. De La Zerda 1 , Andres Leon-Sanchez 1 , Hani El Jammal 1 , 

Christine Boehringer 1 , Ivo Dinov 2 , Prakash Deedwania 1 ; 

1 

Cardiology, UCSF-Fresno, Fresno, CA; 2 Statistics, UCLA, Los 

Angeles, CA 

Relationship between Inflammatory Biomarkers and 

Symptom Perception in Patients with Heart Failure 

Seongkum Heo 1 , Debra K. Moser 2 , Susan J. Pressler 3 , Sandra 

B. Dunbar 4 , Eun Kyeung Song 2 , Jinshil Kim 5 , Terry A. Lennie 2 ; 

1 

Indiana University, Indianapolis; 2 University of Kentucky, 

Lexington; 3 University of Michigan, Ann Arbor; 4 Emory 

University, Atlanta; 5 Michigan State University, East Lansing 

Short-Term Hemodynamic Effects of Add-On Aliskiren 

Therapy in Decompensated Heart Failure: Systemic 

Vascular Resistance Reduction 

Euler C. Brancalhao 1 , Marcelo E. Ochiai 1 , Juliano N. Cardoso 1 , 

Kelly R. Vieira 1 , Raphael S. Puig 1 , Marcelo V. Lima 1 , Antonio P. 

Barretto 1 ; 1 Cotoxo Hospital, Heart Institute of University of Sao 

Paulo, Sao Paulo, SP, Brazil 

The Validation of Self Reported Asthma and COPD as 

Indicators of Lung Disease and Beta Blocker Intolerance 

in Chronic Heart Failure 

Jun R. Chiong 1 , Michelle M. Harris 1 ; 1 Medicine-Cardiology, 

Loma Linda University Medical Center, Loma Linda, CA 

Monday 

P375 

Estimating Expected Weight Loss with Intravenous 

Diuretic Therapy in Hospitalized Heart Failure Patients 

Vandhana Scheller 1 , Cheryl Bartone 1 , Eugene S. Chung 1 ; 1 The 

Christ Hospital, Cincinnati, OH 

P376 

Do Hospital Quality Measures Have Adverse 

Consequences for Patients and The Healthcare System? 

Mohamed Abou Khashan, Michael Serra, Elizabeth Langlois, 

Donna Daniel, Frank Smart; Cardiovascular Medicine, Gagnon 

Cardiovascular Institute, Morristown Memorial Hospital, 

Morristown, NJ 

88 

89

Sept. 15 

Tuesday 

AM 

SYMPOSIUM 


8:30-10:00 AM 

Ballroom A 

SYMPOSIUM 


8:30-10:00 AM 

Ballroom C 

Sept. 15 

Tuesday 

AM 

Tuesday 

Evolving Therapies for Acute Decompensated 

Heart Failure (ADHF): How to Develop a 

New Drug 

Moderators: Uri Elkayam, Los Angeles, CA 

Robert J. Cody, Whitehouse Station, NJ 

8:30 Novel Natriuretic Peptides 

Uri Elkayam, Los Angeles, CA 

8:42 Adenosine Receptor Antagonists 


8:54 New Inotropic Drugs 

John R. Teerlink, San Francisco, CA 

9:06 New Vasodilators 

G. Michael Felker, Durham, NC 

9:18 Initial Steps in the Evaluation of New Drugs for ADHF: 

FDA Point of View 

Abraham M. Karkowsky, Silver Spring, MD 


Learning Objective: Describe evolving therapies for ADHF 

and the challenges in evaluating their efficacy. 

What Every Heart Failure Specialist Should 

Know About the Explosion of Cancer Therapies 

Moderators: Michael L. Maitland, Chicago, IL 

Richard M. Steingart, New York, NY 

8:30 Understanding the New Anti-Cancer Agents: 

Is Cardiotoxicity Unavoidable? 

Thomas Force, Philadelphia, PA 

8:50 Clinical Reversibility of Heart Failure Induced by 

Kinase Inhibitors 

Daniel J. Lenihan, Houston, TX 

9:10 Cardiovascular Disease: The Hidden Killer in Adult 

Survivors of Childhood Cancer 

Ming Hui Chen, Boston, MA 

9:30 Cardiotoxicity of Anthracyclines: 

Is There Anything New? 

Douglas B. Sawyer, Nashville, TN 


Learning Objective: Manage the cardiotoxicity of anticancer 

agents in patients undergoing chemotherapy and in 

survivors of childhood cancer. 

Tuesday 





90 

91

Sept. 15 

Tuesday 

AM 

SYMPOSIUM 


8:30-10:00 AM 

Room 302 

SYMPOSIUM 


8:30-10:00 AM 

Room 304 

Sept. 15 

Tuesday 

AM 

Tuesday 

Clinical Research at a Cross Roads 

Moderators: Bertrum Pitt, Ann Arbor, MI 


8:30 Importance of Site-Based Research for Clinical Progress: 

HF-ACTION Trial 

David J. Whellan, Philadelphia, PA 

8:45 Clinical Cardiovascular Networks are Necessary for 

Conducting Heart Failure Research: Insight from the 

NIH Roadmap Grant 

Robert A. Harrington, Durham, NC 

9:00 The Importance of Committed Investigators: 

Lessons Learned from 40 Years of Coordinating 

Heart Failure Trials 

Jay N. Cohn, Minneapolis, MN. 

9:15 How Can Principal Investigators Survive and Excel in 

Site-Based Research in 2009? 

Jalal K. Ghali, Detroit, MI 

9:30 Study Coordinator Survival Guide: Why Site-Based 

Research is Important 

Patricia A. Adams, Chapel Hill, NC 


Learning Objective: Discuss the role of site-based research 

in clinical progress and outline strategies for its growth. 

Serial Monitoring of Patients with 


Moderators: Eldrin F. Lewis, Boston, MA 

Michael W. Rich, St. Louis, MO 

8:30 Is the Physical Exam Obsolete? 

Mark H. Drazner, Dallas, TX 

8:50 Natriuretic Peptides: Is This the Only 

Biomarker Needed? 


9:10 Implantable Devices: Can they Replace the Swan? 

Robert C. Bourge, Birmingham, AL 

9:30 Telemonitoring: Do We Need Clinic Visits? 

John G.F. Cleland, Kingston-upon-Hull, UK 


Learning Objective: Evaluate the relative value of options 

currently available for serial monitoring of heart failure 

patients. 

Tuesday 





92 

93

Sept. 15 

Tuesday 

AM 

SYMPOSIUM 


8:30-10:00 AM 

Room 311 

POSTERS DISPLAYED 


9:00 AM-7:00 PM 

Exhibit Hall 

Sept. 15 

Tuesday 

AM 

Molecular Therapies for Heart Failure 

PRESENTER AT POSTER 5:45 PM-6:45 PM 

Moderators: Joseph Rabinowitz, Philadelphia, PA 

Anthony Rosenzweig, Boston, MA 

Categories Poster # 

8:30* New Development in Gene Therapy for Heart Failure 

Roger J. Hajjar, New York, NY 

Cardiovascular Physiology 054-082 

8:52* Update on Adenylyl Cyclase Type 6 Gene Therapy 

H. Kirk Hammond, La Jolla, CA 

Cardiovascular Structure 088-092 

9:14* Surgical Gene Delivery for Heart Failure 

Charles R. Bridges, Jr., Philadelphia, PA 

Neurohormones/Cytokines 105-116 

Tuesday 

9:37* S100 Targets for Heart Failure 

Patrick Most, Philadelphia, PA 


Learning Objective: Describe new developments in gene 

therapy for heart failure. 

Molecular Biology and Genetics 126-135 

Surgery, Transplantation, Devices 158-179 

Electrophysiology/Arrhythmias 190-199 

Tuesday 

Clinical Trials 218-234 

Cardiovascular Pharmacology 247-259 

Epidemiology, Prevention 272-282 

Outcomes 317-350 

Clinical Care/Management Strategies 382-413 

Listing for Monday posters begins on page 55 

Listing for Tuesday posters begins on page 111 





94 

95

Sept. 15 

Tuesday 

AM 

CASE DISCUSSION 


10:30 AM-NOON 

Ballroom A 

CASE DISCUSSION 

Sept. 15 

Tuesday 

AM 

Tuesday 

Moderators: Lynne Warner Stevenson, Boston, MA 

Mark A. Winchester, Durham, NC 

Panelists: 

James C. Fang, Cleveland, OH 

Carmelo A. Milano, Durham, NC 

Sanjiv M. Narayan, San Diego, CA 

Sara C. Paul, Hickory, NC 

Jo Ellen Rodgers, Chapel Hill, NC 

10:30 Case 1: HF post-MI: A 65 yr old male grocery worker is 

referred to you by his PCP for progressive cardiomegaly and 

pulmonary congestion noted on routine CXR. Hx: hypertension, 

hyperlipidemia, type 2 DM, nonsmoker, fam hx CAD and SCD, 

multinodular goiter with hyperthyroidism treated with methimazole 

since 2003. Ant MI 2004; Cath 2004: LVEF 30% with anterior/ 

apical hypokinesis, 100% LAD, 100% RCA with mature 

collaterals. PCI/DES X2 to LAD; Cath 2005: PCI/DES to distal 

75% LAD, LCflx NS; LVEF 50%. Prox LAD stent sites patent. 

He emigrated from Pakistan, describes no symptom limitation or 

chest pain working full-time in produce department. Married w/ 

6 children. Not seen by cardiology for 2 years. Meds: Metoprolol 

XR 200 qd. (ACE intolerant – cough), clopidogrel, aspirin, 

furosemide 20 mg, methimazole, K+, atorvastatin 40 mg. Current 

exam: 140/102 mmHg, P 66, 166 lbs, large goiter, JVP 6 cm, clear 

lungs, LV impulse 3 cm L of MCL, widely split S2; 2/6 apical 

HSM, no gallop; no abdominal organomegaly, no edema. ECG: 

NSR, LVH, BAE, RBBB- QRS 0.142 msec, Q waves anterior and 

inferior leads. Labs: Hgb 14, A1C 6.3%, TC 149, LDL 79, TG 218, 

HDL 27, Na 141, K3.7, BUN 15, Cr 1.0, Mg 2.0, Gluc 106, TSH 

11.08, Free T4 0.44 (0.52-1.21); NT-proBNP 4,108. Echo: LVEF 

< 15%, LVDD 7.0cm, moderate MR. Adenosine stress: 17 % 

LVEF, extensive fixed antero-apical defect, no reversible ischemia. 

How would you approach treatment at this time? Seven months 

later, a neck CT scan was performed showing enlargement of the 

multinodular goiter compared to prior exam. The thyroid produces 

mass effect on the trachea and narrows the trachea to 1 cm in 

transverse diameter. He had some dysphagia and stridor when he 

walks. Endocrinology recommends thyroidectomy, and general 

surgery requests your opinion re: surgical risk. How would you 

respond to a surgical request for cardiology clearance for surgery? 

10:52 Case 2: New Presentation CM: Twenty year old male college 

student-musician noted weight gain and anxiety 2 weeks before 

presenting with dysarthria and facial droop. Head CT revealed 

left basal ganglia infarct. Echo revealed EF 16%, LVDD 7.6 cm. 

Family history: mother with RVOT tachycardia, uncle with CM, 

Gf with CM/SD age 40, 2 great uncles with CM. History of modest 

cocaine, heavy college level alcohol use, mostly on music road 

trips. Exam: BP 112/82, ST 120, JVP 18 cm, lungs clear. LVI in 

anterior ax line, S1, increased P2, + S3, 2/6 m at apex. Extremities 

warm without edema. TnI negative, BNP 1643, Creat 1.1. How 

would you advise the patient and family about likely prognosis 

and options? 

(continued next page) 

96 

11:14 Case 3: HF with preserved EF: 72 M referred for second 

opinion regarding pericardial stripping procedure. 50 years HTN. 

5 years DM. 2 years ago AFib after fall from roof, positive stress 

test led to cath and to CABG (LIMA to LAD, SVG to diag, ramus, 

PDA, post LV branch,+epicardial RF ablation of AF. Subsequent 

pacer for SSS. Later DES to diag SVG. Previous office manager, 

lives with children. Since surgery. DOE < 1 block since surgery, 

fluctuating ankle edema despite diuretics, poor appetite, increasing 

abdominal girth. Can’t tolerate 1.5 L fluid restriction. Echo: LVEF 

50%, LV 1.3 cm thick, LVD 4.2/2.9 diastolic dysfunction, moderate 

TR, RV enlargement, no respiratory variation in inflow patterns. 

Repeat cath - open grafts, RA 25, RV 46/23, PA 48/27, PCW 28, 

CI 2.2. Exam: BP 120/76 without paradox. CV: JVP 18 cm with 

Kussmaul’s sign. S1, TR, early grating diastolic sound palpable. 

Ascites, 2+ brawny edema with venous disease. Meds: ASA, 

clopidogrel, furosemide 60, metoprolol succinate 100 bid, lisinopril 

5, K+, pravastatin 40, warfarin 10, sotalol 80 bid, diltiazem CD 

240, glucotrol, pioglitazone. How would you determine whether a 

pericardial stripping procedure is indicated? 

11:36 Case 4 Breast CA and LV dysfunction on chemotherapy 

A 41 yr old AA woman is referred to you by her oncologist 

for evaluation of her risk of chemotherapy for breast cancer. 

She is a previously healthy physically active perimenopausal 

woman, who found a mass in her right breast . Right modified 

radical mastectomy, left total mastectomy is performed with 

pathology revealing moderately differentiated infiltrating ductal 

carcinoma. Vascular/lymphatic space invasion was identified. 2 

out of 6 sentinel nodes and 1 out of 16 axillary nodes positive for 

metastatic ductal carcinoma for a total 3 of 22 nodes. Tumor was 

ER positive (77% by IHC), PR positive (49% by IHC) and HER2 

neu strongly positive (3+ by IHC). Also identified was LCIS in 

the left breast. Pathologic stage of infiltrating ductal carcinoma 

is T2N1a. By symptoms, physical exam, and baseline staging 

scans, there was no definitive evidence for metastatic disease. 

Past Medical History: Plantar fasciitis in 8/08; Hypertension – 

treated with lisinopril/HCTZ 10/12.5 mg daily; Tonsillectomy 

and adenoidectomy in 1987; Myomectomy in 2003 for removal 

of uterine fibroid; Injury of the right knee in 2008; required right 

knee surgery. Oncology Treatment Plan: Deliver six cycles of TCH 

chemotherapy (paclitaxel, carboplatin, Herceptin/trastuzumab) 

followed by repeat staging scans followed by radiation therapy 

to the chest wall and draining nodes with restart of every threeweekly 

Herceptin followed by the completion of one full year 

of Herceptin therapy and a minimum of five years of adjuvant 

hormonal therapy. PE: afebrile BP 160/80. P 98 - regular R 16, Wt. 

159lbs, Ht. 5’41/2”. CV exam - nl. ECG: NSR, LVH, NS ST-T 

wave changes; Pretreatment MUGA scan: LVEF of 51% with 

mild septal hypokinesis. nl LV size. Would you advise a change 

in the treatment plan? She tolerated the first cycle of treatment 

without significant problems except for alopecia. She is due to 

start a second cycle of TCH, but her repeat MUGA scan shows an 

LVEF of 42%. Herceptin is stopped and she is referred to you for 

evaluation. What would you recommend for subsequent treatment? 

Learning Objective: Apply practice guidelines, research 

findings, and clinical experience to the management of 

difficult cases in heart failure. 

97 

Tuesday

Sept. 15 

Tuesday 

AM 

SYMPOSIUM 


10:30 AM-NOON 

Ballroom C 

SYMPOSIUM 


10:30 AM-NOON 

Room 302 

Sept. 15 

Tuesday 

AM 

Tuesday 

Teaching Patients with Heart Failure: 

What We Know and What We Need to Learn 

Moderators: Kathleen A. Dracup, San Francisco, CA 


10:30 Diet, Nutrition and Fluids 

Terri A. Lennie, Lexington, KY 

10:50 Activity and Exercise 

Eileen Handberg, Gainesville, FL 

11:10 Medication Management 

J. Herbert Patterson, Chapel Hill, NC 

11:30 Reimbursement and Quality: Should We Be 

Compensated For Doing the Right Thing? 



Learning Objective: Describe current approaches to patient 

education and their limitations in the areas of diet, exercise, 

and medication management. 

Mechanical Cardiac Support in 2009 

Moderators: Soon J. Park, Rochester, MN 

Joseph G. Rogers, Durham, NC 

10:30 Patient and Device Selection: Which Patient, 

Which Pump? 

Mariell L. Jessup, Philadelphia, PA 

10:50 Do Patients Require Replacement of the Entire 

Circulation: The Potential for Partial Circulatory 

Support 

Mark S. Slaughter, Louisville, KY 

11:10 VADs as a Platform to Understand Heart Failure Biology 

and Adjuvant Therapies 

Kenneth B. Margulies, Philadelphia, PA 

11:30 When is High-Risk Conventional Surgery an Alternative 

to Mechanical Support? 

Benjamin C. Sun, Columbus, OH 


Learning Objective: Select appropriate patients and pumps 

for mechanical cardiac support, and discuss the role of 

partial circulatory support and surgical alternatives to 

mechanical cardiac support. 

Tuesday 

98 

99

Sept. 15 

Tuesday 

AM 

SYMPOSIUM 


10:30 AM-NOON 

Room 304 

SYMPOSIUM 


10:30-NOON 

Room 311 

Sept. 15 

Tuesday 

AM 

Tuesday 

Gender Issues in Cardiac Biology and 


Moderators: Charles J. Steenbergen, Baltimore, MD 

Andrea D. Eckhart, Philadelphia, PA 

10:30 Sex Dimorphism in Gene Expression Biology and 


Jennifer L. Hall, Minneapolis, MN 

10:50 Gender Differences in Cardiac Mitochondrial Function 

Elizabeth Murphy, Bethesda, MD 

11:10 Heart Failure: Who We Treat versus Who We Study 

Leslie W. Miller, Washington, DC 

11:30 Biological Effects of Sex and Diet on Heart Failure 

Development 

Leslie A. Leinwand, Boulder, CO 


Learning Objective: Describe gender issues at the biological 

level and the impact of gender on heart failure progression 

and treatment. 

Intracellular Chaos in Failing Cardiomyocytes 

Moderators: Frederica del Monte, Boston, MA 

Junichi Sadoshima, Newark, NJ 

10:30* Crystallin-induced Heart Failure 

Jeffrey Robbins, Cincinnati, OH 

10:52* Functional Heterogeneity of the 20S Proteasome 

Complexes In the Heart 

Peipei Ping, Los Angeles, CA 

11:15* Amyloid Peptides as a Cause of Heart Failure 

Ronglih Liao, Boston, MA 

11:38* Phosphatases in the ER Stress Response 

Yibin Wang, Los Angeles, CA 


Learning Objective: Describe how protein mis-folding and 

aggregation can impair cardiac function. 

Tuesday 

100 

101

Sept. 15 

Tuesday 

PM 

Tuesday 

ORAL ABSTRACT SESSION 


12:30-1:30 PM 

Ballroom A 

Leading Clinical Research 

Moderators: Carl V. Leier, Columbus, OH 

Alan B. Miller, Jacksonville, FL 

12:30* Clinical Validation of a Novel Assay for 020 

Galectin-3 for Risk Assessment in Acutely 

Destabilized Heart Failure 

Christopher R. deFilippi, Robert Christenson, Ravi 

Shah, Anju Bhardwaj, James L. Januzzi, University of 

Maryland, Baltimore, MD 

12:45* Neurogulin-1β Associated with Cardiomyopathy 021 

Etiology, Disease Severity, and Adverse Outcomes 

in Chronic Heart Failure 

Bonnie Ky (2008-09 HFSA Research Fellow), Stephen 

E. Kimmel, Radwan N. Safa, Mary E. Putt, Nancy K. 

Sweitzer, James C. Fang, Douglas B. Sawyer, Thomas P. 

Cappola, University of Pennsylvania, Philadelphia, PA 

1:00* G-Protein Coupled Receptor Kinase Expression 022 

in Lymphocytes: A Novel Biomarker of Left 

Ventricular Systolic Function in Heart Failure 

Patients 

Raphael E. Bonita, Philip W. Raake, Nicholas J. Otis, 

Kurt J. Chuprun, Abhijit Dasgupta, Walter J. Koch, Paul J. 

Mather, Thomas Jefferson University, Philadelphia, PA 

1:15* Severe Right Ventricular Dysfunction Persists 023 

Even After Major Reduction of Volume Status 

Maryse Palardy (2008-09 HFSA Research Fellow), 

Neal K. Lakdawala, Jose M. Rivero, Mahoto Kato, 

Patricia Campbell, Carolyn Y. Ho, Michael M. Givertz, 

Gregory S. Couper, Lynne W. Stevenson, Brigham and 

Women’s Hospital, Boston, MA 


Learning Objective: Discuss findings from leading clinical 

research in heart failure. 

HOW TO SESSIONS 


12:30-1:30 PM 

7. How to Diagnose and Treat Diastolic Heart Failure Room 302 

Peter E. Carson, Washington, DC 

Dalane W. Kitzman, Winston-Salem, NC 

Margaret M. Redfield, Rochester, MN 

Learning Objective: Describe ways to more effectively 

manage and treat diastolic heart failure. 

8. Performance Measures: What Do They Mean for Room 312 

My Practice? 

Harlan M. Krumholz, New Haven, CT 

Ileana L. Piña, Cleveland, OH 

Paul A. Heidenreich, Palo Alto, CA 

Learning Objective: Describe the impact of performance 

measures on the clinical practice of heart failure and 

outline a strategy to address them in your practice. 

9. Recognition and Management of the Cardio-Renal Room 304 

Syndrome in ADHF 

Justin A. Ezekowitz, Edmonton, AB, Canada 

Stephen S. Gottlieb, Baltimore, MD 

Anju Nohria, Boston, MA 

Learning Objective: Recognize and manage the cardiorenal 

syndrome in acute decompensated heart failure. 

10. How to Develop Programs and Materials for Room 311 

Patients with Low Health Literacy 

Ann S. Laramee, Burlington, VT 

Kismet D. Rasmusson, Murray, UT 

Patricia A. Uber, Baltimore, MD 

Learning Objective: Recognize low health literacy in 

patients with heart failure and develop programs and 

materials to address the problem. 

11. Cardio-Oncology: Assessing Heart Failure in the Room 306 

Context of Chemotherapy 

Daniel J. Lenihan, Nashville, TN 

Douglas D. Schocken, Durham, NC 

Lynne Warner Stevenson, Boston, MA 

Learning Objective: Evaluate cardiotoxicity in patients 

undergoing chemotherapy and managing heart failure. 

Sept. 15 

Tuesday 

PM 

Tuesday 

12. Genetic Screening and Counseling Room 310 

for Patients with HF 

Ray E. Hershberger, Miami, FL 

Daniel P. Judge, Baltimore, MD 

Ana I. Morales Reyes, Miami, FL 

Learning Objective: Follow practice guidelines in providing 

genetic screening and counseling for patients with heart failure. 

102 

103

Sept. 15 

Tuesday 

PM 

HYDE PARK 


2:00-3:30 PM 

Ballroom B 

SYMPOSIUM 


2:00-3:30 PM 

Room 302 

Sept. 15 

Tuesday 

PM 

Tuesday 

1:45 Announcement of Awards 

Jay N. Cohn New Investigator Awards 

Nursing Research Award 

2009 Nursing Clinical Excellence Award 

2009-10 HFSA Research Fellowship Awards 

Wilson S. Colucci, Boston, MA 

Corrine Jurgens, Miller Place, NY 

Walter J. Koch, Philadelphia, PA 


Barbara J. Riegel, Philadelphia, PA 

Hyde Park Session 

Moderators: Mandeep R. Mehra, Baltimore, MD 

Douglas D. Schocken, Durham, NC 

2:00* As if Global Warming Were Not Enough: How Patients 

Are Wrecking Clinical Trials in Heart Failure by Making 

Too Much Noise 

Paul J. Hauptman, St. Louis, MO 

2:15* The Art and Science of Self Deception in Expert 

Clinicians 

Patricia A. Uber, Baltimore, MD 

2:30* Clear as an Oropharynx: A 14-Point Review of the 

Absurd Game of Documentation and Heart Failure 

‘Quality’ 

Ronald Witteles, Stanford, CA 

2:45* New Heart Failure Diet: Load up on Fat and 

Lose the Carbs 

William C. Stanley, Baltimore, MD 

3:00* Liposuction Cures Heart Failure with Preserved Ejection 

Fraction (HFPEF) 

Walter J. Paulus, Amsterdam, The Netherlands 

3:15* A Motto for the Heart Failure Society of America 

Mathew S. Maurer, New York, NY 


Learning Objective: Discuss new insights into the field of 

heart failure research, education, and clinical practice. 

Latest Developments on Cardiac Repair 

With Stem Cells 

Moderators: Annarosa Leri, Boston, MA 

Steven Goldman, Tucson, AZ 

2:00* Cardiac Regeneration: iPS, ES, or Endogenous Cells? 

Sean M. Wu, Boston, MA 

2:23* Cell Cycle and Cardiac Progenitor Cells to Induce 

Cardiac Repair 

Hina W. Chaudhry, New York, NY 

2:45* Imaging of Stem Cells in Animal Models 

Joseph Wu, Stanford, CA 

3:08* Cardiac Stem Cells 

Piero Anversa, Boston, MA 


Learning Objective: Discuss recent developments using 

stem cells for cardiac repair. 

Tuesday 





104 

105

Sept. 15 

Tuesday 

PM 

SYMPOSIUM 


2:00-3:30 PM 

Room 304 

DEBATES 


4:00-5:30 PM 

Ballroom B 

Sept. 15 

Tuesday 

PM 

What to Do When Patients Get Better 

Moderators: Arthur M. Feldman, Philadelphia, PA 

Sidney Goldstein, Detroit, MI 

Moderators: Adrian F. Hernandez, Durham, NC 

Patricia P. Chang, Chapel Hill, NC 

2:00 What to do with Medications 

Barry H. Greenberg, San Diego, CA 

DEBATE: Pivatol Clinical Trials Should only be done in 

North America 

2:20 What to do with Devices Due for Replacement 

Philip B. Adamson, Oklahoma City, OK 

2:40 How and When to Follow Up? 

Mark E. Dunlap, Cleveland, OH 

4:00 Protagonist: Robert M. Califf, Durham, NC 

4:15 Antagonist: Karl Swedberg, Gothenburg, Sweden 

4:30 Rebuttal/Summary (7.5 minutes each) 

Tuesday 

3:00 Risk of Recurrent Pregnancy in PPCM 

Kenneth L. Baughman, Boston, MA 


Learning Objective: Identify health risks and opportunities 

for continuing care in patients with heart failure whose 

symptoms improve. 

DEBATE: Clinical Trials should be Conducted in 

Targeted Populations 

4:45 Protagonist: Clyde W. Yancy, Dallas, TX 

5:00 Antagonist: Milton Packer, Dallas, TX 

Tuesday 

5:15 Rebuttal/Summary (7.5 minutes each) 

Learning Objective: Outline arguments for and against 

doing pivotal clinical trials only in North America and doing 

clinical trials in targeted populations. 






106 

107

Sept. 15 

Tuesday 

PM 

SYMPOSIUM 


4:00-5:30 PM 

Room 302 

SYMPOSIUM 


4:00-5:30 PM 

Room 304 

Sept. 15 

Tuesday 

PM 

Assessing Prognosis in Heart Failure Patients: 

Should We Care? 

cGMP in Heart Failure: Pathophysiology and 

Novel Therapeutics 

Tuesday 

Moderators: James A. Hill, Gainesville, FL 

Tamara B. Horwich, Los Angeles, CA 

4:00 Seattle Heart Failure Model: How Can We Improve 

Risk Stratification? 

Wayne C. Levy, Seattle, WA 

4:20 CPX Testing: Is Peak VO 2 

Still Prognostic in 2009? 

Donna M. Mancini, New York, NY 

4:40 Quality of Life: Is There Any Other Meaningful 

Endpoint in Heart Failure? 

John A. Spertus, Kansas City, MO 

5:00 Clinical Application of Risk Stratification: 

Bringing Prognosis to the Bedside 

Jay N. Cohn, Minneapolis, MN 


Learning Objective: Evaluate several prognostic tools and 

endpoints in heart failure and discuss the clinical value of 

risk stratification. 

Moderators: Horng H. Chen, Rochester, MN 

Matthew A. Movsesian, Salt Lake City, UT 

4:00 Role of Particulate Guanylate Cyclase in Heart Failure 


4:20 Role of cGMP-Hydrolyzing PDE1 in Heart Failure 

Chen Yan, Rochester, NY 

4:40 S-Nitrosylation and Adrenergic Regulation of the Heart 

Jonathan Stamler, Durham, NC 

5:00 Novel Therapeutics Targeting Guanylate Cyclase 



Learning Objective: Discuss the role of cGMP signaling 

and the nitric oxide system in the pathogenesis and potential 

treatment of heart failure. 

Tuesday 







108 

109

Sept. 15 

Tuesday 

PM 

Tuesday 

SYMPOSIUM 


4:00-5:30 PM 

Room 311 

Can Signaling Pathways Be Used to Guide 

Therapeutic Advancement in Heart Failure? 

Moderators: Anthony J. Muslin, St. Louis, MO 

Robert S. Ross, San Diego, CA 

4:00* Can a Computer Predict Signaling Networks 

in the Heart? 

Devika Subramanian, Houston, TX 

4:22* Pim-1 and Cardiac Hypertrophy 

Mark A. Sussman, San Diego, CA 

4:45* T-type Calcium Signaling in Heart Failure 

Steven R. Houser, Philadelphia, PA 

5:07* Nuclear CamKll as a Nodal Regulator of Maladaptive 

Cardiac Hypertrophy 

Joan Heller Brown, La Jolla, CA 


Learning Objective: Discuss the role of signaling pathways 

in guiding therapeutic advancement in heart failure. 




P054 

P055 

P056 

P057 

P058 

Posters 


Predictors and Ramifications of Worsening Renal 

Function in Acutely Destabilized Heart Failure: Results 

from the ICON Study 

Ravi V. Shah 1 , A. Mark Richards 2 , Antoni Bayes-Genis 3 , 

Yigal Pinto 4 , John Lainchbury 2 , Jordi Ordonez 3 , Roland van 

Kimmenade 5 , James L. Januzzi 1 ; 1 Department of Medicine, 

Massachusetts General Hospital, Boston, MA; 2 Cardioendocrine 

Research Group, Department of Medicine, University of Otago, 

Christchurch, Christchurch, New Zealand; 3 Department of 

Medicina, Hospital de la Santa Creu i Sant Pau Universitat 

Autònoma, Barcelona, Spain; 4 Heart Failure Research 

Center, University of Amsterdam, Amsterdam, Netherlands; 

5 

Department of Cardiology, University Hospital Maastricht, 

Maastricht, Netherlands 

What Predicts Troponin Release in Acutely 

Decompensated Heart Failure? 

Ravi V. Shah 1 , A. Mark Richards 2 , Antoni Bayes-Genis 3 , 

Yigal Pinto 4 , John Lainchbury 2 , Jordi Ordonez 3 , Roland van 

Kimmenade 5 , James L. Januzzi 1 ; 1 Medicine, Massachusetts 

General Hospital, Boston, MA; 2 Cardioendocrine Research 

Group, Department of Medicine, University of Otago, 

Christchurch, Christchurch, New Zealand; 3 Medicina, 

Hospital de la Santa Creu i Sant Pau Universitat Autònoma, 

Barcelona, Spain; 4 Heart Failure Research Center, University 

of Amsterdam, Amsterdam, Netherlands; 5 Department of 

Cardiology, University Hospital Maastricht, Maastricht, 

Netherlands 

Administration of Erythropoietin Alfa in Patients 

with Heart Failure with a Preserved Ejection Fraction 

(HFPEF) without Elevating Blood Pressure 

Joseph A. Shatzkes 1 , Sergio L. Teruya 1 , Helen R. Gil 1 , Stephen 

Helmke 1 , Mathew S. Maurer 1 ; 1 Division of Cardiology, 

Columbia University, New York, NY 

Sept. 15 

Tuesday 

Posters 

Intramural Dyssynchrony and Response to CRT in 

Heart Failure Patients with and without Previous Right 

Ventricular Pacing 

Alan J. Bank 1 , Christopher L. Kaufman 1 , Kevin V. Burns 1 , 

Joshua Parah 1 , Lauren Johnson 2 , Daniel R. Kaiser 2 ; 

1 

Cardiovascular Research, St. Paul Heart Clinic, St. Paul, MN; 

2 

Medtronic Inc. 

Ascites Is Not Invariably Present in Heart Failure 

Patients with Elevated Intra-Abdominal Pressure 

Poh Shuan Daniel Yeo 1 , Julio A. Barcena 1 , Carmel M. Halley 1 , 

W.H. Wilson Tang 1 ; 1 Cardiovascular Medicine, Cleveland Clinic, 

Cleveland, OH 

tuesday 

110 

111

Sept. 15 

Tuesday 

Posters 

Posters 


Posters 


Sept. 15 

Tuesday 

Posters 

tuesday 

P059 

P060 

P061 

P062 

P063 

P064 

Impact of Serum Iron Availability on Hemoglobin and 

Hemdoynamics in Patients with Advanced Heart Failure 

Micha T. Maeder 1,2 , David M. Kaye 1,2 ; 1 Heart Failure Research 

Group, Baker IDI Heart and Diabetes Institute, Melbourne, 

Victoria, Australia; 2 Heart Center, Alfred Hospital, Melbourne, 

Victoria, Australia 

The Xanthine Oxidase Inhibitors Oxypurinol and 

Allopurinol Reduce Wasting and Improve Cardiac 

Function in Experimental Cancer Cachexia 

Jochen Springer 1 , Anika Hartmann 1 , Sandra Palus 1 , Volker 

Adams 2 , Ruediger von Harsdorf 3 , Stefan D. Anker 1 , Wolfram 

Doehner 1 ; 1 Applied Cachexia Research, CCR, Charite Medical 

School, Germany; 2 Heart Center Leipzig, University Leipzig, 

Leipzig, Germany; 3 Division of Cardiology, University Network 

Hospitals, Toronto, ON, Canada 

Inhibitory Effects of Omega-3 PUFAs on Cardiac 

Fibrosis In Vivo and In Vitro 

Jinghai Chen 1 , Gregory Shearer 1 , Timothy D. O’Connell 1 , 

A. Martin Gerdes 1 , William S. Harris 1 , Dajun Wang 1 ; 

1 

Cardiovascular Health Research Center, Sanford Research/ 

USD, Sioux Falls, SD 

Characterization of a Non-Surgical Mouse Model of 

Acute Non-Ischemic Cardiomyopathy 

Keith A. Youker 1 , Rene Celis 1 , Carlos Orrego 1 , Jerry D. Estep 1 , 

Dale Hamilton 2 , Guillermo Torre-Amione 1 ; 1 Cardiology, The 

Methodist DeBakey Heart Vascular Center, The Methodist 

Hospital, Houston, TX; 2 Medicine, The Methodist Hospital, 

Houston, TX 

Defining Mechanisms of Myocardial Fibrosis in 

Experimental Mild Renal Insufficiency: A Role for TGFβ1 

Receptor and Molecular Ubiquitin Ligase NFKB 

Gene Activation in a Kidney-Heart Connection 

Fernando L. Martin 1 , Paul M. McKie 1 , Josef Korinek 1 , Brenda K. 

Huntley 1 , Gerald E. Harders 1 , Horng H. Chen 1 , John C. Burnett 1 ; 

1 

Cardiorenal Research Laboratory, Mayo Clinic, Rochester, MN 

Skeletal Muscle Function Predicts Both Peak Oxygen 

Consumption and Peak Cardiac Output in Patients with 

Stable Congestive Heart Failure 

David N. Bartov 1 , Sandhya Murthy 1 , Gayathri Kamalakkannan 1 , 

Qiana Smith 1 , J. Julia Shin 1 , Marie Galvao 1 , Daniel Burkhoff 2 , 

Simon Maybaum 1 ; 1 Department of Medicine Division of 

Cardiology, Albert Einstein College of Medicine, Bronx, NY; 

2 

Columbia University, New York, NY 

P065 

P066 

P067 

P068 

P069 

P070 

Pulmonary Heart Disease as a Complication of Chronic 

Obstructive Pulmonary in the Elderly 

Irina V. Talysina 1 , Dmitry V. Preobrazhensky 2 , Boris A. 

Sidorenko 1 , Irina D. Vishinskaya 2 , Svetlana A. Pataraya 1 ; 

1 

Department of Cardiology, Federal State Institution 

“Educational Scientific Centre” Presidential Medical Centre, 

Moscow, Russian Federation; 2 Department of Cardiology, 

Moscow Medical Academy, Moscow, Russian Federation 

A Computer Simulation Study of the Effectiveness of 

Left Ventricular Assist Device with Different Right 

Ventricular Contractilities 

Salvatore A. Chiaramida 1 , Joseph J. Thompson 1 , John M. Toole 1 , 

Ying Sun 2 ; 1 Cardiology, Medical University of South Carolina, 

Charleston, SC; 2 Biomedical Engineering, University of Rhode 

Island, Kingston, RI 

The Prevelence of Common Co-Morbidities Impacts 

the Pathophsyiology of Patients with Heart Failure and 

Normal Ejection Fraction 

Dmitry Abramov 1 , Mathew S. Maurer 1 , Daniel Burkhoff 1 , Jie 

Wang 2 , Kun-Lun He 2 ; 1 Columbia Presbyterian Medical Center, 

NY, NY; 2 Department of Geriatric Cardiology, Chinese PLA 

General Hospital, Beijing, China 

Dyskinetic Left Ventricular Segments Have Better 

Velocity and Strain Compared to Akinetic Left 

Ventricular Segments 

Asim M. Rafique 1 , Jesse Naghi 1 , Ryan Morrissey 1 , Robert J. 

Siegel 1 , Kirsten Tolstrup 1 , Tasneem Z. Naqvi 2 ; 1 Cardiac Non- 

Invasive Lab, Cedars-Sinai Medical Center, Los Angeles, CA; 

2 

Non-Invasive Cardiology, Keck School of Medicine, USC, Los 

Angeles, CA 

Computer Simulation of Hemodynamics with Pulsatile 

and Nonpulsatile Left Ventricular Assist Devices 

Salvatore A. Chiaramida 1 , Joseph J. Thompson 1 , John M. Toole 1 , 

Ying Sun 2 ; 1 Cardiology, Medical University of South Carolina, 

Charleston, SC; 2 Biomedical Engineering, University of Rhode 

Island, Kingston, RI 

Development of Severe Progressive Heart Failure in 

Experimental Cancer Cachexia 

Jochen Springer 1 , Anika Hartmann 1 , Sandra Palus 1 , Aleksandra 

Grzesiak 2 , Elena Aaschia 2 , Stefan D. Anker 1 ; 1 Applied Cachexia 

Research, Center for Cardiovascular Research, Charite Medical 

School, Berlin, Germany; 2 Institute of Pharmacology, Center 

for Cardiovascular Research, Charite Medical School, Berlin, 

Germany 

tuesday 

112 

113

Sept. 15 

Tuesday 

Posters 

Posters 


Posters 


Sept. 15 

Tuesday 

Posters 

tuesday 

P071 

P072 

P073 

P074 

P075 

Can the Physiological Response to Exertion Be Extracted 

during Activities of Daily Living in Heart Failure 

Patients? 

Kenneth C. Beck 1 , Daniel R. Bensimhon 2 , Paul Chase 2 , Dean 

MacCarter 3 ; 1 Boston Scientific CRM, Saint Paul, MN; 2 LeBauer 

Cardiovascular Research Fdn, Greensboro, NC; 3 Aurora Denver 

Cardiology, Denver, CO 

Left Atrial Diastolic Dysfunction and Pulmonary Venous 

Hypertension: Hemodynamic and Echocardiographic 

Characteristics 

Tariq A. Khan, J. Thomas Heywood, Allen D. Johnson, Micheal 

R. Smith, David Rubenson; Cardiology, Scripps Green Hospital 

10666 N Torrey Pine Rd, La Jolla, San Diego 

Functional Differentiation of CRT Responders Vs. Non- 

Responders 

Dean J. MacCarter 1 , Frederick C. Miller 2 , Kenneth B. Gilmet 2 , 

Ross A. Arena 3 ; 1 Clinical Research, Shape Medical Systems, 

St. Paul, MN; 2 EP, Aurora Denver Cardiology, Denver, CO; 

3 

Physical Therapy, Virginia Commonwealth Univ., Richmond, 

VA 

Periodic Breathing Promotes Circulatory Oscillations at 

Rest and during Exercise in Patients with Heart Failure 

Lyle J. Olson 1 , Adelaide M. Arruda-Olson 1 , Jennifer M. Fitz- 

Gibbon 1 , Bruce D. Johnson 1 ; 1 Mayo Clinic, Rochester, MN 

Predicting Length of Stay in Patients Admitted with 

Acute Decompensated Diastolic Dysfunction 

Sirtaz Adatya 1 , Elissa Kim 1 , Nitesh Sood 1 , Adarsh Bhardwaj 1 , 

Richard Soucier 1 ; 1 University of Connecticut, Hartford, CT 

P079 

P080 

P081 

P082 

Obesity and Smoking Might Be Independent 

Contributor in the Etiopathogenesis of Non Ischemic 


Tokir Mujtaba, Muhammad Chaudhry, Shaukat Ali, Mutahir 

Khan, Balendu C. Vasavada; Internal Medicine, Long Island 

College Hospital, Brooklyn, NY; Internal Medicine, Long 

Island College Hospital, Brooklyn, NY; Cardiology, Long Island 

College Hospital, Brooklyn, NY; Cardiology, Long Island 

College Hospital, Brooklyn, NY; Cardiology, Long Island 

College Hospital, Brooklyn, NY 

Timing Rather Than the Tissue Doppler Imaging Profile 

of the Mitral Annulus Might Be a Better Indicator of 

Left Ventricular Diastolic Dysfunction 

Sameer J. Khandhar, Kathy Edelman, Beth Gulyasy, Angel 



Right–Left Mismatch in the ESCAPE Population: 

Discordance between Right and Left Sided Filling 

Pressures before and after Therapy 

Patricia Campbell, Mark Drazner, Mahoto Kato, Maryse 

Palardy, Neal Lakdawala, Akshay S. Desai, Lynne W. 

Stevenson, Anju Nohria; Department of Cardiology, Brigham 

and Women’s Hospital, Boston, MA 

Does the Relationship between Natriuretic Hormones 

and Diastolic Function Differ by Race? 

Gaston K. Kapuku 1,2 , Harry C. Davis 1 , Patrick Thomas 3 , James 

Januzzi 3 , Gregory Harshield 1 ; 1 Pediatrics, Medical College of 

GA, Augusta, GA; 2 Medicine, Medical College of GA, Augusta, 

GA; 3 Medine, Massachusetts General Hospital, Boston, MA 

tuesday 

P076 

P077 

P078 

Three Dimensional Echocardiography Provides New 

Indexes for the Evaluation of Pulmonary Hypertension 

Tomoko Nakao 1 , Atsushi Yao 1 , Masaru Hatano 1 , Taro Shiga 1 , 

Makoto Sonoda 1 , Koichiro Kinugawa 1 , Yasunobu Hirata 1 , Ryozo 

Nagai 1 ; 1 Cardiovascular Medicine, Graduate School of Medicine, 

University of Tokyo, Tokyo, Japan 

Murine Transverse Aortic Constriction (TAC) Is a 

Highly Variable Experimental Model Which Mimics 

Hypertensive Remodeling in Human Hypertension 

Selma F. Mohammed, Jimmy Storlie, S. Jeson Sangaralingham, 

Elise Oehler, Lorna Bowen, Donna Meyer, Robert D. Simari, 

John C. Burnett, Jr., Margaret M. Redfield; Cardiovascular 

Diseases, Mayo Clinic, Rochester, MN 

Is Myocardial Ischemia the Cause of the Progressive 

Decrease in Ejection Fraction during Acute 

Decompensated Heart Failure ? 

Carlos M. Orrego 1 , Guillermo Torre-Amione 1 ; 1 Cardiology, The 

Methodist Hospital, Houston, TX 

P088 

P089 

P090 


Withdrawn 

The Determinants of Right Ventricular Failure in 

Patients Admitted with Acute Left Heart Failure 

Robert Berkowitz 1 , Eyad Alhaj 1 , Kumar Satya 1 , Muhamed Saric 1 , 

Monica Sanchez 1 , Ramzan Zakir 1 ; 1 Heart Failure, Hackensack 

University Medical Center, Hackensack, NJ 

Differences in Right Ventricular Function between 

Ischemic and Nonischemic Cardiomyopathy 

Navin Rajagopalan, Marc A. Simon, Pawel T. Zymek, Angel 



114 

115

Sept. 15 

Tuesday 

Posters 

Posters 


Posters 


Sept. 15 

Tuesday 

Posters 

tuesday 

P091 

P092 

P105 

P106 

P107 

P108 

Progressive Decline in Circulating CNP with Aging 

Is Associated with Progressive Cardiac Fibrosis and 

Myocardial Impairment 

S. Jeson Sangaralingham 1 , Fernando L. Martin 1 , Paul M. 

McKie 1 , Tomoko Ichiki 1 , Selma F. Mohammed 1 , Gerald E. 

Harders 1 , Elise A. Oehler 1 , Horng H. Chen 1 , Margaret M. 

Redfield 1 , John C. Burnett, Jr. 1 ; 1 Cardiorenal Laboratory, 

Division of Cardiovascular Diseases, Mayo Clinic, Rochester, 

MN 

Non-Dilated Cardiomyopathy: Changes in Left 

Ventricular Size and Function over Time and the Impact 

of Atrial Fibrillation 

Timothy S. Draper, Jr. 1 , Edgar C. Schick 1 , William H. Gaasch 1 ; 

1 

Cardiovasular Medicine, Lahey Clinic, Burlington, MA 


Correlation between Elevated D-Dimer and BNP Levels 

in Various Clinical Diagnoses 

Muhammad M. Chaudhry 1 , Nikolas Wanahita 1 , Mutahir Khan 1 , 

Ahmed F. Aslam 1 , Abhijit Gundale 1 , Balendu C. Vasavada 1 ; 

1 

Cardiology, Long Island College Hospital, Brooklyn, NY 

The Predictive Relations of Anaerobic Threshold 

and VE/VCO2 Slope with NT-proBNP and Activity 

Questionnaire Scores 

Leonidas V. Athanasopoulos 1 , Athanasios Dritsas 1 , Dennis V. 

Cokkinos 1 ; 11 st Cardiology Department, Onassis Cardiac Surgery 

Center, Athens, Greece 

Elevated Serotonin Levels in Patients with Systolic Heart 


Nitasha Sarswat 1 , Ramesh Chandra 1 , Timothy J. Vittorio 2 , 

Ronald Zolty 1 ; 1 Cardiology, Albert Einstein College of Medicine, 

Bronx, NY; 2 Cardiology, Mount Sinai School of Medicine, New 

York, NY 

NT-proBNP Does Not Predict the Length of Hospital 

Stay in Patients Admitted with Systolic Heart Failure 

Exacerbation 

Ali Ahmad 1 , Emile Klada 1 , Dawood Elgergawy 1 , Bashey 

Baquar 1 , Parag Mehta 1 ; 1 Medicine, New York Methodist 

Hospital, Brooklyn, NY 

P109 

P110 

P111 

P112 

P113 

The Degree of Natriuretic Peptide System Activation in 

Stable and High Risk Chf Characterized by Increased 

Cystatin C Is Not Reflected in cGMP Activation 

John A. Schirger 1 , Horng H. Chen 1 , Josh Slusser 2 , David Hodge 2 , 

Denise Heublein 1 , Alessandro Cataliotti 1 , Sharon Sandberg 1 , 

John C. Burnett, Jr. 1 ; 1 Cardiovascular Diseases, Cardiorenal 

Research Laboratory, Mayo Clinic, Rochester, MN; 2 Department 

of Biostatistics, Mayo Clinic, Rochester, MN 

Early Elevations in BNP up to Two Months before Actual 

Decompensation Predict Heart Failure Hospitalizations 

Pam R. Taub 1 , Ellen Fitzpatrick 1 , Kimberly Tran 1 , Kevin 

Shah 1 , Kevin Jiang 1 , Paul Clopton 1 , Mitchell Saltzburg 2 , Robert 

Fitzgerald 1 , Alan Maisel 1 ; 1 Divison of Cardiology, Veterans 

Affairs San Diego Health Care System, University of California 

San Diego, San Diego, CA; 2 Cardiology, Midwest Heart 

Specialists, Lombard, IL 

Comparison of Cardiac and Inflammatory Biomarker 

Levels between Carriers and Non-Carriers of MYBPC3 

Gene Mutation for Hypertrophic Cardiomyopathy 

W.H. Wilson Tang 1 , Baozhong Xin 2 , Leah Nye 2 , Sabe De 1 , Allen 

G. Borowski 1 , Stanley L. Hazen 1 , Heng Wang 2 ; 1 Cardiovascular 

Medicine, Cleveland Clinic, Cleveland, OH; 2 Das Deutsch 

Center Clinic for Special Needs Children, Middlefield, OH 

Troponin Release in Patients Admitted with Acute 

Decompensated Heart Failure and Renal Dysfunction: 

Results from the Pilot Phase of the PROTECT Trial 

Marco Metra 1 , Howard C. Dittrich 2 , Gad Cotter 3 , Barry 

M. Massie 4 , Piotr Ponikowski 5 , Gang Jia 6 , Kenji P. Fujita 6 , 

Christopher M. O’Connor 7 ; 1 University of Brescia, Brescia, 

Italy; 2 University of California, San Diego, San Diego, CA; 

3 

Momentum Research, Inc, Durham, NC; 4 University of 

California, San Francisco, San Francisco, CA; 5 Clinical Military 

Hospital, Wroclaw, Poland; 6 Merck Research Laboratories, 

Rahway, NJ; 7 Duke University, Durham, NC 

Determinants of Circulating Corin in Healthy Subjects 

Tomoko Ichiki 1 , Brenda K. Huntley 1 , Denise M. Heublein 1 , 

S. Jeson Sangaralingham 1 , Fernando L. Martin 1 , John A. 

Schirger 1 , Fima Macheret 1 , Michihisa Jougasaki 2 , John C. 

Burnett, Jr. 1 ; 1 Division of Cardiovascular Diseases, Mayo Clinic, 

Rochester, MN; 2 Clinical Research, Kagoshima Medical Center, 

Kagoshima, Japan 

tuesday 

P114 

Calcitonin Gene-Related Peptide as a Potential Marker 

of Compensation in Patients with Acute Heart Failure 

Exacerbations 

Adib Asrabadi 1 , Alejandro Barbagelata 2 , Ming-He Huang 2 , 

Vishal Kapur 2 ; 1 Internal Medicine, University of Texas Medical 

Branch, Galveston, TX; 2 Cardiology, University of Texas 

Medical Branch, Galveston, TX 

116 

117

Sept. 15 

Tuesday 

Posters 

Posters 


Posters 


Sept. 15 

Tuesday 

Posters 

tuesday 

P115 

P116 

P126 

P127 

P128 

P129 

Plasma Myeloperoxidase Activity in Chronic Heart 


Harish Manyam 1 , Laurie Machen 1 , Carrie Melegari 1 , Diane 

Vido 1 , Kishan Jasti 1 , George Sokos 1 , Raymond Benza 1 , Srinivas 

Murali 1 ; 1 Gerald McGinnis Cardiovascular Institute, Allegheny 

General Hospital, Pittsburgh, PA 

Extracellular Matrix Protein Interactions with 

Natriuretic Peptide and Integrin Receptors in Human 

Cardiac Fibroblasts 

Brenda K. Huntley 1 , Tomoko Ichiki 1 , John C. Burnett, Jr. 1 ; 

1 

Cardiorenal Research, Mayo Clinic, Rochester, MN 


Regulation of β-Adrenergic Receptors in Pediatric Heart 


Shelley Miyamoto 1 , Carmen Sucharov 1 , Penny Nelson 1 , Rebecca 

Sobus 1 , Brian Stauffer 1 ; 1 Pediatrics and Medicine, University of 

Colorado Denver, Aurora, CO 

Adiponectin Protects Doxorubicin-Induced 

Cardiomyopathy in Mice 

Masanori Konishi 1 , Go Haraguchi 1 , Takashi Ishihara 1 , Hirokazu 

Ohigashi 1 , Mitsuaki Isobe 1 ; 1 Cardiovascular Medicine, Tokyo 

Medical and Dental University, Bunkyo-ku, Tokyo, Japan 

Cellular FLICE-Inhibitory Protein Protects Against 

Cardiac Remodeling after Myocardial Infarction 

Mark S. Moon 1,2 , HongLiang Li 2 , Min Nian 2 , Manyin Chen 2 , 

Chen Liu 2 , Peter P. Liu 1,2,3 ; 1 University of Toronto, Toronto, ON, 

Canada; 2 Division of Cardiology, University Health Network, 

Toronto, ON, Canada; 3 Institute of Circulatory and Respiratory 

Health, Canadian Institutes of Health Research, Toronto, ON, 

Canada 

Myocardial Upregulation of hnRNP-C Predicts Short 

Term Recovery in Patients with Acute Systolic Heart 


Kimberly A. Parks 1 , Marc J. Semigran 1 , James R. Stone 1 ; 

1 

Massachusetts General Hospital, Harvard Medical School, 

Boston, MA 

P131 

P132 

P133 

P134 

P135 

Functional Significance of Cardiac Beta3 Adrenergic 

Receptors in Alcoholic Cardiomyopathy 

Che-Ping Cheng 1 , Heng-Jie Cheng 1 , Satoshi Masutani 1 , 

William G. Hundley 1 , James B. Daunais 2 , David P. Friedman 2 , 

Kathleen A. Grant 3 ; 1 Internal Medicine-Cardiology, Wake 

Forest University School of Medicine, Winston-Salem, NC; 

2 

Physiology and Pharmacology, Wake Forest University School 

of Medicine, Winston-Salem, NC; 3 Department of Behavioral 

Neuroscience, Oregon Health and Science University, Portland, 

OR 

Loss of BMPR2B in Zebrafish Causes Augmented BMP- 

Signaling through Recruitment of an Alternative Type 2 

Receptor 

Daniel Washko 1 , Calum A. MacRae 1 , Jordan T. Shin 1 ; 1 CVRC, 

Massachusetts General Hospital, Charlestown, MA 

The Impact of the AMPD1 Gene Polymorphism on 

Exercise Capacity in Patients with Chronic Heart Failure 

Prabhu T. Alahakoon 1 , Alex J. Auseon 1 , Carl V. Leier 1 , Philip F. 

Binkley 1 ; 1 Cardiovascular Medicine, The Ohio State University 


The Role of Autophagy in Iron-Overload 

Cardiomyopathy: A Model of Diastolic Heart Failure 

Due to Oxidative Stress 

Guo Hua Li 1 , Yu Shi 1 , Yu Chen 1 , Mei Sun 1 , Geoffrey de Couto 1 , 

Masahiro Fukuoka 1 , Xiaoxia Wang 1 , Fayez Dawood 1 , Manyin 

Chen 1 , Meredith Li 1 , Youan Liu 1 , Neelam Khaper 2 , Peter Liu 1,3 ; 

1 

Toronto General Hospital, University Health Network, Toronto, 

ON, Canada; 2 Medical Sciences Division, Lakehead University, 

Thunder Bay, ON, Canada; 3 Canadian Institute of Health 

Research Group, University of Toronto, Toronto, ON, Canada; 

4 

Canada 

Failing Human Hearts Display Elevated PDE5 

Expression Levels in Right Ventricle 

Xiaoyin Shan 1 , Kamran Haleem 1 , Kenneth B. Margulies 1 ; 

1 

Cardiovascular Research Institute, University of Pennsylvania, 



tuesday 

P130 

Sarcomeric Dilated Cardiomyopathy: Onset from 

Infancy to Late Adulthood 

Neal K. Lakdawala 1 , Samantha Baxter 2 , Elizabeth Duffy 2 , Raju 

Kucherlapati 2 , J.G. Seidman 3 , Christine E. Seidman 1,3 , Carolyn 

Y. Ho 1 , Birgit Funke 2 ; 1 Cardiovascular Division, Brigham and 

Women’s Hospital, Boston, MA; 2 Pathology, Laboratory for 

Molecular Medicine, Cambridge, MA; 3 Department of Genetics, 

Harvard Medical School, Boston, MA 

P158 

Re-Opening of the Aortic Valve Following LVAD 

Implantation with Heartmate Ii 

Sabe De 1 , Peter Eckman 1 , Randall Starling 1 , Richard Grimm 1 , 

Maria Mountis 1 , W.H. Wilson Tang 1 ; 1 Cardiovascular Medicine, 

Cleveland Clinic Foundation, Cleveland, OH 

118 

119

Sept. 15 

Tuesday 

Posters 

Posters 


Posters 


Sept. 15 

Tuesday 

Posters 

tuesday 

P159 

P160 

P161 

P162 

P163 

P164 

Impact of ‘De Novo Antibodies’ on Transplant Coronary 

Artery Disease and Cellular Rejection after Heart 

Transplantation 

Taro Sasaoka 1 , Tomoko S. Kato 1 , Noboru Oda 1 , Yoshihiro 

Murata 1 , Noboru Yanase 1 , Kazuhiko Hashimura 1 , Hatsue I. 

Ueda 1 , Suguru Yamamoto 1 , Toshiaki Shishido 2 , Masaharu Sada 2 , 

Mitsuaki Isobe 3 , Takeshi Nakatani 1 ; 1 National Cardiovascular 

Center, Osaka, Japan; 2 National Cardiovascular Center Research 

Institute, Osaka, Japan; 3 Tokyo Medical and Dental University, 

Tokyo, Japan 

Improved Long-Term Performance of Pulsatile Extra 

Corporeal Left Ventricular Assist Device 

Taro Sasaoka 1 , Tomoko S. Kato 1 , Noboru Oda 1 , Yoshihiro 

Murata 1 , Masanobu Yanase 1 , Kazuhiko Hashimura 1 , Junjiro 

Kobayashi 1 , Toshiaki Shishido 2 , Mitsuaki Isobe 3 , Takeshi 

Nakatani 1 ; 1 National Cardiovascular Center, Osaka, Japan; 

2 

National Cardiovascular Center Research Institute, Osaka, 

Japan; 3 Tokyo Medical and Dental University, Tokyo, Japan 

Isolating the Renal Venous System from Systolic Reflux 

in Severe Tricuspid Regurgitation Using Transcatheter 

Valves 

Carolyn S.P. Lam 1 , Selma F. Mohammed 1 , Jimmy R. Storlie 1 , 

Lorna A. Bowen 1 , Pamela K. Ryno 1 , Elisa A. Oehler 1 , Donna M. 

Meyer 1 , Margaret M. Redfield 1 ; 1 Mayo Clinic, Rochester, MN 

Lack of Hemodynamic Augmentation with Cardiac 

Resynchronization Therapy in Majority of Patients with 

Left Ventricular Assist Devices 

Peter M. Eckman 1 , Sabe K. De 1 , Anthony Nunez 2 , Gonzalo 

V. Gonzalez-Stawinski 2 , Bruce L. Wilkoff 1 , Richard A. 

Grimm 1 , Randall C. Starling 1 , W.H. Wilson Tang 1 ; 1 Heart 

Vascular Institute-Cardiovascular Medicine, Cleveland Clinic 

Foundation, Cleveland, OH; 2 Heart Vascular Institute-Thoracic 

and Cardiovascular Surgery, Cleveland Clinic Foundation, 

Cleveland, OH 

Beyond EVEREST: Percutaneous Mitral Repair in 

Heart Failure Patients with Severe Lv Dysfunction 

Sven Meyer 1 , Olaf Franzen 1 , Loant Baholli 1 , Achim Barmeyer 1 , 

Dietmar Koschyk 1 , Stephan Baldus 1 , Thomas Meinertz 1 , 

Angelika Costard-Jaeckle 1 ; 1 Department of Cardiology, 

University Heart Center, Hamburg, Germany 

Novel Use of Electroanatomic Mapping System 

for Intraoperative CRT Device AV and VV Timing 

Optimization 

Imran K. Niazi 1 , Peter Chelius 2 , Stuart P. Rosenberg 2 , Kyungmoo 

Ryu 2 , Michael Yang 2 ; 1 Arrhythmia Center for Southern 

Wisconsin, Milwaukee, WI; 2 St. Jude Medical, Sylmar, CA 

P165 

P166 

P167 

P168 

P169 

P170 

Reappearance of a Normal Circadian Rhythm after 

Ventricular Assist Device Implantation 

Mark S. Slaughter 1 , Michael S. Ising 1 , Daniel Tamez 2 , Gerry 

O’Driscoll 3 , Neil Voskoboynikov 2 , Carlo R. Bartoli 1 , Steven C. 

Koenig 1 , Guruprasad A. Giridharan 1 ; 1 University of Louisville, 

Louisville, KY; 2 HeartWare Inc., Miami Lakes, FL; 3 Royal Perth 

Hospital, Perth, Australia 

Pneumatosis Intestinalis Associated with Orthotopic 

Heart Transplantation in Adults 

Nisha L. Bhatia 1 , D. Eric Steidley 1 , Robert L. Scott 1 , Alvin C. 

Silva 2 , Francisco A. Arabia 3 , Farouk Mookadam 1 ; 1 Division of 

Cardiovascular Diseases, Mayo Clinic Arizona, Scottsdale, 

AZ; 2 Division of Radiology, Mayo Clinic Arizona, Scottsdale, 

AZ; 3 Division of Cardiothoracic Surgery, Mayo Clinic Arizona, 

Scottsdale, AZ 

Lack of Concordance between the Optimal Sites of 

Lv Pacing as Determined by Invasive Hemodynamic 

Recordings and the Sites of Latest LV Mechanical 

Activation Determined by Tissue Doppler Imaging (TDI) 

Dusan Z. Kocovic, Steven Rothman, Nancy Britton, Scott 

Cox, Simone Musco, Glen Miske, Mark Heimann; Cardiology, 

Lankenau Hospital, Wynnewood, PA 

Left Atrial Function in Heart Transplant Recipients 

Jennifer M. Wright 1 , Nilam Patel 1 , Theodore Maglione 1 , 

Biljana Pavlovic-Surjancev 1 , Thriveni Sanagala 1 ; 1 Division of 

Cardiology, Loyola University Medical Center, Maywood, IL 

Barriers to Heart Transplantation: One Urban Center’s 

Findings 

Carolyn J. Van Why 1 , Natalie Pierson 1 , Colleen Flanagan 3 , 

Anne Canny 1 , Jill Bilkins 3 , Stephanie Cozzi 1 , Melissa 

Connolly 3 , Elizabeth Shore 3 , Sharon Rubin 1 , Scott Silvestry 2 , 

David Whellan 1 , Linda Bogar 1 , Paul J. Mather 1 ; 1 Department 

of Medicine, Jefferson Medical College, Philadelphia, 

PA; 2 Department of Surgery, Jefferson Medical College, 

Philadelphia, PA; 3 Thomas Jefferson University Hospital, 

Jefferson Medical College, Philadelphia, PA 

Left Ventricular Torsion Is Reduced in Heart Transplant 

Patients 

Christine Nardi 1 , Elizabeth Przepiorka 1 , Theodore Maglione 1 , 

Alain Heroux 1 , Thriveni Sanagala 1 ; 1 Division of Cardiology, 

Loyola University Medical Center, Maywood, IL 

tuesday 

120 

121

Sept. 15 

Tuesday 

Posters 

Posters 


Posters 


Sept. 15 

Tuesday 

Posters 

tuesday 

P171 

P172 

P173 

P174 

P175 

Peripheral Transcriptomes in End-Stage Heart Failure: 

Inflammatory Signature Pre LVAD 

Jeffrey J. Teuteberg 1 , Kathy Lockard 2 , Karen Hanley-Yanez 1 , 

Karen Janosko 1 , Lori DeGore 2 , Christian Bermudez 2 , Jay 

Bhama 2 , Ravi Ramani 1 , Marc Simon 1 , David Ishizawar 1 , 

Charles McTiernan 1 , Robert L. Kormos 2 , Dennis McNamara 1 ; 

1 

Cardiovascular Institute, University of Pittsburgh, Pittsburgh, 

PA; 2 Heart, Lung, Esophageal Surgery Institute, University of 

Pittsburgh, Pittsburgh, PA 

Daily Maximum and Median Respiratory Rate Are 

Elevated during Clinical Events When Compared to a 

Post-Implant Baseline in CRT-D Patients 

Bela Merkely 1 , Jochem Stockinger 2 , Joseph L. Mont I Girbau 3 , 

Yi Zhang 4 , Torsten Kayser 5 , Viktoria A. Averina 4 , Nicholas D. 

Wold 4 , Poul-Erik Bloch Thomsen 6 ; 1 Semmelweiss University 

Budapest - Cardiovascularis Centrum, Budapest, Hungary; 

2 

Herzzentrum Bad Krozingen, Bad Krozingen, Germany; 

3 

Hospital Clínico de Barcelona, Barcelona, Spain; 4 Boston 

Scientific, St Paul, MN; 5 Boston Scientific, Brussels, Belgium; 

6 

KAS Gentofte Hospital, Hellerup, Denmark 

Daily Maximum and Median Respiratory Rate Become 

Elevated Several Weeks before HF Hospitalization in 

Patients with Implantable Devices 

Joseph L. Mont I Girbau 1 , Bernd Lemke 2 , Bela Merkely 3 , 

Yi Zhang 4 , Torsten Kayser 5 , Viktoria A. Averina 4 , Nicholas 

D. Wold 4 , Poul-Erik Bloch-Thomsen 6 ; 1 Hospital Clínico de 

Barcelona, Barcelona, Spain; 2 Kliniken GmbH, Klinikum 

Lüdenscheid, Lüdenscheid, Germany; 3 Semmelweiss University 

Budapest - Cardiovascularis Centrum, Budapest, Hungary; 

4 

CRM, Boston Scientific, St Paul, MN; 5 Europe, Boston 

Scientific, Brussels, Belgium; 6 KAS Gentofte Hospital, 

Hellerup, Denmark 

Preoperative Clinical Profiles Predict Prognosis after 

Left Ventricular Assist Device Implantation 

Taro Shiga 1 , Koichiro Kinugawa 1 , Masaru Hatano 1 , Atsushi 

Yao 1 , Takashi Nishimura 3 , Minoru Ono 2 , Yasunobu Hirata 1 , 

Shunei Kyo 3 , Shinichi Takamoto 2 , Ryozo Nagai 1 ; 1 Department 

of Cardiovascular Medicine, The University of Tokyo Hospital, 

Tokyo, Japan; 2 Department of Cardiac Surgery, The University 

of Tokyo Hospital, Tokyo, Japan; 3 Department of Therapeutic 

Strategy for Heart Failure, Graduate School of Medicine, The 

University of Tokyo, Tokyo, Japan 

Survival Estimation by Seattle Heart Failure Model and 

Heart Failure Survival Score in Patients Undergoing 

Elective Left Ventricular Assist Device Placement 

Haree Vongooru, Jagroop Basraon, Adeesh Agnihotri, Wayne 

Levy, Inder Anand, Marc Pritzker; University of Minnesota, 

MN; University of Washington, WA 

P176 

P177 

P178 

P179 

P190 

A Novel Approach to Management of Acute Rejection 

with Percutaneous Ventricular Assist Device Insertion in 

Two Adolescent Heart Transplant Patients 

Rakesh K. Singh 1 , Linda J. Addonizio 1 , Marc Richmond 1 , Julie 

Vincent 1 , Alejandro Torres 1 , Mathew Williams 2,3 ; 1 Division of 

Pediatric Cardiology, Columbia University Medical Center, 

New York, NY; 2 Division of Cardiothoracic Surgery, Columbia 

University Medical Center, New York, NY; 3 Division of Adult 

Cardiology, Columbia University Medical Center, New York, 

NY 

Echo Doppler Evaluation of Left Atrial Pressure in 

Heart Transplant Recipients 

Theodore J. Maglione 1 , Jennifer Wright 1 , Nilamkumar Patel 1 , 

Joan Gusmano 1 , Biljana Pavlovic-Surjancev 1 , Alain Heroux 1 , 

Thriveni Sanagala 1 ; 1 Cardiology, Loyola University Medical 

Center, Maywood, IL 

Long-Term Outcomes of Combined Orthotopic Heart- 

Liver Transplantation with Complete Cardio-Pulmonary 

Bypass Support: A Case Series 

Gordan Samoukovic 1 , Amy Neville 1 , Nadia Giannetti 2 , Marcelo 

Cantarovich 2 , Renzo Cecere 1 ; 1 Surgery, McGill University 

Health Centre, Montreal, QC, Canada; 2 Medicine, McGill 

University Health Centre, Montreal, QC, Canada 

Low Dose Nesiritide Infusion Leads to Rapid and 

Sustained Improvement in Renal Function in 

Patients with Acute Renal Failure Early Post Cardiac 

Transplantation 

Stephen M. Chrzanowski 1 , Christopher Wolfe 2 , Mariell L. 

Jessup 1 , Michael A. Acker 2 , Joyce W. Wald 1 , Paul R. Forfia 1 ; 

1 

Medicine/Cardiovascular, University of Pennsylvania, 

Philadelphia, PA; 2 Surgery/Cardiothoracic, University of 

Pennsylvania, Philadelphia, PA 


A Comparison of Cardiac Resynchronization Therapy 

Optimization Using QuickOpt® and Echocardiographic 

Parameters 

Riple Hansalia 1 , William Duvall 1 , Samantha Buckley 1 , Bryan 

Tilton 2 , Kari Poole 2 , Li-Yin Lee 2 , Avi Fischer 1 ; 1 Cardiovascular 

Institute, Mount Sinai School of Medicine, New York, NY; 

2 

CRMD, St. Jude Medical, Sylmar, CA 

tuesday 

122 

123

Sept. 15 

Tuesday 

Posters 

Posters 


Posters 


Sept. 15 

Tuesday 

Posters 

tuesday 

P191 

Feasibility Study of Acute Ischemia Detection with 

Biventricular Pacing in Canine 

Jeffery D. Snell 1 , Rupinder Bharmi 1 , Ryan Rooke 1 , Nikolai 

Korsun 1 , Sam Fatemi 1 , Bruce Morley 1 , Jay R. Snell 1 ; 1 CRMD 

Research, St. Jude Medical, Sylmar, CA 

P192 Incidence of Tachyarrhythmia Therapy Utilization in 132 

Primary Prevention Patients at a Single Center 

James Hurley 1 , Brent Robinson 1 , Charles Melton 1 , Minakshi 

Patel 1 , Joseph Saporito 1 , Sandra B. Charlton 2 , James J. Sims 2 ; 

1 

Texarkana Cardiology Associates, Texarkana, TX; 2 Medtronic, 

Inc., Moundsview, MN 

P193 

P194 

P195 

P196 

P197 

Prognostic Impact of Atrial Fibrillation and Other 

Electrocardiogrphic Indices in a Multi-Ethnic Singapore 

Population with Well-Defined Clinical Heart Failure on a 

3-Year Follow Up 

Gerard K.T. Leong 1 , Benji Y.Z. Lim 1 , Kenneth B.K. Tan 1 , Kee 

Tung Tan 1 , Vern Hsen Tan 1 , Siang Chew Chai 1 , Ping Ping Goh 1 ; 

1 

Cardiology, Changi General Hospital, Singapore, Singapore 

Defibrillator Utilization Rates in 234 Elderly Patients 

Receiving Cardiac Resynchronization Therapy 

Thomas A. Charlton 1 , Frank A. McGrew 1 , Eric E. Johnson 1 , 

Mark A. Coppess 1 , Barbara Hamilton 1 , Sandra B. Charlton 2 , 

James J. Sims 2 ; 1 Stern Cardiovascular Clinic, Germantown, TN; 

2 

Medtronic, Inc., Moundsview, MN 

Change in P Wave Duration on Electrocardiogram 

Correlates with Effective Treatment of Heart Failure: 

Sapan N. Talati 1 , Siva Mulpuru 1 , Naresh Mori 1 , Balendu C. 

Vasavada 1 ; 1 Internal Medicine and Cardiovascular Disease, Long 

Island College Hospital, Brooklyn, NY 

Relationship of Left Ventricular Conduction Delays to 

QRS Configuration in Patients with Left Ventricular 

Dysfunction 

Niraj Varma 1 ; 1 Heart and Vascular Institute, Cleveland Clinic, 

Cleveland, OH 

Prognostic Significance of Heart Rate Variability, 

Ventricular Arrhythmic Burden and a Novel Non- 

Invasive Marker Score in Heart Failure Patients with 

Preserved Ejection Fraction 

Karthik Gujja 1 , Vinay Pai 1 , Moinakthar Lala 1 , Mutahir Khan 1 , 

Darshan Patel 1 , Ameeta Ahuja 1 , Balendu Vasavada 1 ; 1 Division 

of Cardiology, Department of Internal Medicine, Long Island 

College Hospital, Brooklyn, NY 

P198 

P199 

P218 

P219 

P220 

Utilization of Device Therapy in Heart Failure: Impact 

of Subgroups and Co-Morbidities 

Spencer H. Kubo 1 , Alan J. Bank 1 , Thomas H. Johnson 1 , Denise 

Carlson 1 , Ann Hayden 1 , Marjorie Webb 1 , Stuart W. Adler 1 , David 

N. Dunbar 1 , Pierce J. Vatterot 1 , Gregory Granrud 1 , Dent R. 

Underwood 1 , Michael Peterson 1 ; 1 St. Paul Heart Clinic, St. Paul, 

MN 

Optimal Atrio-Ventricular Delay during Left Ventricular 

Pacing Can Be Approximated from Electrical 

Conduction Parameters 

Yaariv Khaykin 1 , Derek Exner 2 , David Burnie 3 , John Sapp 4 , 

Sandeep Aggarwal 2 , Sandra Owen 2 , Aleksandre Sambelashvili 5 ; 

1 

Southlake Regional Health Centre, Newmarket, ON, Canada; 

2 

Libin Cardiovascular Institute of Alberta, Calgary, AB, Canada; 

3 

University of Ottawa Heart Institute, Ottawa, ON, Canada; 

4 

Queen Elizabeth II Health Sciences Center, Halifax, NS, 

Canada; 5 Medtronic Inc., Mounds View, MN 


Structural and Functional Reverse Remodeling of the 

Left Atrium after Catheter Ablation of Atrial Fibrillation 

with Normal Vs. Reduced Left Ventricular Systolic 

Function 

Suman S. Kuppahally 1 , Nathan Burgon 1 , Troy Badger 1 , Nazem 

Akoum 1 , Stephen Ishihara 1 , Sheldon E. Litwin 1 , Nassir F. 

Marrouche 1 ; 1 Cardiology, University of Utah, Salt Lake City, UT 

Phase II Safety Study Evaluating the Novel Cardiac 

Myosin Activator, CK-1827452, in Patients with Ischemic 

Cardiomyopathy and Angina 

Barry H. Greenberg 1 , Will Chou 2 , Rafael Escandon 2 , Jacqueline 

H. Lee 2 , Khalil G. Saikali 2 , Fady Malik 2 , Andrew A. Wolff 2 , 

Tamaz Shaburishvili 3 ; 1 Cardiology, University of California, San 

Diego, San Diego, CA; 2 Clinical Research and Development, 

Cytokinetics, South San Francisco, CA; 3 Diagnostic Services 

Clinic, Tbilisi, Georgia 

Phase IIa Study of the NPR-A Agonist, PL-3994, in 

Healthy Adult Volunteers with Controlled Hypertension 

Domenic Sica 1 , Robert Jordan 2 , Steven A. Fischkoff 2 ; 

1 

Virginia Commonwealth University, Richmond, VA; 2 Palatin 

Technologies, Inc., Cranbury, NJ 

tuesday 

124 

125

Sept. 15 

Tuesday 

Posters 

Posters 


Posters 


Sept. 15 

Tuesday 

Posters 

tuesday 

P221 

P222 

P223 

How Does Complete Capture Management Contribute 

to the Effectiveness of Cardiac Resynchronization in HF 

Patients? 

Dieter Zenker 1 , Francis Murgatroyd 2 , Haran Burri 3 , Finn Tore 

Gjestvang 4 , Joerg Schwab 5 , Sabine Janko 6 , Amos Katz 7 ; 1 Georg- 

August Universitaet Goettingen, Goettingen, Germany; 2 Kings 

College Hospital, London, United Kingdom; 3 HUG- Hopitaux 

Universitaires Geneve, Geneva, Switzerland; 4 Sorlandet 

Sykehus, Kristiansand, Norway; 5 University of Bonn, Bonn, 

Germany; 6 Klinikum Muenchen Bogenhausen, Muenchen, 

Germany; 7 Barzilai Medical Center, Ashkelon, Israel 

Clinical Use of Very High BNP Is Limited 

Catherine Law 1 , Charles Glover 1 , Kaaron Benson 2 , Maya 

Guglin 1 ; 1 Department of Cardiology, Universtity of South 

Florida, Tampa, FL; 2 Clinical Laboratory, H. Lee Moffitt Cancer 

Center, Tampa, FL 

Time to Treatment and Vasodilator Efficacy in Acute 

Heart Failure: Results from the Pre-RELAX-AHF Study 

G. Michael Felker 1 , John R. Teerlink 2 , Piotr Ponikowski 3 , 

Adriaan A. Voors 4 , Gerasimos Filippatos 5 , Barry H. Greenberg 6 , 

Sam L. Teichman 7 , Gad Cotter 8 , Beth D. Weatherley 8 , Marco 

Metra 9 ; 1 Division of Cardiology, Duke Clinical Research 

Institute, Durham, NC; 2 Section of Cardiology, University of 

California-San Francisco, San Francisco, CA; 3 Cardiology 

Department, Clinical Military Hospital, Wroclaw, Poland; 

4 

Department of Cardiology, University Medical Center, 

Groningen, Netherlands; 5 Department of Cardiology, University 

Hospital Attikon, Athens, Greece; 6 Division of Cardiology, 

University of California-San Diego, San Diego, CA; 7 Corthera, 

Inc, San Mateo, CA; 8 Momentum Research, Inc, Durham, NC; 

9 

Section of Cardiovascular Diseases, University of Brescia, 

Brescia, Italy 

P227 

P228 

P229 

Echocardiographic Detection of Increases in Ejection 

Fraction in Patients with Heart Failure Receiving the 

Selective Cardiac Myosin Activator, CK-1827452 

Jonathan H. Goldman 1 , John R. Teerlink 2 , Khalil G. Saikali 3 , 

Fady Malik 3 , Andrew A. Wolff 3 ; 1 Medical Affairs, ICON Medical 

Imaging, Warrington, PA; 2 Cardiology, University of California, 

San Francisco, CA; 3 Clinical Research and Development, 

Cytokinetics, South San Francisco, CA 

Exercise Limb Blood Flow Is Reduced Despite Adequate 

Cardiac Output in Elderly Patients with Heart Failure 

Chirapa Puntawagkoon 1 , Dalane W. Kitzman 1 , Stephen B. 

Kritchevsky 2 , Craig A. Hamilton 3 , Barbara Nicklas 2 , Xiaoyan 

Leng 4 , Peter H. Brubaker 5 , William G. Hundley 1 ; 1 Cardiology, 

Wake Forest University School of Medicine, Winston Salem, 

NC; 2 Internal Medicine (Gerontology and Geriatric Medicine 

Section), Wake Forest University School of Medicine, 

Winston Salem, NC; 3 Biomedical Engineering, Wake Forest 

University School of Medicine, Winston Salem, NC; 4 Public 

Health Sciences, Wake Forest University School of Medicine, 

Winston Salem, NC; 5 Health and Exercise Science, Wake Forest 

University School of Medicine, Winston Salem, NC 

Are the Symptom Improvements with Percutaneous 

Mitral Valve Annuloplasty for Functional Mitral 

Regurgitation Due to Changes in Heart Failure 

Medications? 

Wayne C. Levy 1 , Joachim Schofer 3 , Uta C. Hoppe 4 , Tomasz 

Siminiak 5 , Michael Haude 6 , David G. Reuter 2 ; 1 Division 

of Cardiology, University of Washington, Seattle, WA; 

2 

Cardiac Dimensions, Kirkland, WA; 3 Hamburg University 

Cardiovascular Center, Hamburg, Germany; 4 University of 

Cologne, Germany; 5 Poznan University Medical Sciences, 

Poland; 6 Stadtische Kliniken Neuss, Germany 

tuesday 

P224 

P225 

Progress Report on Non-Invasive Diagnosis of 

Asymptomatic Left Ventricular Systolic Dysfunction 

Yoseph Rozenman 1 , Daniel A. Goor 2 , Renee Rotzak 1 ; 1 Heart 

Institute, Wolfson Medical Center, Holon, Israel; 2 Sackler 

School of Medicine, University of Tel Aviv, Tel Aviv, Israel 

The AFFIRM Trial: Patients Who Switched from Rate to 

Rhythm Control Felt Better in Sinus Rhythm 

Maya Guglin, Ren Chen, Anne B. Curtis; Cardiology, University 

of South Florida, Tampa, FL 

P230 

Cardiac Resynchronization, Not Atrial Support Pacing, 

Improves Quality of Life in Heart Failure Patients 

David O. Martin 1 , John D. Day 2 , Stacia Merkel Kraus 3 , Kira Q. 

Stolen 4 , Shelly Christman 4 ; 1 Cleveland Clinic, Cleveland, OH; 

2 

Intermountain Medical Center, Salt Lake City, UT; 3 The Integra 

Group, Brooklyn Park, MN; 4 Boston Scientific CRM, St. Paul, 

MN 

P226 

Life Threatening Arrhythmia Prediction in Heart Failure 

Patients Via Cardiac MRI 

Nishant Kalra 1 , Vincent L. Sorrell 1 ; 1 Cardiology, University of 

Arizona, Tucson, AZ 

126 

127

Sept. 15 

Tuesday 

Posters 

Posters 


Posters 


Sept. 15 

Tuesday 

Posters 

tuesday 

P231 

P232 

P233 

P234 

P247 

Correlation with Signs of Heart Failure and Stability 

of Assessment of Dyspnea in Patients Hospitalized for 

Acute Decompensated Heart Failure 

Ann Marie McNeill 1 , Beth Davison Weatherley 2 , Cynthia 

J. Girman 1 , Christopher Edwards 2 , George A. Mansoor 1 , 

Howard C. Dittrich 3 , Gadi Cotter 2 ; 1 Merck, Upper Wales, PA; 

2 

Momentum Research Inc, Durham, NC; 3 School of Medicine, 

Univ of California San Diego, La Jolla, CA 

Electric Tomography – A Novel Voltage Based Modality 

for Assessing LV Performance with LV Stimulation 

Michael K. Cao 1 , Ray V. Matthews 1 , Greg Moon 2 , Yashar 

Behzadi 2 , Jerold S. Shinbane 1 , David A. Cesario 1 , Leslie A. 

Saxon 1 ; 1 Division of Cardiovascular Medicine, USC Keck 

School of Medicine, Los Angeles, CA; 2 Proteus Biomedical, 

Redwood, CA 

Diagnostic Utility of B-Natriuretic Peptide in Evaluation 

of Diastolic Dysfunction 

Btissama Essadiqi 1 , Charaf E. Ahnadi 2 , Andrew Grant 2 , 

Serge Lepage 1 ; 1 Cardiology Department, Centre Hospitalier 

Universitaire de Sherbrooke, Sherbrooke, QC, Canada; 

2 

Collaborative Research for Clinical Diagnostics, Centre 

Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, 

Canada 

Statins Do Not Significantly Affect Muscle Sympathetic 

Nerve Activity in Humans with Non-Ischemic Heart 


Tamara B. Horwich 1 , Holly R. Middlekauff 1 , Robb MacLellan 1 , 

Gregg C. Fonarow 1 ; 1 Medicine/Cardiology, UCLA, Los Angeles, 

CA 


Gpr30 Receptor Activation Improves Cardiac Function 

in Intact Female mRen2.Lewis Rats 

Jewell A. Jessup 1 , Sarah H. Lindsey 2 , Mark C. Chappell 1,2 , 

Leanne Groban 1,3 ; 1 Physiology and Pharmacology, Wake 


2 

The Hypertension and Vascular Research Center, Wake 


3 

Anesthesiology, Wake Forest University School of Medicine, 

Winston Salem 

P248 

P249 

P250 

P251 

P252 

P253 

Influence of Varying Geographic Populations on 

Outcomes in Large Beta-Blocker Trials in Heart Failure 

Christopher O’Connor 1 , Mona Fiuzat 1 , Michael Caron 2 , Bruce 

Koch 2 , Gordon Davis 2 , Michael Bristow 2,3 ; 1 Duke University 

Medical Center; 2 ARCA Biopharma; 3 University of Colorado 

Health Sciences Center 

Forced Expiratory Volume in 1 Second (FEV1) as a 

Predictor of Carvedilol Dose Optimization in Chronic 

Heart Failure with Chronic Airway Disease 

Jun R. Chiong 1 ; 1 Medicine-Cardiology, Loma Linda University 

Medical Center, Loma Linda, CA 

Effect of β Adrenoreceptor Antagonism on Left 

Ventricular Ejection Fraction in Hispanic Subjects with 

Chronic Heart Failure: A Multi-Ethnic Comparison 

Iosif Kelesidis 1 , Christopher Varughese 1 , Patrick Hourani 1 , 

Ronald Zolty 1 ; 1 Department of Medicine/Cardiology, Albert 

Einstein College of Medicine, Bronx, NY 

Whether Heart Rate Is a Measure of Response to Beta- 

Blocker Therapy for Heart Failure? 

Jadwiga M. Nessler 1 , Bohdan J. Nessler 1 , Mariusz Kitlinski 2 , 

Ilona Palka 1 , Wieslawa Piwowarska 1 ; 1 Dpt of Coronary Disease, 

Inst. of Cardiology, John Paul II Hospital, Cracow, Poland; 2 Dpt 

of Cardiology, University Hospital, Malmoe, Sweden 

Left Ventricular Ejection Fraction Decline after 

Response to Beta Blocker Therapy in African American, 

Hispanic and Caucasian Patients with Non-Ischemic 


Patrick Hourani 1 , Iosif Kelesidis 1 , Christopher Varughese 1 , 

Ronald Zolty 1 ; 1 Internal Medicine/Cardiology, Albert Einstein 

College of Medicine/Montefiore Medical Center, Bronx, NY 

Experiment with a New Drug (TAMERIT) of Treating 

MI Which Protects the Myocardium and Prevents Heart 


Musa Tajuddinovich Abodiv, Irina G. Danilova, Ravishankar 

Polisetty, S.U. Medvedeva, M.A. Rantsev, I.F. Gette, 

Tsarapultser Pyoter Alekseyvich, Divya Sai Katikaneni; 

Immunology, Sechenov Medical Academy, Moscow, Russian 

Federation; Biological Sciences, Institute of Immunology 

and Physiology, Ekaterinburg, Russian Federation; Director 

R&D, Sai Ganga Panacea LLC, Moscow, Russian Federation; 

Biological Sciences, Institute of Immunology and Physiology, 

Ekaterinburg, Russian Federation; Biological Sciences, 

Institute of Immunology and Physiology, Ekaterinburg, Russian 

Federation; Biological Sciences, Institute of Immunology and 

Physiology, Ekaterinburg, Russian Federation 

tuesday 

128 

129

Sept. 15 

Tuesday 

Posters 

Posters 


Posters 


Sept. 15 

Tuesday 

Posters 

tuesday 

P254 

P255 

P256 

Initial Observations of Intravenous CD-NP, Chimeric 

Natriuretic Peptide, on Renal Functions in Chronic 

Heart Failure Patients 

H. Lieu, S. Goldsmith, J. Neutal, B. Massie, J. Burnett; Dept. 

of Cardiology, UCSF, San Francisco, CA; Dept. of Cardiology, 

Univ. of MN, Minneapolis, MN; Dept. of Cardiology, OCRC 

Research Center, Tustin, CA; Dept. of Cardiology, VA. Hospital 

San Francisco, San Francisco, CA; Dept. of Cardiology, Mayo 


Nesiritide Worsens Renal Insufficiency in Right 

Ventricular Failure 

Nitasha Sarswat 1 , Ronak Chaudhari 1 , Iosif Kelesidis 1 , 

Christopher Varughese 1 , Ronald Zolty 1 ; 1 Cardiology, Albert 

Einstein College of Medicine, Bronx, NY 

Activated Vitamin D Compound Doxercalciferol 

Prevents the Development of Cardiac Hypertrophy in 

Dahl Salt Sensitive Rats 

Jun H. Choi 1 , Qingen Ke 1 , Soochan Bae 1 , Natalya Bodyak 1 , 

Christine Kajunski 2 , Steve Strugnell 2 , Cynthia Arbeeny 2 , Ravi 

Thadhani 3 , Peter M. Kang 1 ; 1 Cardiovascular Diseases, Beth 

Israel Deaconess Medical Center, Boston, MA; 2 Genzyme 

Corporation, Cambridge, MA; 3 Renal Unit, Massachusetts 

General Hospital, Boston, MA 

P272 

P273 

The Effect of Renin-Angiotensin System Inhibition on 

All-Cause Mortality in Hospitalized Elderly Systolic 

Heart Failure Patients with Chronic Kidney Disease 

Ali Ahmed 1,2 , Michael W. Rich 3 , Richard M. Allman 1,2 , 

Inmaculada Aban 1 , Paul W. Sanders 1,2 , Louis J. Dell’Italia 1,2 , 

Donna K. Arnett 1 , Thomas E. Love 4 , George L. Bakris 5 ; 

1 

University of Alabama at Birmingham, Birmingham, AL; 

2 

Veterans Affairs Medical Center, Birmingham, AL; 3 Washington 

University, St. Louis, MO; 4 Case Western Reserve University, 

Cleveland, OH; 5 University of Chicago, Chicago, IL 

Pro-B-Type Natriuretic Peptide: A Novel, Specific 

Biomarker for Detection of Left Ventricular Dysfunction 

in the General Community 

Fima Macheret 1 , Denise Heublein 1 , Brian Lahr 1 , Lisa Costello- 

Boerrigter 1 , Paul McKie 1 , Guido Boerrigter 1 , Sharon Sandberg 1 , 

Richard Rodeheffer 1 , Alessandro Cataliotti 1 , John C. Burnett, Jr. 1 ; 

1 

Cardiorenal Research Laboratory, Division of Cardiovascular 

Disease, Mayo Clinic, Rochester, MN 

P274 Characteristics and Prognostic Impact of Type 2 

Diabetes Mellitus on a Well Defined Multi-Ethnic Asian 

Clinical Heart Failure Population – A 3-Year Follow-Up 

Gerard K.T. Leong 1 , Siang Chew Chai 1 , Ping Ping Goh 1 ; 

1 

Cardiology, Changi General Hospital, Singapore, Singapore 

tuesday 

P257 

P258 

P259 

The Aldosterone Antagonist Spironolactone Improves 

Cardiac Function in Experimental Cancer Cachexia 

Jochen Springer 1 , Sandra Palus 1 , Stephan von Haehling 1 , Stefan 

D. Anker 1 ; 1 Applied Cachexia Research, CCR, Charite Medical 

School, Berlin, Germany 

Effects of B-Adrenergic Blockade on Left Ventricular 

Remodeling among Hispanic, African Americans and 

Caucasians with Chronic Heart Failure 

Christopher J. Varughese 1 , Iosif Kelesidis 1 , Patrick Hourani 1 , 

Ronald Zolty 1 ; 1 Department of Cardiology/Division of 

Congestive Heart Failure, Einstein - Montefiore Medical Center, 

Bronx, NY 

Left Ventricular Ejection Fraction Decline after 

Response to Beta Blocker Therapy in Patients with Non- 

Ischemic Cardiomyopathy 

Patrick Hourani 1 , Iosif Kelesidis 1 , Christopher Varughese 1 , 

Ronald Zolty 1 ; 1 Internal Medicine/Cardiology, Albert Einstein 

College of Medicine/Montefiore Medical Center, Bronx, NY 

P275 

P276 

P277 

Echocardiographic Risk Stratification in Heart Failure: 

Applying the Better Method for LV Systolic Function 

Assessment 

Jesper Kjaergaard 1 , Jens Jakob Thune 1 , Dilek Akkan 1 , Lars 

Kober 1 , Christian Torp-Pedersen 2 , Christian Hassager 1 ; 

1 

Department of Cardiology, Copenhagen University Hospital 

Rigshospitalet, Copenhagen, Denmark; 2 Department of 

Cardiology, Copenhagen University Hospital Gentofte, 

Hellerup, Denmark 

Influenza and Pneumococcal Vaccination in Heart 

Failure Patients: A Neglected Recommendation 

Wolney A. Martins 1 , Renata T. Souza 1 , Isaias F. Cabral 1 , Thyago 

A. Furquim 1 , Margarete D. Ribeiro 1,2 , Luciana S. Nogueira 1 , 

Gelsomina A. Pereira 1 , Lucia B. Oliveira 1 , Flavia Louback 1 , 

Fernanda Dadalto 1 , Paulo P. Camandaroba 2 ; 1 Heart Failure 

Clinic, Serra Dos Órgãos University Center, Teresópolis, 

RJ, Brazil; 2 Department of Health, Prefeitura Municipal, 

Teresópolis, RJ, Brazil 

Initiation of Nitrates and Hydralazine in Heart Failure 

Patients Reduces Readmission Rates for Heart Failure 

Cyrus Wong 1 , Nitasha Sarswat 1 , Ronald Zolty 1 ; 1 Cardiology, 

Albert Einstein-Montefiore Medical Center, Bronx, NY 

130 

131

Sept. 15 

Tuesday 

Posters 

Posters 


Posters 

Outcomes 

Sept. 15 

Tuesday 

Posters 

tuesday 

P278 

P279 

P280 

P281 

P282 

Predictors of Adherence to a Low Sodium Diet Using 

the Theory of Planned Behavior in Patients with Heart 


Jia-Rong Wu 1 , Terry A. Lennie 1 , Sandra B. Dunbar 2 , Susan J. 

Pressler 3 , Debra K. Moser 1 ; 1 University of KY, CON, Lexington, 

KY; 2 Emory University, SON, Atlanta, GA; 3 University of MI, 

SON, Ann Arbor, MI 

Usefulness of Simple Clinical Markers for Diagnosing 

Heart Failure with Preserved Left Ventricular Ejection 

Fraction in Argentinean Hospical II Registry 

Eduardo R. Perna 1 , Maria L. Coronel 1 , Juan P. Cimbaro Canella 1 , 

Fabian Diez 2 , Roberto M. Colque 2 , Lilia L. Lobo Marquez 2 , 

Carlos Poy 2 , Gustavo Bargazzi 2 , Pablo M. Alvarenga 2 , Sergio 

V. Perrone 2 ; 1 Heart Failure Clinic, Instituto de Cardiologia J. 

F. Cabral, Corrientes, Argentina; 2 Heart Failure Committee, 

Federacion Argentina de Cardiologia, Argentina 

Low Utilization of Aldosterone Antagonists (AA) and 

Digoxin upon Hospital Discharge in Veterans Consulted 

to a Two-Tiered Interventional, Multi-Disciplinary Heart 

Failure Disease Management Program (HFDMP) 

Shawn D. Anderson 1 , Edlira Maska 1 , Tamarah Jungklaus 1 , 

Amy Mullikin 1 , Lynnette Boyer 1 , Don N. Reeder 1 , Carsten 

Schmalfuss 1,2 , Richard S. Schofield 1,2 ; 1 Cardiology Section, 

Department of Veterans Affairs Medical Center, Gainesville, 

FL; 2 Division of Cardiovascular Medicine, University of Florida 

College of Medicine, Gainesville, FL 

Amino Terminal Pro-B-Type Natriuretic Peptide 

Predicts Mortality, Congestive Heart Failure, Stroke and 

Myocardial Infarction in the General Population but 

Not in the Absence of Traditional Cardiovascular Risk 

Factors or Structural Changes of the Heart 

Paul McKie 1 , Richard Rodeheffer 1 , Brian Lahr 1 , Fernando 

Martin 1 , Alessandro Cataliotti 1 , Guido Boerrigter 1 , Margaret 

Redfield 1 , John Burnett, Jr. 1 ; 1 Cardiorenal Research Laboratory, 

Mayo Clinic, Rochester, MN 

Chronic Renal Insufficiency: Prevalence in the General 

Population and Improved Detection of Cardiac Disease 

in Combination with BNP Assays 

Alessandro Cataliotti 1 , Richard J. Rodeheffer 1 , Carilyn 

S.P. Lam 1 , Guido Boerrigter 1 , Margaret M. Redfield 1 , Fima 

Macheret 1 , Lisa C. Costello-Boerrigter 1 , Horng H. Chen 1 , Paul 

M. McKie 1 , Valentina Cannone 1 , John C. Burnett 1 ; 1 Cardiorenal 

Research Laboratory, Mayo Clinic, Rochester, MN 

P317 

P318 

P319 

P320 

P321 

P322 

Prevalence of Anaemia and the Effects of Nebivolol on 

Haemoglobin Values in Patients with Chronic Heart 

Failure: Results from the SENIORS Database 

Stephan von Haehling 1 , Daphne Babalis 2 , Michael Roghton 2 , 

Dirk J. van Veldhuisen 3 , Philip A. Poole-Wilson 4 , Marcus 

Flather 2 , Stefan D. Anker 1 ; 1 Charite, Berlin, Germany; 2 Royal 

Brompton Hospital, London, United Kingdom; 3 University 

Medical Center, Groningen, Netherlands; 4 Imperial College, 

London, United Kingdom 

Diastolic Function Is a Better Predictor of Survival 

Than Systolic Function in Patients with Advanced Heart 


Asim M. Rafique 1 , Ryan Morrissey 1 , Jesse Naghi 1 , Robert J. 

Siegel 1 , Kirsten Tolstrup 1 , Swaminatha Gurudevan 1 ; 1 Cardiac 

Non-Invasive Lab, Cedars-Sinai Medical Center, Los Angeles, 

CA 

Visual Assessment of Left Ventricular Mechanical 

Dyssynchrony Predicts Response to Cardiac 

Resynchronization Therapy 

Simon Biner 1 , Asim M. Rafique 1 , Kirsten Tolstrup 1 , Robert 

J. Siegel 1 ; 1 Cardiac Non-Invasive Lab, Cedars-Sinai Medical 

Center, Los Angeles, CA 

Does Participation in the HF Network Indicate Better 

Practices of Care for Heart Failure Patients: CHF 

QUERI 

Anju Sahay 1 , Paul A. Heidenreich 1 ; 1 Chronic Heart Failure 

(CHF) QUERI, Department of Veterans Affairs, Palo Alto, CA 

Is Persistent Hyponatremia Associated with Increased 

Mortality in Heart Failure Patients in the Community? 

Sudip Ghosh 1 , Noel I. O Kelly 2 , Judith Smith 2 , Jonathan Dexler 2 , 

Coty Carroll-Hawkins 2 ; 1 Dept of Medical Sciences, University 

of Leicester Medical School/University Hospitals Leicester, 

Leicester, Leicestershire, United Kingdom; 2 Dept of County 

Health Services, Leicestershire County Rutland Primary Care 

Trust, Melton Mowbray, Leicestershire, United Kingdom 

A New Method to Maintain the Dry Clinical Profile 

and Improve Outcome in Ambulatory Advanced Heart 


Daniele Torres 1 , Gaspare Parrinello 1 , Salvatore Paterna 1 , Pietro 

Di Pasquale 1 , Caterina Trapanese 1 , Alessia Torres 1 , Giuseppe 

Licata 1 ; 1 Biomedical Department of Internal and Specialist 

Medicine, Heart Failure Unit, University Hospital of Palermo, 

Palermo, Italy 

tuesday 

132 

133

Sept. 15 

Tuesday 

Posters 

Posters 

Outcomes 

Posters 

Outcomes 

Sept. 15 

Tuesday 

Posters 

tuesday 

P323 

P324 

P325 

P326 

Hemoglobin Drop during Hospitalization Predicts Poor 

Survival in Anemic Patients with Acute Decompensated 


Srinath S. Vemuri 1 , Veli K. Topkara 1 , Amandeep Dhaliwal 1 , Anita 

Deswal 1 , Biykem Bozkurt 1 ; 1 Division of Cardiology, Michael 

E. Debakey Veterans Affairs Medical Center (MEDVAMC), 

Winters Center for Heart Failure Research, Baylor College of 

Medicine, Houston, TX 

Characterization of Patients Re-Admitted within 30 Days 

of Discharge Following Hospitalization for Heart Failure 

Sandip Zalawadiya 1 , Suleiman Daifallah 2 , Omaima Ali 1 , 

Hammam D. Zmily 1 , Jareer Farah 1 , Jalal K. Ghali 3 ; 1 Internal 

Medicine, Wayne State University/Detroit Medical Center, 

Detroit, MI; 2 Internal Medicine, John D. Dingell VA Medical 

Center, Detroit, MI; 3 Cardiology, Detroit Medical Center, 

Detroit, MI 

Cystatin C and Death in Left Ventricular Systolic 

Dysfunction and Heart Failure 

Andreia Biolo 1 , Myung Lee 1 , Flora Sam 1 ; 1 Medicine/Cardiology, 

Boston University Medical Center, Boston, MA 

The Heart Failure Care Giving Experience: Findings 

from a Population Based Study 

Amy P. Abernethy 1 , David C. Currow 2 , Katy Clarke 3 , Phillip 

J. Newton 4 , Patricia M. Davidson 5 ; 1 Department of Palliative 

and Supportive Services, Flinders University, Adelaide, 

South Australia, Australia; 2 Division of Medical Oncology, 

Department of Medicine Durham, Duke University Medical 

Centre, Durham, NC; 3 Palliative Care, Notre Dame University/ 

Cunningham Centre for Palliative Care, Sydney, NSW, 

Australia; 4 Centre for Cardiovascular and Chronic Care, Curtin 

University, Sydney, NSW, Australia; 5 Institute for Supportive 

and Palliative Care Research Australia, Australia 

P328 

P329 

P330 

P331 

Chronic Heart Failure in Patients with Acute 

Exacerbation of Chronic Obstructive Pulmonary 

Disease: Prevalence, Clinical Characteristics, Treatment 

and Mortality 

Mitja Lainscak 1,2 , Stephan von Haehling 2 , Wolfram Doehner 2 , 

Irena Sarc 1 , Tina Jeric 1 , Kristina Ziherl 1 , Mitja Kosnik 1 , Stanislav 

Suskovic 1 , Stefan D. Anker 2 ; 1 University Clinic Golnik, 

Golnik, Slovenia; 2 Applied Cachexia Research, Department 

of Cardiology, Charité Medical School, Campus Virchow- 

Klinikum, Berlin, Germany 

Daily Physical Activity Levels as Measured by Self- 

Report and Accelerometry in Patients with Heart Failure 

Bunny Pozehl 1 , Kathleen Duncan 1 , Joe Norman 2 , Melody 

Hertzog 1 , Ann Walker 1 ; 1 College of Nursing, University of 

Nebraska Medical Center, Lincoln, NE; 2 Division of Physical 

Therapy Education, University of Nebraska Medical Center, 

Omaha, NE 

Effect of Cardiac Rehabilitation Visits on Mortality 

among Elderly Medicare Beneficiaries with Heart 


David J. Whellan 1 , Bradley G. Hammill 2 , Kevin A. Schulman 2 , 

Lesley H. Curtis 2 ; 1 Medicine, Jefferson Medical College, 

Philadelphia, PA; 2 Duke Clinical Research Institute, Duke 

University, Durham, NC 

Left Ventricle Ejection Fraction Versus NYHA 

Functional Classification in Predicting Postoperative 

Outcomes 

Jagdesh Kandala 1 , Shanmugam Uthamalingam 1 , Marilyn Daley 2 , 

Yvon Baribeau 2 , Sarika Ballari 3 , Robert Capodilupo 2 ; 1 IM, 

DartmouthHitchcock, Manchester, NH; 2 Cardiology, NEHI, 

Manchester, NH; 3 Medicine, SRTR Medical college, Maharastra, 

India 

tuesday 

P327 

Hemodynamic Correlates of Outcomes in Patients 

Hospitalized for Heart Failure 

Imad Hussain 1 , Perry Anarado 1 , Andreas P. Kalogeropoulos 1 , 

Mahdi Chowdhury 1 , Vasiliki V. Georgiopoulou 1 , Amanda 

Methvin 1 , Vikas Bhalla 1 , Deepa Mangalat 1 , Jeffrey Shih 1 , Syed 

A. Agha 1 , Wendy Book 1 , Sonjoy R. Laskar 1 , Andrew L. Smith 1 , 

Javed Butler 1 ; 1 Medicine/Cardiology, Emory University, Atlanta, 

GA 

P332 

P333 

Serum Albumin Levels Predicts Both In-Hospital 

and Mid-Term Mortality among Patients Admitted to 

Hospital with Acute Decompensated Heart Failure 

Shanmugam Uthamalingam 1 , Jagdesh Kandala 1 , Marilyn Daley 1 , 

Robert Capodilupo 1 , James L. Januzzi, Jr. 2 ; 1 Internal Medicine/ 

Cardiology, Catholic Medical Center, Manchester, NH; 

2 

Cardiology, Massachusetts General Hospital, Boston, MA 

Decreased Hospital Readmission with Nitroprusside in 

Acute Decompensated Heart Failure 

Anne P. Spencer 1 , Robert L. Page 2 , Adrian B. Van Bakel 2 ; 

1 

Department of Pharmacy, Roper Saint Francis Healthcare, 

Charleston, SC; 2 Department of Clinical Pharmacy, University 

of Colorado, Denver, CO; 3 Department of Medicine, Medical 

University of South Carolina, Charleston, SC 

134 

135

Sept. 15 

Tuesday 

Posters 

Posters 

Outcomes 

Posters 

Outcomes 

Sept. 15 

Tuesday 

Posters 

P334 

Symptom Assessment, Family Factors, and HF Acute 

Care Visits 

Christina Quinn 1 , Sandra B. Dunbar 2 , Melinda Higgins 2 ; 

1 

Division of Nursing, Gordon College, Barnesville, GA; 2 Nell 

Hodgson Woodruff School of Nursing, Emory University, 

Atlanta, GA 

P340 

Atrioventricular Optimization and Outcomes in a 

Community Heart Failure Clinic 

Marilyn Daley 1 , Jagdesh Kandala 2 , Shanmugam Uthamalingam 2 , 

Robert Capodilupo 1 ; 1 Cardiology, New England Heart Institute, 

Manchester, NH; 2 Internal Medicine, Dartmouth-Hitchcock, 

Manchester, NH 

tuesday 

P335 

P336 

P337 

P338 

P339 

Heart Failure-Specific Quality of Life Is Variably 

Impaired in Veterans with Heart Failure 

Richard Schofield 1,2 , Tamarah Jungklaus 1 , Amy Mullikin 1 , 

Lynnette Boyer 1 , Shawn Anderson 1 , Edlira Maska 1 , Carsten 

Schmalfuss 1,2 , Juan Aranda 1,2 ; 1 Cardiology Section, Department 

of Veterans Affairs Medical Center, Gainesville, FL; 2 Division 

of Cardiovascular Medicine, University of Florida College of 

Medicine, Gainesville, FL 

Predictors of Post Discharge Mortality among Urban 

African Americans Hospitalized with Heart Failure and 

Preserved Ejection Fraction 

Suleiman Daifallah 1 , Omaima Ali 2 , Hammam D. Zmily 2 , Jareer 

Farah 2 , Sandip Zalawadiya 2 , Jalal K. Ghali 3 ; 1 Internal Medicine, 

John D. Dingell VA Medical Center, Detroit, MI; 2 Internal 

Medicine, Wayne State University / Detroit Medical Center, 

Detroit, MI; 3 Cardiology, Detroit Medical Center, Detroit, MI 

Cardiac Resynchronization Therapy in Reversing 

“Decapitated Hypertension” – A Meta-Analysis 

Sameer Ather 1 , Biykem Bozkurt 1 , Srinath Vemuri 1 , Long B. Cao 1 , 

Franz H. Messerli 2 ; 1 Medicine, Baylor College of Medicine, 

Houston, TX; 2 Cardiology, St. Luke’s-Roosevelt Hospital, New 

York, NY 

Predicting Risk among Patients Listed for Heart 

Transplantation: Is It the Same as a General Heart 

Failure Population? 

Vasiliki V. Georgiopoulou 1 , Andreas P. Kalogeropoulos 1 , Amna 

Altaf 1 , Nida Arif 1 , Perry Anarado 1 , Danesh Kella 1 , Maryah 

Mansoor 1 , Grigorios Giamouzis 1 , Syed A. Agha 1 , Wendy Book 1 , 

Sonjoy Laskar 1 , Andrew L. Smith 1 , Javed Butler 1 ; 1 Medicine/ 

Cardiology, Emory University, Atlanta, GA 

Mild Hyponatremia Is Associated with Mortality Risk 

and Risk for Hospitalization in Outpatients with Systolic 


Morten Schou 1 , Finn Gustafsson 2 , Lars Videbaek 3 , Niels Keller 4 , 

John Markenvard 5 , Per R. Hildebrandt 6 ; 1 Cardiology and 

Endocrinology, Hillerod University Hospital (Copenhagen), 

Hillerod, Denmark; 2 Cardiology, Rigshospitalet, Univeristy of 

Copenhagen, Copenhagen N, Denmark; 3 Cardiology, Odense 

University Hospital, Odense, Denmark; 4 Cardiology, Herlev 

Unioversity Hospital (Copenhagen), Herlev, Denmark; 5 Internal 

Medicine, Fredericia County Hospital, Fredericia, Denmark 

P341 

P342 

P343 

P344 

P345 

Anemia, Kidney Disease, and Inpatient Outcomes for 

Heart Failure in California – 2000-2006 

David P. Kao 1 , Elma Kreso 1 , Gregg C. Fonarow 2 , Mori Krantz 1 ; 

1 

Cardiology, Department of Medcine, University of Colorado 

Denver, Aurora, CO; 2 Division of Cardiology, University of 

California Los Angeles, Los Angeles, CA 

Smoking among Women Following Heart 

Transplantation: Should We Be Concerned? 

Lorraine S. Evangelista 1 , Alvina Ter-Galstanyan 2 ; 1 School of 

Nursing, University of California, Los Angeles, Los Angeles, 

CA; 2 School of Public Health, University of California, Los 

Angeles, Los Angeles, CA 

Plasma B-Type Natriuretic Peptide Levels at Discharge 

and Their Decrease from Admission Are Associated with 

Worse Prognosis in Patients with Very Advanced Heart 


Cesar A. Belziti 1 , Sebastian Maldonado 1 , Luis Gomez 1 , Rodolfo 

Pizarro 1 , Norberto Vulcano 1 ; 1 Cardiology. Heart Failure Unit, 

Hospital Italiano de Buenos Aires, Buenos Aires, Argentina 

Significant Survival Benefit in 286 Elderly Primary 

Prevention Patients with Implantable Cardioverter 

Defibrillators 

Frank A. McGrew 1 , Eric E. Johnson 1 , Mark A. Coppess 1 , 

Barbara Hamilton 1 , Sandra B. Charlton 2 , James J. Sims 2 , Thomas 

A. Charlton 3 ; 1 Stern Cardiovascular Clinic, Germantown, TN; 

2 

Medtronic, Inc., Moundsview, MN; 3 Bioengineering, University 

of Pennsylvania School of Engineering and Applied Science, 


Improved Mortality Associated with ACE-I and Beta 

Blocker Therapy in Heart Failure with Preserved 

Ejection Fraction: An Analysis of the Biomarkers in 

Acute Heart Failure (BACH) Trial 

Niraj V. Parekh 1 , Kabir Singh 1 , Paul Clopton 2 , Inder Anand 3 , 

Robert Christenson 4 , Lori B. Daniels 1 , Christopher Hogan 5 , 

Sean-Xavier Neath 1 , Richard Nowak 6 , W. Franklin Peacock 7 , 

Alan Wu 8 , Stefan D. Anker 9 , Alan S. Maisel 1,2 ; 1 UCSD, San 

Diego, CA; 2 Veterans Affairs, San Diego, CA; 3 Veterans Affairs, 

Minneapolis, MN; 4 University of Maryland, Baltimore, MD; 

5 

Virginia Commonwealth University, Richmond, VA; 6 Henry 

Ford Health System, Detroit, MI; 7 Cleveland Clinic, Clevland, 

OH; 8 San Francisco General Hospital, San Francisco, CA; 

9 

Charité-Universitätsmedizin, Berlin, Germany 

tuesday 

136 

137

Sept. 15 

Tuesday 

Posters 

Posters 

Outcomes 

Posters 


Sept. 15 

Tuesday 

Posters 

tuesday 

P346 

P347 

P348 

P349 

P350 

P382 

Futility of Digoxin in a Sub-Population of Heart Failure 

Patients – A Cluster Analysis of DIG Data 

Sameer Ather 1 , Leif Peterson 2 , Vijay Divakaran 1 , Anita Deswal 1 , 

Biykem Bozkurt 1 ; 1 Medicine, Div. of cardiology, Baylor College 

of Medicine, Houston, TX; 2 Biostatistics, Methodist Hospital, 

Houston, TX 

Implantable Device Therapy in Octogenarians and 

Nonagenarians: Insights from a National Hospital 

Database 

Jason Swindle 1 , Michael W. Rich 2 , Patrick McCann 3 , Paul 

J. Hauptman 3 ; 1 Center for Outcomes Research, Saint Louis 

University School of Medicine, St. Louis, MO; 2 Department 

of Medicine, Washington University School of Medicine, St. 

Louis, MO; 3 Department of Medicine, Saint Louis University 

School of Medicine, St. Louis, MO 

Chronic Indwelling Pleural Catheters Reduce 

Hospitalizations in Advanced Heart Failure with 

Refractory Pleural Effusions 

Daniel D. Borgeson 1 , Sebastian A. Defranchi 1 , Carolyn S.P. 

Lam 1 , Grace Lin 1 , Francis C. Nichols III 2 ; 1 Cardiovascular 

Disease and Internal Medicine, Mayo Clinic and Foundation, 

Rochester, MN; 2 Department of Surgery, Mayo Clinic and 

Foundation, Rochester, MN 

Systematic Heart Failure Education Improves Patient 

Self-Care and Self Efficacy 

Sharon Mack 1 , Rochelle Smith, Mark E. Dunlap; 1 Heart_ 

Vascular Center, MetroHealth Medical Center, Cleveland, OH 

Anaemia in Patients Hospitalized for Acute Heart 


Stephan von Haehling 1 , Thomas Kung 1 , L. Hodoscek-Majc 2 , 

Joerg C. Schefold 1 , Wolfram Doehner 1 , Stefan D. Anker 1 , Mitja 

Lainscak 3 ; 1 Cardiology, Charite-Berlin, Berlin, Germany; 

2 

General Hospital Murska Sobota, Murska Sobota, Slovenia; 

3 

University Clinic of Respiratory and Allergic Diseases, Golnik, 

Slovenia 


Agreement between Physician and Patient’s Self 

Assessment of Heart Failure Symptoms Using New York 

Heart Association Classification 

Asim M. Rafique 1 , Tasneem Z. Naqvi 2 ; 1 Cardiac Non-Invasive 

Lab, Cedars-Sinai Medical Center, Los Angeles, CA; 2 Non- 

Invasive Cardiology, Keck School of Medicine, USC, Los 

Angeles, CA 

P383 

P384 

P385 

P386 

P387 

P388 

Symptoms of Anxiety and Depression in Heart Failure 

Patients and Their Caregivers 

Karen I. Harkness 1,2 ; 1 Health Sciences-Nursing, McMaster 

University, Hamilton, ON, Canada; 2 Heart Function Clinic, 

Hamilton Health Sciences, Hamilton, ON, Canada 

Are PHQ-9 and PHQ-2 Depression Score Cutoffs the 

Best Cutoffs for Determining Significant Depression in 

Pts with HF and Mild-Moderate Symptoms? 

Nancy M. Albert 1 , Debra K. Moser 2 , Benjamin Nutter 3 , Leo 

Pozuelo 4 ; 1 Nursing Research, Cleveland Clinic, Cleveland, OH; 

2 

University of Kentucky, Lexington, KY; 3 Cleveland Clinic, 

Cleveland, OH; 4 Cleveland Clinic, Cleveland, OH 

A Quick Fix: Can PHQ-2 Be Used Clinically to Diagnose 

Depression in Patients with Heart Failure? 

Nancy M. Albert 1 , Debra K. Moser 2 , Benjamin Nutter 1 , Leo 

Pozuelo 1 ; 1 Nursing Research and Innovation, Cleveland Clinic, 

Cleveland, OH; 2 University of Kentucky, Lexington, KY; 

3 

Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH; 

4 

Psychiatry, Cleveland Clinic, Cleveland, OH 

Cardiac Resynchronization Therapy Responders 

Have Echo Doppler Optimized AV Intervals Closest to 

Nominal Device Settings 

Keith Miller 1 , Andrew Merliss 1 , Michelle Khoo 2 , William Sauer 2 , 

Gregg Yamada 3 , Vinay Thohan 4 , Rhonda Olmsted 1 , Jason R. 

Brown 5 , Michelle M. Fedewa 5 ; 1 Bryan LGH Heart Institute, 

Lincoln, NE; 2 University of Colorado, Denver, CO; 3 Pacific 

Cardiology, Honolulu, HI; 4 Wake Forest University Health 

Sciences, Winston-Salem, NC; 5 Medtronic, Inc., Minneapolis, 

MN 

Relations of Quality of Life with Left Ventricular 

Ejection Fraction and Body Mass Index 

Leonidas V. Athanasopoulos 1 , Athanasios Dritsas 1 , Dennis 

V. Cokkinos 1 ; 1 1st Cardiology Department, Onassis Cardiac 

Surgery Center, Athens, Greece 

A Novel Heart Failure Disease Management Strategy 

Reduces Heart Failure Readmissions in Veterans with 


Edlira Maska 1 , Tamarah Jungklaus 1 , Amy Mullikin 1 , Shawn 

Anderson 1 , Don Reeder 1 , Donald Chapman 1 , Carsten 

Schmalfuss 1,2 , Juan Aranda 1,2 , Richard Schofield 1,2 ; 1 Cardiology 

Section, Department of Veterans Affairs Medical Center, 

Gainesville, FL; 2 Division of Cardiovascular Medicine, 

University of Florida College of Medicine, Gainesville, FL 

tuesday 

138 

139

Sept. 15 

Tuesday 

Posters 

Posters 


Posters 


Sept. 15 

Tuesday 

Posters 

tuesday 

P389 

P390 

P391 

P392 

P393 

P394 

Comparison of Cardiac Resynchronization Therapy 

(CRT) and Non-CRT Patients Who Experienced 

Threshold Crossing for Intrathoracic Impedance 

Leonardo P.J. Oliveira 1 , Tanya Verga 2 , W.H. Wilson Tang 2 ; 

1 

Department of Internal Medicine, Cleveland Clinic Foundation, 

Cleveland, OH; 2 Department of Cardiovascular Medicine, 

Cleveland Clinic Foundation, Cleveland, OH 

A Meta-Analysis of Two Double-Blind, Placebo 

Controlled, Randomized Trials to Evaluate the Efficacy 

and Safety of Carvedilol Treatment in Non-Dialysis 

Dependent Chronic Kidney Disease Patients with 

Symptomatic or Asymptomatic Systolic Heart Failure 

R. Wali 1 , M. Iyengar 2 , D. Chartyan 3 , M.A. Lukas 2 , C. Cooper 4 , 

A. Cheung 5 ; 1 Medicine, UMMS, Baltimore, MD; 2 Glaxo Smith 

Kline, King of Prussia, PA; 3 Medicine, Brigham and Women’s 

Hospital, Boston, MA; 4 Cardiology, University of Toledo, 

Toledo, OH; 5 Medicine, Utah School of Medicine, Salt Lake 

City, UT 

Impact of Relaxation Training on Measures of 

Anxiety, Pain, and Patient Perceived Outcomes after 

Interventional Electrophysiology (EP) Procedures 

Antreas Hindoyan 1 , Michael K. Cao 1 , Andrew Aikins 1 , Bobby 

Gosh 1 , Jerold S. Shinbane 1 , David A. Cesario 1 , Leslie A. Saxon 1 ; 

1 

Division of Cardiovascular Medicine, USC Keck School of 

Medicine, Los Angeles, CA 

The Unconventional “Face” of Diastolic Heart Failure 

Peter Shaw 1 , Rene Quiroz 1 , Diane Gauthier 1 , Deborah Whalen 1 , 

Flora Sam 1 ; 1 Medicine/Cardiology, Boston University Medical 

Center, Boston, MA 

Dietary Compliance Score Correlates with Physician 

Assessment of Volume Status in Patients with Chronic 


Deborah Armentano 1 , Lee W. Jordan 1 ; 1 Heart Disease 

Management Clinic, Riverside Methodist Hospital, Columbus, 

OH 

Chronic Ambulatory Ultrafiltration for Patients with 

Refractory Heart Failure: Renal Implications 

Amir Kazory 1 , Matthias Goldstein 2 , Ardalan Enkeshafi 2 , Jerald 

Insel 2 ; 1 Department of Medicine - Division of Nephrology, 

University of Florida, Gainesville, FL; 2 Department of Medicine 

- Division of Cardiology, Good Samaritan Hospital, Baltimore, 

MD 

P395 

P396 

P397 

P398 

P399 

P400 

Beneficial Effects of Intensive Nurse Practitioner 

Outpatient Care in Indigent Post-Discharge 

Decompensated Heart Failure Patients 

Cindi T. Hayes 1 , Donna L. Winsor-Dorough 1 , Janet W. 

Montgomery 1 , H.B. Karunaratne 1 ; 1 Florida Hospital 

Cardiovascular Institute, Orlando, FL 

Comparison of Prognostic Factors in Heart Failure 

Patients with Reduced Versus Preserved Left Ventricular 

Ejection Fraction 

Geetha Bhat 1 , Sunil Pauwaa 1 , Pooja Avula 1 , Bernadine Brennan 1 , 

Carol Pisano 1 , Marc Silver 1 ; 1 Center for Heart Transplant and 

Assist Devices, Advocate Christ Medical Center, Oak Lawn, IL 

High Dose Intravenous Furosemide for the Management 

of Acute Cardio-Renal Syndrome 

Faisal Zaeem 1 , Dalia Giedrimiene 1 , Cara Statz 1 , Sanjeev 

Bhavnani 1 , Lynn O’Bara 1 , Joseph Radojevic 1 , Molly Moorer 1 , 

Tari Devoe 1 , Maria Lisboa 1 , Kelly Mueller 1 , Robert Veenstra 1 , 

Debra Cyr 1 , Detlef Wencker 1 ; 1 Cardiology, Hartford Hospital- 

UCONN, Hartford, CT 

The Impact of a Multidisciplinary Approach in the 

Management of Patients with Acute Decompensated 


Sara Tabtabai 1 , Alfred Danielian 1 , Bruce Bernstein 1 , Sabeena 

Arora 1 , Richard Soucier 1 ; 1 Hoffman Heart Institute, St Francis 

Hospital, Hartford, CT 

Quality of Life Differences in Heart Failure Drug 

Combinations 

Shawn D. Anderson 1 , Edlira Maska 1 , Tamarah Jungklaus 1 , 

Amy Mullikin 1 , Lynnette Boyer 1 , Don N. Reeder 1 , Carsten 

Schmalfuss 1,2 , Richard S. Schofield 1,2 ; 1 Cardiology Section, 

Department of Veterans Affairs Medical Center, Gainesville, 

FL; 2 Division of Cardiovascular Medicine, University of Florida 

College of Medicine, Gainesville, FL 

Heart Failure Care Coordinator Improves Core Measure 

Compliance and 30 Day Readmission Rate 

E. Kelly Caslin 1 , JoAnn Z. Ioannou 1 , Stacey Rotman 1 , Stuart 

D. Russell 2 , Hannah Jones 3 , Cheryl R. Dennison 3 ; 1 Department 

of Medicine, Johns Hopkins Medical Institutions, Baltimore, 

MD; 2 Department of Medicine, Division of Cardiology, Johns 

Hopkins University School of Medicine, Baltimore, MD; 

3 

Department of Health Systems and Outcomes, Johns Hopkins 

University School of Nursing, Baltimore, MD 

tuesday 

140 

141

Sept. 15 

Tuesday 

Posters 

Posters 


Posters 


Sept. 15 

Tuesday 

Posters 

P401 

P402 

Patient Risk Stratification for HF Decompensation 

Gregory A. Ewald 1 , F. Roosevelt Gilliam 2 , Robert J. Sweeney 3 ; 

1 

Washington University School of Medicine, St Louis, MO; 

2 

Cardiology Associates of NE Arkansas, Jonesboro, AR; 3 Boston 

Scientific CRM, St Paul, MN 

Device Measured Physical Activity: Is It the New 

6-Minute Hall Walk? 

Sanjeev K. Gulati 1 , John McKenzie 2 , George Crossley 3 , 

Mary Anne Papp 4 , Jason Sims 5 , John Andriulli 6 ; 1 The Sanger 

Clinic, Charlotte, NC; 2 Glendale Memorial Hospital and 

Medical Center, Glendale, CA; 3 Mid-State Cardiology of St. 

Thomas Heart, Nashville, TN; 4 Medical College of Wisconsin, 

Milwaukee, WI; 5 Medtronic, Mounds View, MN; 6 Southern New 

Jersey Cardiac Specialists, Vorhees, NJ 

P408 

P409 

Role of Admission Echocardiography in Predicting 

Outcomes in Patients Hospitalized with Acute Heart 


George George 1 , Gyan Sharma 1 , Marc Rhodes 1 , Sunita Dodani 1 , 

Chandra Kunavarapu 2 ; 1 Cardiology, Medical College of Georgia, 

Augusta, GA; 2 Advanced Heart Failure and Transplant, Texas 

Transplant Institute, San Antonio, TX 

Standardized Heart Failure Education and Enhanced 

Communication at a Community Hospital Resulting in 

Decreased Mortality and Readmissions 

Shannon N. Taft 1 , Donald A. Dawkins 2 ; 1 Cardiac Wellness 

Center, Tri-City Medical Center, Oceanside, CA; 

2 

Cardiovascular Services, Tri-City Medical Center, Oceanside, 

CA 

tuesday 

P403 

P404 

P405 

Exacerbation Prevention Strategies: Fiscal Impact of a 

Dedicated Advanced Heart Failure and Chronic Disease 

Management Rehabilitation Program 

Jun R. Chiong 1,2 , Linda Houston-Feenstra 1,2 , Kenneth Jutzy 1,2 , 

Madlen Aladadyan 2 , Synove Knutsen 2 ; 1 Cardiology, Loma Linda 

University Medical Center, Loma Linda, CA; 2 Public Health - 

Epidemiology, Loma Linda University, Loma Linda, CA 

The Impact of B-Type Natriuretic Peptide, Depression 

and NYHA Classification on Quality of Life in Patients 

with Chronic Heart Failure 

Irma B. Ancheta, Jun Chiong, Alan Miller, Christine Ancheta, 

Cynthia Battie; School of Nursing, University of North Florida, 


Psychosocial Factors Moderate the Relationship between 

Clinical Status and Dyspnea in Both Taiwanese and 

American Heart Failure Patients 

Tsuey-Yuan Huang 1 , Debra K. Moser 2 , Shiow-Li Hwang 3 , Terry 

A. Lennie 2 , Misook L. Chung 2 , Jia-Rong Wu 2 , Martha Biddle 2 , 

Seongkum Heo 4 ; 1 Nursing, Chang Gung Institute of Technology, 

Taoyuan, Taiwan; 2 Nursing, University of Kentucky, Lexington, 

KY; 3 Nursing, Chung Shan Medical University, Taichung, 

Taiwan; 4 Nursing, Indiana University, Indianapolis, IN 

P410 

P411 

P412 

Home Heart Walk: Feasibility in a Cardiac 

Rehabilitation Population and Implications for Chronic 


HuiYun Du 1 , Phillip J. Newton 1 , Bronwyn Everett 2 , Yenna 

Salamonson 2 , Patricia M. Davidson 1 ; 1 Centre for Cardiovascular 

and Chronic Care, Curtin University of Technology, Sydney, 

NSW, Australia; 2 School of Nursing and Midwifery, University 

of Western Sydney, Sydney, NSW, Australia 

Insights from Intra-Thoracic Threshold Crossings in 

Ambulatory Patients with Heart Failure from a Remote, 

Nurse-Run, Internet-Based Surveillance Program 

Leonardo P.J. Oliveira 1 , Tanya Verga 2 , Bruce L. Wilkoff 2 , 

W.H. Wilson Tang 2 ; 1 Department of Internal Medicine, 

Cleveland Clinic Foundation, Cleveland, OH; 2 Department 

of Cardiovascular Medicine, Cleveland Clinic Foundation, 

Cleveland, OH 

Automated HF Decompensation Detection: Results from 

the Decompensation Detection Study (DECODE) 

Gregory A. Ewald, F. Roosevelt Gilliam, Robert J. Sweeney; 

Washington University School of Medicine, St Louis, MO; 

Cardiology Associates of NE Arkansas, Jonesboro, AR; Boston 

Scientific CRM, St Paul, MN 

tuesday 

P406 

Predictors of Recurrent Cardiovascular Hospitalizations 

in Patients with Diastolic Heart Failure 

Madhan Shanmugasundaram 1 , Mindy Fain 2 , Jane Mohler 2 , 

Christopher Wendel 2 , Joseph S. Alpert 3 ; 1 Internal Medicine, 

University of Arizona, Tucson, AZ; 2 Geriatrics and Gerontology, 

University of Arizona, Tucson, AZ; 3 Internal Medicine and 

Cardiology, University of Arizona, Tucson, AZ 

P413 

Psychosocial Impact in a Cohort of Peripartum 

Cardiomyopathy Patients 

Lin Wang 1 , Angela S. Ro 1 , Jordan G. Safirstein 1 , Sree Grandhi 1 , 

Cezar Staniloae 1 ; 1 Department of Cardiology, St. Vincent’s 

Catholic Medical Center, New York, NY 

P407 

An Approach for Incorporating Advanced Care Planning 

Into Heart Failure Specialty Care 

Connie Jaenicke, Judy Wagner, Viorel Florea; Cardiology, 

Minneapolis Veterans Affairs Medical Center, Minneapolis, MN 

142 

143

Sept. 16 

Wednesday 

AM 

SYMPOSIUM 


8:30-10:00 AM 

Ballroom A 

LATE BREAKING CLINICAL TRIALS 


8:30-10:00 AM 

Room 302 

Sept. 16 

Wednesday 

AM 

WEDNESDAY 

The Continuum of Care: From ED to Hospital 

to Home 

Moderators: Larry A. Allen, Denver, CO 

Maureen P. Flattery, Richmond, VA 

8:30 ED Care of the ADHF Patient 

Peter S. Pang, Chicago, IL 

8:50 Inpatient to Home: Getting Discharge Right 

JoAnn Lindenfeld, Denver, CO 

9:10 Selecting Patients for Transplant-MCSD 

Stuart D. Russell, Baltimore, MD 

9:30 End-of-Life Care in HF: When and How 

Erin K. Donaho, Houston, TX 


Learning Objective: Recognize critical points of care 

for patients with heart failure and describe how they are 

effectively managed. 

8:15 HFSA Annual Business Meeting 

Room 306 


Refreshments served in 3rd floor foyer area 

Late Breaking Clinical Trials II 

Moderators: J. Malcolm O. Arnold, London, ON, Canada 

Randall C. Starling, Cleveland, OH 

8:30 Clinical and Prognostic Value of Galectin-3: A Novel 

Fibrosis-Associated Biomarker in Patients with Chronic 


Dirk Jan van Veldhuisen, Dirk J.A. Lok, Kevin Damman, 

Rudolf A. De Boer, Peter van der Meer, Adriaan A. Voors, 

Tiny Jaarsma. University Medical Center Groningen, 

Groningen, The Netherlands 

8:45 Commentary: Inder S. Anand, Minneapolis, MN 

8:52 Relationship of Resting Myocardial Perfusion to Death 

and Hospitalization in Heart Failure Patients: Results 

from the Nuclear Sub-Study of HF-ACTION Trial 

Salvador Borges-Neto, Allen E. Atchley, Dalane W. Kitzman, 

David J. Whellan, Ami E. Iskandrian, Stephen J. Ellis, Linda K. 

Shaw, Robert A. Pagnanelli, Andrew Kao, Khaled Abdul-Nour, 

Greg Ewald, Christopher M. O’Connor, William E. Kraus On 

behalf of the HF-ACTION Trial Investigators. Duke University, 

Durham, NC 

9:07 Commentary: James E. Udelson, Boston, MA 

9:15 Renoprotective and Potassium Sparing Effects of Low 

Dose Dopamine in ADHF 

Filippos Triposkiadis, Grigorios Kiamouzis, Javed Butler, 

Randall C. Starling, Dimitrios Economou, Georgios 

Karayannis, Charalambos Parisis, Dimitrios Rovithis, John 

Nastas, Themistoklis Kyrlidis, Themistoklis Tsaknakis, John 

Sksoularigis. Larissa University Hospital, Larissa, Greece 

9:30 Commentary: G. Michael Felker, Durham, NC 

9:38 MARVEL-1: A Double-Blind, Randomized, 

Controlled Multicenter Study To Assess the Safety and 

Cardiovascular Effects of Myocell Implantation By a 

Catheter Delivery System in Congestive Heart Failure 

Patients Post Myocardial Infarction(s) 

Thomas J. Povsic, Timothy Henry, Andrew Taasig, Dean 

Kereiakis, F. David Fortuin, Alan Niederman, Richard Schatz, 

Richard Spencer, Douglas Owens, Missy Banks, Diane Joseph, 

Rhonda Roberts, Christopher M. O’Connor, Warren Sherman. 

Duke University, Durham, NC 

9:43 Commentary: Joshua M. Hare, Miami, FL 

Learning Objective: Describe the results of recent trials and 

their implications for care of patients with heart failure. 

WEDNESDAY 

144 

145

Sept. 16 

Wednesday 

AM 

SYMPOSIUM 


8:30-10:00 AM 

Room 304 

SYMPOSIUM 


8:30-10:00 AM 

Room 306 

Sept. 16 

Wednesday 

AM 

Putting Heart Failure on the Map 

through Education 

The Forgotten Right Ventricle (RV) and 

Pulmonary Hypertension (PH) 

WEDNESDAY 

(Joint Session: HFSA and HF Association of the ESC) 

Moderators: Douglas L. Mann, St. Louis, MO 

John J.V. McMurray, Glasgow, Scotland, UK 

8:30 Educating Physicians/Scientists 

The US Perspective 

Laura F. Wexler, Cincinnati, OH 

The European Perspective 

Stefan D. Anker, Berlin, Germany 


9:00 Educating Nurses/Other Health Care Practitioners 


Kathleen A. Dracup, San Francisco, CA 


Mary Ryder, Dublin, Ireland 


9:30 Educating Patients/Community 


Marc A. Silver, Oak Lawn, IL 


Kenneth Dickstein, Stavanger, Norway 


Learning Objective: Outline the similarities and differences 

between the European and the US perspective on educating 

professionals and the community about heart failure. 

Moderators: Marc J. Semigran, Boston, MA 

Robert P. Frantz, Rochester, MN 

8:30 Invasive and Non-Invasive Approaches to 

Measuring RV Function 

Hunter C. Champion, Pittsburgh, PA 

8:50 What is on the Horizon: New Targets and New Drugs 

for Pulmonary Hypertension 

Myung H. Park, Baltimore, MD 

9:10 Pulmonary Hypertension in Left-Sided Heart Failure: 

Do Vasoactive Therapies Help? 

Joseph G. Rogers, Durham, NC 

9:30 Managing RV Failure in Patients on Mechanical Support 

Javed Butler, Atlanta, GA 


Learning Objective: Measure RV function and manage RV 

failure in patients on mechanical support and assess options 

for the management of pulmonary hypertension. 

WEDNESDAY 


Room 306 


Room 306 





146 

147

Sept. 16 

Wednesday 

AM 

SYMPOSIUM 


8:30-10:00 AM 

Room 311 

SYMPOSIUM 


10:30 AM-NOON 

Room 302 

Sept. 16 

Wednesday 

AM 

Symptom Assessment and Management 

Insights from Recent Trials and Registries 

Moderators: Sharon Rubin, Philadelphia, PA 

Suzanne J. Wingate, Silver Spring, MD 

Moderators: Kirkwood F. Adams, Jr., Chapel Hill, NC 

James B. Young, Cleveland, OH 

8:30 Dyspnea: Is this the Most Important Endpoint in 

Heart Failure? 

John R. Teerlink, San Francisco, CA 

8:50 Pain: How and in Whom Should We Control It? 

Sarah J. Goodlin, Salt Lake City, UT 

9:10 Fatigue: Can We Measure and Modify? 

Cheryl A. Westlake Canary, San Clemente, CA 

9:30 Depression: Is It Important in Heart Failure? 

Mark D. Sullivan, Seattle, WA 


Learning Objective: Assess and manage key symptoms in 


10:30 INTERMACS 

James K. Kirklin, Birmingham, AL 

10:50 HF-ACTION 

David J. Whellan, Philadelphia, PA 

11:10 I-PRESERVE 

Peter E. Carson, Washington, DC 

11:30 STICH 

Eric J. Velazquez, Durham, NC 


Learning Objective: Discuss key findings about heart failure 

from recent trials and registries. 

WEDNESDAY 

WEDNESDAY 


Room 306 



148 

149

Sept. 16 

Wednesday 

AM 

SYMPOSIUM 


10:30 AM-NOON 

Room 304 

SYMPOSIUM 


10:30 AM-NOON 

Room 306 

Sept. 16 

Wednesday 

AM 

ADHF as a Non-Cardiac Disorder 

Valvular Heart Disease and Heart Failure 

Moderators: Mathew S. Maurer, New York, NY 

Marc A. Silver, Oak Lawn, IL 

Moderators: Julius M. Gardin, Hackensack, NJ 

Todd M. Koelling, Ann Arbor, MI 

10:30 Vascular Stiffness: Why Should We Care? 

James C. Fang, Cleveland, OH 

10:30 Mitrovalve Surgery in Heart Failure 

Keith D. Aaronson, Ann Arbor, MI 

10:50 Renal: Is It the Primary Reason for Decompensation? 

J. Thomas Heywood, La Jolla, CA 

10:50 New Percutaneous Devices of MR 

Andrew Wang, Durham, NC 

11:10 Inflammation: Is This the Primary Pathophysiology of 

Decompensation? 

Anita Deswal, Houston, TX 

11:10 Tricuspid Regurgitation: Is It Important in our Heart 


Blase Carabello, Houston, TX 

11:30 It’s All About the Heart: Old and New Inotropes in 

ADHF 


11:30 Pulmonary Hypertension and Valvular Disease: 

When Is It Too Late to Operate? 

Patrick M. McCarthy, Chicago, IL 



WEDNESDAY 

Learning Objective: Discuss alternative pathologies for 

acute decompensated heart failure. 

Learning Objective: Describe the importance of valvular 

heart disease in heart failure and options for managing it. 

WEDNESDAY 

150 

151

Sept. 16 

Wednesday 

AM 

SYMPOSIUM 


10:30 AM-NOON 

Room 311 

Polyunsaturated Fatty Acids and Heart Failure 

Moderators: Mandeep R. Mehra, Baltimore, MD 

Hector O. Ventura, New Orleans, LA 

10:30 Fat Intake and the Risk for Heart Failure 

Dariush Mozaffarian, Boston, MA 

10:50 Effects of Supplementation with n-3 Polyunsaturated 

Fatty Acids in Patients with Chronic Heart Failure 

Mihai Gheorghiade, Chicago, IL 

11:10 Cardioprotective Effects of Polyunsaturated Fatty Acids: 

Underlying Mechanisms 

William C. Stanley, Baltimore, MD 

11:30 Fatty Acids and Cardiac Arrhythmias in Heart Failure 

David R. Van Wagoner, Cleveland, OH 


WEDNESDAY 

Learning Objective: Discuss the role of polyunsaturated 

fatty acids in the prevention and management of heart 

failure. 

152

Thank you for coming – 

see you next year 

14th Annual 


September 12 – 15, 2010 

San Diego Convention Center 

San Diego, CA 

Abstract Deadline: April 5, 2010 

www.hfsa.org

Clinical Trial Row 

Posters 

LAPTOP 

LOUNGE 

2831 

2733 2732 

2634 

2531 

2432 

2930 

2530 

2632 2731 2730 2829 2830 

2525 

EXHIBIT FLOOR PLAN 

2926 

2924 

2824 

2922 

2920 

2918 

2818 

2916 

2815 

2914 

2813 

2912 

2812 

2910 

2906 

2622 2721 

2620 2719 2722 

2716 

2426 2523 

2422 2519 2522 

2420 2517 

2518 2617 

2416 2515 

2514 2613 

2412 2511 

Exhibit Hall C 

2714 

2705 

2614 

154 

2626 

2406 2506 

Exhibit Hall D 

Registration 

Entrance 

HFSA Exhibitor Booth # 

ABIOMED, Inc. ...................................Booth #2831 

American Heart Association ..........................Booth #2914 

BG Medicine, Inc. ..................................Booth #2517 

Bioenergy Life Science, Inc. ..........................Booth #2920 

Biotronik .........................................Booth #2812 

Boston Scientific Corporation .........................Booth #2722 

Cambridge Heart, Inc. ...............................Booth #2519 

CardioDynamics ...................................Booth #2719 

Cardiomedics, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2714 

CHF Solutions, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2426 

Comsort, Inc . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2412 

Cytokinetics, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2626 

Data Sciences International ...........................Booth #2829 

Daxor Corporation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2813 

Desysion Health Systems, Inc. . . . . . . . . . . . . . . . . . . . . . . . .Booth #2918 

Elsevier, Inc. ......................................Booth #2910 

GeneDX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2617 

Gilead Sciences, Inc. ........................Booth #2620 & #2716 

Healthy Heart Sleep Programs, Inc .....................Booth #2632 

Heart Failure Society of America ......................Booth #2906 

HFSA Laptop Lounge ...............................Booth #2830 

HFSA E-mail Retrieval Stations .......................Booth #2522 

HeartWare, Inc . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2515 

Jarvik Heart, Inc. ...................................Booth #2523 

Medtronic, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2506 

Millar Instruments, Inc. ..............................Booth #2518 

NeuMeDx . .......................................Booth #2511 

NI Medical Ltd. ....................................Booth #2731 

Otsuka America Pharmaceuticals, Inc. ..................Booth #2406 

Oxford University Press . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2916 

Philips Respironics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2613 

Quality Assured Services, Inc. . . . . . . . . . . . . . . . . . . . . . . . .Booth #2622 

St. Jude Medical . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2614 

sanofi-aventis (Lorenox) .............................Booth #2818 

sanofi-aventis (Multaq) ..............................Booth #2824 

Shape Medical Systems, Inc. . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2815 

Society of Chest Pain Centers .........................Booth #2924 

SynCardia Systems, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2721 

The Joint Commission . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2912 

Thoratec Corporation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2514 

Tii Informatix Group . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2420 

TYRX, Inc ........................................Booth #2730 

University of Mississippi Health Care-University Heart . . . .Booth #2422 

Wiley-Blackwell ...................................Booth #2922 

WorldHeart, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2416 

XDx, Inc. .........................................Booth #2525 

Zoll Lifecor Corporation .............................Booth #2705 

155

Clinical Trial Row 

EXHIBITORS 

Amgen 

B1 

RED-HF 

Reduction of Events with Darbepoetin alfa in 

Heart Failure Trial 

Boston Scientific CRM 

B2 

RESET 

Restoration of Chronotropic Competence in Heart 

Failure Patients with Normal Ejection Fraction 

Boston Scientific 

B12 

LSR of ACUITY Spiral 

Longitudinal Surveillance Registry of the 

ACUITY Spiral Lead 

FoldRx Pharmaceuticals, Inc. 

B11 

THAOS 

Transthyretin-Associated Amyloidoses 

Outcomes Survey 


B3 

B4 

B5 

B6 

B7 

B8 

Attain Success Trial 

BLOCK HF 

Biventricular Versus Right Ventricular Pacing in 

Heart Failure Patients with Atrioventricular Block 

OptiVol Care Pathway 

RAFT 

Resynchronization/Defibrillation for Ambulatory 


Shock-Less 

SLS 

System Longevity Study 

Medtronic, Inc/UCSF 

B9 

VEST/PREDICTS 

Vest Prevention of Early Sudden Death Trial 

(VEST) and Prediction of ICD Therapies Study 

(PREDICTS) 

National Institute of Health - National Institute of Neurological 

Disorders and Stroke (NIH-NINDS) 

B10 

WARCEF 

Warfarin vs Aspirin for Reduced Cardiac Ejection 

Fraction 

ABIOMED, Inc .......................................2831 

22 Cherry Hill Drive 

Danvers, MA 01923 

www.abiomed.com 

ABIOMED is a leading provider of medical devices that provide 

circulatory support to accute heart failure patients across the 

continuum of care in heart recovery. Our products are designed to 

enable the heart to rest, heal and recover by improving blood flow 

and/or performing the pumping of the heart. 

American Heart Association.............................2914 

7272 Greenville Avenue 

Dallas, TX 75231 

www.americanheart.org 

The American Heart Association/American Stroke Association offers 

a complete portfolio of quality improvement programs dedicated to 

bettering patient care through guideline adherence. The programs 

address improving quality of patient care for patients of heart disease 

and stroke from primary prevention all the way through outpatient 

care. 

BG Medicine, Inc......................................2517 

610 N. Lincoln Street 

Waltham, MA 02451 

www.bg-medicine.com 

BG Medicine is a biotechnology company focused on the discovery, 

development, and commercialization of novel diagnostics to improve 

patient outcomes and contain healthcare costs. Of particular interest to 

our partners is BG’s ongoing study and development of Galectin-3, an 

active player in fibrosis and adverse remodeling in heart failure patients. 

Bioenergy Life Science, Inc..............................2920 

13840 Johnson Street NE 

Ham Lake, MN 55304 

www.bioenergy.com 

The mission of Bioenergy Life Science is to improve lives by 

restoring health and vitality to the body’s core energy supply. 

Its product offerings (Corvalen®) focus on indications that affect 

millions worldwide, including heart failure, neuromuscular disease, 

fatigue, anti-aging, sports nutrition, and energy health. Corvalen 

is all natural, safe and clinically proven. 

156 

157

EXHIBITORS 

EXHIBITORS 

Biotronik. ...........................................2812 

6024 Jean Road 

Lake Oswego, OR 97035 

www.biotronik.com 

BIOTRONIK is a world leader in the development of cardiac rhythm 

management devices. The BIOTRONIK Home Monitoring® and 

BIOTRONIK’s latest defibrillator in cardiac resynchronization therapy, 

the Lumax 540 series, automatically monitors and trends patients’ 

heart failure status through daily, wireless transmissions of clinically 

significant heart failure diagnostic data. 

Boston Scientific Corporation. ..........................2722 

4100 Hamline Avenue North 


www.bostonscientific.com 

Boston Scientific is a worldwide developer, manufacturer, and 

marketer of medical devices whose products are used in a broad 

range of interventional medical specialties. With approximately 

25,000 employees and annual revenue of more than $8 billion, 

Boston Scientific is the world’s largest medical device company 

dedicated to less-invasive therapies. 

Cambridge Heart, Inc. .................................2519 

100 Ames Pond Drive, Suite 100 

Tewksbury, MA 01876 

www.cambridgeheart.com 

Cambridge Heart offers the HearTwave® II system, a third generation 

Microvolt T-Wave Alternans (MTWA) testing platform for assessing 

a patient’s risk of sudden cardiac arrest. The system employs the 

Analytic Spectral Method, the only technique reimbursed by Medicare 

for measuring MTWA. The HearTwave® II can be used for standard 

stress testing as well as MTWA assessment. 

CardioDynamics ......................................2719 

6175 Nancy Ridge Drive 

Suite 300 

San Diego, CA 92121 

www.cardiodynamics.com 

In minutes, BioZ ICG (Impedance Cardiography) technology 

provides noninvasive hemodynamic parameters, including cardiac 

output and fluid status, for patients with heart failure, dyspnea, and 

resistant hypertension. ICG is a Medicare-covered test used in over 

5 million patient applications to assist physicians select and optimize 

cardiovascular medications including ACEs, BBs, and diuretics. 

Cardiomedics, Inc. ....................................2714 

18872 Bardeen Avenue 

Irvine, CA 92612 

www.cardiomedics.com 

Cardiomedics, Inc., a leader in external counterpulsation, is the only 

ECP manufacturer with a patented Graduated Low Pressure Regimen 

that has been clinically proven to reduce mortality on average in heart 

failure patients by 90%, increase LVEFs by 23%, reduce CHF Class 

by 36%, and reduce hospitalizations by 87.5%. 

CHF Solutions, Inc. ...................................2426 

7601 Northland Drive 

Suite 170 

Brooklyn Park, MN 55428 

Phone: 866-709-4030 

Fax: 763-463-4663 

Website: www.chfsolutions.com 

CHF Solutions Inc. has pioneered aquapheresis therapy for patients 

with fluid overload. Inpatient or outpatient, peripheral or central, 

remove excess salt and water with aquapheresis and the Aquadex 

FlexFlow. Its low blood flow, low extracorporeal blood volume, and 

precise removal rates allow you to expand the number of services that 

you offer and the types of patients that you see. 

Comsort, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2412 

11311 McCormick Road, Suite 203 

Hunt Valley, MD 21031 

www.comsort.com 

Founded in 1991, COMSORT Inc. is committed to positively 

impacting the state of healthcare delivery, both globally and locally, 

by developing state-of-the art technologies that empower providers, 

organizations, and the pharmaceutical industry to support their 

customers and constituents. 

Cytokinetics, Inc. .....................................2626 

280 E Grand Ave 

South San Francisco, CA 94080 

www.cytokinetics.com 

Cytokinetics, Inc. is a biopharmaceutical company focused on 

the discovery, development and commercialization of novel small 

molecule drugs that specifically target the cytoskeleton. Cytokinetics’ 

heart failure program is focused towards small molecule activators 

of cardiac myosin, the cytoskeletal motor protein in cardiac muscle 

responsible for cardiac contraction. 

158 

159

EXHIBITORS 

Data Sciences International .............................2829 

119 14th Street NW, Suite 100 


www.datasci.com 

Data Sciences International (DSI) offers a wide variety of 

physiological monitoring solutions for respiratory, cardiovascular, 

and CNS applications involving acute or chronic studies. Products 

include data collection and analysis systems coupled with hardwired 

amplifiers, implantable telemetry, and externally worn telemetry. Sales 

offices throughout Europe, USA and Asia provide local support and 

product experience. 

Daxor Corporation ....................................2813 

350 Fifth Avenue 

Suite 7120 

New York, NY 10118 

www.daxor.com 

Daxor Corporation’s BVA-100® Blood Volume Analyzer is a 

semi-automated instrument patented for direct measurement of 

blood volume, red cell and plasma volume. The system utilizes the 

Volumex® injection-collection kit for a multi-sample blood volume. 

Measurement of blood volume is applicable for hypertension, CHF, 

transfusion, ICU/CCU, anemia, orthostatic hypotension and syncope. 

Desysion Health Systems, Inc............................2918 

436 Inspiration Lane 

Gaithersburg, MD 20878 

www.desysion.com 

Desysion Health Systems, Inc. is a healthcare information technology 

company providing clinical intelligence to assist health care specialists 

collect, analyze and use medical information to improve management 

of patients with chronic conditions. Our CHF Manager application 

provides EMR and clinical intelligence capabilities to HF specialists 

and centers. 

Elsevier, Inc. .........................................2910 

1600 JFK Blvd., Suite 1860 

Philadelphia, PA 19103 

www.elsevier.com 

Elsevier is proud to publish the Journal of Cardiac Failure, the official 

journal of the Heart Failure Society of America. Please stop by our 

booth to view the latest issue of the Journal and browse our other 

books and journals in the field of cardiology. 

EXHIBITORS 

GeneDx..............................................2617 

207 Perry Parkway 

Gaithersburg, MD 20877 

Phone: 301-519-2100 

www.genedx.com 

GeneDx offers testing for almost 200 rare Mendelian disorders, 

using DNA sequencing and deletion/duplication analysis of the 

associated gene(s). GeneDx also offers genetic testing services for 

inherited cardiac disorders such as hypertrophic cardiomyopathy, 

dilated cardiomyopathy and arrhythmias. Our services include 

mutation analysis, carrier testing, prenatal diagnosis, and mutation 

confirmations. 

Gilead Sciences, Inc............................ 2620 & 2716 

333 Lakeside Drive 

Foster City, CA 94404 

www.gilead.com 

Gilead Sciences is a biopharmaceutical company that discovers, 

develops and commercializes innovative therapeutics in areas of 

unmet medical need. The company’s mission is to advance the 

care of patients suffering from life-threatening diseases worldwide. 

Headquartered in Foster City, California, Gilead has operations in 

North America, Europe and Australia. 

Healthy Heart Sleep Programs, Inc.......................2632 

210 Quincy Avenue 

Brockton, MA 02302 

www.healthyheartsleep.com 

Healthy Heart Sleep Programs, Inc. is designed to provide cardiology 

practices and heart hospitals with a fully integrated program to 

diagnose and treat Obstructive Sleep Apnea. 

Heart Failure Society of America.........................2906 

Court International, Suite 240 South 



www.hfsa.org 

The Society welcomes you to our 13th Annual Scientific Meeting. 

We hope you enjoy your stay in Boston and look forward to seeing 

you at the 14th Annual Scientific Meeting, September 12-15, 2010, 

San Diego, CA. Please visit our booth for more information about 

the Society. 

160 

161

EXHIBITORS 

HFSA Laptop Lounge..................................2830 

HFSA E-mail Retrieval Stations..........................2522 

During exhibit hours, this booth will have computers available for 

attendees to retrieve their e-mail. 

HeartWare, Inc .......................................2515 

205 Newbury Street 

Framingham, MA 01701 

www.heartware.com 

HeartWare, Inc. develops and manufactures a line of miniature, 

circulatory support devices designed to treat patients with advanced 

heart failure. The HeartWare® Ventricular Assist System incorporates 

the HVAD Pump with state-of-the-art patient peripherals. The 

HeartWare® System is commercially available in Europe and is the 

subject of a US IDE trial. 

Jarvik Heart, Inc. .....................................2523 

333 West 52nd Street 

New York, NY 10019 

www.jarvikheart.com 

Implanted within the ventricle, the Jarvik 2000 is the smallest fulloutput 

permanent Ventricular Assist Device for the treatment of heart 

failure. The Jarvik 2000 has demonstrated durability and reliability 

for over seven years - the longest implant period by any single assist 

device. Over 325 Jarvik 2000s have been implanted. 

Medtronic, Inc........................................2506 

710 Medtronic Parkway 

Minneapolis, MN 55432 

www.medtronic.com 

Medtronic is the world’s leading medical device company, partnering 

with clinicians to provide evidence to identify, assess, treat and 

monitor patients with heart disease. Visit us for the latest advances in 

evidence, heart failure diagnostics, products and services that improve 

and save lives every day. 

EXHIBITORS 

Millar Instruments, Inc.................................2518 

6001-A Gulf Freeway 

Houston, TX 77023-5417 

www.millarinstruments.com 

Millar Instruments manufactures a complete line of Mikro-Tip cardiac 

pressure and pressure-volume (PV) catheters for evaluation of cardiac 

function. Our catheters range from 8F down to 1F, with single to 

multiple sensors. Millar’s PV system is capable of simultaneously 

measuring high fidelity left ventricular pressure and volume in small 

and large animal models. 

NeuMeDx............................................2511 

2014 Ford Road, Unit G 

Bristol, PA 19007 

www.neumedx.com 

NeuMeDx is the U.S. home of the new, patented family of 

PhysioFlow® Signal Morphology-based Impedance Cardiography 

(SM-ICG) products. Easy-to-use, safe products that provide 

accurate and repeatable measurements of patient hemodynamics in a 

wide variety of patient care setting and various clinical conditions. 

NI Medical Ltd. ......................................2731 

3 En Hay St 

Kfav Mallal, 45920 

Isreal 

www.nimedical.co.il 

NI Medical introduces a new diagnostic tool, the NICaS CS, for the 

doctor’s personal kit. This impedance-based medical laptop is for 

measuring cardiac output and for assessment of Asymptomatic Left 

Ventricular Systolic Dysfunction (ALVSD). Early diagnosis of ALVSD 

may prevent sudden cardiac death and the evolution of congestive 


Otsuka America Pharmaceuticals, Inc. ....................2406 

2440 Research Boulevard 

Rockville, MD 20850 

www.otsuka-us.com 

Otsuka is hard at work investigating potential new treatments, 

with numerous compounds in various stages of development to treat 

disorders of the cardiovascular, gastrointestinal, respiratory, renal, and 

central nervous systems, and to treat cancer and ophthalmic disorders. 

Our goal is to create new products for better health worldwide. 

162 

163

EXHIBITORS 

Oxford University Press ................................2916 

2001 Evans Road 

Cary, NC 27513 

www.oup.com 

Oxford University Press publishes some of the most respected medical 

and scientific books and journals in the world, including European 

Journal of Heart Failure, the official international journal of the 

European Society of Cardiology and one of the top publications in the 

field. Visit http://eurjhf.oxfordjournals.org for more information. 

Philips Respironics. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2613 

1010 Murry Ridge Lane 

Murrysville, PA 15668 

www.respironics.com 

Philips Respironics, a global leader in the sleep and respiratory 

markets, is passionate about improving the quality of people’s lives 

with solutions designed around the needs of our customers and their 

patients. Innovation is driven by gaining insight into the needs of the 

people who use our products for sleep management, oxygen therapy, 

noninvasive ventilation and respiratory drug delivery. 

Quality Assured Services, Inc............................2622 

70 S. Keller Road 

Orlando, FL 32810 

www.QualityAssuredServices.com 

QAS is the only company in the US with CMS approval as a provider 

for outpatient VAD equipment, for driveline supplies and for INR 

devices for patient self-testing. QAS works with patients nationwide 

to provide services, medical devices and testing capabilities in a home 

setting. For more information, visit www.QualityAssuredServices.com. 

St. Jude Medical. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2614 

807 Las Cimas Parkway 

Suite 400 

Austin, TX 78746 

www.sjm.com 

St. Jude Medical develops medical technology and services that focus 

on putting more control into the hands of those who treat cardiac, 

neurological and chronic pain patients worldwide. The company is 

dedicated to advancing the practice of medicine by reducing risk 

wherever possible and contributing to successful outcomes for every 

patient. For more information, please visit www.sjm.com. 

EXHIBITORS 

sanofi-aventis (Lovenox®) ..............................2818 

55 Corporate Drive 

Bridgewater, NJ 08807 

www.sanofi-aventis.com 

Sanofi-aventis U.S. is an affiliate of sanofi-aventis, a leading 

global pharmaceutical company, discovers, develops and distributes 

therapeutic solutions to improve the lives of everyone. For more 

information, visit www.sanofi-aventis.us or www.sanofi-aventis.com. 

sanofi-aventis (Multaq).................................2824 

55 Corporate Drive 

Bridgewater, NJ 08807 

www.sanofi-aventis.us 

Sanofi-aventis U.S. is an affiliate of sanofi-aventis, a leading 

global pharmaceutical company, discovers, develops and distributes 

therapeutic solutions to improve the lives of everyone. For more 

information, visit www.sanofi-aventis.us or www.sanofi-aventis.com. 

Shape Medical Systems, Inc..............................2815 

MedTech Center 

5000 Township Parkway 


www.shapemedsystems.com 

Shape Medical Systems provides predictive modeling to improve 

the detection and therapeutic outcome assessment of heart and lung 

disease. Technology assesses cardiopulmonary function, defines the 

probable source of heart or lung limitations, quantifies prognosis, 

predicts future risk, provides recommendations regarding future 

treatment and monitors the ongoing clinical response to therapy. 

Society of Chest Pain Centers............................2924 

770 Jasonway Avenue, Suite 1B 

Columbus, OH 43214 

www.scpcp.org 

The Society of Chest Pain Centers is a process improvement based 

non-profit organization dedicated to helping facilities develop efficient 

methods of caring for their Acute Heart Failure and Chest Pain 

patients. The Society offers a unique patient-centered accreditation 

based upon best practice and protocols resulting in better outcomes. 

164 

165

EXHIBITORS 

SynCardia Systems, Inc. ...............................2721 

1992 E. Silverlake Rd. 

Tucson, AZ 85713 

www.syncardia.com 

The CardioWest temporary Total Artificial Heart (TAH-t) is the only 

FDA and CE approved device that provides circulatory restoration in 

morbidly ill patients with irreversible bi-ventricular failure, bridging 

them to transplantation. Visit our booth for updates on clinical studies 

for the Companion Driver, Freedom discharge driver, 50cc TAH-t, and 

pediatric VAD. 

The Joint Commission..................................2912 

One Renaissance Blvd 

Oakbrook Terrace, IL 60181 

www.jointcommission.org 

The Joint Commission is introducing a new advanced certification 

for heart failure, using Get with the Guidelines heart failure measures 

as the clinical practice requirement. Advanced certification in heart 

failure provides a comprehensive evaluation of this patient population. 

Certification of your heart failure program demonstrates excellence in 

fostering better outcomes 

Thoratec Corporation..................................2514 

6035 Stoneridge Drive 

Pleasanton, CA 94588 

www.thoratec.com 

With over 12,000 patient implants and three decades of experience, 

Thoratec® Corporation offers the broadest portfolio of mechanical 

circulatory support devices. Thoratec’s product line includes the 

CentriMag® Acute Circulatory Support Device, HeartMate® LVAS, 

Thoratec PVAD and IVAD, and the newly FDA approved 

HeartMate II for bridge to transplantation. 

Tii Informatix Group. .................................2420 

700 North 4th Street 

Richmond, VA 23219 

www.tii-informatix.com 

Tii Informatix Group (Tii), a subsidiary of UNOS, is a CRO and 

technology services provider that offers consulting, data management, 

clinical trial support, and custom programming services to 

pharmaceutical, biotech, device and other healthcare organizations. 

Our involvement with INTERMACS, the ISHLT Global Thoracic 

Registry and others give us unique perspective in this space. 

EXHIBITORS 

TYRX, Inc ...........................................2730 

1 Deer Park Drive, Suite G 

Monmouth Junction, NJ 08852 

Website: www.tyrx.com 

AIGISRx Anti-Bacterial Envelope by TYRX, Inc. contains the 

antimicrobial antibiotics, minocycline and rifampin, which have been 

shown to reduce infection by pathogens (including MRSA) that are 

the cause of a majority of infections associated with CRMD implants. 

AIGISRx is also intended to aid in the stabilization of CRMD 

placement. 

University of Mississippi Health Care-University Heart ......2422 

2500 N. State Street 

Jackson, MS 39216 

www.umhc.com 

University Heart, a component of University of Mississippi 

Healthcare, is a comprehensive cardiac and vascular program 

serving patients from across Mississippi and the region. University 

Heart offers Mississippi’s only cardiac transplant program and only 

Academic Medical Center based cardiovascular program. We are a 

certified Get with the Guidelines facility. 

Wiley-Blackwell.......................................2922 

350 Main Street 

Malden, MA 02148 

www.wiley.com 

Wiley-Blackwell meets the information needs of cardiology 

professionals in a wide variety of ways. Visit booth #2922 for the 

latest issue of Congestive Heart Failure and to purchase books at a 

discount. Wiley-Blackwell is the scientific, technical, medical, and 

scholarly publishing business of John Wiley & Sons. 

WorldHeart, Inc.......................................2416 

7799 Pardee Lane 

Oakland, CA 94621 

www.worldheart.com 

World Heart Corporation develops implantable mechanical circulatory 

support systems for long-term use. Its 4th-generation Levacor VAD 

is the only bearingless, fully magnetically levitated implantable 

centrifugal rotary pump to have seen clinical use. Current focus is on 

activities leading to the start of a U.S. clinical trial. 

166 

167

EXHIBITORS 

XDx Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2525 

3260 Bayshore Blvd. 

Brisbane, CA 94005 

www.xdx.com 

XDx is a molecular diagnostics company focused on the discovery, 

development and commercialization of non-invasive gene expression 

testing in the areas of transplant medicine and autoimmunity. The 

company has developed a proprietary method of utilizing gene 

expression in blood that provides a new tool for physicians to 

manage the care of heart transplant patients. 

ZOLL Lifecor Corporation..............................2705 

121 Freeport Road 

Pittsburgh, PA 15238 

www.lifecor.com 

ZOLL Lifecor Corporation, a subsidiary of ZOLL Medical, 

manufactures LifeVest, the first and only wearable cardioverter 

defibrillator. The LifeVest, worn outside of the body, does not rely 

on bystander intervention for restoration of a patient’s normal heart 

rhythm. The LifeVest offers patients immediate protection, constant 

monitoring and peace of mind. 

168 

AUTHOR INDEX 

13th Annual Scientific Meeting 


“P” preceding number indicates a poster 

Aaronson, Keith D. 

151, P144 

Aaschia, Elena 

P070 

Aban, Inmaculada 

P272 

Abdalrhim, Ahmed D. 42 

Abdul-Nour, Khaled 145 

Abel, E. Dale 

P027 

Abernethy, Amy P. 

P326 

Abodiv, Musa Tajuddinovich 

P253 

Abou Khashan, Mohamed 

P376 

AbouEzzeddine, Omar F. 

P298 

Abraham, William T. 

39, 45, P051, P200, P261, P365 

Abramov, Dmitry 

P067 

Abramson, B.L. 

P357 

Acker, Michael A. 

P179 

Ackerman, Stephen 

P029 

Adam, Pleister 

P371 

Adams, Jr., Kirkwood F. 149 

Adams, Patricia A. 92 

Adams, Volker 

P060 

Adamson, Philip B. 

106, P051, P365 

Adatya, Sirtaz 

P075 

Addonizio, Linda J. 

P176 

Adesunloye, Bamidele 

P262 

Adler, Stuart W. 

P198 

Advani, Andrew 

P120 

Aggarwal, Sandeep 

P199 

Agha, Syed A. 

P313, P314, P327, P338 

Agler, Deborah 

P142 

agler, deborrah 

P083 

Agnihotri, Adeesh 

P175 

Agosto, Mariela 

P245 

Ahmad, Ali 

P083, P108 

Ahmed, Ali 

P272 

Ahmet, Ismayil 

P238 

Ahn, Sylvie A. 

P305 

Ahnadi, Charaf E. 

P233 

Ahuja, Ameeta 

P197 

Aikins, Andrew 

P391 

Ajijola, Olujimi A. 

P187 

Akkan, Dilek 

P275 

Akoum, Nazem 

P218 

Aladadyan, Madlen 

P403 

Alahakoon, Prabhu T. 

P032, P133 

Albert, N.M. 

P209, P210, P211 

Albert, Nancy M. 

39, 40, P384, P385 

169

AUTHOR INDEX 

Alekseyvich, Tsarapultser Pyoter P253 

Alessandro, Cataliotti 

P239 

Alexander, Jude 

P300 

Alexis, Jeffrey 

P181, P310 

Alexis, Jeffrey D. 44 

Al-Habeeb, Waleed 

P294 

Alhaj, Eyad 

P089 

Ali, Ahmed 

P292 

Ali, Omaima 

P308, P324, P336 

Ali, Shaukat 

P079 

Allen, Larry A. 

144, P152 

Allman, Richard M. 

P272 

Almog, Remo 

P150 

Alpert, Joseph S. 

P406 

Altaf, Amna 

P338 

Alvarenga, Pablo M. 

P279 

Amaki, Makoto 

P359 

Ambardekar, Amrut V. 

P152 

Ameenuddin, Syed 

44, P093, P094 

Amipara, R. 

P260 

Amir, Sherman 

P151 

Amsterdam, Ezra 

P186 

Anand, Inder 

P175, P345 

Anand, Inder S. 

42, 145, P217 

Anarado, Perry 

P313, P314, P327, P338 

Ancheta, Christine 

P404 

Ancheta, Irma B. 

P404 

Andersen, Jon T. 

P236 

Anderson, Shawn 

P335, P355, P388 

Anderson, Shawn D. 

P280, P399 

Andriulli, John 

P374, P402 

Anker, Stefan D. 42, 146, P060, P070, P188, 

P257, P317, P328, P345, P350 

Anversa, Piero 105 

Arab, Sara 

P119 

Arab, Shima 43 

Arabia, Francisco A. 

P166 

Aranda, Juan 

P335, P355, P388 

Arbeeny, Cynthia 

P256 

Arcement, Lee 

P312 

Arena, Ross A. 

P073 

Arif, Nida 

P338 

Armbruster, Rebecca 

P271 

Armentano, Deborah 

P393 

Arnett, Donna K. 

P272 

Arnold, J. Malcolm O. 145 

Arnold, Malcolm 

P361 

Aronowitz, Mark 

P122 

Arora, Sabeena 

P398 

170 

AUTHOR INDEX 

Arruda-Olson, Adelaide M. 

P074 

Artemenko, Sergey 

P137 

Artemenko, Sregey 

P138 

Asai, Kuniya 

P269 

Ashley, Euan A. 52 

Aslam, Ahmed F. 

P105 

Aspromonte, Nadia 

P316 

Asrabadi, Adib 

P114 

Atchley, Allen E. 145 

Athanasopoulos, Leonidas V. 

P106, P368, P387 

Ather, Sameer 

P337, P346 

Auseon, Alex J. 

P032, P133 

Averina, Viktoria A. 

P172, P173 

Avula, Pooja 

P396 

Ayers, Colby R. 

P353 

Azad, Nahid 

P357 

Aziz, Emad 42 

Babalis, Daphne 

P317 

Babayan, Zaruhi V. 

P045 

Bach, David S. 

P204 

Badger, Troy 

P218 

Badloe, Sabrina 

P312 

Bae, Soochan 

P256 

Bahl, Joeseph 

P140 

Baholli, Loant 

P163 

Baicu, C. 

P039 

Bakris, George L. 

P272 

Baldus, Stephan 

P163 

Ballari, Sarika 

P331 

Bank, Alan J. 

35, P057, P198 

Banks, Missy 145 

Bantly, Andrew 

P052 

Bantly, Andrew D. 

P034 

Baquar, Bashey 

P108 

Barantke, Melanie 

P187 

Barbagelata, Alejandro 

P114 

Barcena, Julio A. 

P058 

Bargas, Royce 

P189 

Bargazzi, Gustavo 

P279 

Baribeau, Yvon 

P331 

Barmeyer, Achim 

P163 

Barouch, Lili A. 43 

Barretto, Antonio P. 

P380 

Barrios, Perla 

P270 

Barry, Mary B. 

P245 

Barst, R.J. 

P206 

Bartoli, Carlo R. 

P165 

Bartone, Cheryl 

P375 

Bartov, D. 

P156 

171

AUTHOR INDEX 

Bartov, David N. 

P064 

Basraon, Jagroop 

P175 

Battie, Cynthia 

P404 

Batyraliev, Talantbek A. 

P041 

Bauer, Lisa 

P356 

Baughman, Kenneth L. 106 

Bax, Jeroen 

P200 

Baxter, Samantha 

P130 

Bayes-Genis, Antoni 

P054, P055 

Beck, Kenneth C. 

P071 

Bedja, Djahida 43 

Behzadi, Yashar 

P232 

Bell, Stephen 

P087 

Belziti, Cesar A. 

P343 

Ben Shabat, Yael 

P150 

Bennett, Alexandra A. 

P358 

Bennett, Edward S. 

P045 

Bennett, Tom D. 

P051, P365 

Bensimhon, Daniel R. 

P071 

Benson, Kaaron 

P222 

Benza, Raymond 

P115 

Berg, Robert 

P028 

Bergeson, Steve 

P360 

Berkowitz, Robert 

P089 

Bermudez, Christian 

P171 

Bernstein, Bruce 

P398 

Bersell, Kevin 43 

Bertoni, Alain G. 

P268 

Besse, Whitney 

P245 

Betensky, Brian 

P124 

Bhalla, Vikas 

P313, P314, P327 

Bhama, Jay 

P171 

Bhardwaj, Adarsh 

P075 

Bhardwaj, Anju 

102, P095 

Bhardway, Rishi 

P141 

Bharmi, Rupinder 

P191 

Bhat, Geetha 

P396 

Bhatia, Nisha L. 

P166 

Bhatia, Sapna 

P240 

Bhavnani, Sanjeev 

P397 

Bhavnani, Sanjeev P. 

P182 

Bhuiyan, Taslima 

P046 

Bianco, Nicole 

P315 

Biddle, Martha 

P405 

Bierman, A.S. 

P357 

Bigger, Rachel 

P216 

Bilkins, Jill 

P169 

Biner, Simon 

P319 

Binkley, Philip F. 

P032, P133 

172 

AUTHOR INDEX 

Biolo, Andreia 

P103, P117, P124, P325 

Birkhahn, R. 

P260 

Birks, Emma J. 

P146 

Bishopric, Nanette H. 50 

Bisognano, John D. 

P204 

Blandea, Dan 

P187 

Blaxall, Burns C. 52 

Bloch Thomsen, Poul-Erik 

P172 

Bloch-Thomsen, Poul-Erik 

P173 

Bodmer, Rolf 43 

Bodyak, Natalya 

P256 

Boehmer, John 

P181 

Boehmer, John P. 

35, 40, P201, P377 

Boehringer, Christine 

P378 

Boerrigter, Guido 

P093, P094, P273, P281, P282 

Bogar, Linda 

P169 

Bolger, Dennis T. 

P362 

Bolli, Roberto 48 

Bonita, Raphael E. 102 

Book, Wendy 

P313, P314, P327, P338 

Boonyasirinant, Thananya 

P208 

Borgeson, Daniel D. 

P348 

Borggrefe, M. 

P136 

Borlaug, Barry A. 

P373 

Borowski, Allen 

P123 

Borowski, Allen G. 

P111 

Botross, Mina 42 

Botta, Cristian 

P270 

Bourge, R. 

P206 

Bourge, Robert C. 

93, P051, P365 

Bowen, Lorna 

P077 

Bowen, Lorna A. 

P161 

Boyer, Lynnette 

P280, P335, P355, P399 

Boyle, Andrew J. 

P144 

Bozkurt, Biykem 

P323, P337, P346 

Brancalhao, Euler C. 

P380 

Brennan, Bernadine 

P396 

Brewer, Robert J. 

P149 

Bridges, Jr., Charles R. 94 

Brieke, Andreas 

P152, P189 

Brien, Jo-anne 

P358 

Bright, Megan 

P043, P044 

Bristow, Michael 

42, P244, P248 

Britton, Nancy 

P040, P167 

Broesch, Lynn 

P372 

Brown, Jason R. 

P386 

Brown, Joan Heller 110 

Brown, Mary W. 39 

Brubaker, Peter H. 

P228 

173

AUTHOR INDEX 

Brunso-Bechtold, Judy K. 

P100 

Buckley, Samantha 

P190 

Burgon, Nathan 

P218 

Burkhoff, Daniel 

P064, P067 

Burnett, J. 

P254 

Burnett, John C. 

42, P063, P282 

Burnett, Jr., John 

P239, P281 

Burnett, Jr., John C. 36, 42, 49, 109, P077, P091, 

P093, P094, P102, P109, P113, 

P116, P273 

Burnie, David 

P199 

Burns, Kevin V. 

P057 

Burri, Haran 

P221 

Butler, Javed 145, 147, P313, P314, P327, 

P338 

Butte, Atul 37 

Caboral, Meriam F. 41 

Cabral, Isaias F. 

P276 

Calame, James 

P087 

Califf, Robert M. 107 

Calvin, Andrew D. 

P096 

Camandaroba, Paulo P. 

P276 

Campbell, Janis 

P291 

Campbell, Patricia 

102, P081 

Campbell, Patricia L. 

P294 

Canadian Heart Failure Network P361 

Canary, Cheryl A. Westlake 148 

Canby, Robert C. 39 

Cannom, David S. 39 

Cannone, Valentina 

P282 

Canny, Anne 

P169 

Cantarovich, Marcelo 

P178 

Cao, Long B. 

P337 

Cao, Michael K. 

P232, P391 

Capodilupo, Robert 

P331, P332, P340 

Cappola, Thomas A. 

P101 

Cappola, Thomas P. 52, 102 

Carabello, Blase A. 151 

Carasso, Shemy 

P151 

Cardoso, Juliano N. 

P380 

Carlson, Denise 

P198 

Caron, Michael 

P248 

Carroll-Hawkins, Coty 

P321 

Carson, Peter E. 103, 149 

Caslin, E. Kelly 

P400 

Cataliotti, Alessandro 

44, 49, P109, P273, P281, P282 

Cecere, Renzo 

P178 

Celis, Rene 

P062 

Cercek, Bojan 

P242 

174 

AUTHOR INDEX 

Cesario, David A. 

P232, P391 

Chai, Siang Chew 

P193, P274 

Chambless, Lloyd E. 

P268 

Champion, Hunter C. 147 

Chan, Annie 43 

Chandler, Margaret P. 54 

Chandra, Ramesh 

P107, P295 

Chang, Patricia P. 

106, P268 

Channon, Keith M. 43 

Chaparro, Sandra V. 45 

Chapman, Donald 

P388 

Chappell, Mark C. 

P100, P247 

Charlton, Sandra B. 

P192, P194, P344 

Charlton, Thomas A. 

P194, P344 

Chartyan, D. 

P390 

Chase, Paul 

P071 

Chatterjee, Kanu 47 

Chaudhari, Ronak 

P255 

Chaudhry, Hina W. 105 

Chaudhry, Muhammad 

P079 

Chaudhry, Muhammad M. 

P105 

Chauhan, Chirag A. 

P036 

Cheema, Omar M. 

P035 

Chelius, Peter 

P164 

Chen, Horng H. 42, 44, 49, 109, P063, P091, 

P102, P109, P282 

Chen, Jinghai 

P061 

Chen, Manyin 

P118, P119, P128, P134 

Chen, Michael M. 

P213 

Chen, Ming Hui 91 

Chen, Ren 

P180, P225, P265 

Chen, Yu 

P134 

Chen, Yue-Feng 

P240 

Chen, Zengyi 

P087 

Cheng, Che-Ping 

P131 

Cheng, Heng-Jie 

P131 

Cheriyath, pramil 

P264 

Cheriyath, Pramil 

P309 

Cherniavskiy, Alexander 

P137, P138, P139 

Chernich, Josh 

P149 

Chess, David J. 

P026 

Cheung, A. 

P390 

Chiaramida, Salvatore A. 

P066, P069 

Chioncel, Ovidiu 

P097 

Chiong, Jun 

P404 

Chiong, Jun R. 

P249, P286, P381, P403 

Chirife, Raul 

P184 

Chisner, Michael 

P029 

Chiu, Amy 

P212 

175

AUTHOR INDEX 

Chiu, Fu-Chun 

P085 

Cho, Yong K. 

P051, P365 

Choi, Jun H. 

P256 

Chopra, Vijay K. 

P217 

Chou, Jessie 

P042 

Chou, Will 

P219 

Chowdhury, Mahdi 

P313, P314, P327 

Choy, AnnaMaria 

P304 

Christenson, Robert 

102, P345 

Christian, Timothy 

P087 

Christman, Shelly 

P038, P230 

Christopher, Eric 

P300 

Christopher, Kenneth B. 

P367 

Chrzanowski, Stephen M. 

P179 

Chua, Cindy 

P212 

Chun, Sung 

P125 

Chung, Eugene S. 

P200, P375 

Chung, Misook L. 

41, P303, P405 

Chuprun, Kurt J. 102 

Cimbaro Canella, Juan P. 

P270, P279, P316 

Cirino, Allison 42 

Clark, Patricia C. 

P364 

Clarke, Katy 

P326 

Clary, Greg 

P300 

Clausell, Nadine 

P103, P117 

Cleland, John G.F. 39, 51, 93 

Clopton, Paul 

P110, P345 

Coburn, Tamora 

P240 

Cochino, Emil 

P097 

Cody, Robert J. 90 

Cohn, Jay N. 31, 92, 108 

Cokkinos, Dennis V. 

P106, P368, P387 

Colan, Steven D. 42 

Coleman, Craig 

P182 

Colque, Roberto M. 

P270, P279 

Colucci, Wilson S. 

53, 104, P124 

Compton, Steven 39 

Connelly, Kim A. 

P120 

Connolly, Louise 

P289 

Connolly, Melissa 

P169 

Conte, John V. 

P144 

Cooper, C. 

P390 

Cooper, Lawton S. 

P307 

Cooper, Leslie T. 

44, P201, P310 

Coppess, Mark A. 

P194, P344 

Corbisiero, Raffaele 

P271 

Coronel, Maria L. 

P270, P279, P316 

Costard-Jaeckle, Angelika 

P163 

Costanzo, Maria Rosa 47 

176 

AUTHOR INDEX 

Costello-Boerrigter, Lisa 

P273 

Costello-Boerrigter, Lisa C. 

P093, P094, P282 

Cotter, G. 

P215 

Cotter, Gad 

P112, P203, P207, P223, P243 

Cotter, Gadi 

P231 

Cotts, William G. 

P144 

Couper, Gregory S. 102 

Cox, Scott 

P040, P167 

Coyle, David J. 

P374 

Cozzi, Stephanie 

P169 

Crijns, H.J. 

P136 

Crossley, George 

P374, P402 

Cuffe, Michael 

P284, P300 

Currow, David C. 

P326 

Curtis, A.B. 

P209, P210, P211 

Curtis, Anne B. 

39, P180, P225 

Curtis, Lesley H. 

P330 

CY 1121 Investigators 

P213 

Cyr, Debra 

P397 

Czerska, Barbara 

P149 

Dadalto, Fernanda 

P276 

Dai, Jing 

P027 

Daifallah, Suleiman 

P308, P324, P336 

D’Alessandro, D. 

P156 

Daley, Marilyn 

P331, P332, P340 

Damman, Kevin 145 

Daneshvar, Daniel 

P242 

Danet-Desnoyers, Gwenn 

P034 

Daniel, Donna 

P376 

Danielian, Alfred 

P398 

Daniels, Lori B. 

P098, P345 

Danilova, Irina G. 

P253 

Darsaklis, Konstadina 

P306 

Dasgupta, Abhijit 102 

Daubert, James P. 39, 46 

Daunais, James B. 

P131 

David, Feldman 

P371 

Davidson, Patricia M. 

41, P326, P410 

Davidson-Ray, Linda 

P307 

d’Avila, Andre 

P042 

Davis, Gordon 

P244, P248 

Davis, Harry C. 

P082 

Davison Weatherley, B. 

P215 

Davison Weatherley, Beth 

P231 

Dawkins, Donald A. 

P409 

Dawood, Fayez 

43, P118, P119, P134 

Day, John D. 

P038, P230 

Daya, Samantapudi 

P246 

De, Sabe P086, P111, P123, P142, P143, 

177

AUTHOR INDEX 

P158 

De, Sabe K. 

P162 

De Boer, Rudolf A. 145 

de Coute, Geoffrey 43 

de Couto, Geoffrey 

P119, P134 

De Ferrari, G.M. 

P136 

De La Zerda, David J. 

P378 

de Leeuw, Peter 

P204 

del Monte, Frederica 101 

Dean, Evelyn 

P266 

Debes, Colleen H. 

P353 

Dec, G. William 

P201, P310 

Deedwania, Prakash 

P378 

Deedwania, Prakash C. 46 

deFilippi, Christopher R. 102 

Defranchi, Sebastian A. 

P348 

Degani, N. 

P357 

DeGore, Lori 

P171 

Deible, Christopher R. 

P036 

Dell’Italia, Louis J. 

P272 

Dellefave, Lisa 42 

DeNapoli, Jessica 

P124 

Denfield, S.W. 

P287 

Deng, Yingzi 

P297 

Dennert, R. 

P136 

Dennison, Cheryl R. 

P400 

DeNofrio, David 

P144, P153 

Depalma, Steve 42 

Desai, Akshay S. 

P081, P237 

Desai, Milind Y. 

P208 

DeSantis, S. 

P039 

Deswal, Anita 

49, 150, P323, P346 

Dev, Sandesh 

P299 

Devoe, Tari 

P397 

Dexler, Jonathan 

P321 

Dhaliwal, Amandeep 

P323 

Dhesi, Pavittarpaul 

P242 

Di Pasquale, Pietro 

P322 

Di Tano, Giuseppe 

P316 

Dickstein, Kenneth 146 

Diez, Fabian 

P270, P279 

Dinov, Ivo 

P378 

Dittrich, Howard C. 

P112, P231 

Divakaran, Vijay 

P346 

Dodani, Sunita 

P408 

Doehner, Wolfram 

P060, P188, P328, P350 

Donaho, Erin K. 144 

Doody, Robert 

P124 

Dorn II, Gerald W. 

50, P125 

178 

AUTHOR INDEX 

Dracup, Kathleen A. 98, 146 

Draper, Jr, Timothy S. 

P092 

Drazner, Mark 

P081 

Drazner, Mark H. 

93, P353 

Dreyer, W.J. 

P287 

Dries, Daniel L. 

P101 

Dritsas, Athanasios 

P106, P368, P387 

Drost, Conrad 

P149 

Druley, Todd E. 

P125 

Du, HuiYun 

P410 

Du, Wei 

P183 

Dubi, Shay 

P151 

Duffy, Elizabeth 

P130 

Dulay, Mario 

P146 

Dumitru, Ioana 

P370 

Dunbar, David N. 

P198 

Dunbar, Sandra B. 

41, P278, P334, P364, P379 

Duncan, David E. 37 

Duncan, Kathleen 

P329 

Dunlap, Mark E. 

106, P283, P349 

Dunn, Patrick J. 

P267 

Dupree, Carla S. 40 

Durand, Jean-Bernard 

P212 

Duvall, William 

P190 

Dweik, Raed 

P086 

Eckhart, Andrea 100 

Eckman, Peter 

P158 

Eckman, Peter M. 

P162 

Economou, Ddimitios 145 

Eddy, Steven 

P029 

Edelman, Kathy 

P037, P080 

Edwards, Christopher 

P231 

Edwards, P. 

P156 

Einstadter, Douglas 

P283 

El Jammal, Hani 

P378 

Elami, Amir 

P151 

Elgergawy, Dawood 

P083, P108 

Elkayam, Uri 90 

Ellis, Stephen J. 145 

Elser, Jeremy A. 

P052 

Enkeshafi, Ardalan 

P394 

Escandon, Rafael 

P219 

Essadiqi, Btissama 

P233 

Estep, Jerry D. 

P035, P062, P141 

Estes, N.A. Mark 39 

Evangelista, Lorraine S. 

P290, P342 

Everett, Bronwyn 

P410 

Ewald, Greg 145 

Ewald, Gregory A. 

P401, P412 

179

AUTHOR INDEX 

Ewy, Gordon A. 

P028 

Exner, Derek 

P199 

Ezekowitz, Justin A. 103 

Fain, Mindy 

P406 

Fang, James C. 96, 102, 150 

Farah, Jareer 

P308, P324, P336 

Farasat, S. Morteza 

P362 

Farber, Harrison W. 

P296 

Farooki, Sophia 

P306 

Farrar, David 

P144 

Fatemi, Sam 

P191 

Favro, David 

P291 

Fay, Justin C. 

P125 

Feaganes, John 

P203 

Fedewa, Michelle M. 

P386 

Feld, Yair 

P150, P151 

Feldman, Arthur M. 107 

Feldman, David 

P200 

Feldman, David S. 50 

Felker, G. Michael 47, 90, 145, P203, P207, P223, 

P243 

Felker, GM 

P215 

Fergus, Icilma V. 

P045 

Fernandez, Lynn T. 

P353 

Filippatos, G. 

P215 

Filippatos, Gerasimos 

P203, P223 

Fischer, Avi 

P190 

Fischkoff, Steven A. 

P220 

Fischman, Daniel 

P264 

Fishel, Robert 39 

Fitzgerald, Robert 

P110 

Fitz-Gibbon, Jennifer M. 

P074, P096 

Fitzpatrick, Ellen 

P110 

Fiuzat, Mona P244, P248, P284, P285, P299, 

P300 

Flamm, Scott D. 

P208 

Flanagan, Colleen 

P169 

Flather, Marcus 

P317 

Flattery, Maureen P. 144 

Florea, Viorel 

P407 

Flores-Arredondo, Jose 

P050 

Fonarow, G.C. 

P209, P210, P211 

Fonarow, Gregg C. 

32, 39, 51, 98, P234, P341 

Force, Thomas 34, 91 

Foreman, Aimee J. 

P296 

Foreman, Blair 39 

Forfia, Paul R. 

30, P179 

Forman, Daniel E. 

P311 

Fortuin, F. David 145 

180 

AUTHOR INDEX 

Foster, Elyse 39 

Francis, Gary S. 37, 51 

Frantz, Robert P. 147 

Franzen, Olaf 

P163 

Friedman, David P. 

P131 

Friedman, Joelle Y. 

P307 

Fujita, Kenji P. 

P112 

Fukuoka, Masahiro 

P118, P119, P134 

Funke, Birgit 

42, P130 

Furquim, Thyago A. 

P276 

Gaasch, William H. 

53, P092 

Gabrielson, Kathleen L. 43 

Galvao, Marie 

P064 

Gao, Erhe 44 

Garcia, Mario 

P024 

Gardin, Julius M. 151 

Gary, Rebecca A. 

P364 

Gattis Stough, W. 

P209, P210, P211 

Gattis Stough, Wendy 39 

Gauthier, Diane 

P392 

Gavazzi, A. 

P136 

Gayet, Enrique 

P184 

George, George 

P408 

Georgescu, Serban 

P122 

Georgiopoulou, Vasiliki V. 

P313, P314, P327, P338 

Gerdes, A. Martin 

P061 

Gerdes, Anthony M. 

P240 

Gerritse, Bart 

P200 

Gerstenblith, Gary 

P362 

Gette, I.F. 

P253 

Ghali, Jalal K. 

92, P308, P324, P336 

Gheorghiade, M. 

P209, P210, P211 

Gheorghiade, Mihai 39, 47, 152 

Ghio, Stefano 

P200 

Ghosh, Sudip 

P321 

Giamouzis, Grigorios 

P338 

Giannetti, Nadia 

P178, P306 

Giedrimiene, Dalia 

P397 

Gil, Helen R. 

P056 

Gilbert, Richard E. 

P120 

Gilliam, F. Roosevelt 

P401, P412 

Gilmet, Kenneth B. 

P073 

Giridharan, Guruprasad A. 

P165 

Girman, Cynthia J. 

P231 

Givertz, Michael M. 

40, 47, 102, P202, P237 

Gjestvang, Finn Tore 

P221 

Gliga, Brooke 

P031 

Glover, Charles 

P222 

Goh, Ping Ping 

P193, P274 

181

AUTHOR INDEX 

Goldman, Jonathan H. 

P213, P227 

Goldman, Steven 

105, P140 

Goldraich, Livia A. 

P103 

Goldsmith, S. 

P254 

Goldsmith, Steven R. 47 

Goldstein, D. 

P156 

Goldstein, Matthias 

P394 

Goldstein, S.L. 

P287 

Goldstein, Sidney 107 

Gomez, Luis 

P343 

Gonzalez-Stawinski, Gonzalo P158 

Gonzalez-Stawinski, Gonzalo V. P162 

Gonzalez-Stawinski, Gonzolo P144 

Goodlin, Sarah J. 148 

Goor, Daniel A. 

P224 

Gorcsan, III, John 35 

Gordon, Myrtle Y. 42 

Goruppi, Sandro 

P122 

Gosh, Bobby 

P391 

Gottlieb, Joshua D. 

P030 

Gottlieb, Stephen S. 

103, P030 

Gradman, Alan H. 33 

Graham, Jennifer 

P216 

Grancelli, Hugo 

P184 

Grandhi, Sree 

P413 

Granrud, Gregory 

P198 

Grant, Andrew 

P233 

Grant, Kathleen A. 

P131 

Grape, Jimmy 

P216 

Greco, Peter J. 

P283 

Greenberg, B. 

P215 

Greenberg, Barry H. 51, 106, P203, P207, P219, 

P223, P243 

Greenberg, Henry 39 

Grimm, Richard 

P083, P142, P158 

Grimm, Richard A. 

P047, P049, P143, P162 

Groban, Leanne 

P100, P247 

Grogan, Donna 

P046 

Grzesiak, Aleksandra 

P070 

Guerchi, Juan P. 

P184 

Guertin, Danette 

P182 

Guglin, Maya 

P180, P222, P225, P265 

Gujja, Karthik 

P197 

Gulati, Sanjeev K. 

P374, P402 

Gulyasy, Beth 

P037, P080 

Gundale, Abhijit 

P105 

Gurudevan, Swaminatha 

P318 

Gusmano, Joan 

P177 

Gustafsson, Finn 

P339 

182 

AUTHOR INDEX 

Gutterman, David D. 

P043, P044 

Haas, Garrie 39 

Hachiya, Hitoshi 

P354 

Haddad, Haissam 

P361 

Hager, David 

P245 

Hajjar, Roger 

P024 

Hajjar, Roger J. 94 

Hale, Ashley B. 43 

Haleem, Kamran 

P135 

Hall, Jennifer L. 100 

Hall, R. 

P357 

Hall, W. Jackson 39 

Halley, Carmel M. 

P058 

Halliday, Barbara L. 

P283 

Hamilton, Barbara 

P194, P344 

Hamilton, Craig A. 

P228 

Hamilton, Dale 

P062 

Hammill, Bradley G. 

P330 

Hammond, H. Kirk 94 

Handberg, Eileen 98 

Hanley-Yanez, Karen 

44, P171 

Hanna, Mazen 

P033 

Hansalia, Riple 

P190 

Haraguchi, Go 

P127, P148, P354 

Harders, Gerald E. 

42, P063, P091 

Hare, Joshua M. 48, 145 

Hari, Parameswaran 

P043, P044 

Haring, Bernhard 43 

Harkness, Karen I. 

41, P383 

Harrell, Tanya 

P187 

Harrington, Robert A. 92 

Harris, Michelle M. 

P381 

Harris, William S. 

P061 

Harshield, Gregory 

P082 

Hartlage, Gregory 

P265 

Hartley, Howard L. 

P311 

Hartmann, Anika 

P060, P070 

Hasegawa, Takuya 

P359 

Hashimura, Kazuhiko 

P159, P160, P359 

Hassager, Christian 

P084, P275 

Hatano, Masaru 

P076, P174 

Haude, Michael 

P229 

Hauptman, Paul J. 

45, 104, P301, P347 

Hayden, Ann 

P198 

Hayes, Cindi T. 

P395 

Hazen, Stanley L. 

P111 

He, Kun-Lun 

P067 

Heidenreich, Paul A. 

103, P320 

Heimann, Mark 

P040, P167 

183

AUTHOR INDEX 

Heinle, J.S. 

P287 

Heist, E. Kevin 

P042, P187 

Heitner, John F. 45 

Helmke, Stephen 

P056 

Henry, Timothy 145 

Heo, Seongkum 

41, P379, P405 

Hernandez, Adrian F. 106 

Heroux, Alain 

P170, P177 

Herre, John M. 

P155 

Hershberger, Ray E. 103 

Hertzog, Melody 

P329 

Herzog, Eyal 42 

Heublein, Denise 

P109, P273 

Heublein, Denise M. 

P093, P094, P113 

Heywood, J. Thomas 

39, 150, P072, P372 

Heywood, J.T. 

P209, P210, P211 

Higgins, Melinda 

P334, P364 

Higgins, Steve I. 39 

Hildebrandt, Per R. 

P339 

Hill, James A. 108 

Hill, Michael F. 

P031 

Hilpisch, Kathryn 

P085 

Hilwig, Ronald 

P028 

Hindes, Anna 

P125 

Hindoyan, Antreas 

P391 

Hirao, Kenzo 

P354 

Hirata, Yasunobu 

P076, P174 

Ho, Carolyn Y. 

42, 102, P130 

Hodge, David 

P109 

Hodoscek-Majc, L. 

P350 

Hogan, Christopher 

P345 

Homburger, Ann 

P266 

Honein, G. 

P357 

Hoppe, Bobbi 

P186 

Hoppe, Uta C. 

P229 

Hoque, Mohammad 

P293 

Horwich, Tamara B. 

108, P234 

Hourani, Patrick 

P185, P250, P252, P258, P259 

Houser, Steven R. 110 

Houston-Feenstra, Linda 

P403 

Howlett, Jonathan 

P361 

Howlett, Jonathan G. 44 

Huang, Ming-He 

P114 

Huang, Tsuey-Yuan 

P405 

Huda, Nazmul 

P293 

Huebert, Vince 

P029 

Hundley, William G. 

P131, P228 

Hunt, Sharon A. 45 

Huntley, Brenda 

P239 

184 

AUTHOR INDEX 

Huntley, Brenda K. 

42, P063, P102, P113, P116 

Hurley, James 

P192 

Hussain, Imad 

P313, P314, P327 

Hwang, Shiow-Li 

P405 

Iacovoni, A. 

P136 

Ichiki, Tomoko 

P091, P102, P113, P116 

Ignaszewski, Andrew 

P361 

Ilsar, Itamar 

P241 

IMAC Investigators 

P181, P310 

Insel, Jerald 

P394 

Ioannou, JoAnn Z. 

P400 

Iovanna, Juan 

P122 

Iruela-Arispe, Luisa 44 

Ishihara, Stephen 

P218 

Ishihara, Takashi 

P127, P148 

Ishikawa, San-e 

P104 

Ishizawar, David 

P171 

Ishizawar, David C. 44 

Ising, Michael S. 

P165 

Iskandrian, Ami E. 145 

Isobe, Mitsuaki 

P127, P148, P159, P160, P354 

Iyengar, M. 

P390 

Jaakkimainen, R.L. 

P357 

Jaarsma, Tiny 145 

Jaenicke, Connie 

P407 

Janko, Sabine 

P221 

Janosko, Karen 

P171 

Jansz, Peter 

P146 

Januzzi, James 

P082 

Januzzi, James L. 

102, P054, P055, P095 

Januzzi, Jr., James L. 

31, 49, 93, P332 

Jasti, Kishan 

P115 

Javaheri, Shahrokh 

P261 

Jaye, Deborah A. 

P235 

Jefferies, J.L. 

P287 

Jeric, Tina 

P328 

Jerosch-Herold, Michael 45 

Jessup, Jewell A. 

P100, P247 

Jessup, Mariell L. 

45, 99, P179 

Jia, Gang 

P112 

Jiang, Kevin 

P110 

Jiang, Wei 

P284, P300 

John, Ranjit 

P144 

Johnson, Allen D. 

P072 

Johnson, Bruce D. 

P074 

Johnson, Eric E. 

P194, P344 

Johnson, Johanna 

P307 

Johnson, Lauren 

P057 

Johnson, Maryl R. 

P099 

185

AUTHOR INDEX 

Johnson, Nicholle M. 

P140 

Johnson, Thomas H. 

P198 

Jones, Graham R.D. 

P358 

Jones, Hannah 

P400 

Jones, Paul W. 

P377 

Jong, Philip 

P305 

Jordan, Lee W. 

P393 

Jordan, Robert 

P220 

Jorde, Ulrich 

P144 

Joseph, Diane 145 

Joseph, Jacob 

P289 

Jougasaki, Michihisa 

P113 

Judge, Daniel P. 103 

Juneman, Elizabeth 

P140 

Jungklaus, Tamarah 

P280, P335, P355, P388, P399 

Jurgens, Corrine 104 

Jutzy, Kenneth 

P403 

Kaiser, Daniel R. 

P057 

Kajimoto, Katsuya 

P269 

Kajstura, Jan 48 

Kajunski, Christine 

P256 

Kalogeropoulos, Andreas P. 

P313, P314, P327, P338 

Kalra, Nishant 

P028, P226 

Kamalakkannan, G. 

P156 

Kamalakkannan, Gayathri 

P064 

Kandala, Jagdesh 

P331, P332, P340 

Kang, Peter M. 

P256 

Kantor, Paul F. 

P351 

Kanzaki, Hideaki 

P359 

Kao, Andrew 145 

Kao, David P. 

P263, P341 

Kapoor, Kapil 

P238 

Kapral, M. 

P357 

Kapuku, Gaston K. 

P082 

Kapur, Vishal 

P114 

Karayannis, Georgios 145 

Karia, Darshak H. 

P293 

Karkowsky, Abraham M. 90 

Karpawich, Peter P. 

P183 

Karunaratne, H.B. 

P395 

Kasper, Edward K. 

P362 

Kass, David A. 

33, 35, 43, 109, P246 

Katikaneni, Divya Saki 

P253 

Kathiresan, Sekar 52 

Kato, Mahoto 

102, P081, P202, P294, P311 

Kato, Tomoko S. 

P157, P159, P160 

Katra, Rodolphe 

P200 

Katra, Rodolphe P. 

P085 

Katz, Amos 

P221 

186 

AUTHOR INDEX 

Katz, Arnold M. 44 

Kaufman, Christopher L. 

P057, P204 

Kaushik, Saurabh 

P047 

Kawase, Yoshiaki 

P024 

Kaye, David M. 

P059 

Kayser, Torsten 

P172, P173 

Kazory, Amir 

P394 

Ke, Qingen 

P256 

Kelesidis, Iosif P185, P250, P252, P255, P258, 

P259 

Kella, Danesh 

P338 

Keller, Niels 

P339 

Kelly, Daniel P. 43, 54 

Kelly, Darren J. 

P120 

Kereiakis, Dean 145 

Kern, Karl B. 

P028 

Ketelslegers, Jean-Marie 

P305 

Khairallah, Ramzi J. 

P026 

Khakoo, Aarif 

P212 

Khalid, Fatima R. 

P045 

Khalid, M. Rizwan 

P045 

Khalil, Ahmad 

P035, P050 

Khan, Mutahir 

P079, P105, P197 

Khan, Tariq A. 

P072 

Khandhar, Sameer J. 

P037, P080 

Khaper, Neelam 

P134 

Khaykin, Yaariv 

P199 

Khera, A. 

P025, P154 

Khoo, Michelle 

P386 

Khoo, Michelle S.C. 

P189 

Khullar, P. 

P260 

Kiamouzis, Grigorios 145 

Kiljanek, Lukasz R. 

P309 

Kim, Elissa 

P075 

Kim, J.J. 

P287 

Kim, Jinshil 

P379 

Kim, Raymond J. 45 

Kimmel, Stephen E. 102 

Kinugawa, Koichiro 

P076, P174 

Kirklin, James K. 149 

Kirkpatrick, J. 

P025, P154 

Kirven, Justin 

P360 

Kitakaze, Masafumi 

P359 

Kitlinski, Mariusz 

P251 

Kitzman, Dalane W. 

103, 145, P228 

Kjaergaard, Jesper 

P084, P275 

Klada, Emile 

P108 

Klein, Helmut 39 

Klein, H. 

P136 

187

AUTHOR INDEX 

Kluger, Jeffrey 

P182 

Knutsen, Synove 

P403 

Kobayashi, Junjiro 

P157, P160 

Kober, Lars 

P084, P236, P275 

Koch, Bruce 

P248 

Koch, Walter J. 34, 37, 44, 102, 104 

Kocovic, Dusan Z. 

P040, P167 

Koelling, Todd M. 

151, P202 

Koenig, Steven C. 

P165 

Komamura, Kazuo 

P157 

Konishi, Masanori 

P127, P148 

Konstam, Marvin A. 45, 51 

Korinek, Josef 

42, 44, P063 

Kormos, Robert L. 

P171 

Korsun, Nikolai 

P191 

Koschyk, Dietmar 

P163 

Kosnik, Mitja 

P328 

Kostis, John B. 

P297 

Kostis, William J. 

P297 

Koval, C. 

P039 

Krantz, Mori 

P341 

Kraus, William E. 145 

Kreso, Elma 

P341 

Krishnamani, Rajan 

P153 

Krishnan, Ranga 

P284, P300 

Kritchevsky, Stephen B. 

P228 

Krum, Henry 41 

Krumholz, Harlan M. 103 

Kubo, Norifumi 

P104 

Kubo, Spencer H. 

P198 

Kucherlapati, Raju 

P130 

Kuchibhatla, Maragatha 

P284, P300 

Kuhn, Bernhard 

43, P024 

Kukin, Marrick 42 

Kumar, Praneet 

P086 

Kumar, Sanjay 

P047 

Kumarapeli, Asangi R. 

P034 

Kunavarapu, Chandra 

P408 

Kung, Thomas 

P188, P350 

Kuppahally, Suman S. 

P218 

Kuschyk, J. 

P136 

Kwiatkowski, Pawel 

P147 

Ky, Bonnie 

102, P101 

Kyo, Shunei 

P174 

Kyriakis, John 

P122 

Kyrlidis, Themistoklis 145 

Lacomis, Joan 

P036 

Ladage, Dennis 

P024 

LaFramboise, Louise 

P370 

188 

AUTHOR INDEX 

Lahr, Brian 

P273, P281 

Lai, Ling 43 

Lainchbury, John 

P054, P055 

Lainscak, Mitja 

P328, P350 

Lak, Lea 

P151 

Lakatta, Edward G. 

P238 

Lakdawala, Neal 

P081 

Lakdawala, Neal K. 

42, 102, P130, P294 

Lala, Moinakthar 

P197 

Lam, Carilyn S.P. 

P282 

Lam, Carolyn S.P. 42, P053, P161, P302, P348, 

P373 

Lancaster, Jordan J. 

P140 

Lanfear, David 

P149 

Lanfear, David E. 

43, P291 

Lang, Chim C. 

P304 

Langlois, Elizabeth 

P376 

Laramee, Ann S. 103 

Larionov, Petr 

P138 

Laskar, Sonjoy 

P338 

Laskar, Sonjoy R. 

P313, P314, P327 

Law, Catherine 

P222 

Lawhorn, Stephanie 

P266 

Lawler, Casey 

P360 

LeBlanc, Marie-Helene 

P361 

Lee, Christopher S. 

P369 

Lee, Jacqueline H. 

P213, P219 

Lee, Jae Y. 

P351 

Lee, Kyoung Suk 41 

Lee, Li-Yin 

P190 

Lee, Myung 

P325 

Lee, Richard T. 48 

Leier, Carl V. 

102, P032, P133 

Leinwand, Leslie A. 100 

Lemke, Bernd 

P173 

Leng, Xiaoyan 

P228 

Lenihan, Daniel J. 

91, 103, P212 

Lennie, Terry A. 

41, 98, P278, P303, P379, P405 

Leone, Teresa 43 

Leong, Gerard K.T. 

P193, P274 

Leon-Sanchez, Andres 

P378 

Lepage, Serge 

P233 

Leri, Annarosa 105 

Lesinski, Amanda K. 

P366 

Levy, Daniel E. 33 

Levy, Wayne 

P175 

Levy, Wayne C. 

108, P229 

LeWinter, Martin M. 

P087 

Lewis, Eldrin F. 

93, P294, P311, P312 

189

AUTHOR INDEX 

Leyton-Mange, Jordan S. 43 

Li, Guo Hua 

43, P134 

Li, Guohua 

P118 

Li, HongLiang 

P128 

Li, Hong-Liang 

P119 

Li, Meredith 

P118, P134 

Li, Yanhong 

P307 

Liang, Bruce T. 

P245 

Liao, Ronglih 101 

Libbus, Imad 

P217 

Licata, Giuseppe 

P322 

Lieu, H. 

P254 

Liggett, Stephen B. 52 

Lim, Benji Y.Z. 

P193 

Lim, Tiong K. 

P304 

Lima, Marcelo V. 

P380 

Lin, Grace 

45, P348 

Lin, Jiunn-Lee 

P085 

Lin, Lian-Yu 

P085 

Lin, Marina R. 

P100 

Lindenfeld, JoAnn 

40, 144, P244 

Lindsey, Sarah H. 

P247 

Ling, Zhenghong 43 

Lipperman, Michal 

P150 

Lisboa, Maria 

P397 

Little, W.C. 

P206 

Little, William C. 33 

Litwin, Sheldon E. 

P218 

Liu, Chen 

P119, P128 

Liu, Peter 

P134 

Liu, Peter P. 

43, 44, 53, P118, P119, P128 

Liu, Youan 

43, P119, P134 

Lobo Marquez, Lilia L. 

P270, P279 

Lockard, Kathy 

P171 

Loebe, Matthias 

P141 

Lok, Dirk J.A. 145 

Lopez-Candales, Angel 

P037, P080, P090 

Louback, Flavia 

P276 

Love, Thomas E. 

P272 

Lovett, Eric G. 

P204 

Lowery, Christopher M. 

P152 

Lukas, M.A. 

P390 

Lustgarten, Daniel 

P087 

Lymperopoulos, Anastasios 44 

Macarie, Cezar 

P097 

MacCarter, Dean 

P071 

MacCarter, Dean J. 

P073 

Macdonald, Peter 41 

Macdonald, Peter S. 

P358 

190 

AUTHOR INDEX 

Machen, Laurie 

P115 

Macheret, Fima 

P113, P273, P282 

Macin, Stella M. 

P316 

Mack, Sharon 

P349 

Macklin, Eric A. 

P187 

MacLellan, Robb 

P234 

MacRae, Calum A. 

P048, P132 

Maeder, Micha T. 

P059 

Maekawa, Yuichiro 43 

Magalski, Anthony 

P266 

Maglione, Theodore 

P168, P170 

Maglione, Theodore J. 

P177 

Mahoney, Douglas W. 

P093, P094 

Maisel, Alan 

P110 

Maisel, Alan S. 

49, P098, P345 

Maitland, Michael L. 91 

Makovey, Iryna 

P187 

Maldonado, Sebastian 

P343 

Malik, Fady 

P219, P227 

Malik, Fady I. 

P213 

Mammen, Pradeep P.A. 

P353 

Mancini, Donna M. 108 

Mangalat, Deepa 

P313, P314, P327 

Mann, Doulas L. 51, 146 

Mansoor, George A. 

P231 

Mansoor, Maryah 

P338 

Manyam, Harish 

P115 

Manyin, Chen 43 

Marbury, Thomas C. 

P214 

Margulies, Kenneth B. 

48, 99, P034, P052, P135 

Markenvard, John 

P339 

Markham, David 

P181 

Markham, David W. 

P201, P353 

Marley, Stephen B. 42 

Marrouche, Nassir F. 

P218 

Martin, David O. 

P038, P230 

Martin, Fernando 

P239, P281 

Martin, Fernando L. 

42, 44, P063, P091, P113 

Martins, Wolney A. 

P276 

Maska, Edlira 

P280, P335, P355, P388, P399 

Masood, Yasmin 

P087 

Massey, Mona 

P212 

Massie, B. 

P254 

Massie, Barry M. 

31, 36, 90, 150, P112 

Masutani, Satoshi 

P131 

Mather, Paul 

P181, P310 

Mather, Paul J. 

40, 102, P169 

Mathier, Michael A. 

30, 98, P036 

Matkovich, Scot J. 

P125 

191

AUTHOR INDEX 

Matsui, Takashi 

P027 

Matthews, Ray V. 

P232 

Maurer, Mathew 

P046 

Maurer, Mathew S. 

104, 150, P056, P067 

May, Christopher 

P294 

Maybaum, S. 

P156 

Maybaum, Simon 

P064, P145 

Mazhari, Reza 

P241, P246 

McBride, Mark L. 39 

McBride, M.L. 

P209, P210, P211 

McCann, Patrick 

P347 

McCarthy, Patrick M. 151 

McCarty, David 

P187 

McCauley, B. 

P025, P154 

McClure, C. 

P039 

McGee, Edward C. 

P144 

McGoon, Michael D. 

P296 

McGrew, Frank A. 

P194, P344 

McIntyre, Kevin 

P289 

Mckenzie, John 

P374 

McKenzie, John 

P402 

McKenzie, John P. 

P216 

McKie, Paul 

P239, P273, P281 

McKie, Paul M. 

42, P063, P091, P282 

McMurray, John J.V. 146 

McNally, Elizabeth M. 42, 52 

McNamara, Dennis 

P171 

McNamara, Dennis M. 

44, 45, P181, P201, P310 

McNeill, Ann Marie 

P231 

McRae, Scott 39 

McTiernan, Charles 

P171 

Medin, Jeffrey A. 43 

Medvedeva, S.U. 

P253 

Mehra, M. 

P209, P210, P211 

Mehra, Mandeep R. 39, 104, 152 

Mehta, Parag 

P108 

Mehurg, S. 

P039 

Meinertz, Thomas 

P163 

Melegari, Carrie 

P115 

Melton, Charles 

P192 

Menachery, Elizabeth P. 

P362 

Mercola, Mark 43 

Merkel Kraus, Stacia 

P038, P230 

Merkely, Bela 

P172, P173 

Merliss, Andrew 

P386 

Messerli, Franz H. 

P337 

Messineo, Frank C. 

P045 

Methvin, Amanda 

P313, P314, P327 

Metkus, Thomas S. 

P367 

192 

AUTHOR INDEX 

Metra, M. 

P215 

Metra, Marco 

P112, P203, P207, P223, P243 

Meyer, Donna 

P077 

Meyer, Donna M. 

P161 

Meyer, Philippe 

P292 

Meyer, Sven 

P163 

Meyer, Timothy E. 

P377 

Michael, Craig 

P371 

Middlekauff, Holly R. 

P234 

Migrino, Raymond Q. 

P043, P044 

Milani, Loredano 

P316 

Milano, Carmelo A. 96 

Milasinovic, G. 

P136 

Miller, Alan 

P404 

Miller, Alan B. 102 

Miller, Frederick C. 

P073 

Miller, Karen L. 43 

Miller, Keith 

P386 

Miller, Leslie W. 100 

Milli, Massimo 

P316 

Minami, Yuichiro 

P269 

Mirzoyev, Sultan A. 

P298 

Misgeld, Carola 

P188 

Mishra, Suchita 42 

Miske, Glen 

P167 

Mitchell, Judith E. 41 

Mitra, Robi D. 

P125 

Miyamoto, Shelley 

P126 

Mizue, Nobuo 43 

Mizuno, Kyoichi 

P269 

Mizuno, Masayuki 

P269 

Moens, An L. 43 

Mogulla, Vanajakshi 

P153 

Mohammad, Marwan M. 

P366 

Mohammed, Selma F. 

42, P077, P091, P161 

Mohler, Jane 

P406 

Molkentin, Jeffery D. 34, 54 

Momomura, Shin-ichi 

P104 

Mont I Girbau, Joseph L. 

P172, P173 

Montgomery, Janet W. 

P395 

Mookadam, Farouk 

P166 

Moon, Greg 

P232 

Moon, Mark S. 

P119, P128 

Moore, Jonni S. 

P034 

Moore, Sherry 

P266 

Moorer, Molly 

P397 

Morales, D.L. 

P287 

Moran, John J. 

P099 

Moreno, Jorge 

P050 

193

AUTHOR INDEX 

Moreyra, Abel E. 

P297 

Morgan, Jeffrey A. 

P149 

Mori, Naresh 

P195 

Moriguchi, Emilio 

P103 

Morley, Bruce 

P191 

Morrissey, Ryan 

P068, P318 

Moser, Debra K. 41, 45, P278, P303, P379, 

P384, P385, P405 

Mosley, Thomas H. 

P268 

Moss, Arthur J. 39 

Most, Patrick 94 

Mosto, Hugo 

P184 

Moughrabi, Samira 

P290 

Mouhayer, Elie 

P212 

Mountis, Maria 

P142, P158 

Movsesian, Matthew A. 109 

Mozaffarian, Dariush 152 

Mueller, Kelly 

P397 

Mujtaba, Tokir 

P079 

Mulcahy, J. 

P039 

Muller, David 

P271 

Mullikin, Amy 

P280, P335, P355, P388, P399 

Mulpuru, Siva 

P195 

Munakata, Ryo 

P269 

Murai, Koji 

P269 

Murali, Srinivas 

P115 

Murata, Yoshihiro 

P159, P160 

Murgatroyd, Francis 

P221 

Murphy, Elizabeth 100 

Murthy, Kinnari 

P293 

Murthy, S. 

P156 

Murthy, Sandhya 

P064 

Musco, Simone 

P167 

Mushtag, Aliya 

P141 

Muslin, Anthony J. 110 

Nader, Amjad 42 

Nagai, Ryozo 

P076, P174 

Nagashima, Michitaka 

P269 

Naghi, Jesse 

P068, P318 

Najjar, Samer S. 

P030, P362 

Naka, Yoshifumi 

P144 

Nakamura, Tomohiro 

P104 

Nakao, Tomoko 

P076 

Nakatani, Takeshi 

P157, P159, P160 

Naqvi, Tasneem Z. 

P068, P382 

Narayan, Sanjiv M. 46, 96 

Nardi, Christine 

P170 

Narula, Jagat 

P310 

Nastas, John 145 

194 

AUTHOR INDEX 

Neath, Sean-Xavier 

P345 

Nekrasova, Nataliya I. 

P041 

Nelson, Penny 

P126 

Nemeh, Hassan 

P149 

Nessler, Bohdan J. 

P251 

Nessler, Jadwiga M. 

P251 

Neutal, J. 

P254 

Neville, Amy 

P178 

Newton, Phillip J. 

41, P326, P410 

Nguyen, Viviane 

P306 

Ni, Hanyu 

P268 

Nian, Min 

P128 

Niazi, Imran K. 

P164 

Nichols III, Francis C. 

P348 

Nicklas, Barbara 

P228 

Niederman, Alan 145 

Nijjar, Prabhjot 

P293 

Nikolskaya, Alena 

P235 

Nishimura, Rick A. 

P302, P373 

Nishimura, Takashi 

P174 

Niu, Xiaulin 43 

Nogueira, Luciana S. 

P276 

Nohria, Anju 

103, P081, P202 

Norman, Joe 

P329 

Nowak, Richard 

P345 

Nunez, Anthony 

P162 

Nutter, Benjamin 

P384, P385 

Nye, Leah 

P111, P123 

Nyegaard, Mette 

P236 

O Kelly, Noel I. 

P321 

Obalampalli, Kalyan 

P216 

O’Bara, Lynn 

P397 

Ochiai, Marcelo E. 

P380 

O’Connell, Carol 

P289 

O’Connell, Timothy D. 

P061 

O’Connor, C. 

P209, P210, P211 

O’Connor, Christopher 

P248, P284, P285, P299, P300 

O’Connor, Christopher M. 37, 39, 92, 104, 145, P112, 

P307 

O’Connor, Erin 

P300 

Oda, Noboru 

P159, P160 

O’Driscoll, Gerry 

P146, P165 

Oehler, Elisa A. 

P161 

Oehler, Elise 

P077 

Oehler, Elise A. 

44, P091 

Ogston, Simon A. 

P304 

Ohara, Takahiro 

P359 

Ohigashi, Hirokazu 

P127, P148, P354 

Okonko, Darlington O. 42 

195

AUTHOR INDEX 

Oliveira, Leonardo P.J. 

P389, P411 

Oliveira, Lucia B. 

P276 

Ollerton, Richard 41 

Olmsted, Rhonda 

P386 

Olson, Eric N. 34 

Olson, Lyle J. 

P074, P096 

Olson, Timothy 

P239 

Olson, Timothy M. 

P093, P094 

Ommen, Steve R. 

P053, P302 

Ono, Minoru 

P174 

Onwuanyi, Anekwe 

P262 

Ordonez, Jordi 

P054, P055 

Orencole, Mary 

P187 

O’Rourke, Brian 54 

Orrego, Carlos 

P050, P062, P141 

Orrego, Carlos M. 

P035, P078 

O’Shea, Karen M. 

P026 

Otis, Nicholas J. 102 

Owen, Sandra 

P199 

Owens, A. 

P025, P154 

Owens, Douglas 145 

Owusu, Priscilla 

P245 

Packer, Milton 30, 107 

Packman, Jeff 

P046 

Pagani, Francis D. 

P144 

Page, Robert L. 

P333 

Pagnanelli, Robert A. 145 

Pai, Vinay 

P197 

Paland, Matthias 

P188 

Palardy, Maryse 

102, P081, P294 

Palka, Ilona 

P251 

Palma, Eugen 

P295 

Palus, Sandra 

P060, P070, P257 

Pang, Peter S. 144 

Papp, Mary Anne 

P402 

Parah, Joshua 

P057 

Parisis, Charalambos 145 

Parekh, Niraj V. 

P345 

Park, Myung H. 30, 147 

Park, Soon J. 99 

Parks, Kimberly A. 

P129 

Parra Moreno, Jaime 

P316 

Parrinello, Gaspare 

P322 

Parthasarathy, Sampath 

P147 

Pastori, Julio 

P184 

Pataraya, Svetlana A. 

P065 

Patel, Ankit A. 

P035 

Patel, Ayan R. 

P046 

Patel, Darshan 

P197 

196 

AUTHOR INDEX 

Patel, Minakshi 

P192 

Patel, Nilam 

P168 

Patel, Nilamkumar 

P177 

Patel, Parag C. 

P353 

Patel, Vinod 

P265 

Paterna, Salvatore 

P322 

Patlolla, Vishnu 

P153 

Patten, Richard 

P122 

Patterson, J. Herbert 98 

Paul, Sara C. 96 

Paulson, James F. 

P155 

Paulus, Walter J. 104 

Pauly, Daniel 

P181 

Pauly, Daniel F. 44 

Pauriah, Mahesh 

P304 

Pauwaa, Sunil 

P396 

Pavlovic-Surjancev, Biljana 

P168, P177 

Payne-Emerson, Heather 41 

Peacock, W. Franklin 

P345 

Pecini, Redi 

P084 

Pereira, Gelsomina A. 

P276 

Perna, Eduardo R. 

P270, P279, P316 

Perrone, Sergio V. 

P270, P279 

Peters, Ian 

P264 

Petersen, John 

P355 

Petersen, Morten 

P236 

Peterson, Brett J. 

P200 

Peterson, Edward L. 

P291 

Peterson, Leif 

P346 

Peterson, Michael 

P198 

Peterson, Pamela 

P263 

Pfeffer, Marc A. 39 

Pham, Duc Thinh 

P144 

Phan, Anita 

P242 

Philip, Binkley F. 

P366 

Phillips, Angela 

P147 

Piano, Mariann R. 41 

Picard, Michael 

P187 

Pierson, Natalie 

P169 

Piña, Ileana L. 

51, 103, P307 

Ping, Peipei 101 

Pinsky, Michael R. 

P036 

Pinto, Yigal 

P054, P055 

Pisano, Carol 

P396 

Pitt, Bertram 92 

Piwowarska, Wieslawa 

P251 

Pizarro, Rodolfo 

P343 

Pokushalov, Evgeniy 

P137, P138, P139 

Polisetty, Ravishankar 

P253 

197

AUTHOR INDEX 

Ponikowski, Piotr 

P112, P203, P207, P223, P243 

Poole, Kari 

P190 

Poole-Wilson, Philip A. 

42, P317 

Popovic, Zoran 

P083, P142 

Popovic, Zoran B. 

P049, P143 

Port, J. David 50 

Poulsen, Henrik E. 

P236 

Poveschenko, Olga 

P137 

Povsic, Thomas J. 145 

Poy, Carlos 

P270, P279 

Pozehl, Bunny 

P329, P356 

Pozuelo, Leo 

P384, P385 

Predescu, Dragos 

P351 

Preobrazhensky, Dmitry V. 

P041, P065 

Pressler, Susan J. 

41, P278, P379 

Price, J.F. 

P287 

Pritzker, Marc 

P175 

Prohorova, Darya 

P139 

Przepiorka, Elizabeth 

P170 

Puig, Raphael S. 

P380 

Pulimi, Sandeep 42 

Puntawagkoon, Chirapa 

P228 

Puntawangkoon, Chirapa 

P049, P143 

Putt, Mary E. 102 

Quinn, Christina 

P334, P364 

Quiroz, Rene 

P392 

Ra, Hong 

P293 

Raake, Philip W. 102 

Rabadi, Oday L. 

P291 

Rabinowitz, Joseph 94 

Radojevic, Joseph 

P397 

Raff, Heather 

P263 

Rafique, Asim 

P242 

Rafique, Asim M. 

P068, P318, P319, P382 

Rajagopalan, Navin 

P090 

Rajamanickam, Anitha 

P033 

Ramani, Ravi 

P171 

Rantsev, M.A. 

P253 

Rasmusson, Kismet D. 103 

Raspopovic, S. 

P136 

Rauchhaus, Matthias 

P188 

Reddy, Naveen C. 

P217 

Reddy, Vivek Y. 46 

Redetzke, Rebecca A. 

P240 

Redfield, M.M. 

P206 

Redfield, Margaret 

P281 

Redfield, Margaret M. 42, 103, P077, P091, P093, 

P094, P161, P282, P298, P373 

Redington, Andrew N. 

P351 

198 

AUTHOR INDEX 

Redwood, Charles S. 42 

Reed, Shelby D. 

P307 

Reeder, Don 

P388 

Reeder, Don N. 

P280, P399 

Reilly, Carolyn M. 

P364 

Ren, Shuxun 44 

Rengo, Giuseppe 44 

Reuter, David G. 

P229 

Reyes, Ana I. Morales 103 

Reynolds, Christopher C. 

P265 

Reynolds, D. 

39, P209, P210, P211 

Rhodes, Marc 

P408 

Ribeiro, Margarete D. 

P276 

Rich, Michael W. 

93, P272, P301, P347 

Richards, A. Mark 

P054, P055 

Richmond, Marc 

P176 

Riegel, Barbara 

104, P369 

Rivero, Jose M. 102 

Ro, Angela S. 

P413 

Robbins, Jeffrey 34, 101 

Roberts, II, Lyman J. 

P031 

Roberts, Rhonda 145 

Robinson, Brent 

P192 

Robinson, Paul 42 

Rockman, Howard A. 34 

Rodeheffer, Richard 

P273, P281 

Rodeheffer, Richard J. 

P093, P094, P282 

Rodgers, Jo Ellen 96 

Rogers, Joseph 

P285, P299 

Rogers, Joseph G. 99, 147 

Roghton, Michael 

P317 

Rohde, Luis E. 

P103, P117 

Rojas, N. 

P260 

Rolstad, Julie 

P266 

Romanov, Alexander 

P137, P138, P139 

Rooke, Ryan 

P191 

Rosamond, Wayne D. 

P268 

Rose, Beth 44 

Rosen, Lior 

P150 

Rosenberg, Stuart P. 

P042, P164 

Rosenzweig, Anthony 

94, P027 

Ross, Robert S. 110 

Rossano, J.W. 

P287 

Rothman, Steven 

P040, P167 

Rotman, Stacey 

P400 

Rotzak, Renee 

P224 

Rousseau, Michel F. 

P305 

Rovithis, Dimitrios 145 

Rozenman, Yoseph 

P224 

199

AUTHOR INDEX 

Rubenson, David 

P072 

Ruberg, Frederick L. 

P046 

Rubin, Sharon 

148, P169 

Ruiz-Lozano, Pilar 43 

Rush, Pam 

P360 

Ruskin, Jeremy N. 

P187 

Russell, Stuart D. 

144, P038, P144, P268, P400 

Ryder, Mary 146 

Ryno, Pamela K. 

P161 

Ryu, Kyungmoo 

P042, P164 

Sabbah, Hani N. 

43, P241 

Sabbah, Michael S. 

P241 

Sada, Masaharu 

P159 

Sadoshima, Junichi 101 

Safa, Radwan N. 102 

Safirstein, Jordan G. 

P413 

Sahay, Anju 

P320 

Sai-Sudhakar, Chittoor 

P147 

Saikali, Khalil G. 

P213, P219, P227 

Salamonson, Yenna 

P410 

Saltzberg, Mitchell T. 

P315 

Saltzburg, Mitchell 

P110 

Salvaro, Roberto 

P117 

Sam, Flora 

P325, P392 

Sambandam, Nanda 43 

Sambelashvili, Aleksandre 

P199 

Samdarshi, Tandaw 

P268 

Samoukovic, Gordan 

P178 

Sanagala, Thriveni 

P168, P170, P177 

Sanchez, Monica 

P089 

Sandberg, Sharon 

P109, P273 

Sanders, Paul W. 

P272 

Sangaralingham, S. Jeson 

42, 44, P077, P091, P102, P113 

Santos, Katia G. 

P103, P117 

Sanzo, A. 

P136 

Saporito, Joseph 

P192 

Sapp, John 

P199 

Sarc, Irena 

P328 

Saric, Muhamed 

P089 

Sarkar, Shantanu 39 

Sarswat, Nitasha 

P107, P145, P255, P277 

Sasaoka, Taro 

P159, P160 

Sata, Yusuke 

P157 

Sato, Naoki 

P269 

Satya, Kumar 

P089 

Sauer, William 

P386 

Sauer, William H. 

P152, P189 

Sawyer, Douglas B. 91, 102 

Saxon, Leslie A. 

45, P232, P377, P391 

200 

AUTHOR INDEX 

Schatz, Richard 145 

Schefold, Joerg C. 

P350 

Scheller, Vandhana 

P375 

Schick, Edgar C. 

P092 

Schilling, Joel D. 43 

Schirger, John A. 

44, P109, P113 

Schlundt, Brittany 

P043, P044 

Schmalfuss, Carsten 

P280, P335, P355, P388, P399 

Schocken, Douglas D. 103, 104 

Schofer, Joachim 

P229 

Schofield, Richard 

P335, P355, P388 

Schofield, Richard S. 

P280, P399 

Schone, A. 

P136 

Schou, Morten 

P339 

Schrier, Robert W. 36 

Schulman, Kevin A. 

P307, P330 

Schumacher, Jayne 

P245 

Schwab, Joerg 

P221 

Schwammenthal, Ehud 

P151 

Schwartz, Alan 

P030 

Schwartz, David A. 37 

Schwartz, P.J. 

P136 

Scimia, Maria Cecilia 43 

Scott, Jonathon 

P371 

Scott, Robert L. 

P166 

Sebro, Nadew S. 

P155 

Seidman, Christine E. 

42, P027, P130 

Seidman, J.G. 

42, P027, P130 

Semigran, Hannah L. 

P048 

Semigran, Marc 

P187 

Semigran, Marc J. 

147, P129 

Seo, Yaewon 

P370 

Serra, Michael 

P376 

Serrano, Sergio 

P050 

Seth, Milan 

P029, P377 

Sethares, Kristen A. 

P288 

Setoguchi, Soko 

P294 

Setser, Randolph M. 

P208 

Settles, Sharon J. 

P307 

Shaburishvili, Tamaz 

P219 

Shah, Ankit 

P352 

Shah, Dipan J. 

P035 

Shah, Kevin 

P110 

Shah, Ravi 

102, P095 

Shah, Ravi V. 

P054, P055, P237 

Shah, Sanjiv J. 

P352 

Shahabi, Nooshin 

P216 

Shahar, Eyal 

P268 

Shan, Xiaoyin 

P135 

201

AUTHOR INDEX 

Shanmugasundaram, Madhan 

P406 

Shapiro, Scott 

P024 

Sharma, G.V.R.K. 

P289 

Sharma, Gyan 

P408 

Sharma, Hari O.M. 42 

Sharma, V. 

P260 

Shatzkes, Joseph A. 

P056 

Shaw, Linda K. 145 

Shaw, Peter 

P392 

Shay, Dubi 

P150 

Shearer, Gregory 

P061 

Sheppard, Richard 

44, P181 

Sherman, Warren 145 

Shetty, Veena 

P362 

Sheu, Shey-Shing 54 

Shi, Yu 

43, P118, P119, P134 

Shiga, Taro 

P076, P174 

Shih, Jeffrey 

P313, P314, P327 

Shin, J. Julia 

P064 

Shin, Jordan T. 

P048, P132 

Shinbane, Jerold S. 

P232, P391 

Shishido, Toshiaki 

P159, P160 

Shmilovitch, Micahl 

P151 

Shofti, Rona 

P151 

Shore, Elizabeth 

P169 

Shroff, Sanjeev G. 

P036 

Sica, Domenic 

P220 

Sidorenko, Boris A. 

P065 

Siegel, Robert J. 

P068, P318, P319 

Sigg, Daniel C. 

P235 

Silva, Alvin C. 

P166 

Silvello, Daiane 

P103, P117 

Silver, Marc 

P396 

Silver, Marc A. 146, 150 

Silvestry, Scott 

P169 

Simari, Robert D. 

42, P077 

Siminiak, Tomasz 

P229 

Simon, Marc 

P171 

Simon, Marc A. 

P036, P090 

Sims, James J. 

P192, P194, P344 

Sims, Jason 

P402 

Singh, Jagmeet P. 

P042, P187 

Singh, Kabir 

P098, P345 

Singh, Manpreet 42 

Singh, Rakesh K. 

P176 

Siwik, Deborah 

P124 

Sksoularigis, John 145 

Slaughter, Mark S. 

99, P165 

Slorach, Cameron 

P351 

202 

AUTHOR INDEX 

Slusser, Josh 

P109 

Slusser, Joshua P. 

P093, P094 

Smart, Frank 

P376 

Smid, J. 

P136 

Smith, Andrew 

P364 

Smith, Andrew L. 

P313, P314, P327, P338 

Smith, Cheryl 

P149 

Smith, E.O. 

P287 

Smith, Gareth 

P351 

Smith, Judith 

P321 

Smith, Micheal R. 

P072 

Smith, Qiana 

P064 

Smith, Rochelle 

P349 

Smithies, Oliver 34 

Snell, Jay R. 

P191 

Snell, Jeffery D. 

P191 

Sobus, Rebecca 

P126 

Sokos, George 

P115 

Solomon, Scott D. 31, 45 

Somers, Virend K. 

P096 

Song, Eun Kyeung 

41, P379 

Sonoda, Makoto 

P076 

Sood, Nitesh 

P075 

Sorajja, Paul 

P053, P302, P373 

Sorrell, Vincent L. 

P028, P226 

Soucier, Richard 

P075, P398 

Souza, Renata T. 

P276 

Sparks, Elizabeth 42 

Spencer, Anne P. 

P333 

Spencer, Richard 145 

Spertus, John 

P284 

Spertus, John A. 108 

Spevack, D. 

P156 

Spinale, F. 

P039 

Spinale, Francis G. 53 

Splett, Vincent 

P085 

Springer, Jochen 

P060, P070, P257 

Srivastava, Deepak 50 

Srivatsa, Uma 

P186 

St. John Sutton, M. 

P025, P154 

Stamler, Jonathan 109 

Staniloae, Cezar 

P413 

Stanley, William C. 

104, 152, P026 

Starling, Randall 

P142, P158 

Starling, Randall C. 40, 145, P143, P144, P162, 

P181, P201 

Statz, Cara 

P397 

Stauffer, Brian 

P126 

Stecher, Scott 

P214 

203

AUTHOR INDEX 

Steenbergen, Charles J. 100 

Stees, Christopher S. 

P189 

Steidley, D. Eric 

P166 

Steingart, Richard M. 91 

Stevenson, Lynne W. 

102, P081, P294, P311 

Stevenson, Lynne Warner 39, 96, 103 

Stevenson, William G. 46 

Stockinger, Jochem 

P172 

Stolen, Kira Q. 

P038, P230 

Stone, James R. 

P129 

Storlie, Jimmy 

P077 

Storlie, Jimmy R. 

P161 

Stroud, R. 

P039 

Strueber, Martin 

P146 

Strugnell, Steve 

P256 

Struthers, Allan D. 

P304 

Subramanian, Devika 110 

Sucharov, Carmen 

P126 

Sullivan, Mark D. 148 

Sun, Benjamin 

P147 

Sun, Benjamin C. 99 

Sun, Mei 

P119, P134 

Sun, Ying 

P066, P069 

Suskovic, Stanislav 

P328 

Sussman, Mark A. 110 

Suzuki, Jun-ichi 

P148 

Swan, Suzanne K. 

P214 

Swedberg, Karl 107 

Sweeney, Robert J. 

P401, P412 

Sweitzer, Nancy K. 

45, 102, P099 

Swindle, Jason 

P301, P347 

Szalai, Alexander J. 

P118 

Taasig, Andrew 145 

Tabtabai, Sara 

P398 

Tada, Yuko 

P104 

Taepke, Robert T. 

P365 

Taft, Shannon N. 

P409 

Takamoto, Shinichi 

P174 

Takano, Teruo 

P269 

Talan, Mark I. 

P238 

Talati, Sapan N. 

P195 

Talysina, Irina V. 

P041, P065 

Tamez, Daniel 

P165 

Tan, Kee Tung 

P193 

Tan, Kenneth B.K. 

P193 

Tan, Vern Hsen 

P193 

Tanaka, Keiji 

P269 

Tang, W.H. Wilson 49, P058, P086, P111, P123, 

P142, P143, P158, P162, P389, 

204 

AUTHOR INDEX 

P411 

Tassisa, Gudaye 

P285, P299 

Tate, Janet 

P245 

Taub, Pam R. 

P110 

Taylor, Christopher 

P371 

Teerlink, J.R. 

P215 

Teerlink, John R. 90, 148, P203, P207, P213, 

P223, P227, P243 

Tehrani, Faramarz 

P242 

Teichman, S.L. 

P215 

Teichman, Sam L. 

P203, P207, P223, P243 

Teisanu, Gilda 

P097 

Tejani, Shezad 

P118 

Tentori, Cristina 

P184 

Ter-Galstanyan, Alvina 

P290, P342 

Teruya, Sergio L. 

P056 

Testani, J. 

P025, P154 

Teuteberg, Jeffrey J. 

P171 

Thadhani, Ravi 

P256 

Thai, Hoang M. 

P140 

Thai, Kerri 

P120 

Thohan, Vinay 

P181, P386 

Thomas, James 

P123, P142 

Thomas, James D. 

P049, P143 

Thomas, Patrick 

P082 

Thompson, Brenda S. 

P353 

Thompson, Joseph J. 

P066, P069 

Thompson, S. 

P039 

Thune, Jens Jakob 

P084, P275 

Tian, Rong 54 

Ticho, Barry 

P214 

Tilton, Bryan 

P190 

Timmons, Mitchell 

P044 

Tita, Cristina 

P149 

Toledo, Gloria B. 39 

Tolstrup, Kirsten 

P068, P318, P319 

Tong, Kathleen L. 

P186 

Toole, John M. 

P066, P069 

Topkara, Veli K. 

P323 

Tormey, Deborah 42 

Torp-Pedersen, Christian 

P084, P236, P275 

Torre, Guillermo A. 

P035 

Torre-Amione, Guillermo P050, P062, P078, P141, P201, 

P310 

Torres, Alejandro 

P176 

Torres, Alessia 

P322 

Torres, Daniele 

P322 

Toto, Kathleen H. 45 

Tran, Kim 

P098 

205

AUTHOR INDEX 

Tran, Kimberly 

P110 

Trapanese, Caterina 

P322 

Triposkiadis, Filippos 145 

Truran, Seth 

P043, P044 

Tsaknakis, Themistoklis 145 

Tubishevitz, Amit 

P150 

Tunin, Richard S. 

P246 

Uber, Patricia A. 103, 104 

Udelson, James E. 36, 145 

Ueda, Hatsue 

P157 

Ueda, Hatsue I. 

P159 

Uju-Eke, Oluchi 

P291 

Underwood, Dent R. 

P198 

Unemori, E. 

P215 

Unemori, Elaine 

P203, P207 

Upadhyay, Gaurav 

P187 

Usmani, Ali 

P033 

Uthamalingam, Shanmugam 

P331, P332, P340 

Vaishnava, Prashant 

P312 

Vallania, Francesco M.L. 

P125 

Valle, Roberto 

P316 

Van Bakel, Adrian B. 

P333 

van Bommel, Rutger 35 

Van Booven, Derek J. 

P125 

van der Meer, Peter 145 

van der Walt, Christelle 

P096 

van Kimmenade, Roland 

P054, P055 

Van Mieghem, Walter 

P305 

van Rooij, Eva 50 

van Veldhuisen, Dirk J. 

P317 

van Veldhuisen, Dirk Jan 145 

Van Wagoner, David R. 152 

Van Why, Carolyn J. 

P169 

VanBuren, Peter 

P087 

Vardeny, Orly 

P099 

Varma, Niraj 

P196 

Varughese, Christopher 

P250, P252, P255, P259 

Varughese, Christopher J. 

P185, P258 

Vasavada,, Balendu 

P197 

Vasavada, Balendu C. 

P079, P105, P195 

Vatterot, Pierce J. 

P198 

Veenstra, Robert 

P397 

Velazquez, Eric J. 45, 149 

Velho, Fabio M. 

P117 

Vemuri, Srinath 

P337 

Vemuri, Srinath S. 

P323 

Ventura, Hector O. 39, 152 

Verga, Tanya 

P389, P411 

Verhaert, David 

P049, P142, P143 

206 

AUTHOR INDEX 

Verma, Subodh 

P118 

Videaek, Lars 

P339 

Vido, Diane 

P115 

Vieira, Kelly R. 

P380 

Vincent, Julie 

P176 

Vishinskaya, Irina D. 

P065 

Vittorio, Timothy J. 

P107, P145 

von Haehling, Stephan 

P188, P257, P317, P328, P350 

von Harsdorf, Ruediger 

P060 

Vongooru, Haree 

P175 

Voors, A. 

P215 

Voors, Adriaan A. 

145, P207, P223, P243 

Voors, Adrian A. 

P203 

Voskoboynikov, Neil 

P165 

Vulcano, Norberto 

P343 

Vyshinskaya, Irina D. 

P041 

Wagenknecht, Lynne E. 

P268 

Wagner, Judy 

P407 

Wald, Joyce W. 

P179 

Wali, R. 

P390 

Walker, Ann 

P329 

Walsh, Kenneth 

P026 

Walsh, M.N. 

P209, P210, P211 

Walsh, Mary N. 39, 40 

Wanahita, Nikolas 

P105 

Wang, Alice 

P241 

Wang, Andrew 151 

Wang, Dajun 

P061 

Wang, Derek 

P118 

Wang, Heng 

P111, P123 

Wang, Jie 

P067 

Wang, Lin 

P413 

Wang, Mengjun 

P241 

Wang, Xiaoxia 

P134 

Wang, Yibin 44, 101 

Wang, Yih-Chih 

P085 

Wang, ZhiZhang 

P031 

Washko, Daniel 

P132 

Watanabe, Masataka 

P359 

Watkins, Hugh 42 

Weatherley, Beth D. 

P203, P223 

Webb, Marjorie 

P198 

Weinberger, Howard 

P189 

Wencker, Detlef 

P245, P397 

Wendel, Christopher 

P406 

Wexler, Laura F. 45, 146 

Wexler, Randy 

P371 

Whalen, Deborah 

P392 

Whellan, David 

P169 

207

AUTHOR INDEX 

Whellan, David J. 

92, 145, 149, P307, P330 

White, Michel 

P292 

Wiegers, S. 

P025, P154 

Wieselthaler, George 

P146 

Wilber, David 39 

Wilber, Loretta J. 

P286 

Wilcox, Jane E. 

P352 

Wilkoff, Bruce 

P049 

Wilkoff, Bruce L. 

46, P143, P162, P411 

Williams, Celeste 

P149 

Williams, Keith 

P216 

Williams, L. Keoki 

P291 

Williams, Mathew 

P176 

Winchester, Mark A. 96 

Wingate, Suzanne J. 148 

Winsor-Dorough, Donna L. 

P395 

Wisnieski, Derek R. 

P036 

Witteles, Ronald 104 

Wittstein, Ilan 

P201, P310 

Wold, Nicholas D. 

P172, P173 

Wolf, Matthew J. 48 

Wolfe, Christopher 

P179 

Wolff, Andrew A. 

P213, P219, P227 

Wong, Aaron K.F. 

P304 

Wong, Cyrus 

P277 

Woods, Patricia 

P289 

Wright, Jennifer 

P177 

Wright, Jennifer M. 

P168 

Wu, Alan 

P101, P345 

Wu, David 

P291 

Wu, Jia-Rong 

41, P278, P405 

Wu, Joseph 105 

Wu, Sean M. 105 

Xiao, Yong-Fu 

P235 

Xin, Baozhong 

P111, P123 

Yamada, Gregg 

P386 

Yamamoto, Suguru 

P159 

Yan, Chen 109 

Yanase, Masanobu 

P160 

Yanase, Noboru 

P159 

Yancy, C.W. 

P209, P210, P211 

Yancy, Clyde W. 

36, 39, 107, P353 

Yang, Michael 

P042, P164 

Yang, Ronghua 43 

Yang, Yingbo 

P186 

Yao, Atsushi 

P076, P174 

Yeo, Poh Shuan Daniel 

P058 

Yokoyama, Hiroyuki 

P359 

Youker, Keith 

P035 

208 

AUTHOR INDEX 

Youker, Keith A. 

P050, P062 

Young, James B. 149 

Yu, A. 

P025, P154 

Yu, Chih-Chieh 

P085 

Zabel, M. 

P136 

Zaeem, Faisal 

P182, P397 

Zafar, F. 

P287 

Zakir, Ramzan 

P089 

Zalawadiya, Sandip 

P308, P324, P336 

Zareba, Wojciech 39 

Zehtabchi, S. 

P260 

Zenker, Dieter 

P221 

Zhang, Liyong 

P119 

Zhang, Yi 

P172, P173 

Zhu, Ying 

P214 

Ziherl, Kristina 

P328 

Zilberman, Mark V. 

P183 

Zile, M. 

P039 

Zile, M.R. 

P206 

Zile, Michael R. 53 

Zmily, Hammam D. 

P308, P324, P336 

Zolty, R. 

P156 

Zolty, Ronald P107, P145, P185, P250, P252, 

P255, P258, P259, P277, P295 

Zucker, Mark 

P310 

Zucker, Mark J. 

P201 

Zuker, Mark 

P181 

Zymek, Pawel T. 

P090 

209

hynes Convention Center 

hynes Convention Center 

Second Level 

Third Level 

Registration Entrance 

210 

211

Download - Heart Failure Society of America

Create successful ePaper yourself

Delete template?

Save as template?